???global.info.a_carregar???
Identification

Personal identification

Full name
Jens Juul Holst

Citation names

  • Holst, Jens

Author identifiers

Ciência ID
081E-4844-A3E3
ORCID iD
0000-0001-6853-3805
Education
Degree Classification
1978
Concluded
 Doctor of Medical Sciences, (Docteur)
University of Copenhagen,, Denmark
1970
Concluded
 Jens Juul Holst (Master)
Major in Master in Medical Sciences, Graduation from Medical School, University of Copenhagen
University of Copenhagen,, Denmark
Affiliation

Positions / Appointments

Category
Host institution 		Employer
1996 - Current Full Professor of Medical Physiology University of Copenhagen BMI, Denmark
2007 - 2018 Vice chairman Dept. Biomedical Sciences Kobenhavns Universitet Panum Instituttet, Denmark
1989 - 1996 Professor of physiology (docent), Dept. Medical Physiology Kobenhavns Universitet Panum Instituttet, Denmark
Københavns Universitet, Denmark

Others

Category
Host institution 		Employer
2010 - Current Scientific Director/Senior Group Leader Kobenhavns Universitet Novo Nordisk Fondens Center for Grundlæggende Metabolisk Forskning, Denmark
Kobenhavns Universitet Novo Nordisk Fondens Center for Grundlæggende Metabolisk Forskning, Denmark
1996 - Current Member of the Royal Danish Academy of Science and Letters. Kongelige Danske Videnskabernes Selskab, Denmark
Kongelige Danske Videnskabernes Selskab, Denmark
1993 - Current Member of the Danish Academy for Natural Sciences. Aarhus Universitet, Denmark
Aarhus Universitet, Denmark
2007 - 2018 Vice chairman Dept. Biomedical Sciences, University of Copenhagen Kobenhavns Universitet Panum Instituttet, Denmark
University of Copenhagen BMI, Denmark
1991 - 1996 Research professor by appointment the Danish Medical Research Council. Danmarks Frie Forskningsfond, Denmark
Danmarks Frie Forskningsfond, Denmark
1978 - 1989 Associate professor, Dept. Medical Physiology, UCPH Kobenhavns Universitet Panum Instituttet, Denmark
1972 - 1988 Surgeon at the Emergency Ward Bispebjerg Hospital, Denmark
1977 - 1978 Assistant professor, Dept. Medical Physiology C, Kobenhavns Universitet Panum Instituttet, Denmark
1976 - 1977 Senior research fellow, Dept. Clinical Chemistry Bispebjerg Hospital, Denmark
1975 - 1976 Research fellow, Dept. Clinical Chemistry Bispebjerg Hospital, Denmark
1971 - 1975 Research assistant, Dept. Surgery A Bispebjerg Hospital, Denmark
1970 - 1972 Training in surgery Bispebjerg Hospital, Denmark
Outputs

Publications

Book chapter
  1. Sten Madsbad; Jens Juul Holst. "Treatment with GLP-1 Receptor Agonists". edited by E Bonora; R DeFronzo. Springer, 2018.
    10.1007/978-3-319-27317-4_20-1
  2. Wolfgang Langhans; Jens Juul Holst. "Afferent Endocrine Control of Eating". edited by Dickson, {Suzanne L., 24-54. Wiley-Blackwell, 2016.
    10.1002/9781118839317.ch2
  3. Jens Juul Holst. "Incretin hormones as a target for therapy". edited by Stephen Gough, 11-30. Springer, 2016.
    10.1007/978-3-319-08982-9_2
  4. Jens Juul Holst; Carolyn Deacon; Bolette Hartmann; Jens Pedersen. "Glucagon-like peptides 1 and 2, enteroglucagon, glicentin and oxyntomodulin". edited by AJ Kastin, 1241-1250. Elsevier, 2013.
  5. Tina Vilsbøll; Jens Juul Holst. "Inkretiner". edited by Jannik Hilsted; Knut Borch-Johnsen; Christiansen, {Jens Sandahl, 67-74. Munksgaard, 2011.
  6. Erik Hviid Larsen; Jens Juul Holst. "Insulinets vej ind i det danske samfund". edited by Nielsen, {Marita Akh{\o, 85-94. Det Kongelige Danske Videnskabernes Selskab, 2010.
  7. Tina Vilsbøll; Filip Krag Knop; Carolyn Deacon; Jens Juul Holst. "Incretin hormones and diabetes mellitus". edited by Stehouwer, {Coen D.A., 99-114. Clinical Publishing, 2009.
  8. Jens Juul Holst; A. Kastin. "Glucagon-like peptides 1 and 2, enteroglucagon, glicentin and oxyntomodulin.". 1057-1064. Elsevier, 2006.
  9. Jens Juul Holst; T. Hughes. "Incretin mimetics in the treatment of type 2 diabetes mellitus". 17-19. Touch Briefings, 2006.
  10. Cathrine Ørskov; Jens Juul Holst. "Neurogenic nitric oxide and exocrine secretion in the gastrointestinal tract". 131-131. Portland Press Ltd., 2000.
  11. Jens Juul Holst. "Regulatory peptides of the gastrointestinal tract". 96-115. Small Bowel Disorders, 2000.
  12. Jens Juul Holst. "Nutrients of animal origin and function of gut hormones". 13-22. Elsevier, 1998.
  13. Jens Juul Holst. "Regulatory Peptides of the Gut". Kluwer Academic Publishers, 1998.
  14. M.A. Nauck; W. Schepp; Jens Juul Holst; W.H. Schmiegel. "Effects of GLP-1 on gastric and pancreatic exocrine secretion and on gastrointestinal motility.". 194-206. Karger, 1997.
  15. Jens Juul Holst; C. Ørskov; Bolette Hartmann; Carolyn Deacon. "Posttranslational processing of proglucagon and postsecretory fate of proglucagon products.". 24-48. Karger, 1997.
  16. C. Ørskov; Jens Juul Holst. "Secretion and effects of glucagon-like peptide-1 (GLP-1) in healthy volunteers and NIDDM subjects.". 513-516. Elsevier Sci. Intl. Congress Series 1100, 1995.
  17. Jens Juul Holst. "Human Glucagon-like peptide-1, - six important topics.". 537-546. Kluwer Academic Publishers, 1995.
  18. P. Layer; M. v d Ohe; Jens Juul Holst. "Postprandial glucagon-like peptide-1 (GLP-1) release in states of normal and disturbed luminal nutrient digestion.". 547-550. Kluwer Academic Publishers, 1995.
  19. Jens Juul Holst; Cathrine Ørskov. "Glucagon and other proglucagon-derived peptides". 305-340. Raven Press, 1994.
  20. Jens Juul Holst. "Isolated organs as replacements for vertebrate animals". 397-408. CRC Press, 1994.
  21. Jens Juul Holst; P. Schmidt. "Gut hormones and intestinal function". 137-164. Bailliere, 1994.
  22. A. Raben; H.B. Andersen; N.J. Christensen; J. Madsen; Jens Juul Holst; A. Astrup. "Postprandial lipid oxidation reduced and carbohydrate oxidation increased in postobese subjects". 135-137. John Libbey, 1994.
  23. Jens Juul Holst. "Neuromediators in the control of pancreatic secretion". 72-78. Polish Physiological Society, 1993.
  24. Jens Juul Holst; T. Nørre Ramussen; P. Schmidt; S.S. Poulsen. "Transmitters in the control of gastrin and acid secretion in the pig stomach". 243-258. Raven Press, 1993.
  25. G.E. Holle; I. Demir; J. Dietl; J.F. Rehfeld; Jens Juul Holst. "Effect of chemical myenteric ablation on the structure proliferation and endocrine cells in the small intestinal mucosa". Aspen Publishers, 1992.
  26. Jens Juul Holst. "Role of classical and peptidergic neurotransmitters in insulin secretion". Portland Press, 1991.
  27. Jens Juul Holst. "Chap.10. Degradation of glucagons". 167-180. CRC Press, 1991.
  28. Jens Juul Holst; Cathrine Ørskov; Maurizio Bersani. "7 Heterogeneity of Islet Hormones". 125-152. Raven Press, 1991.
  29. Jens Juul Holst. "10.Differences in the control of somatostatin release from antrum and fundus". 139-149. Aspen Publishers, 1991.
Conference abstract
  1. K. K. B. Clemmensen; M. B. Blond; H. Amadid; L. Bruhn; D. Vistisen; K. Karstoft; F. Persson; et al. "Are interventions with dapagliflozin, metformin and exercise associated with changes in plasma glucagon concentrations in individuals with prediabetes? The PRE-D trial". 2020.
  2. S. M. N. Heimbuerger; B. Hoe; C. N. Nielsen; N. C. Bergmann; Bolette Hartmann; Jens Juul Holst; J. Størling; et al. "Six-day subcutaneous GIP infusion increases glycaemic time in range in patients with type 1 diabetes". 2020.
  3. A. Andersen; P. G. Jorgensen; J. I. Bagger; M. P. A. Baldassarre; M. Christensen; K. U. Abelin; J. Faber; et al. "The impact of acute glycaemic fluctuations on left ventricular systolic function in insulin-treated type 2 diabetes". 2020.
  4. M. Mose; N. Moller; N. Jessen; U. R. Mikkelsen; B. Christensen; E. Raakvaag; Jens Juul Holst; J. L. Jørgensen; N. Rittig. "Metabolic effects of beta-lactoglobulin, casein and whey supplementations during controlled catabolic inflammation in humans". 2020.
  5. B. Hoe; S. M. N. Heimburger; Lærke Smidt Gasbjerg; A. R. Lanng; M. B. Lynggaard; Bolette Hartmann; Jens Juul Holst; et al. "GIP infusion in patients with type 1 diabetes seems to attenuate post-prandial glucose excursions after prandial insulin over-dose and physical activity". 2020.
  6. S. A. S. Kjeldsen; S. Zraika; S. Mongovin; L. H. Hansen; D. Terzic; P. D. Mark; P. Plomgaard; et al. "Neprilysin inhibition increases plasma glucagon concentrations in humans with possible implications for hepatic amino acid metabolism". 2020.
  7. Katrine Douglas Galsgaard; J. Lee; B. T. Hubbard; X. -M. Zhang; G. W. Cline; A. R. Nasiri; Jens Juul Holst; et al. "Glucagon promotes hepatic autophagy by AMPK-mediated mTORC1 inhibition". 2020.
  8. J. R. Lundgren; E. M. Bladbjerg; Charlotte Janus; Lasse Gliemann; L. M. Olsen; Christian Rimer Juhl; S. B. K. Jensen; et al. "Weight loss-induced improvements of endothelial function and cardiovascular risk factors are maintained with exercise, liraglutide or the combination". 2020.
  9. Marie Winther-Sørensen; Katrine Douglas Galsgaard; A. Santos; J. Pedersen; Anna Skab Hassing; Morten Dall; Jonas Thue Treebak; et al. "Hepatic steatosis and glucagon resistance develope in parallel resulting in hyperglucagonaemia and hyperaminoacidaemia". 2020.
  10. M. N. Thomsen; M. J. Skytte; A. Samkani; M. H. Carl; P. Weber; Arne Astrup; Thomas Meinert Larsen; et al. "Reduced carbohydrate and increased protein and fat in the diet augment the positive effect of weight loss on glucose control in type 2 diabetes patients". 2020.
  11. A. Lund; M. Baekdal; S. W. Nielsen; C. P. Hansen; J. H. Storkholm; Bolette Hartmann; Jens Juul Holst; T. Vilsbøll; F. K. Knop. "Empagliflozin decreases fasting and postprandial hyperglycaemia in totally pancreatectomised patients: a randomised, double-blinded, placebo-controlled study". 2020.
  12. M. Baekdal; A. Lund; M. P. A. Baldassare; K. Rose; J. Egholk; M. B. Christensen; C. P. Hansen; et al. "Counterregulatory responses to hypoglycaemia in totally pancreatectomised patients". 2020.
  13. K. M. Petersen; S. Bogevig; T. Riis; N. A. W. Andersson; K. P. Dalhoff; Jens Juul Holst; F. K. Knop; et al. "Cardiovascular effects of high-dose glucagon: a randomised clinical trial". 2020.
  14. Charlotte Janus; S. B. K. Jensen; J. Lundgren; L. M. Olsen; Christian Rimer Juhl; Bente Merete Stallknecht; Jens Juul Holst; S. Madsbad; Signe Torekov. "Diet-induced weight loss improves sleep quality and the improvements are sustained after 1 year weight maintenance with exercise and liraglutide". 2020.
  15. S. B. K. Jensen; Charlotte Janus; J. R. Lundgren; Christian Rimer Juhl; M. B. Blond; Bente Merete Stallknecht; Jens Juul Holst; S. Madsbad; Signe Torekov. "Exercise alone and in combination with liraglutide improves cardiorespiratory fitness and physical functioning during weight loss maintenance". 2020.
  16. Christian Rimer Juhl; J. Burgdorf; C. Knudsen; S. Veedfald; Jens Juul Holst; JK Kanters; Signe Torekov. "Drug-induced blockade of the voltage-gated potassium channel Kv11.1 (hERG-channel) decreases glucose-stimulated insulin secretion and increases insulin sensitivity". 2020.
  17. C. Martinussen; M. S. Svane; K. N. Bojsen-Moller; B. V. Andersen; O. J. Hulme; D. V. Byrne; H. R. Siebner; et al. "Effect of macronutrient composition and energy content on post-prandial secretion of satiety hormones and next meal food intake". 2020.
    10.1007/s00125-020-05221-5
  18. M. S. Svane; H. H. Johannesen; C. Martinussen; K. N. Bojsen-Moller; M. L. Hansen; A. E. Hansen; Carolyn Deacon; et al. "Effects of a six-week intervention with glucagon-like peptide-1 receptor analogue on pancreatic volume, oedema and DNA synthesis in obese men". 2020.
  19. Lili Niu; Rajat Gupta; Philipp E. Geyer; Nicolai Wewer Albrechtsen; Lise L. Gluud; Alberto Santos; Sophia Doll; et al. "Plasma proteome profiling discovers potential biomarkers of non-alcoholic fatty liver disease". 2019.
  20. Jenna Elizabeth Hunt; Bolette Hartmann; Jens Juul Holst; Hannelouise Kissow. "Dietary Fiber is Essential to Maintain L Cell Secretion and Intestinal Weight". 2019.
    10.1016/S0016-5085(19)38051-5
  21. Jenna Elizabeth Hunt; Mohammad Yassin; Jørgen Olsen; johanne agerlin Windeløv; Katrine Douglas Galsgaard; Jens Juul Holst; Hannelouise Kissow. "Intestinal Growth in Glucagon Receptor Knockout Mice is Not Associated with the Formation of Aom/DSS-Induced Tumours". 2019.
    10.1016/S0016-5085(19)38651-2
  22. M. Nilsson; K. Bove; E. Suhrs; T. Hermann; J. Rungby; S. Madsbad; Bolette Hartmann; et al. "Effects of the GLP-1 (9-36) metabolite on coronary and peripheral vascular function in obese adults". 2019.
  23. Anna Jonsson; Sara Elizabeth Stinson; Signe Torekov; T. D. Clausen; L. Kelstrup; K. Faerch; Niels Grarup; et al. "Genome-wide association study of circulating levels of glucagon during an oral glucose tolerance test". 2019.
  24. C. Martinussen; S. Veedfald; C. Dirksen; K. N. Bojsen-Moller; M. S. Svane; G. V. Hall; V. B. Kristiansen; Jens Juul Holst; S. Madsbad. "Glucose absorption via SGLT1 is important for incretin hormone secretion after gastric bypass surgery". 2019.
  25. C. C. Ohrstrom; D. L. Hansen; Jens Juul Holst; U. L. Kielgast; D. Worm. "Are early dumping and postprandial hypoglycaemia after Roux-en-Y gastric bypass related events?". 2019.
    10.2337/db19-2073-P
  26. T. F. Dejgaard; C. Frandsen; U. Kielgast; H. U. Andersen; B. Thorsteinsson; T. Krarup; Jens Juul Holst; S. Madsbad. "Liraglutide preserved insulin secretion in adults with newly diagnosed type 1 diabetes: the NewLira trial". 2019.
    10.2337/db19-59-OR
  27. Lærke Smidt Gasbjerg; E. J. Bari; S. Stensen; B. Hoe; A. R. Lanng; D. S. Mathiesen; M. B. Christensen; et al. "The efficacy of GIP(3-30)NH2 as a GIP receptor antagonist in humans". 2019.
  28. S. Stensen; Lærke Smidt Gasbjerg; L. L. Krogh; A. H. Sparre-Ulrich; K. Skov-Jeppesen; M. H. Jensen; Bolette Hartmann; et al. "Endogenous glucose-dependent insulinotropic polypeptide exerts diverging and tissue specific in obese patients with type 2 diabetes". 2019.
  29. Alexander S. Christensen; Sofie Haedersdal; Heidi Storgaard; Kathrine Rose; Nina L. Hansen; Jens Juul Holst; Torben Hansen; Filip K. Knop; Vilsbøll Tina. "GIP and GLP-1 Potentiate Sulfonylurea-Induced Insulin Secretion in HNF1A Diabetes". 2019.
    10.2337/db19-981-P
  30. Jenna Elizabeth Hunt; Bolette Hartmann; Christoph Ullmer; Jens Juul Holst; Hannelouise Kissow. "Stimulation of the Bile Acid Receptor Tgr5 Promotes Intestinal Growth". 2018.
    10.1016/S0016-5085(18)31452-5
  31. S. Lin; B. Stoll; J. Robinson; J. Pastor; S. Cruz; P. Lau; J. Marini; et al. "Differential Action of TGR5 Agonists on GLP-2Secretion and Promotion of Intestinal Adaptation in a Piglet Short Bowel Model". 2018.
  32. N. C. Bergmann; A. Lund; S. M. Heimburger; Lærke Smidt Gasbjerg; N. R. Jorgensen; L. Jessen; Bolette Hartmann; et al. "Mono- and co-activation of the GIP and GLP-1 receptors inhibits bone resorption". 2018.
  33. I. Steineck; A. Ranjan; S. Schmidt; Jens Juul Holst; K. Norgaard. "MODERATE EXERCISE DOES NOT IMPAIR THE EFFECT OF GLUCAGON IN INSULIN PUMP TREATED INDIVIDUALS WITH TYPE 1 DIABETES: A RANDOMIZED CROSSOVER STUDY". 2018.
  34. M. M. Helsted; Lærke Smidt Gasbjerg; A. R. Lanng; S. Stensen; Bolette Hartmann; M. B. Christensen; Jens Juul Holst; et al. "The role of the incretins in the postprandial bone remodelling". 2018.
  35. Lærke Smidt Gasbjerg; M. M. Helsted; A. H. Sparre-Ulrich; A. R. Lanng; S. Stensen; M. H. Jakobsen; Bolette Hartmann; et al. "Postprandial effects of individual and combined GIP and GLP-1 receptor antagonism in healthy subjects". 2018.
  36. C. Martinussen; K. N. Bojsen-Moller; C. Dirksen; M. S. Svane; Jens Juul Holst; S. Madsbad. "L cell secretory responses after gastric bypass surgery can be imitated in un-operated individuals by modulating carbohydrate digestion". 2018.
  37. Bo Broberg; Jan Madsen; Stefan Fuglsang; Jens Juul Holst; Karl Bang Christensen; Casper Rydahl; Thomas Idorn; Bo Feldt-Rasmussen; Mads Hornum. "Gastrointestinal Motility in Patients with End-Stage Renal Diease on Chronic Hemodialysis". 2018.
    10.1093/ndt/gfy104.SaO009
  38. I. I. K. Steineck; A. Ranjan; S. Schmidt; T. R. Clausen; Jens Juul Holst; K. Norgaard. "Preserved glucose response to low-dose glucagon after exercise in insulin pump-treated individuals with type 1 diabetes". 2018.
  39. K. Skov-Jeppesen; M. Svane; C. Martinussen; Maria Buur Nordskov Gabe; Lærke Smidt Gasbjerg; S. Madsbad; Jens Juul Holst; Mette Marie Rosenkilde; Bolette Hartmann. "Separate effects of glucagon like peptide-2 (GLP-2) and glucose-dependent insulinotropic polypeptide (GIP) on bone remodelling". 2018.
  40. M. Nilsson; K. Bove; E. Suhrs; T. Hermann; S. Madsbad; Jens Juul Holst; E. Prescott; M. Zander. "The effect of DPP-4 protected GLP-1 (7-36) on coronary microcirculation in obese adults". 2018.
  41. V. Booz; Charlotte Bayer Christiansen; R. E. Kuhre; M. Y. Saltiel; L. Sturla; G. Sociali; E. Zocchi; Jens Juul Holst; S. Bruzzone. "Abscisic acid controls the release of insulin from beta-cells, Glucagon-Like Peptide-1 from intestinal L-cells and glucagon from alpha-cells". 2017.
  42. A. B. Lund; M. F. Grøndahl; J. I. Bagger; Jens Juul Holst; M. Christensen; T. Vilsboll; F. K. Knop. "Glucagon elimination is increased in patients with type 2 diabetes". 2017.
  43. A. Bronden; A. Alber; U. Rohde; J. F. Rehfeld; Jens Juul Holst; T. Vilsboll; F. K. Knop. "Metformin potentiates bile acid-induced GLP-1 secretion in patients with type 2 diabetes". 2017.
  44. J. I. Bagger; A. B. Lund; Nicolai Wewer Albrechtsen; M. Christensen; M. F. Grøndahl; C. P. Hansen; J. Storkholm; et al. "Increased liver fat content in totally pancreatectomised patients". 2017.
    10.1007/s00125-017-4350-z
  45. L. S. Hansen; A. H. Sparre-Ulrich; Berit Svendsen; M. Christensen; Bolette Hartmann; F. K. Knop; Jens Juul Holst; Mette Marie Rosenkilde. "Combined N-terminal and C-terminal truncations of Glucose dependent Insulinotropic Polypeptide (GIP) are potent and efficient GIP receptor antagonists". 2015.
    10.1007/s00125-015-3687-4
  46. Mark Hvistendahl; Christopher F. Brandt; Siri Tribler; Rahim Naimi; Bolette Hartmann; Jens Juul Holst; Jens Frederik Rehfeld; et al. "The glucagon-like peptide-1 receptor agonist liraglutide reduces jejunostomy output and improves intestinal absorption in short bowel syndrome patients with intestinal failure". 2015.
  47. T. Idorn; F. K. Knop; M. B. Jorgensen; T. Jensen; M. Resuli; P. M. Hansen; Karl Bang Christensen; et al. "Safety and efficacy of liraglutide in patients with type 2 diabetes and end-stage renal disease: an investigator-initiated, randomised, placebo-controlled trial". 2014.
    10.1007/s00125-014-3355-0
  48. Rune Ehrenreich Kuhre; Charlotte Rasmussen Frost; Berit Svendsen; Jens Juul Holst. "Glucose Stimulates GLP-1 Secretion from Isolated Perfused Rat Small Intestine by SGLT1 and GLUT2 Mediated Uptake, Causing V-gated Calcium Channel Activation". 2014.
    10.2337/db14-1741-2092
  49. Julie Berg Schmidt; Nikolaj Ture Gregersen; Susi Pedersen; Mette S Nielsen; Lone Vestergaard Nielsen; Jens Juul Holst; Dorte Lindqvist Hansen; et al. "The effect of Roux-en-Y gastric bypass surgery on energy expenditure and appetite: a randomized human study including “pair fed” control subjects". 2013.
  50. M. J. Mandoe; K. B. Hansen; F. K. Knop; Jens Juul Holst; Harald S. Hansen. "Incretin hormones in patients with type 2 diabetes are increased by diet-oil, a pro-drug for the GPR 119 receptor agonist, 2-oleoyl-glycerol". 2012.
  51. Julie Berg Schmidt; Nikolaj Ture Gregersen; Susie Dawn Pedersen; Jens Juul Holst; Thue W. Schwartz; Arne Astrup; Anders Sjödin. "Effects of intravenous infusions of PYY3-36 and GLP-1, as monoinfusion and in combination, on ad libitum energy intake in healthy obese subjects". 2012.
    10.1016/j.regpep.2012.05.071
  52. Julie Berg Schmidt; Luise Enggaard Gunvald; Nikolaj Ture Gregersen; Susie Dawn Pedersen; Jens Juul Holst; Dorte Lindqvist Hansen; Dorte Worm; et al. "Roux-en-Y gastric bypass surgery does not preserve energy expenditure in humans". 2012.
  53. Anita Belza Sparre; Mejse Quistorff Sørensen; Jens Juul Holst; Jens Frederik Rehfeld; Arne Astrup. "Protein dose-response effect on glp-1, pyy and appetite in male subjects". 2011.
  54. K. Aaboe; F.K. Knop; Tina Vilsbøll; Carolyn Deacon; Jens Juul Holst; S. Madsbad; T. Krarup. "Twelve weeks treatment with the DPP-4 inhibitor sitagliptin improves glycaemic control, but does not improve GLP-1 secretion, in patients with type 2 diabetes - a randomised trial". 2009.
  55. K. Faerch; Allan Vaag; Jens Juul Holst; T. Hansen; Charlotte Glumer; Knut Borch-Johnsen. "Determinants of glycemic charges in normoglycemic individuals". 2008.
  56. Birgitte Sloth; Anette Pia Due; Thomas Meinert Larsen; Jens Juul Holst; A Heding; Arne Astrup. "The effect of a high monounsaturated fatty acid, low glycemic index diet and a low fat diet on satiety, appetite regulatory hormones and glucose metabolism during a 6 mo weight maintenance period". 2008.
  57. Birgitte Sloth; Inger Krog-Mikkelsen; D. Dimitrov; Jens Juul Holst; Anne Flint; Inge Tetens; I. Björck; et al. "Effects of low vs. high glycemic index diets on appetite and energy expenditure". 2004.
Conference paper
  1. Thomas Thymann; I. Le Huërou-Luron; Y.M. Petersen; Mette Skou Hedemann; Jan Elnif; B.B. Jensen; Bolette Hartmann; Jens Juul Holst; Per Torp Sangild. "Glucagon-like peptide 2 (Glp-2) stimulates intestinal function during weaning". 2011.
  2. B. K. Møller; A. Flint; D. Pedersen; A. B. Raben; I. Tetens; Jens Juul Holst; Arne Astrup. "Prediction of glycemic index in mixed meals". 2003.
  3. I. le Huërou-Luron; Y.M. Petersen; B. Hartmann; Jens Juul Holst; P.T. Sangild. "Exogenous GLP-2 has only marginal effects on weaning-induced intestinal adaption in piglets". 2003.
  4. T.T. Nielsen; P.T. Sangild; J. Elnif; K. Sorensen; T. Leser; Jens Juul Holst; B. Hartmann; B.B. Jensen; M.S. Hedemann. "Effects of GLP-2 treatment and antibiotics on gut structure and function during pig weanling diarrhea". 2003.
  5. Y. M. Petersen; D. G. Burrin; M. Schmidt; J. Elnif; B. Hartmann; Jens Juul Holst; P. T. Sangild. "Glucagon-like peptide 2 stimulates small-intestine growth and maturation in the pig fetus and neonate". 2001.
  6. D. G. Burrin; B. Stoll; R. Jiang; Y. Petersen; J. Elnif; R. K. Buddington; M. Schmidt; et al. "Glucagon-like peptide 2 stimulates intestinal growth by decreasing proteolysis and apoptosis in parenterally fed premature piglets". 2001.
  7. J. Elnif; R. K. Buddington; Y. M. Petersen; B. Hartmann; Jens Juul Holst; M. Schmidt; D. G. Burrin; P. T. Sangild. "Intestinal nutrient absorption in newborn pigs in response to enteral nutrition or treatment with glucagon-like peptide 2". 2001.
  8. Y. M. Petersen; Jens Juul Holst; B. Hartmann; P. T. Sangild. "Perinatal gut growth is not regulated by glucagon-like peptide 2". 2001.
  9. A. Flint; A. Raben; Jens Juul Holst; Arne Astrup. "Glucagon-like peptide-1 suppresses energy expenditure in obese humans". 1999.
  10. A. Flint; A. Raben; Jens Juul Holst; Arne Astrup. "Glucagon-like peptide-1 promotes satiety and suppresses energy intake in humans". 1997.
  11. P. T. Sangild; L. Hilsted; L. Bjørnskov-Bartholdy; Jens Juul Holst; J. F. Trahair. "Circulating GRP and gastrin in fetal lambs in response to luminal infusion of fluids". 1997.
  12. P. T. Sangild; L. Hilsted; L. Bjørnskov-Bartholdy; Jens Juul Holst; J. F. Trahair. "Gastrin release in the fetal lamb in response to luminal infusion of amniotic fluid, milk or GRP". 1996.
Conference poster
  1. S. Haedersdal; A. Lund; H. Maagensen; E. Nielsen-Hannerup; Jens Juul Holst; F. Knop; T. Vilsboll. "Individual and combined glucose-lowering effects of glucagon receptor antagonism and sodium-glucose cotransporter 2 inhibition". 2018.
    10.2337/db18-1942-P
  2. A. Raben; K. Andersen; M. A. Karberg; Jens Juul Holst; Arne Astrup. "Positive effects on plasma glucose & appetite by industrial modification of starch". 1996.
Encyclopedia entry
  1. Rune Ehrenreich Kuhre; Nicolai Wewer Albrechtsen; Jens Juul Holst. "Pancreatic effects of GLP-1". In Diapedia. European Association for the Study of Diabetes (EASD), 2014. https://curis.ku.dk/portal/en/publications/pancreatic-effects-of-glp1(b53ee63c-3b92-462c-b14d-8ffb58ff4983).html.
    10.14496/dia.5104336169.8
  2. Emilie Balk-Møller; Jens Juul Holst; Rune Ehrenreich Kuhre. "Incretin secretion: direct mechanisms". In Diapedia. European Association for the Study of Diabetes (EASD), 2014. https://curis.ku.dk/portal/en/publications/incretin-secretion-direct-mechanisms(2e8684b7-0143-4a26-aeff-617d9a114d30).html.
    10.14496/dia.5105252812.7
Journal article
  1. Christina Gar; Stefanie J. Haschka; Stefanie Kern-Matschilles; Barbara Rauch; Vanessa Sacco; Cornelia Prehn; Jerzy Adamski; et al. "The liver–alpha cell axis associates with liver fat and insulin resistance: a validation study in women with non-steatotic liver fat levels". Diabetologia (2021): https://doi.org/10.1007/s00125-020-05334-x.
    10.1007/s00125-020-05334-x
  2. Daniel B Andersen; Kaare V Grunddal; Jens Pedersen; Rune E Kuhre; Mari L Lund; Jens J Holst; Cathrine Ørskov. "Using a Reporter Mouse to Map Known and Novel Sites of GLP-1 Receptor Expression in Peripheral Tissues of Male Mice". Endocrinology 162 3 (2021): https://doi.org/10.1210/endocr/bqaa246.
    10.1210/endocr/bqaa246
  3. Jens J. Holst; Sten Madsbad. "What is Diabetes Remission?". Diabetes Therapy (2021): https://doi.org/10.1007/s13300-021-01032-y.
    10.1007/s13300-021-01032-y
  4. Kim K. B. Clemmensen; Martin B. Blond; Hanan Amadid; Lea Bruhn; Dorte Vistisen; Kristian Karstoft; Frederik Persson; et al. "No effects of dapagliflozin, metformin or exercise on plasma glucagon concentrations in individuals with prediabetes: A post hoc analysis from the randomized controlled PRE-D trial". Diabetes, Obesity and Metabolism (2021): https://doi.org/10.1111/dom.14246.
    10.1111/dom.14246
  5. Sara E Stinson; Anna E Jonsson; Morten A V Lund; Christine Frithioff-Bøjsøe; Louise Aas Holm; Oluf Pedersen; Lars Ängquist; et al. "Fasting plasma GLP-1 associates with overweight/obesity and cardiometabolic risk factors in children and adolescents". The Journal of Clinical Endocrinology & Metabolism (2021): https://doi.org/10.1210/clinem/dgab098.
    10.1210/clinem/dgab098
  6. Morten Hindsø; Anja Birk Kuhlman; Tine Lovsø Dohlmann; Michael Taulo Lund; Bolette Hartmann; Jens Juul Holst; Steen Larsen; Jørn Wulff Helge. "Effect of 6 weeks of very low-volume high-intensity interval training on oral glucose-stimulated incretin hormone response". European Journal of Sport Science (2021): 1-17. https://doi.org/10.1080/17461391.2021.1877830.
    10.1080/17461391.2021.1877830
  7. Amra Jujic; Peter M. Nilsson; Naeimeh Atabaki-Pasdar; Anna Dieden; Tiinamaija Tuomi; Paul W. Franks; Jens Juul Holst; et al. "Glucose-Dependent Insulinotropic Peptide in the High-Normal Range Is Associated With Increased Carotid Intima-Media Thickness". Diabetes Care 44 1 (2021): 224-230. https://doi.org/10.2337/dc20-1318.
    10.2337/dc20-1318
  8. Berit Svendsen; Jens J. Holst. "Paracrine regulation of somatostatin secretion by insulin and glucagon in mouse pancreatic islets". Diabetologia (2021): https://doi.org/10.1007/s00125-020-05288-0.
    10.1007/s00125-020-05288-0
  9. Anne Christin Meyer-Gerspach; Jürgen Drewe; Wout Verbeure; Carel W. le Roux; Ludmilla Dellatorre-Teixeira; Jens F. Rehfeld; Jens J. Holst; et al. "Effect of the Natural Sweetener Xylitol on Gut Hormone Secretion and Gastric Emptying in Humans: A Pilot Dose-Ranging Study". Nutrients 13 1 (2021): 174-174. https://doi.org/10.3390/nu13010174.
    10.3390/nu13010174
  10. Anna Billeschou; Jenna Elizabeth Hunt; Aruna Ghimire; Jens J. Holst; Hannelouise Kissow. "Intestinal Adaptation upon Chemotherapy-Induced Intestinal Injury in Mice Depends on GLP-2 Receptor Activation". Biomedicines (2021): https://doi.org/10.3390/biomedicines9010046.
    10.3390/biomedicines9010046
  11. Christian Laugesen; Signe Schmidt; Jens Juul Holst; Kirsten Nørgaard; Ajenthen G. Ranjan. "The effect of preceding glucose decline rate on low-dose glucagon efficacy in individuals with type 1 diabetes: A randomized crossover trial". Diabetes, Obesity and Metabolism (2021): https://doi.org/10.1111/dom.14301.
    10.1111/dom.14301
  12. Ali Asmar; Per K Cramon; Meena Asmar; Lene Simonsen; Charlotte M Sorensen; Sten Madsbad; Bolette Hartmann; et al. "The Renal Extraction and the Natriuretic Action of GLP-1 in Humans Depend on Interaction With the GLP-1 Receptor". The Journal of Clinical Endocrinology & Metabolism (2021): https://doi.org/10.1210/clinem/dgaa643.
    10.1210/clinem/dgaa643
  13. Mads Juul Skytte; Amirsalar Samkani; Arne Astrup; Jan Frystyk; Jens Frederik Rehfeld; Jens Juul Holst; Sten Madsbad; et al. "Effects of carbohydrate restriction on postprandial glucose metabolism, beta-cell function, gut hormone secretion, and satiety in patients with type 2 diabetes". American Journal of Physiology: Endocrinology and Metabolism 320 1 (2021): E7-E18. https://curis.ku.dk/portal/en/publications/effects-of-carbohydrate-restriction-on-postprandial-glucose-metabolism-betacell-function-gut-hormone-secretion-and-satiety-in-patients-with-type-2-diabetes(6af9807c-a1d8-4388-9d60-e0702f0ae91b).html.
    10.1152/ajpendo.00165.2020
  14. Eelco van Duinkerken; Gabriel Bernardes; Liselotte van Bloemendaal; Dick J. Veltman; Frederik Barkhof; Daniel C. Mograbi; Victor E. A. Gerdes; et al. "Cerebral effects of glucagon-like peptide-1 receptor blockade before and after Roux-en-Y gastric bypass surgery in obese women". Diabetes, Obesity and Metabolism 23 2 (2021): 415-424. https://curis.ku.dk/portal/en/publications/cerebral-effects-of-glucagonlike-peptide1-receptor-blockade-before-and-after-rouxeny-gastric-bypass-surgery-in-obese-women(60f69a17-79e7-41a5-bf0a-3c5ead66e256).html.
    10.1111/dom.14233
  15. Lærke Smidt Gasbjerg; Emilie J. Bari; Signe Stensen; Bjorn Hoe; Amalie R. Lanng; David S. Mathiesen; Mikkel B. Christensen; et al. "Dose-dependent efficacy of the glucose-dependent insulinotropic polypeptide (GIP)receptor antagonistGIP(3-30)NH2 on GIP actions in humans". Diabetes, Obesity and Metabolism 23 1 (2021): 68-74. https://curis.ku.dk/portal/en/publications/dosedependent-efficacy-of-the-glucosedependent-insulinotropic-polypeptide-gipreceptor-antagonistgip330nh2-on-gip-actions-in-humans(01c18cb0-557e-4f67-84b5-26d664d6d9d0).html.
    10.1111/dom.14186
  16. Caroline C. Øhrstrøm; Dorte L. Hansen; Urd Lynge Kielgast; Marianne Lerbæk Bergmann; Simon Veedfald; Jens Juul Holst; Dorte Worm. "Counterregulatory responses to postprandial hypoglycemia after Roux-en-Y gastric bypass". Surgery for Obesity and Related Diseases 17 1 (2021): 55-63. https://curis.ku.dk/portal/en/publications/counterregulatory-responses-to-postprandial-hypoglycemia-after-rouxeny-gastric-bypass(a5f29557-ec14-419a-89c9-9bf6839511ce).html.
    10.1016/j.soard.2020.08.037
  17. Julie Abildgaard; Thorkil Ploug; Anette Tonnes Pedersen; Pia Eiken; Bente Klarlund Pedersen; Jens Juul Holst; Bolette Hartmann; Birgitte Lindegaard. "Preserved postprandial suppression of bone turnover markers, despite increased fasting levels, in postmenopausal women". Bone 143 (2021): https://curis.ku.dk/portal/en/publications/preserved-postprandial-suppression-of-bone-turnover-markers-despite-increased-fasting-levels-in-postmenopausal-women(45d45f23-be4c-4b07-a1d4-e665a70f4249).html.
    10.1016/j.bone.2020.115612
  18. Geke Aline Boer; Jens Juul Holst. "Incretin Hormones and Type 2 Diabetes—Mechanistic Insights and Therapeutic Approaches". Biology (2020): https://doi.org/10.3390/biology9120473.
    10.3390/biology9120473
  19. Sofie Hædersdal; Asger Lund; Elisabeth Nielsen-Hannerup; Henrik Maagensen; Gerrit van Hall; Jens J. Holst; Filip K. Knop; Tina Vilsbøll. "The Role of Glucagon in the Acute Therapeutic Effects of SGLT2 Inhibition". Diabetes (2020): db200369-db200369. https://doi.org/10.2337/db20-0369.
    10.2337/db20-0369
  20. Mette S. Nielsen; Bodil Just Christensen; Julie Berg Schmidt; Louise Tækker; Lotte Holm; Susanne Lunn; Christian Ritz; et al. "Predictors of weight loss after bariatric surgery—a cross-disciplinary approach combining physiological, social, and psychological measures". International Journal of Obesity 44 11 (2020): 2291-2302. https://doi.org/10.1038/s41366-020-0576-9.
    10.1038/s41366-020-0576-9
  21. Mette Y. Johansen; Kristian Karstoft; Christopher S. MacDonald; Katrine B. Hansen; Helga Ellingsgaard; Bolette Hartmann; Nicolai J. Wewer Albrechtsen; et al. "Effects of an intensive lifestyle intervention on the underlying mechanisms of improved glycaemic control in individuals with type 2 diabetes: a secondary analysis of a randomised clinical trial". Diabetologia 63 11 (2020): 2410-2422. https://doi.org/10.1007/s00125-020-05249-7.
    10.1007/s00125-020-05249-7
  22. Louise Vedtofte; Emilie Bahne; Signe Foghsgaard; Jonatan I. Bagger; Camilla Andreasen; Charlotte Strandberg; Peter M. Gørtz; et al. "One Year’s Treatment with the Glucagon-Like Peptide 1 Receptor Agonist Liraglutide Decreases Hepatic Fat Content in Women with Nonalcoholic Fatty Liver Disease and Prior Gestational Diabetes Mellitus in a Randomized, Placebo-Controlled Trial". Journal of Clinical Medicine (2020): https://doi.org/10.3390/jcm9103213.
    10.3390/jcm9103213
  23. Nikolaj Rittig; Mads Svart; Henrik Holm Thomsen; Esben Thyssen Vestergaard; Jens Frederik Rehfeld; Bolette Hartmann; Jens Juul Holst; et al. "Oral D/L-3-Hydroxybutyrate Stimulates Cholecystokinin and Insulin Secretion and Slows Gastric Emptying in Healthy Males". The Journal of Clinical Endocrinology & Metabolism 105 10 (2020): https://doi.org/10.1210/clinem/dgaa483.
    10.1210/clinem/dgaa483
  24. Mads N. Thomsen; Mads J. Skytte; Arne Astrup; Carolyn F. Deacon; Jens J. Holst; Sten Madsbad; Thure Krarup; Steen B. Haugaard; Amirsalar Samkani. "The clinical effects of a carbohydrate-reduced high-protein diet on glycaemic variability in metformin-treated patients with type 2 diabetes mellitus: A randomised controlled study". Clinical Nutrition ESPEN (2020): https://doi.org/10.1016/j.clnesp.2020.07.002.
    10.1016/j.clnesp.2020.07.002
  25. Amelia K. Fotheringham; Jonatan I. Bagger; Danielle J. Borg; Domenica A. McCarthy; Jens J. Holst; Tina Vilsbøll; Filip K. Knop; Josephine M. Forbes. "Circulating Levels of the Soluble Receptor for AGE (sRAGE) during Escalating Oral Glucose Dosages and Corresponding Isoglycaemic i.v. Glucose Infusions in Individuals with and without Type 2 Diabetes". Nutrients 12 10 (2020): 2928-2928. https://doi.org/10.3390/nu12102928.
    10.3390/nu12102928
  26. Rasmus Fuglsang-Nielsen; Elin Rakvaag; Bente Langdahl; Knud Erik Bach Knudsen; Bolette Hartmann; Jens Juul Holst; Kjeld Hermansen; Søren Gregersen. "Effects of whey protein and dietary fiber intake on insulin sensitivity, body composition, energy expenditure, blood pressure, and appetite in subjects with abdominal obesity". European Journal of Clinical Nutrition (2020): https://doi.org/10.1038/s41430-020-00759-4.
    10.1038/s41430-020-00759-4
  27. Alexander S. Christensen; Sofie Hædersdal; Julie Støy; Heidi Storgaard; Ulla Kampmann; Julie L. Forman; Marta Seghieri; et al. "Efficacy and Safety of Glimepiride With or Without Linagliptin Treatment in Patients With HNF1A Diabetes (Maturity-Onset Diabetes of the Young Type 3): A Randomized, Double-Blinded, Placebo-Controlled, Crossover Trial (GLIMLINA)". Diabetes Care 43 9 (2020): 2025-2033. https://doi.org/10.2337/dc20-0408.
    10.2337/dc20-0408
  28. Francis S. Willard; Jonathan D. Douros; Maria Buur Nordskov Gabe; Aaron D. Showalter; David B. Wainscott; Todd M. Suter; Megan E. Capozzi; et al. "Tirzepatide is an imbalanced and biased dual GIP and GLP-1 receptor agonist". JCI insight 5 17 (2020): https://curis.ku.dk/portal/en/publications/tirzepatide-is-an-imbalanced-and-biased-dual-gip-and-glp1-receptor-agonist(b80e9b5a-b66f-40b9-b147-1499515f8ed3).html.
    10.1172/jci.insight.140532
  29. Mikkel B Christensen; Asger B Lund; Niklas R Jørgensen; Jens J Holst; Tina Vilsbøll; Filip K Knop. "Glucose-Dependent Insulinotropic Polypeptide (GIP) Reduces Bone Resorption in Patients With Type 2 Diabetes". Journal of the Endocrine Society 4 9 (2020): https://doi.org/10.1210/jendso/bvaa097.
    10.1210/jendso/bvaa097
  30. Mads Juul Skytte; Amirsalar Samkani; Arne Astrup; Thomas Meinert Larsen; Jan Frystyk; Henrik Enghusen Poulsen; Trine Henriksen; et al. "Effects of a highly controlled carbohydrate-reduced high-protein diet on markers of oxidatively generated nucleic acid modifications and inflammation in weight stable participants with type 2 diabetes; a randomized controlled trial". Scandinavian Journal of Clinical and Laboratory Investigation 80 5 (2020): 401-407. https://doi.org/10.1080/00365513.2020.1759137.
    10.1080/00365513.2020.1759137
  31. Alexander S. Christensen; Sofie Hædersdal; Heidi Storgaard; Kathrine Rose; Nina L. Hansen; Jens J. Holst; Torben Hansen; Filip K. Knop; Tina Vilsbøll. "GIP and GLP-1 Potentiate Sulfonylurea-Induced Insulin Secretion in Hepatocyte Nuclear Factor 1a Mutation Carriers". Diabetes 69 9 (2020): 1989-2002. https://doi.org/10.2337/db20-0074.
    10.2337/db20-0074
  32. Mette Søeby; Joan B. Nielsen; Steen B. Pedersen; Sigrid B. Gribsholt; Jens Juul Holst; Bjørn Richelsen. "Relationship between biochemical and symptomatic hypoglycemia after RYGB. Responses to a mixed meal test". Surgery for Obesity and Related Diseases 16 9 (2020): 1179-1185. https://curis.ku.dk/portal/en/publications/relationship-between-biochemical-and-symptomatic-hypoglycemia-after-rygb-responses-to-a-mixed-meal-test(9f86b919-d051-4cbc-9d54-a7ec3464b58c).html.
    10.1016/j.soard.2020.04.024
  33. Jens Juul Holst; Mette Marie Rosenkilde. "GIP as a Therapeutic Target in Diabetes and Obesity: Insight From Incretin Co-agonists". The Journal of Clinical Endocrinology & Metabolism 105 8 (2020): https://doi.org/10.1210/clinem/dgaa327.
    10.1210/clinem/dgaa327
  34. Ali Asmar; Per K Cramon; Meena Asmar; Lene Simonsen; Charlotte Mehlin Sørensen; Sten Madsbad; Cedric Moro; et al. "Increased oral sodium chloride intake in humans amplifies selectively postprandial GLP-1 but not GIP, CCK, and gastrin in plasma". Physiological Reports 8 15 (2020): https://curis.ku.dk/portal/en/publications/increased-oral-sodium-chloride-intake-in-humans-amplifies-selectively-postprandial-glp1-but-not-gip-cck-and-gastrin-in-plasma(7424c6ea-1dbe-43a8-8d9d-589ffa01c6e4).html.
    10.14814/phy2.14519
  35. Jonas S. Quist; Marie M. Jensen; Kim K. B. Clemmensen; Hanne Pedersen; Natasja Bjerre; Joachim Størling; Martin B. Blond; et al. "Protocol for a single-centre, parallel-group, randomised, controlled, superiority trial on the effects of time-restricted eating on body weight, behaviour and metabolism in individuals at high risk of type 2 diabetes". BMJ Open 10 8 (2020): https://curis.ku.dk/portal/en/publications/protocol-for-a-singlecentre-parallelgroup-randomised-controlled-superiority-trial-on-the-effects-of-timerestricted-eating-on-body-weight-behaviour-and-metabolism-in-individuals-at-high-risk-of-type-2(8cb4338b-b57.
    10.1136/bmjopen-2020-037166
  36. Stella F. S. Xu; Daniel B. Andersen; Jose M. G. Izarzugaza; Rune E. Kuhre; Jens J. Holst. "In the rat pancreas, somatostatin tonically inhibits glucagon secretion and is required for glucose-induced inhibition of glucagon secretion". Acta Physiologica (2020): https://doi.org/10.1111/apha.13464.
    10.1111/apha.13464
  37. Caroline T.B. Juel; Asger Lund; Maria M. Andersen; Carsten P. Hansen; Jan H. Storkholm; Jens F. Rehfeld; Gerrit van Hall; et al. "The GLP-1 receptor agonist lixisenatide reduces postprandial glucose in patients with diabetes secondary to total pancreatectomy". Diabetologia 63 (2020): 1285-1298. https://curis.ku.dk/portal/en/publications/the-glp1-receptor-agonist-lixisenatide-reduces-postprandial-glucose-in-patients-with-diabetes-secondary-to-total-pancreatectomy(e6d57dda-36a3-4a74-b881-28a3854119fb).html.
    10.1007/s00125-020-05158-9
  38. Christoffer Martinussen; Simon Veedfald; Carsten Dirksen; Kirstine N Bojsen-Møller; Maria S Svane; Nicolai Wewer Albrechtsen; Gerrit van Hall; et al. "The effect of acute dual SGLT1/SGLT2 inhibition on incretin release and glucose metabolism after gastric bypass surgery". American Journal of Physiology: Endocrinology and Metabolism 318 6 (2020): E956-E964. https://curis.ku.dk/portal/en/publications/the-effect-of-acute-dual-sglt1sglt2-inhibition-on-incretin-release-and-glucose-metabolism-after-gastric-bypass-surgery(76b69983-6ef0-4868-bb57-f9a51f7b1cdb).html.
    10.1152/ajpendo.00023.2020
  39. Samuel A. J. Trammell; Jens S. Svenningsen; Jens J. Holst; Matthew P. Gillum; Rune E. Kuhre. "Hepatic Bile Acid Reuptake in the Rat Depends on Bile Acid Conjugation but Not on Agonistic Properties towards FXR and TGR5". Molecules (2020): https://doi.org/10.3390/molecules25102371.
    10.3390/molecules25102371
  40. Amra Jujic; Naeimeh Atabaki-Pasdar; Peter M. Nilsson; Peter Almgren; Liisa Hakaste; Tiinamaija Tuomi; Lisa M. Berglund; et al. "Glucose-dependent insulinotropic peptide and risk of cardiovascular events and mortality". Diabetologia 63 5 (2020): 1043-1054. https://curis.ku.dk/portal/en/publications/glucosedependent-insulinotropic-peptide-and-risk-of-cardiovascular-events-and-mortality(cd1126c9-9368-42eb-9483-eeae5301dc38).html.
    10.1007/s00125-020-05093-9
  41. Mette S Nielsen; Christian Ritz; Nicolai J Wewer Albrechtsen; Jens Juul Holst; Carel W le Roux; Anders Sjödin. "Oxyntomodulin and Glicentin May Predict the Effect of Bariatric Surgery on Food Preferences and Weight Loss". The Journal of Clinical Endocrinology & Metabolism 105 4 (2020): https://doi.org/10.1210/clinem/dgaa061.
    10.1210/clinem/dgaa061
  42. Natasha C. Bergmann; Lærke S. Gasbjerg; Sebastian M. Heimbürger; Liva S.L. Krogh; Flemming Dela; Bolette Hartmann; Jens J. Holst; et al. "No Acute Effects of Exogenous Glucose-Dependent Insulinotropic Polypeptide on Energy Intake, Appetite, or Energy Expenditure When Added to Treatment With a Long-Acting Glucagon-Like Peptide 1 Receptor Agonist in Men With Type 2 Diabetes". Diabetes Care 43 3 (2020): 588-596. https://doi.org/10.2337/dc19-0578.
    10.2337/dc19-0578
  43. Simon Veedfald; Louise Vedtofte; Kirsa Skov-Jeppesen; Carolyn F Deacon; Bolette Hartmann; Tina Vilsbøll; Filip K Knop; Mikkel B Christensen; Jens J Holst. "Glucose-Dependent Insulinotropic Polypeptide Is a Pancreatic Polypeptide Secretagogue in Humans". The Journal of Clinical Endocrinology & Metabolism 105 3 (2020): e502-e510. https://doi.org/10.1210/clinem/dgz097.
    10.1210/clinem/dgz097
  44. Lærke S. Gasbjerg; Natasha C. Bergmann; Signe Stensen; Mikkel B. Christensen; Mette M. Rosenkilde; Jens J. Holst; Michael Nauck; Filip K. Knop. "Evaluation of the incretin effect in humans using GIP and GLP-1 receptor antagonists". Peptides 125 (2020): 170183-170183. https://doi.org/10.1016/j.peptides.2019.170183.
    10.1016/j.peptides.2019.170183
  45. Jens Juul Holst; Mette Marie Rosenkilde. "Recent advances of GIP and future horizons". Peptides 125 (2020): 170230-170230. https://doi.org/10.1016/j.peptides.2019.170230.
    10.1016/j.peptides.2019.170230
  46. M.A. Nauck; H. Holle; M. Kahle; A. Tytko; C.F. Deacon; J.J. Holst; J.J. Meier. "No evidence of tachyphylaxis for insulinotropic actions of glucose-dependent insulinotropic polypeptide (GIP) in subjects with type 2 diabetes, their first-degree relatives, or in healthy subjects". Peptides 125 (2020): 170176-170176. https://doi.org/10.1016/j.peptides.2019.170176.
    10.1016/j.peptides.2019.170176
  47. Lærke Smidt Gasbjerg; Mads M. Helsted; Bolette Hartmann; Alexander H. Sparre-Ulrich; Simon Veedfald; Signe Stensen; Amalie R. Lanng; et al. "GIP and GLP-1 Receptor Antagonism During a Meal in Healthy Individuals". Journal of Clinical Endocrinology and Metabolism 105 3 (2020): e725-e738. https://curis.ku.dk/portal/en/publications/gip-and-glp1-receptor-antagonism-during-a-meal-in-healthy-individuals(a917768d-692f-4828-970f-beb8ffb711a5).html.
    10.1210/clinem/dgz175
  48. Samyah Shadid; Kessewa Abosi-Appeadu; Anne-Sophie De Maertelaere; Justine Defreyne; Laurens Veldeman; Jens J. Holst; Bruno Lapauw; Tina Vilsbøll; Guy T’Sjoen. "Effects of Gender-Affirming Hormone Therapy on Insulin Sensitivity and Incretin Responses in Transgender People". Diabetes Care (2020): dc191061-dc191061. https://doi.org/10.2337/dc19-1061.
    10.2337/dc19-1061
  49. Agnethe May Ahnfeldt; Ole Bæk; Yan Hui; Charlotte Holme Nielsen; Karina Obelitz-Ryom; Tilla Busk-Anderson; Anne Ruge; et al. "Nutrient Restriction has Limited Short-Term Effects on Gut, Immunity, and Brain Development in Preterm Pigs". The Journal of Nutrition (2020): https://doi.org/10.1093/jn/nxaa030.
    10.1093/jn/nxaa030
  50. William G. Tharp; Dhananjay Gupta; Olga Sideleva; Carolyn F. Deacon; Jens J. Holst; Dariush Elahi; Richard E. Pratley. "Effects of Pioglitazone on Glucose-Dependent Insulinotropic Polypeptide–Mediated Insulin Secretion and Adipocyte Receptor Expression in Patients With Type 2 Diabetes". Diabetes (2020): db181163-db181163. https://doi.org/10.2337/db18-1163.
    10.2337/db18-1163
  51. Mattea Müller; Gerben D. A. Hermes; Emanuel E. Canfora; Jens J. Holst; Erwin G. Zoetendal; Hauke Smidt; Freddy Troost; et al. "Effect of wheat bran derived prebiotic supplementation on gastrointestinal transit, gut microbiota, and metabolic health: a randomized controlled trial in healthy adults with a slow gut transit". Gut Microbes (2020): https://doi.org/10.1080/19490976.2019.1704141.
    10.1080/19490976.2019.1704141
  52. Emilie Balk-Møller; Johanne Agerlin Windeløv; Berit Svendsen; Jenna Hunt; Seyed Mojtaba Ghiasi; Charlotte Mehlin Sørensen; Jens Juul Holst; Hannelouise Kissow. "Glucagon-Like Peptide 1 and Atrial Natriuretic Peptide in a Female Mouse Model of Obstructive Pulmonary Disease". Journal of the Endocrine Society (2020): https://doi.org/10.1210/jendso/bvz034.
    10.1210/jendso/bvz034
  53. Ida M. Modvig; Charlotte B. Christiansen; Jens F. Rehfeld; Jens J. Holst; Simon Veedfald. "CCK-1 and CCK-2 receptor agonism do not stimulate GLP-1 and neurotensin secretion in the isolated perfused rat small intestine or GLP-1 and PYY secretion in the rat colon". Physiological Reports 8 2 (2020): https://doi.org/10.14814/phy2.14352.
    10.14814/phy2.14352
  54. Lærke S. Gasbjerg; Bolette Hartmann; Mikkel B. Christensen; Amalie R. Lanng; Tina Vilsbøll; Niklas R. Jørgensen; Jens J. Holst; Mette M. Rosenkilde; Filip K. Knop. "GIP’s effect on bone metabolism is reduced by the selective GIP receptor antagonist GIP(3–30)NH2". Bone 130 (2020): 115079-115079. https://doi.org/10.1016/j.bone.2019.115079.
    10.1016/j.bone.2019.115079
  55. Eva W Iepsen; Jinyi Zhang; Mette Hollensted; Sten Madsbad; Torben Hansen; Jens Juul Holst; Niklas R Jørgensen; Jens-Christian Holm; Signe Torekov. "Adults with pathogenic MC4R mutations have increased final height and thereby increased bone mass". Journal of Bone and Mineral Metabolism 38 1 (2020): 117-125. https://curis.ku.dk/portal/en/publications/adults-with-pathogenic-mc4r-mutations-have-increased-final-height-and-thereby-increased-bone-mass(5c64e7aa-e86c-4d2e-8b94-6e13780301aa).html.
    10.1007/s00774-019-01034-8
  56. Christoffer Martinussen; Carsten Dirksen; Kirstine N. Bojsen-Moller; Maria S. Svane; Elin R. Carlsson; Bolette Hartmann; Trine R. Clausen; et al. "Intestinal sensing and handling of dietary lipids in gastric bypass-operated patients and matched controls". American Journal of Clinical Nutrition 111 1 (2020): 28-41. https://curis.ku.dk/portal/en/publications/intestinal-sensing-and-handling-of-dietary-lipids-in-gastric-bypassoperated-patients-and-matched-controls(a0616631-2940-4ea5-9365-e5a3af06b429).html.
    10.1093/ajcn/nqz272
  57. Morten B. Jørgensen; Thomas Idorn; Casper Rydahl; Henrik P. Hansen; Iain Bressendorff; Lisbet Brandi; Nicolai J. Wewer Albrechtsen; et al. "Effect of the Incretin Hormones on the Endocrine Pancreas in End-Stage Renal Disease". Journal of Clinical Endocrinology and Metabolism 105 3 (2020): e564-e574. https://curis.ku.dk/portal/en/publications/effect-of-the-incretin-hormones-on-the-endocrine-pancreas-in-endstage-renal-disease(9bb2b427-72d3-4330-b2e3-c1138ae8489d).html.
    10.1210/clinem/dgz048
  58. Sara Lind Jepsen; Esben Thyssen Vestergaard; Pierre Larraufie; Fiona Mary Gribble; Frank Reimann; Jens Otto Lunde Jorgensen; Jens Juul Holst; Rune Ehrenreich Kuhre. "Ghrelin Does Not Directly Stimulate Secretion of Glucagon-like Peptide-1". Journal of Clinical Endocrinology & Metabolism 105 1 (2020): 266-275. https://curis.ku.dk/portal/en/publications/ghrelin-does-not-directly-stimulate-secretion-of-glucagonlike-peptide1(7aca0406-7892-4148-b89b-4e0687cb84de).html.
    10.1210/clinem/dgz046
  59. Jinyi Zhang; Christian Rimer Juhl; Louise Hylten-Cavallius; Morten Salling-Olsen; Linneberg A; Jens Juul Holst; Torben Hansen; JK Kanters; Signe Torekov. "Gain-of-function mutation in the voltage-gated potassium channel gene KCNQ1 and glucose-stimulated hypoinsulinemia - case report". B M C Endocrine Disorders 20 (2020): https://curis.ku.dk/portal/en/publications/gainoffunction-mutation-in-the-voltagegated-potassium-channel-gene-kcnq1-and-glucosestimulated-hypoinsulinemia--case-report(ab423ce9-a80a-4b32-92e8-3aca189889fc).html.
    10.1186/s12902-020-0513-x
  60. David S. Mathiesen; Jonatan Bagger; Katrine B. Hansen; Anders E. Junker; Astrid Plamboeck; Signe Harring; Thomas Idorn; et al. "No detectable effect of a type 2 diabetes-associated TCF7L2 genotype on the incretin effect". Endocrine Connections 9 12 (2020): 1221-1232. https://curis.ku.dk/portal/en/publications/no-detectable-effect-of-a-type-2-diabetesassociated-tcf7l2-genotype-on-the-incretin-effect(8a276a8b-a53f-4ac1-a9ba-19d24ae6c159).html.
    10.1530/EC-20-0471
  61. Kim K.B. Clemmensen; Jonas S. Quist; Dorte Vistisen; Daniel R. Witte; Anna Jonsson; Oluf Pedersen; Torben Hansen; et al. "Role of fasting duration and weekday in incretin and glucose regulation". Endocrine Connections 9 4 (2020): 279-288. https://curis.ku.dk/portal/en/publications/role-of-fasting-duration-and-weekday-in-incretin-and-glucose-regulation(619778de-2d68-41a0-9478-6fbc4501c0db).html.
    10.1530/EC-20-0009
  62. Lise Gether; Jacob P. Thyssen; Mette Gyldenlove; Bolette Hartmann; Jens Juul Holst; Signe Foghsgaard; Tina Vilsbøll; Filip K. Knop. "Normal insulin sensitivity, glucose tolerance, gut incretin and pancreatic hormone responses in adults with atopic dermatitis". Diabetes, Obesity and Metabolism 22 11 (2020): 2161-2169. https://curis.ku.dk/portal/en/publications/normal-insulin-sensitivity-glucose-tolerance-gut-incretin-and-pancreatic-hormone-responses-in-adults-with-atopic-dermatitis(23cd1874-79c5-4775-b2eb-eaace7a917a6).html.
    10.1111/dom.14146
  63. Marie Winther-Sørensen; Katrine Douglas Galsgaard; Alberto Santos; Samuel Addison Jack Trammell; Karolina Sulek; Rune E. Kuhre; Jens Pedersen; et al. "Glucagon acutely regulates hepatic amino acid catabolism and the effect may be disturbed by steatosis". Molecular Metabolism 42 (2020): https://curis.ku.dk/portal/en/publications/glucagon-acutely-regulates-hepatic-amino-acid-catabolism-and-the-effect-may-be-disturbed-by-steatosis(a3aa669a-5ae6-452c-899c-8bd9411cbea4).html.
    10.1016/j.molmet.2020.101080
  64. Maria S. Svane; Helle H. Johannesen; Christoffer Martinussen; Kirstine N. Bojsen-Moller; Martin Lundsgaard Hansen; Adam E. Hansen; Carolyn Deacon; et al. "No effects of a 6-week intervention with a glucagon-like peptide-1 receptor agonist on pancreatic volume and oedema in obese men without diabetes". Diabetes, Obesity and Metabolism 22 10 (2020): 1837-1846. https://curis.ku.dk/portal/en/publications/no-effects-of-a-6week-intervention-with-a-glucagonlike-peptide1-receptor-agonist-on-pancreatic-volume-and-oedema-in-obese-men-without-diabetes(f39b2fa1-5870-4bda-a44f-590e73c838b7).html.
    10.1111/dom.14106
  65. Tatyana Dmitrievna Fedorova; Karoline Knudsen; Bolette Hartmann; Jens Juul Holst; Frank Viborg Mortensen; Klaus Krogh; Per Borghammer. "In vivo positron emission tomography imaging of decreased parasympathetic innervation in the gut of vagotomized patients". Neurogastroenterology and Motility 32 3 (2020): https://curis.ku.dk/portal/en/publications/in-vivo-positron-emission-tomography-imaging-of-decreased-parasympathetic-innervation-in-the-gut-of-vagotomized-patients(c188f84e-9fe9-451d-b842-fe7436352f34).html.
    10.1111/nmo.13759
  66. Ida M. Modvig; Daniel Andersen; Kaare Villum Grunddal; Rune E. Kuhre; Christoffer Martinussen; Charlotte Bayer Christiansen; Cathrine Ørskov; et al. "Secretin release after Roux-en-Y gastric bypass reveals a population of glucose-sensitive S cells in distal small intestine". International Journal of Obesity 44 9 (2020): 1859-1871. https://curis.ku.dk/portal/en/publications/secretin-release-after-rouxeny-gastric-bypass-reveals-a-population-of-glucosesensitive-s-cells-in-distal-small-intestine(800236bc-d4dd-4041-a7ff-40d0695dbc0f).html.
    10.1038/s41366-020-0541-7
  67. Christian Zinck Jensen; Kirstine N. Bojsen-Møller; Maria S. Svane; Line M. Holst; Kjeld Hermansen; Bolette Hartmann; Nicolai Wewer Albrechtsen; et al. "Responses of gut and pancreatic hormones, bile acids, and fibroblast growth factor-21 differ to glucose, protein, and fat ingestion after gastric bypass surgery". American Journal of Physiology - Gastrointestinal and Liver Physiology 318 4 (2020): G661-G672. https://curis.ku.dk/portal/en/publications/responses-of-gut-and-pancreatic-hormones-bile-acids-and-fibroblast-growth-factor21-differ-to-glucose-protein-and-fat-ingestion-after-gastric-bypass-surgery(50c85278-19bd-47b6-9ad7-8ec4b6c52ae3).html.
    10.1152/ajpgi.00265.2019
  68. Marie Reeberg Sass; Nicolai Wewer Albrechtsen; Jens Pedersen; Kristine Juul Hare; Nis Borbye-Lorenzen; Katalin Kiss; Tina Vilsbøll; et al. "Secretion of parathyroid hormone may be coupled to insulin secretion in humans". Endocrine Connections 9 7 (2020): 747-754. https://curis.ku.dk/portal/en/publications/secretion-of-parathyroid-hormone-may-be-coupled-to-insulin-secretion-in-humans(941ac92c-e31e-4639-b62c-d865053a3093).html.
    10.1530/EC-20-0092
  69. Daniel R. Crabtree; William Buosi; Claire L. Fyfe; Graham W. Horgan; Yannis Manios; Odysseas Androutsos; Angeliki Giannopoulou; et al. "Appetite Control across the Lifecourse". Nutrients 12 12 (2020): https://curis.ku.dk/portal/en/publications/appetite-control-across-the-lifecourse(ae0a3f2a-761d-46bd-b439-2df11406e618).html.
    10.3390/nu12123710
  70. Yannik B. Schönknecht; Silke Crommen; Birgit Stoffel-Wagner; Martin Coenen; Rolf Fimmers; Jens Juul Holst; Marie Christine Simon; Peter Stehle; Sarah Egert. "Acute Effects of Three Different Meal Patterns on Postprandial Metabolism in Older Individuals with a Risk Phenotype for Cardiometabolic Diseases". Molecular Nutrition and Food Research 64 9 (2020): https://curis.ku.dk/portal/en/publications/acute-effects-of-three-different-meal-patterns-on-postprandial-metabolism-in-older-individuals-with-a-risk-phenotype-for-cardiometabolic-diseases(dccada5f-397c-453e-aa3d-610a36f6720f).html.
    10.1002/mnfr.201901035
  71. Nicklas J. Johansen; Thomas F. Dejgaard; Asger Lund; Camilla Schluntz; Christian S. Frandsen; Julie Forman; Nicolai Wewer Albrechtsen; et al. "Efficacy and safety of meal-time administration of short-acting exenatide for glycaemic control in type 1 diabetes (MAG1C)". The Lancet Diabetes & Endocrinology 8 4 (2020): 313-324. https://curis.ku.dk/portal/en/publications/efficacy-and-safety-of-mealtime-administration-of-shortacting-exenatide-for-glycaemic-control-in-type-1-diabetes-mag1c(ac533e4f-cae9-4f4c-9edb-e53aef06af03).html.
    10.1016/S2213-8587(20)30030-9
  72. N. Hedback; M. Hindso; A. K. Linddal; K. N. Bojsen-Moller; N. B. Jorgensen; C. Dirksen; A. Moller; et al. "Effect of meal texture on glucose excursions after bariatric surgery". Diabetologia 63 SUPPL 1 (2020): S203-S203. https://curis.ku.dk/portal/en/publications/effect-of-meal-texture-on-glucose-excursions-after-bariatric-surgery(5c379115-bc91-48fa-b7b3-2bbf46cd4cd0).html.
  73. Thomas D. Madsen; Lasse H. Hansen; John Hintze; Zilu Ye; Shifa Jebari; Daniel Andersen; Hiren J Joshi; et al. "An atlas of O-linked glycosylation on peptide hormones reveals diverse biological roles". Nature Communications 11 1 (2020): https://curis.ku.dk/portal/en/publications/an-atlas-of-olinked-glycosylation-on-peptide-hormones-reveals-diverse-biological-roles(cf43b936-b3d5-44a2-98d8-7e609c9e197b).html.
    10.1038/s41467-020-17473-1
  74. Simon Veedfald; Jens Frederik Rehfeld; Gerrit vanHall; Lars Bo Svendsen; Jens Juul Holst. "Gut hormone secretion, gastric emptying and glucose absorption after frequently sampled oral glucose and liquid mixed meal tests in young men". Neurogastroenterology and Motility 32 SI (2020): https://curis.ku.dk/portal/en/publications/gut-hormone-secretion-gastric-emptying-and-glucose-absorption-after-frequently-sampled-oral-glucose-and-liquid-mixed-meal-tests-in-young-men(0c44d07b-38d3-4f9b-b3ff-594da7aa4460).html.
  75. Aleksander Eiken; Stefan Fuglsang; Markus Eiken; Maria S Svane; Rune E. Kuhre; Nicolai Wewer Albrechtsen; Svend H. Hansen; et al. "Bilio-enteric flow and plasma concentrations of bile acids after gastric bypass and sleeve gastrectomy". International Journal of Obesity 44 (2020): 1872-1883. https://curis.ku.dk/portal/en/publications/bilioenteric-flow-and-plasma-concentrations-of-bile-acids-after-gastric-bypass-and-sleeve-gastrectomy(b3b44d4b-3b9c-4574-9858-412935e338ed).html.
    10.1038/s41366-020-0578-7
  76. Sofia S. Pereira; Ivana Jarak; Rui A. Carvalho; Pedro F. Oliveira; Marco G. Alves; Marta Guimaraes; Rui Almeida; et al. "Different Malabsorptive Obesity Surgery Interventions Result in Distinct Postprandial Amino Acid Metabolomic Signatures". Obesity Surgery 30 (2020): 4019-4028. https://curis.ku.dk/portal/en/publications/different-malabsorptive-obesity-surgery-interventions-result-in-distinct-postprandial-amino-acid-metabolomic-signatures(c3e80639-55c4-4fed-8788-e12a200b58cf).html.
    10.1007/s11695-020-04774-z
  77. Katrine Douglas Galsgaard; Jens Pedersen; Sasha A.S. Kjeldsen; Marie Winther-Sørensen; Elena Stojanovska; Hendrik Vilstrup; Cathrine Ørskov; Nicolai Wewer Albrechtsen; Jens Juul Holst. "Glucagon receptor signaling is not required for N-carbamoyl glutamate- And L-citrulline-induced ureagenesis in mice". American Journal of Physiology - Gastrointestinal and Liver Physiology 318 5 (2020): G912-G927. https://curis.ku.dk/portal/en/publications/glucagon-receptor-signaling-is-not-required-for-ncarbamoyl-glutamate-and-lcitrullineinduced-ureagenesis-in-mice(ab5642bf-0e54-4b6d-bddb-8ab717307bdc).html.
    10.1152/ajpgi.00294.2019
  78. Jenna Elizabeth Hunt; Anna Billeschou; johanne agerlin Windeløv; Bolette Hartmann; Christoph Ullmer; Jens Juul Holst; Hannelouise Kissow. "Pharmacological activation of TGR5 promotes intestinal growth via a GLP-2 dependent pathway in mice". American Journal of Physiology: Gastrointestinal and Liver Physiology 318 6 (2020): G980-G987. https://curis.ku.dk/portal/en/publications/pharmacological-activation-of-tgr5-promotes-intestinal-growth-via-a-glp2-dependent-pathway-in-mice(f3189bee-9775-4d94-89dc-1897e8a639bd).html.
    10.1152/ajpgi.00062.2020
  79. Carolina B. Lobato; Sofia S. Pereira; Marta Guimaraes; Bolette Hartmann; Nicolai Wewer Albrechtsen; Linda Hilsted; Jens Juul Holst; Mario Nora; Mariana P. Monteiro. "A Potential Role for Endogenous Glucagon in Preventing Post-Bariatric Hypoglycemia". Frontiers in Endocrinology 11 (2020): https://curis.ku.dk/portal/en/publications/a-potential-role-for-endogenous-glucagon-in-preventing-postbariatric-hypoglycemia(94edbd61-2a16-4516-ac76-ed9d9e9b9af9).html.
    10.3389/fendo.2020.608248
  80. Victoria Higgins; Shervin Asgari; Jill K. Hamilton; Anna Wolska; Alan T. Remaley; Bolette Hartmann; Jens Juul Holst; Khosrow Adeli. "Postprandial Dyslipidemia, Hyperinsulinemia, and Impaired Gut Peptides/Bile Acids in Adolescents with Obesity". Journal of Clinical Endocrinology & Metabolism 105 4 (2020): 1228-1241. https://curis.ku.dk/portal/en/publications/postprandial-dyslipidemia-hyperinsulinemia-and-impaired-gut-peptidesbile-acids-in-adolescents-with-obesity(8fc83f23-968f-46dd-ab7c-f35e090b219b).html.
    10.1210/clinem/dgz261
  81. Mads M. Helsted; Lærke Smidt Gasbjerg; Amalie R. Lanng; Natasha C. Bergmann; Signe Stensen; Bolette Hartmann; Mikkel B. Christensen; et al. "The role of endogenous GIP and GLP-1 in postprandial bone homeostasis". Bone 140 (2020): https://curis.ku.dk/portal/en/publications/the-role-of-endogenous-gip-and-glp1-in-postprandial-bone-homeostasis(dd056e9b-bfad-4eb4-b9f2-a71eebb43136).html.
    10.1016/j.bone.2020.115553
  82. Mathias E. Jensen; Aurelio Galli; Morgane Thomsen; Kathrine L. Jensen; Gerda K. Thomsen; Mette K. Klausen; Tina Vilsboll; et al. "Glucagon-like peptide-1 receptor regulation of basal dopamine transporter activity is species-dependent". Neurochemistry International 138 (2020): https://curis.ku.dk/portal/en/publications/glucagonlike-peptide1-receptor-regulation-of-basal-dopamine-transporter-activity-is-speciesdependent(a6ee07ab-f420-4ef7-87a6-07d16d2ce0f7).html.
    10.1016/j.neuint.2020.104772
  83. Rasmus Fuglsang-Nielsen; Elin Rakvaag; Peter Vestergaard; Bolette Hartmann; Jens Juul Holst; Kjeld Hermansen; Søren Gregersen; Jakob Starup-Linde. "Consumption of nutrients and insulin resistance suppress markers of bone turnover in subjects with abdominal obesity". Bone 133 (2020): https://curis.ku.dk/portal/en/publications/consumption-of-nutrients-and-insulin-resistance-suppress-markers-of-bone-turnover-in-subjects-with-abdominal-obesity(2fcdf6c0-fcf9-462a-bf28-03ee4198ffb3).html.
    10.1016/j.bone.2020.115230
  84. Caroline C. Ohrstrom; Dorte L. Hansen; Urd Lynge Kielgast; Bolette Hartmann; Jens Juul Holst; Dorte Worm. "A Low Dose of Pasireotide Prevents Hypoglycemia in Roux-en-Y Gastric Bypass-Operated Individuals". Obesity Surgery 30 (2020): 1605-1610. https://curis.ku.dk/portal/en/publications/a-low-dose-of-pasireotide-prevents-hypoglycemia-in-rouxeny-gastric-bypassoperated-individuals(5a0db064-5090-4d68-9670-9e2e4ac3d1c8).html.
    10.1007/s11695-019-04248-x
  85. Marcel H. A. Muskiet; Lennart Tonneijck; Mark M. Smits; Mark H. H. Kramer; D. Margriet Ouwens; Bolette Hartmann; Jens Juul Holst; et al. "Effects of DPP-4 Inhibitor Linagliptin Versus Sulfonylurea Glimepiride as Add-on to Metformin on Renal Physiology in Overweight Patients With Type 2 Diabetes (RENALIS)". Diabetes Care 43 11 (2020): 2889-2893. https://curis.ku.dk/portal/en/publications/effects-of-dpp4-inhibitor-linagliptin-versus-sulfonylurea-glimepiride-as-addon-to-metformin-on-renal-physiology-in-overweight-patients-with-type-2-diabetes-renalis(9576545b-1460-460f-b467-065cb186e2d5).html.
    10.2337/dc20-0902
  86. Kasper M. Petersen; Søren Bøgevig; Troels Riis; Niklas W. Andersson; Kim P. Dalhoff; Jens Juul Holst; Filip K. Knop; et al. "High-Dose Glucagon Has Hemodynamic Effects Regardless of Cardiac Beta-Adrenoceptor Blockade". Journal of the American Heart Association 9 21 (2020): https://curis.ku.dk/portal/en/publications/highdose-glucagon-has-hemodynamic-effects-regardless-of-cardiac-betaadrenoceptor-blockade(fde7fa71-543a-411f-b713-88d95d2ae7e4).html.
    10.1161/JAHA.120.016828
  87. Katrine Douglas Galsgaard; Sara Lind Jepsen; Sasha A. S. Kjeldsen; Jens Pedersen; Nicolai Wewer Albrechtsen; Jens Juul Holst. "Alanine, arginine, cysteine, and proline, but not glutamine, are substrates for, and acute mediators of, the liver-a-cell axis in female mice". American Journal of Physiology: Endocrinology and Metabolism 318 6 (2020): E920-E929. https://curis.ku.dk/portal/en/publications/alanine-arginine-cysteine-and-proline-but-not-glutamine-are-substrates-for-and-acute-mediators-of-the-livercell-axis-in-female-mice(0f171ee6-c70b-402e-b7f4-9775854d6ee0).html.
    10.1152/ajpendo.00459.2019
  88. Caroline C. Øhrstrøm; Dorte Worm; Urd Lynge Kielgast; Jens Juul Holst; Dorte L. Hansen. "Evidence for Relationship Between Early Dumping and Postprandial Hypoglycemia After Roux-en-Y Gastric Bypass". Obesity Surgery 30 3 (2020): 1038-1045. https://curis.ku.dk/portal/en/publications/evidence-for-relationship-between-early-dumping-and-postprandial-hypoglycemia-after-rouxeny-gastric-bypass(8299d835-a0a9-49b7-be69-cab213a225bf).html.
    10.1007/s11695-020-04387-6
  89. Malte P. Suppli; Jonatan I. Bagger; Asger Lund; Mia Demant; Gerrit van Hall; Charlotte Strandberg; Merete J. Kønig; et al. "Glucagon Resistance at the Level of Amino Acid Turnover in Obese Subjects With Hepatic Steatosis". Diabetes 69 6 (2020): 1090-1099. https://curis.ku.dk/portal/en/publications/glucagon-resistance-at-the-level-of-amino-acid-turnover-in-obese-subjects-with-hepatic-steatosis(aafe9801-3307-4c9b-a7cd-e7ff1cc03f16).html.
    10.2337/db19-0715
  90. Julie Steen Pedersen; Marte Opseth Rygg; Viggo Bjerregaard Kristiansen; Beth Hærstedt Olsen; Reza Rafiolsadat Serizawa; Jens Juul Holst; Sten Madsbad; et al. "Nonalcoholic Fatty Liver Disease Impairs the Liver-Alpha Cell Axis Independent of Hepatic Inflammation and Fibrosis". Hepatology Communications 4 11 (2020): 1610-1623. https://curis.ku.dk/portal/en/publications/nonalcoholic-fatty-liver-disease-impairs-the-liveralpha-cell-axis-independent-of-hepatic-inflammation-and-fibrosis(16bf9c6a-83eb-4822-a80b-91fb748b88c6).html.
    10.1002/hep4.1562
  91. Elisa P. Jensen; Sophie Møller; Aleksander Vauvert Hviid; Simon Veedfald; Jens Juul Holst; Jens Pedersen; Cathrine Ørskov; Charlotte Mehlin Sørensen. "GLP-1-induced renal vasodilation in rodents depends exclusively on the known GLP-1 receptor and is lost in prehypertensive rats". American Journal of Physiology: Renal Physiology 318 6 (2020): F1409-F1417. https://curis.ku.dk/portal/en/publications/glp1induced-renal-vasodilation-in-rodents-depends-exclusively-on-the-known-glp1-receptor-and-is-lost-in-prehypertensive-rats(e415d7df-4b3c-4038-ab49-61c8304abeda).html.
    10.1152/ajprenal.00579.2019
  92. Nina L. Hansen; Andreas Bronden; Christina C. Nexoe-Larsen; Alexander S. Christensen; David P. Sonne; Jens F. Rehfeld; Nicolai Wewer Albrechtsen; et al. "Glucagon-Like Peptide 2 Inhibits Postprandial Gallbladder Emptying in Man". Clinical and Translational Gastroenterology 11 12 (2020): https://curis.ku.dk/portal/en/publications/glucagonlike-peptide-2-inhibits-postprandial-gallbladder-emptying-in-man(de26f2a0-f18a-4a35-9896-753b0edfa5db).html.
    10.14309/ctg.0000000000000257
  93. Julia Nicole DeBenedictis; Siren Nymo; Karoline Haagensli Ollestad; Guro Akersveen Boyesen; Jens Frederik Rehfeld; Jens Juul Holst; Helen Truby; Bard Kulseng; Catia Martins. "Changes in the Homeostatic Appetite System After Weight Loss Reflect a Normalization Toward a Lower Body Weight". Journal of Clinical Endocrinology & Metabolism 105 7 (2020): e2538-e2546. https://curis.ku.dk/portal/en/publications/changes-in-the-homeostatic-appetite-system-after-weight-loss-reflect-a-normalization-toward-a-lower-body-weight(080ed81f-803b-4724-a5fb-b987a197d188).html.
    10.1210/clinem/dgaa202
  94. Benoit Gobron; Beatrice Bouvard; Sagar Vyavahare; Liv V. V. Blom; Kristian K. Pedersen; johanne agerlin Windeløv; Geke Aline Boer; et al. "Enteroendocrine K Cells Exert Complementary Effects to Control Bone Quality and Mass in Mice". Journal of Bone and Mineral Research 35 7 (2020): 1363-1374. https://curis.ku.dk/portal/en/publications/enteroendocrine-k-cells-exert-complementary-effects-to-control-bone-quality-and-mass-in-mice(5e505607-b8f0-4dac-8256-06dbec459a7a).html.
    10.1002/jbmr.4004
  95. Sara Vieira-Silva; Gwen Falony; Eugeni Belda; Trine Nielsen; Judith Aron-Wisnewsky; Rima Chakaroun; Sofia K Forslund; et al. "Statin therapy is associated with lower prevalence of gut microbiota dysbiosis". Nature 581 7808 (2020): 310-315. https://curis.ku.dk/portal/en/publications/statin-therapy-is-associated-with-lower-prevalence-of-gut-microbiota-dysbiosis(74e76aa2-3cf0-42b4-b177-c7f38c1a2469).html.
    10.1038/s41586-020-2269-x
  96. A. S. Christensen; S. Haedersdal; J. Stoy; H. Storgaard; U. Kampmann; M. Seghieri; Jens Juul Holst; et al. "Linagliptin as add-on treatment to glimepiride in patients with HNF1A-diabetes (MODY3)". Diabetologia 63 SUPPL 1 (2020): S78-S79. https://curis.ku.dk/portal/en/publications/linagliptin-as-addon-treatment-to-glimepiride-in-patients-with-hnf1adiabetes-mody3(8b91d1a7-104b-452d-848f-a2239a393b3e).html.
  97. Simon Birk Kjær Jensen; Julie Rehné Lundgren; Charlotte Janus; Christian Rimer Juhl; Lisa Møller Olsen; Mads Rosenkilde; Jens Juul Holst; et al. "Protocol for a randomised controlled trial of the combined effects of the GLP-1 receptor agonist liraglutide and exercise on maintenance of weight loss and health after a very low-calorie diet". BMJ Open 9 11 (2019): https://curis.ku.dk/portal/en/publications/protocol-for-a-randomised-controlled-trial-of-the-combined-effects-of-the-glp1-receptor-agonist-liraglutide-and-exercise-on-maintenance-of-weight-loss-and-health-after-a-very-lowcalorie-diet(dcbbdaf6-63b5-43bd-84.
    10.1136/bmjopen-2019-031431
  98. Ole Lindgård Dollerup; Samuel Addison Jack Trammell; Bolette Hartmann; Jens Juul Holst; Britt Christensen; Niels Møller; Matthew Gillum; Jonas Thue Treebak; Niels Jessen. "Effects of Nicotinamide Riboside on Endocrine Pancreatic Function and Incretin Hormones in Nondiabetic Men With Obesity". The Journal of clinical endocrinology and metabolism 104 11 (2019): 5703-5714. https://curis.ku.dk/portal/en/publications/effects-of-nicotinamide-riboside-on-endocrine-pancreatic-function-and-incretin-hormones-in-nondiabetic-men-with-obesity(a7c167bb-2ea8-4bba-a401-f0740f3c5c1e).html.
    10.1210/jc.2019-01081
  99. Jens J. Holst; Nicolai J. Wewer Albrechtsen. "Methods and Guidelines for Measurement of Glucagon in Plasma". International Journal of Molecular Sciences (2019): https://doi.org/10.3390/ijms20215416.
    10.3390/ijms20215416
  100. Nicolai J Wewer Albrechtsen; Jens Pedersen; Katrine D Galsgaard; Marie Winther-Sørensen; Malte P Suppli; Lina Janah; Jesper Gromada; et al. "The Liver–a-Cell Axis and Type 2 Diabetes". Endocrine Reviews (2019): https://doi.org/10.1210/er.2018-00251.
    10.1210/er.2018-00251
  101. Lea Tischmann; Mathijs Drummen; Blandine Gatta-Cherifi; Anne Raben; Mikael Fogelholm; Bolette Hartmann; Jens J. Holst; et al. "Effects of a High-Protein/Moderate-Carbohydrate Diet on Appetite, Gut Peptides, and Endocannabinoids—A Preview Study". Nutrients (2019): https://doi.org/10.3390/nu11102269.
    10.3390/nu11102269
  102. Anne Ørgaard; Sara Lind Jepsen; Jens Juul Holst. "Short-chain fatty acids and regulation of pancreatic endocrine secretion in mice". Islets (2019): 1-9. https://doi.org/10.1080/19382014.2019.1587976.
    10.1080/19382014.2019.1587976
  103. L. S. Hansen; Lærke Smidt Gasbjerg; A. Bronden; N. B. Dalsgaard; E. Bahne; S. Stensen; P. H. Hellmann; et al. "The role of glucagon-like peptide 1 for the postprandial effects of metformin in type 2 diabetes". Diabetologia 62 Supl. 1/SI (2019): S57-S58. https://curis.ku.dk/portal/en/publications/the-role-of-glucagonlike-peptide-1-for-the-postprandial-effects-of-metformin-in-type-2-diabetes(b09ae62d-8abb-44d5-9116-66ce5e511bd3).html.
  104. Sine Knorr; Birgitte Bytoft; Zuzana Lohse; Anne B. Boisen; Tine D. Clausen; Rikke B. Jensen; Peter Damm; et al. "Fatty Liver Among Adolescent Offspring of Women With Type 1 Diabetes (the EPICOM Study)". Diabetes Care 42 8 (2019): 1560-1568. https://doi.org/10.2337/dc19-0571.
    10.2337/dc19-0571
  105. Daniel Kandel; Kirstine Nyvold Bojsen-Møller; Maria Saur Svane; Amirsalar Samkani; Arne Astrup; Jens J Holst; Sten Madsbad; Thure Krarup. "Mechanisms of action of a carbohydrate-reduced, high-protein diet in reducing the risk of postprandial hypoglycemia after Roux-en-Y gastric bypass surgery". The American Journal of Clinical Nutrition (2019): https://doi.org/10.1093/ajcn/nqy310.
    10.1093/ajcn/nqy310
  106. Christoffer Martinussen; Kirstine Nyvold Bojsen-Møller; Carsten Dirksen; Maria Saur Svane; Viggo Bjerregaard Kristiansen; Bolette Hartmann; Jens Juul Holst; Sten Madsbad. "Augmented GLP-1 Secretion as Seen After Gastric Bypass May Be Obtained by Delaying Carbohydrate Digestion". Journal of Clinical Endocrinology and Metabolism 104 8 (2019): 3233–3244-3233–3244. https://curis.ku.dk/portal/en/publications/augmented-glp1-secretion-as-seen-after-gastric-bypass-may-be-obtained-by-delaying-carbohydrate-digestion(7ffe9cf1-1138-4ecb-8afe-dc48bf29ebc5).html.
    10.1210/jc.2018-02661
  107. Natasha Chidekel Bergmann; Asger Lund; Lærke Smidt Gasbjerg; Niklas Rye Jørgensen; Lene Jessen; Bolette Hartmann; Jens Juul Holst; et al. "Separate and Combined Effects of GIP and GLP-1 Infusions on Bone Metabolism in Overweight Men Without Diabetes". The Journal of Clinical Endocrinology & Metabolism (2019): https://doi.org/10.1210/jc.2019-00008.
    10.1210/jc.2019-00008
  108. Esben Thyssen Vestergaard; Astrid Johanneson Hjelholt; Rune E Kuhre; Niels Møller; Pierre Larraufie; Fiona M Gribble; Frank Reimann; et al. "Acipimox Acutely Increases GLP-1 Concentrations in Overweight Subjects and Hypopituitary Patients". The Journal of Clinical Endocrinology & Metabolism (2019): https://doi.org/10.1210/jc.2018-02503.
    10.1210/jc.2018-02503
  109. Ali Asmar; Per K Cramon; Lene Simonsen; Meena Asmar; Charlotte Mehlin Sørensen; Sten Madsbad; Cedric Moro; et al. "Extracellular Fluid Volume Expansion Uncovers a Natriuretic Action of GLP-1". The Journal of clinical endocrinology and metabolism 104 7 (2019): 2509–2519-2509–2519. https://curis.ku.dk/portal/en/publications/extracellular-fluid-volume-expansion-uncovers-a-natriuretic-action-of-glp1(9e0dd915-1000-4663-82c6-7ed1f1d35cfb).html.
    10.1210/jc.2019-00004
  110. Meena Asmar; Ali Asmar; Lene Simonsen; Flemming Dela; Jens Juul Holst; Jens Bülow. "GIP-induced vasodilation in human adipose tissue involves capillary recruitment". Endocrine Connections 8 6 (2019): 806-813. https://curis.ku.dk/portal/en/publications/gipinduced-vasodilation-in-human-adipose-tissue-involves-capillary-recruitment(165a4e4c-d6c3-4ea2-b809-af8ee217421e).html.
    10.1530/EC-19-0144
  111. Bárbara G. Patrício; Tiago Morais; Marta Guimarães; Simon Veedfald; Bolette Hartmann; Linda Hilsted; Jens Juul Holst; Mário Nora; Mariana P. Monteiro. "Gut hormone release after gastric bypass depends on the length of the biliopancreatic limb". International Journal of Obesity 43 5 (2019): 1009-1018. https://curis.ku.dk/portal/en/publications/gut-hormone-release-after-gastric-bypass-depends-on-the-length-of-the-biliopancreatic-limb(d1b6556f-d2a5-4c2a-ac86-c0a6f9b259b9).html.
    10.1038/s41366-018-0117-y
  112. Sen Lin; Barbara Stoll; Jason Robinson; Jose J. Pastor; Juan C. Marini; Ignacio R. Ipharraguerre; Bolette Hartmann; et al. "Differential action of TGR5 agonists on GLP-2 secretion and promotion of intestinal adaptation in a piglet short bowel model". A J P: Gastrointestinal and Liver Physiology (Online) 316 5 (2019): G641-G652. https://curis.ku.dk/portal/en/publications/differential-action-of-tgr5-agonists-on-glp2-secretion-and-promotion-of-intestinal-adaptation-in-a-piglet-short-bowel-model(f57d7044-d25b-45ee-82b1-541a6e014b49).html.
    10.1152/ajpgi.00360.2018
  113. Ida M. Modvig; Rune E. Kuhre; Jens Juul Holst. "Peptone-mediated glucagon-like peptide-1 secretion depends on intestinal absorption and activation of basolaterally located Calcium-Sensing Receptors". Physiological Reports 7 8 (2019): https://curis.ku.dk/portal/en/publications/peptonemediated-glucagonlike-peptide1-secretion-depends-on-intestinal-absorption-and-activation-of-basolaterally-located-calciumsensing-receptors(12670b4f-cb84-45dd-8f4e-cec848ba85d4).html.
    10.14814/phy2.14056
  114. Natasha C Bergmann; Asger Lund; Lærke Smidt Gasbjerg; Emma C E Meessen; Maria M Andersen; Sigrid Bergmann; Bolette Hartmann; et al. "Effects of combined GIP and GLP-1 infusion on energy intake, appetite and energy expenditure in overweight/obese individuals". Diabetologia 62 4 (2019): 665-675. https://curis.ku.dk/portal/en/publications/effects-of-combined-gip-and-glp1-infusion-on-energy-intake-appetite-and-energy-expenditure-in-overweightobese-individuals(babc76ef-75ca-4f98-a124-e028fc1ce9ee).html.
    10.1007/s00125-018-4810-0
  115. Rune Ehrenreich Kuhre; Charlotte Bayer Christiansen; Seyed Mojtaba Ghiasi (Ghiasi, S.M.); Maria Buur Nordskov Gabe; Patricia Almine Skat-Rørdam; Ida Marie Modvig; Thomas Mandrup-Poulsen; et al. "Neuromedin U Does Not Act as a Decretin in Rats". Cell Metabolism 29 3 (2019): 719--726.e1--e5-719--726.e1--e5. https://curis.ku.dk/portal/en/publications/neuromedin-u-does-not-act-as-a-decretin-in-rats(855b0ff7-e256-4d29-9d03-53745cf0f4eb).html.
    10.1016/j.cmet.2018.10.008
  116. Lili Niu; Philipp E Geyer; Nicolai J Wewer Albrechtsen; Lise L Gluud; Alberto Santos; Sophia Doll; Peter V Treit; et al. "Plasma proteome profiling discovers novel proteins associated with non-alcoholic fatty liver disease". Molecular Systems Biology 15 3 (2019): https://doi.org/10.15252/msb.20188793.
    10.15252/msb.20188793
  117. Malin Nilsson; Kira Bang Bové; Elena Suhrs; Thomas Hermann; Sten Madsbad; Jens Juul Holst; Eva Prescott; Mette Zander. "The effect of DPP-4-protected GLP-1 (7-36) on coronary microvascular function in obese adults". IJC Heart and Vasculature 22 (2019): 139-144. https://curis.ku.dk/portal/en/publications/the-effect-of-dpp4protected-glp1-736-on-coronary-microvascular-function-in-obese-adults(323649e6-9a88-418d-8e74-8aaa4104e06a).html.
    10.1016/j.ijcha.2019.01.004
  118. Morgane Thomsen; Jens Juul Holst; Anna Molander; Kristian Linnet; Maurice Ptito; Anders Fink-Jensen. "Effects of glucagon-like peptide 1 analogs on alcohol intake in alcohol-preferring vervet monkeys". Psychopharmacology 236 2 (2019): 603–611-603–611. https://curis.ku.dk/portal/en/publications/effects-of-glucagonlike-peptide-1-analogs-on-alcohol-intake-in-alcoholpreferring-vervet-monkeys(a6c0c8c3-7b65-40d9-8473-65641294011f).html.
    10.1007/s00213-018-5089-z
  119. Hannah Elena Suhrs; Kristoffer Flintholm Raft; Kira Bové; Steen Madsbad; Jens Juul Holst; Mette Zander; Eva Prescott. "Effect of liraglutide on body weight and microvascular function in non-diabetic overweight women with coronary microvascular dysfunction". International Journal of Cardiology 283 (2019): 28-34. https://curis.ku.dk/portal/en/publications/effect-of-liraglutide-on-body-weight-and-microvascular-function-in-nondiabetic-overweight-women-with-coronary-microvascular-dysfunction(8634d6b9-572b-4257-bad2-ffc21e53e720).html.
    10.1016/j.ijcard.2018.12.005
  120. Henrik Munch Roager; Josef Korbinian Vogt; Mette Kristensen; Lea Benedicte Skov Hansen; Sabine Ibrügger; Rasmus Baadsgaard Mærkedahl; Martin Iain Bahl; et al. "Whole grain-rich diet reduces body weight and systemic low-grade inflammation without inducing major changes of the gut microbiome". Gut 68 1 (2019): 83-93. https://curis.ku.dk/portal/en/publications/whole-grainrich-diet-reduces-body-weight-and-systemic-lowgrade-inflammation-without-inducing-major-changes-of-the-gut-microbiome(3635f562-cbee-4d27-803f-cc07b9f15d25).html.
    10.1136/gutjnl-2017-314786
  121. Jan L. Madsen; Morten Damgaard; Stefan Fuglsang; Carsten Dirksen; Jens J. Holst; Jesper Graff. "Gastrointestinal motility, gut hormone secretion, and energy intake after oral loads of free fatty acid or triglyceride in older and middle-aged men". Appetite 132 (2019): 18-24. https://doi.org/10.1016/j.appet.2018.09.020.
    10.1016/j.appet.2018.09.020
  122. M. Baekdal; A. Lund; Nicolai Wewer Albrechtsen; J. Egholk; T. Jorsal; C. T. Black-Juel; Jenna Elizabeth Hunt; et al. "Gut-derived glucagon in man". Diabetologia 62 Supl. 1/SI (2019): S231-S231. https://curis.ku.dk/portal/en/publications/gutderived-glucagon-in-man(28e4ff62-80b9-41f8-8047-0813f62aba7c).html.
  123. Teresa Mezza; Simona Moffa; Pietro Manuel Ferraro; Giuseppe Quero; Umberto Capece; Andrea Carfi; Chiara M. A. Cefalo; et al. "Bile Modulates Secretion of Incretins and Insulin: A Study of Human Extrahepatic Cholestasis". Journal of Clinical Endocrinology & Metabolism 104 7 (2019): 2685-2694. https://curis.ku.dk/portal/en/publications/bile-modulates-secretion-of-incretins-and-insulin-a-study-of-human-extrahepatic-cholestasis(bf6c3c4d-5424-4638-a645-78a3a1b1cbeb).html.
    10.1210/jc.2018-02804
  124. Meena Asmar; Ali Asmar; Lene Simonsen; Jens Juul Holst; Jens Bülow. "RETRACTION: Glucose-Dependent Insulinotropic Polypeptide Increases Blood Flow in Adipose Tissue of Humans by Recruiting Capillaries (Retraction of Vol 104, Pg 16, 2019)". Journal of Clinical Endocrinology & Metabolism 104 1 (2019): W1-W9. https://curis.ku.dk/portal/en/publications/retraction-glucosedependent-insulinotropic-polypeptide-increases-blood-flow-in-adipose-tissue-of-humans-by-recruiting-capillaries-retraction-of-vol-104-pg-16-2019(f793dc26-7da6-4403-b299-71c57fb39e82).html.
    10.1210/jc.2018-01651
  125. Thomas Hoffmann Morville; Tine Dohlmann; Anja B. Kuhlman; Tine Monberg; Mimmi Torp; Bolette Hartmann; Jens Juul Holst; et al. "Glucose homeostasis in statin users-The LIFESTAT study". Diabetes - Metabolism: Research and Reviews (Print Edition) 35 3 (2019): https://curis.ku.dk/portal/en/publications/glucose-homeostasis-in-statin-usersthe-lifestat-study(c8a58cf5-f7af-4a1e-8bbc-3afd72479bff).html.
    10.1002/dmrr.3110
  126. Valeria Booz; Charlotte Bayer Christiansen; Rune Ehrenreich Kuhre; Monika Yosifova Saltiel; Giovanna Sociali; Nicola Schaltenberg; Alexander W. Fischer; et al. "Abscisic acid stimulates the release of insulin and of GLP-1 in the rat perfused pancreas and intestine". Diabetes - Metabolism: Research and Reviews (Print Edition) 35 (2019): https://curis.ku.dk/portal/en/publications/abscisic-acid-stimulates-the-release-of-insulin-and-of-glp1-in-the-rat-perfused-pancreas-and-intestine(6e021628-aaf4-416e-bebf-c7bece878864).html.
    10.1002/dmrr.3102
  127. Christian Stevns Hansen; Christian Seerup Frandsen; Jesper Fleischer; Dorte Vistisen; Jens Juul Holst; Lise Tarnow; Filip Krag Knop; et al. "Liraglutide-Induced Weight Loss May be Affected by Autonomic Regulation in Type 1 Diabetes". Frontiers in Endocrinology 10 (2019): https://curis.ku.dk/portal/en/publications/liraglutideinduced-weight-loss-may-be-affected-by-autonomic-regulation-in-type-1-diabetes(e9241ddd-33dc-4f13-b3c6-1da63c491d87).html.
    10.3389/fendo.2019.00242
  128. Rune E. Kuhre; Jens Juul Holst. "Mechanisms Underlying Gut Hormone Secretion Using the Isolated Perfused Rat Small Intestine". Journal of Visualized Experiments 144 (2019): https://curis.ku.dk/portal/en/publications/mechanisms-underlying-gut-hormone-secretion-using-the-isolated-perfused-rat-small-intestine(2474737a-f5ba-4e52-9b2c-fbb35906108f).html.
    10.3791/58533
  129. Mads Gustav Juul Skytte; Amirsalar Samkani; Amy D Petersen; Mads Norvin Thomsen; Arne Astrup; Elizaveta Chabanova; Jan Frystyk; et al. "A carbohydrate-reduced high-protein diet improves HbA1c and liver fat content in weight stable participants with type 2 diabetes". Diabetologia 62 11 (2019): 2066-2078. https://curis.ku.dk/portal/en/publications/a-carbohydratereduced-highprotein-diet-improves-hba1c-and-liver-fat-content-in-weight-stable-participants-with-type-2-diabetes(a46703ac-ec6e-4c2b-a288-4da1e196850f).html.
    10.1007/s00125-019-4956-4
  130. Charlotte Bayer Christiansen; Samuel Addison Jack Trammell; Nicolai Wewer Albrechtsen; Kristina Schoonjans; Reidar Albrechtsen; Matthew Gillum; Rune Ehrenreich Kuhre; Jens Juul Holst. "Bile acids drive colonic secretion of glucagon-like-peptide 1 and peptide-YY in rodents". American Journal of Physiology: Gastrointestinal and Liver Physiology 316 5 (2019): G574-G584. https://curis.ku.dk/portal/en/publications/bile-acids-drive-colonic-secretion-of-glucagonlikepeptide-1-and-peptideyy-in-rodents(69aff6aa-c046-4947-b410-7492f9b06f7e).html.
    10.1152/ajpgi.00010.2019
  131. Tina Jorsal; Nicolai Wewer Albrechtsen; Marie M Christensen; Brynjulf Mortensen; Erik Wandall; Ebbe Langholz; Steffen Friis; et al. "Investigating Intestinal Glucagon after Roux-en-Y Gastric Bypass Surgery". Journal of Clinical Endocrinology and Metabolism 104 12 (2019): 6403–6416-6403–6416. https://curis.ku.dk/portal/en/publications/investigating-intestinal-glucagon-after-rouxeny-gastric-bypass-surgery(39e86066-0a62-4e07-84eb-236b77c01fe8).html.
    10.1210/jc.2019-00062
  132. Louise Lang Lehrskov; Regitse Hojgaard Christensen; Anne-Sophie Wedell-Neergaard; Grit Elster Legaard; Emma Dorph; Monica Korsager Larsen; Marie Henneberg; et al. "Effects of Exercise Training and IL-6 Receptor Blockade on Gastric Emptying and GLP-1 Secretion in Obese Humans: Secondary Analyses From a Double Blind Randomized Clinical Trial". Frontiers in Physiology 10 (2019): https://curis.ku.dk/portal/en/publications/effects-of-exercise-training-and-il6-receptor-blockade-on-gastric-emptying-and-glp1-secretion-in-obese-humans-secondary-analyses-from-a-double-blind-randomized-clinical-trial(74a1d734-4630-4d49-be5c-3ec6aa4a0d6b).
    10.3389/fphys.2019.01249
  133. Sofia S Pereira; Marta Guimarães; Rui Almeida; Ana M Pereira; Carolina B Lobato; Bolette Hartmann; Linda Hilsted; et al. "Biliopancreatic diversion with duodenal switch (BPD-DS) and single-anastomosis duodeno-ileal bypass with sleeve gastrectomy (SADI-S) result in distinct post-prandial hormone profiles". International Journal of Obesity 43 (2019): 2518-2527. https://curis.ku.dk/portal/en/publications/biliopancreatic-diversion-with-duodenal-switch-bpdds-and-singleanastomosis-duodenoileal-bypass-with-sleeve-gastrectomy-sadis-result-in-distinct-postprandial-hormone-profiles(dea5bcc1-5e14-47e2-b826-22a8cc43d1df)..
    10.1038/s41366-018-0282-z
  134. Ann Bjørnshave; Trine Nygaard Johansen; Bashar Amer; Trine Kastrup Dalsgaard; Jens Juul Holst; Kjeld Hermansen. "Pre-meal and postprandial lipaemia in subjects with the metabolic syndrome". British Journal of Nutrition 121 3 (2019): 312-321. https://curis.ku.dk/portal/en/publications/premeal-and-postprandial-lipaemia-in-subjects-with-the-metabolic-syndrome(20e60e7f-8bec-495d-8bac-b94c984a490b).html.
    10.1017/S0007114518003264
  135. Sara Lind Jepsen; Kaare Villum Grunddal; Nicolai Wewer Albrechtsen; Maja S Engelstoft; Maria Buur Nordskov Gabe; Elisa P Jensen; Cathrine Ørskov; et al. "Paracrine Crosstalk between Intestinal L- and D-cells Controls Secretion of Glucagon-Like Peptide-1 in mice". American Journal of Physiology: Endocrinology and Metabolism 317 6 (2019): E1081-E1093. https://curis.ku.dk/portal/en/publications/paracrine-crosstalk-between-intestinal-l-and-dcells-controls-secretion-of-glucagonlike-peptide1-in-mice(42e3df0d-bb3b-4f3e-b14a-d74e3ad514af).html.
    10.1152/ajpendo.00239.2019
  136. Kirsa Skov-Jeppesen; Maria S Svane; Christoffer Martinussen; Maria Buur Nordskov Gabe; Lærke Smidt Gasbjerg; Simon Veedfald; Kirstine N Bojsen-Møller; et al. "GLP-2 and GIP exert separate effects on bone turnover". Bone 125 (2019): 178-185. https://curis.ku.dk/portal/en/publications/glp2-and-gip-exert-separate-effects-on-bone-turnover(ec9ecf43-df92-435c-843e-4c6f342002f7).html.
    10.1016/j.bone.2019.05.014
  137. Katrine Hygum; Jakob Starup-Linde; Torben Harslor; Niklas Rye Jorgensen; Bolette Hartmann; Jens Juul Holst; Bente L. Langdahl. "The diurnal variation of bone formation is attenuated in adult patients with type 2 diabetes". European Journal of Endocrinology 181 3 (2019): 221-231. https://curis.ku.dk/portal/en/publications/the-diurnal-variation-of-bone-formation-is-attenuated-in-adult-patients-with-type-2-diabetes(8036b8c8-fbf0-49bc-b579-f7540d776415).html.
    10.1530/EJE-19-0309
  138. Martin Larsson; Cesare Patrone; Mia von Euler; Jens Juul Holst; David Nathanson. "GLP-1 secretion in acute ischemic stroke: association with functional outcome and comparison with healthy individuals". Cardiovascular Diabetology 18 (2019): https://curis.ku.dk/portal/en/publications/glp1-secretion-in-acute-ischemic-stroke-association-with-functional-outcome-and-comparison-with-healthy-individuals(4a5f0a98-0f13-4234-ad5e-001f6c7dc834).html.
    10.1186/s12933-019-0896-z
  139. Isabelle I. K. Steineck; Ajenthen Ranjan; Signe Schmidt; Trine R. Clausen; Jens Juul Holst; Kirsten Norgaard. "Preserved glucose response to low-dose glucagon after exercise in insulin-pump-treated individuals with type 1 diabetes". Diabetologia 62 4 (2019): 582-592. https://curis.ku.dk/portal/en/publications/preserved-glucose-response-to-lowdose-glucagon-after-exercise-in-insulinpumptreated-individuals-with-type-1-diabetes(d645b076-dbd3-47fb-839f-8af41f1ea672).html.
    10.1007/s00125-018-4807-8
  140. Maria S. Svane; Kirstine N. Bojsen-Moller; Christoffer Martinussen; Carsten Dirksen; Jan L. Madsen; Søren Reitelseder; Lars Holm; et al. "Postprandial Nutrient Handling and Gastrointestinal Hormone Secretion After Roux-en-Y Gastric Bypass vs Sleeve Gastrectomy". Gastroenterology 156 6 (2019): 1627-1641. https://curis.ku.dk/portal/en/publications/postprandial-nutrient-handling-and-gastrointestinal-hormone-secretion-after-rouxeny-gastric-bypass-vs-sleeve-gastrectomy(29a53a82-e729-4f95-ae03-d335b564ab72).html.
    10.1053/j.gastro.2019.01.262
  141. Katrine Douglas Galsgaard; Jens Pedersen; Filip K Knop; Jens Juul Holst; Nicolai Wewer Albrechtsen. "Glucagon Receptor Signaling and Lipid Metabolism". Frontiers in Physiology 10 (2019): https://curis.ku.dk/portal/en/publications/glucagon-receptor-signaling-and-lipid-metabolism(3f702a4f-fc48-4b24-8139-672f6485b7fd).html.
    10.3389/fphys.2019.00413
  142. M S Ebbesen; H Kissow; Bolette Hartmann; J S Gørløv; K Kielsen; Jens Juul Holst; K Müller. "Glucagon-like peptide-1 is a marker of systemic inflammation in patients treated with high-dose chemotherapy and autologous stem cell transplantation". Biology of Blood and Marrow Transplantation 25 6 (2019): 1085-1091. https://curis.ku.dk/portal/en/publications/glucagonlike-peptide1-is-a-marker-of-systemic-inflammation-in-patients-treated-with-highdose-chemotherapy-and-autologous-stem-cell-transplantation(53af41fc-aa54-43ba-93bc-2ebed123bb4d).html.
    10.1016/j.bbmt.2019.01.036
  143. Christopher M. Mulla; Allison B. Goldfine; Jonathan M. Dreyfuss; Sander Houten; Hui Pan; David M. Pober; Nicolai Wewer Albrechtsen; et al. "Plasma FGF-19 Levels are Increased in Patients with Post-Bariatric Hypoglycemia". Obesity Surgery 29 7 (2019): 2092-2099. https://curis.ku.dk/portal/en/publications/plasma-fgf19-levels-are-increased-in-patients-with-postbariatric-hypoglycemia(4cb932a2-fdf5-4357-81f0-444745015d78).html.
    10.1007/s11695-019-03845-0
  144. Rune E Kuhre; Seyed Mojtaba Ghiasi (Ghiasi, S.M.); Alice E. Adriaenssens; Nicolai Wewer Albrechtsen; Daniel Andersen; Alexander Aivazidis; Lihua Chen; et al. "No direct effect of SGLT2 activity on glucagon secretion". Diabetologia 62 6 (2019): 1011-1023. https://curis.ku.dk/portal/en/publications/no-direct-effect-of-sglt2-activity-on-glucagon-secretion(985e22be-0ce4-499b-944c-2d6f442356e9).html.
    10.1007/s00125-019-4849-6
  145. Ann Bjørnshave; Jens Juul Holst; Kjeld Hermansen. "A pre-meal of whey proteins induces differential effects on glucose and lipid metabolism in subjects with the metabolic syndrome". European Journal of Nutrition 58 2 (2019): 755-764. https://curis.ku.dk/portal/en/publications/a-premeal-of-whey-proteins-induces-differential-effects-on-glucose-and-lipid-metabolism-in-subjects-with-the-metabolic-syndrome(f8b11d80-c2a4-4b8e-a6b7-8b1568314d63).html.
    10.1007/s00394-018-1684-3
  146. Preeshila Behary; George Tharakan; Kleopatra Alexiadou; Nicholas Johnson; Nicolai Wewer Albrechtsen; Julia Kenkre; Joyceline Cuenco; et al. "Combined GLP-1, Oxyntomodulin, and Peptide YY Improves Body Weight and Glycemia in Obesity and Prediabetes/Type 2 Diabetes". Diabetes Care 42 7 (2019): https://curis.ku.dk/portal/en/publications/combined-glp1-oxyntomodulin-and-peptide-yy-improves-body-weight-and-glycemia-in-obesity-and-prediabetestype-2-diabetes(756223b0-e6c0-4485-a133-e8cedc357e48).html.
    10.2337/dc19-0449
  147. Caroline Christfort Ohrstrom; Dorte Worm; Anna Hojager; Ditte Andersen; Jens Juul Holst; Urd Lynge Kielgast; Dorte Lindqvist Hansen. "Postprandial hypoglycaemia after Roux-en-Y gastric bypass and the effects of acarbose, sitagliptin, verapamil, liraglutide and pasireotide". Diabetes, Obesity and Metabolism 21 9 (2019): 2142-2151. https://curis.ku.dk/portal/en/publications/postprandial-hypoglycaemia-after-rouxeny-gastric-bypass-and-the-effects-of-acarbose-sitagliptin-verapamil-liraglutide-and-pasireotide(fe2e490d-4ea9-4249-92d6-17aac7af1fdf).html.
    10.1111/dom.13796
  148. Jonas Salling Quist; Martin Bæk Blond; Anne Sofie Gram; Carina Bjørnskov Steenholt; Charlotte Janus; Jens Juul Holst; Jens F Rehfeld; et al. "Effects of active commuting and leisure-time exercise on appetite in individuals with overweight and obesity". Journal of Applied Physiology 126 4 (2019): 941-951. https://curis.ku.dk/portal/en/publications/effects-of-active-commuting-and-leisuretime-exercise-on-appetite-in-individuals-with-overweight-and-obesity(2524a7db-3722-4d85-aff8-d675231c7ff5).html.
    10.1152/japplphysiol.00239.2018
  149. Jens Juul Holst. "The incretin system in healthy humans". Metabolism 96 (2019): 46-55. https://curis.ku.dk/portal/en/publications/the-incretin-system-in-healthy-humans(248c0e97-dfba-4c8a-8e34-db08563fa468).html.
    10.1016/j.metabol.2019.04.014
  150. Carsten Dirksen; Jesper Graff; Stefan Fuglsang; Jens F. Rehfeld; Jens Juul Holst; Jan L. Madsen. "Energy intake, gastrointestinal transit, and gut hormone release in response to oral triglycerides and fatty acids in men with and without severe obesity". American Journal of Physiology: Gastrointestinal and Liver Physiology 316 3 (2019): G332-G337. https://curis.ku.dk/portal/en/publications/energy-intake-gastrointestinal-transit-and-gut-hormone-release-in-response-to-oral-triglycerides-and-fatty-acids-in-men-with-and-without-severe-obesity(16e6aa2c-f82b-4b1c-a831-28cda047c368).html.
    10.1152/ajpgi.00310.2018
  151. Anne-Marie Lundsgaard; Jacob Bak Holm; Kim Sjøberg; Kirstine N Bojsen-Møller; Lene S Myrmel; Even Fjære; Benjamin Jensen; et al. "Mechanisms preserving insulin action during high dietary fat intake". Cell Metabolism 29 1 (2019): 50--63, e1--e4-50--63, e1--e4. https://curis.ku.dk/portal/en/publications/mechanisms-preserving-insulin-action-during-high-dietary-fat-intake(ea4500c7-51bd-4a2d-bced-e1827fdbae30).html.
    10.1016/j.cmet.2018.08.022
  152. Jens Juul Holst; Nicolai Wewer Albrechtsen; Mette Marie Rosenkilde; Carolyn Deacon. "Physiology of the Incretin Hormones, GIP and GLP-1-Regulation of Release and Posttranslational Modifications". Comprehensive Physiology 9 4 (2019): 1339-1381. https://curis.ku.dk/portal/en/publications/physiology-of-the-incretin-hormones-gip-and-glp1regulation-of-release-and-posttranslational-modifications(3eb977aa-7f80-4f8f-8b4e-94363a4b4b96).html.
    10.1002/cphy.c180013
  153. Rahim M Naimi; Mark Hvistendahl; Lotte H Enevoldsen; Jan L Madsen; Stefan Fuglsang; Steen Seier Poulsen; Hannelouise Kissow; et al. "Glepaglutide, a novel long-acting glucagon-like peptide-2 analogue, for patients with short bowel syndrome". The Lancet Gastroenterology and Hepatology 4 5 (2019): 354-363. https://curis.ku.dk/portal/en/publications/glepaglutide-a-novel-longacting-glucagonlike-peptide2-analogue-for-patients-with-short-bowel-syndrome(0ac9442d-c222-4b1d-a816-92fb12fa5d17).html.
    10.1016/S2468-1253(19)30077-9
  154. Amalie R. Lanng; Lærke Smidt Gasbjerg; Natasha C. Bergmann; Sigrid Bergmann; Mads M. Heisted; Matthew Gillum; Bolette Hartmann; et al. "Gluco-metabolic effects of oral and intravenous alcohol administration in men". Endocrine Connections 8 10 (2019): 1372-1382. https://curis.ku.dk/portal/en/publications/glucometabolic-effects-of-oral-and-intravenous-alcohol-administration-in-men(dedbfefb-8509-4bba-b132-3d84093280ab).html.
    10.1530/EC-19-0317
  155. Julie R. Lundgren; Kristine Faerch; Daniel R. Witte; Anna Jonsson; Oluf Pedersen; Torben Hansen; Torsten Lauritzen; et al. "Greater glucagon-like peptide-1 responses to oral glucose are associated with lower central and peripheral blood pressures". Cardiovascular Diabetology 18 1 (2019): https://curis.ku.dk/portal/en/publications/greater-glucagonlike-peptide1-responses-to-oral-glucose-are-associated-with-lower-central-and-peripheral-blood-pressures(d1c8ab75-0773-47b6-af0f-040837631455).html.
    10.1186/s12933-019-0937-7
  156. Shaunte Baboumian; Spiro P. Pantazatos; Shiva Kothari; James McGinty; Jens Juul Holst; Allan Geliebter. "Functional Magnetic Resonance Imaging (fMRI) of Neural Responses to Visual and Auditory Food Stimuli Pre and Post Roux-en-Y Gastric Bypass (RYGB) and Sleeve Gastrectomy (SG)". Neuroscience 409 (2019): 290-298. https://curis.ku.dk/portal/en/publications/functional-magnetic-resonance-imaging-fmri-of-neural-responses-to-visual-and-auditory-food-stimuli-pre-and-post-rouxeny-gastric-bypass-rygb-and-sleeve-gastrectomy-sg(1cc442e5-f3c1-41e2-ad8f-10eb837ff6a4).html.
    10.1016/j.neuroscience.2019.01.061
  157. Anne Nissen; Simone Marstrand; Kirsa Skov-Jeppesen; Lasse Bremholm; Mads Hornum; Ulrik B. Andersen; Jens Juul Holst; Mette Marie Rosenkilde; Bolette Hartmann. "A Pilot Study Showing Acute Inhibitory Effect of GLP-1 on the Bone Resorption Marker CTX in Humans". JBMR plus 3 10 (2019): https://curis.ku.dk/portal/en/publications/a-pilot-study-showing-acute-inhibitory-effect-of-glp1-on-the-bone-resorption-marker-ctx-in-humans(af1a3468-af58-41fa-8cbe-ce455310d16e).html.
    10.1002/jbm4.v3.10
  158. Nils B Jørgensen; Kirstine N Bojsen-Møller; Carsten Dirksen; Christoffer Martinussen; Maria S Svane; Viggo B Kristiansen; Jens Juul Holst; Sten Madsbad. "Sustained Improvements in Glucose Metabolism Late After Roux-En-Y Gastric Bypass Surgery in Patients with and Without Preoperative Diabetes". Scientific Reports 9 1 (2019): https://curis.ku.dk/portal/en/publications/sustained-improvements-in-glucose-metabolism-late-after-rouxeny-gastric-bypass-surgery-in-patients-with-and-without-preoperative-diabetes(bf1d68e1-8d8c-48e4-833c-b91c9463cc3c).html.
    10.1038/s41598-019-51516-y
  159. Emanuel Steiner; Robert Breuer; Lukas Kazianka; Marlene Wewalka; Thomas Stimpfl; Birgit Reiter; Jens Juul Holst; Johannes Miholic. "Gastric Emptying and Distal Gastrectomy Independently Enhance Postprandial Glucagon-Like Peptide-1 Release After a Mixed Meal and Improve Glycemic Control in Subjects Having Undergone Pancreaticoduodenectomy". Pancreas 48 7 (2019): 953-957. https://curis.ku.dk/portal/en/publications/gastric-emptying-and-distal-gastrectomy-independently-enhance-postprandial-glucagonlike-peptide1-release-after-a-mixed-meal-and-improve-glycemic-control-in-subjects-having-undergone-pancreaticoduoden(ffcc87d5-a4d.
    10.1097/MPA.0000000000001361
  160. Julie R. Larsen; Camilla K. Svensson; Louise Vedtofte; Mathilde Lund Jakobsen; Hans Søe Jespersen; Michelle I. Jakobsen; Kamuran Koyuncu; et al. "High prevalence of prediabetes and metabolic abnormalities in overweight or obese schizophrenia patients treated with clozapine or olanzapine". CNS Spectrums 24 4 (2019): 441-452. https://curis.ku.dk/portal/en/publications/high-prevalence-of-prediabetes-and-metabolic-abnormalities-in-overweight-or-obese-schizophrenia-patients-treated-with-clozapine-or-olanzapine(eddd331b-a666-4c8f-a483-5d8f9e9a67cb).html.
    10.1017/S1092852918001311
  161. Katrine Douglas Galsgaard; Marie Winther-Sørensen; Jens Pedersen; Sasha A S Kjeldsen; Mette Marie Rosenkilde; Nicolai Wewer Albrechtsen; Jens Juul Holst. "Glucose and Amino Acid Metabolism in Mice Depend Mutually on Glucagon and Insulin Receptor Signaling". American Journal of Physiology: Endocrinology and Metabolism 316 4 (2019): E660-E673. https://curis.ku.dk/portal/en/publications/glucose-and-amino-acid-metabolism-in-mice-depend-mutually-on-glucagon-and-insulin-receptor-signaling(a2606d13-8dca-4921-a2a6-6d5400777128).html.
    10.1152/ajpendo.00410.2018
  162. Lærke Smidt Gasbjerg; Mads M Helsted; Bolette Hartmann; Mette H Jensen; Maria Buur Nordskov Gabe; Alexander H Sparre-Ulrich; Simon Veedfald; et al. "Separate and Combined Glucometabolic Effects of Endogenous Glucose-Dependent Insulinotropic Polypeptide and Glucagon-like Peptide 1 in Healthy Individuals". Diabetes 68 3 (2019): 906-917. https://curis.ku.dk/portal/en/publications/separate-and-combined-glucometabolic-effects-of-endogenous-glucosedependent-insulinotropic-polypeptide-and-glucagonlike-peptide-1-in-healthy-individuals(45c3c2e1-d16b-4d3a-a0dd-e6ba9f360704).html.
    10.2337/db18-1123
  163. Olga Rudenko; Jin Shang; Alexander Munk; Jeppe Hvidtfeldt Ekberg; Natalia Petersen; Maja S Engelstoft; Kristoffer Lihme Egerod; et al. "The aromatic amino acid sensor GPR142 controls metabolism through balanced regulation of pancreatic and gut hormones". Molecular Metabolism 19 (2019): 49-64. https://curis.ku.dk/portal/en/publications/the-aromatic-amino-acid-sensor-gpr142-controls-metabolism-through-balanced-regulation-of-pancreatic-and-gut-hormones(520e9174-bdbf-4616-8b5c-108e08cdd6f6).html.
    10.1016/j.molmet.2018.10.012
  164. Sara Baidassano; Lærke Smidt Gasbjerg; Husun Sheyma Kizilkaya; Mette Marie Rosenkilde; Jens Juul Holst; Bolette Hartmann. "Increased Body Weight and Fat Mass After Subchronic GIP Receptor Antagonist, but Not GLP-2 Receptor Antagonist, Administration in Rats". Frontiers in Endocrinology 10 (2019): https://curis.ku.dk/portal/en/publications/increased-body-weight-and-fat-mass-after-subchronic-gip-receptor-antagonist-but-not-glp2-receptor-antagonist-administration-in-rats(a2f11b07-5310-4a58-bbf1-791e6d94e78b).html.
    10.3389/fendo.2019.00492
  165. Charlotte Janus; Dorte Vistisen; Hanan Amadid; Daniel R Witte; Torsten Lauritzen; Søren Brage; Anne-Louise Bjerregaard; et al. "Habitual activity associates with lower fasting and greater glucose-induced GLP-1 response in men". Endocrine Connections 8 12 (2019): 1607–1617-1607–1617. https://curis.ku.dk/portal/en/publications/habitual-activity-associates-with-lower-fasting-and-greater-glucoseinduced-glp1-response-in-men(5bb0f4ac-2cb9-40dd-9f7a-d127eec213f9).html.
    10.1530/EC-19-0408
  166. Mattea Muller; Manuel A. Gonzalez Hernandez; Gijs H. Goossens; Dorien Reijnders; Jens Juul Holst; Johan W. E. Jocken; Hans van Eijk; Emanuel E. Canfora; Ellen E. Blaak. "Circulating but not faecal short-chain fatty acids are related to insulin sensitivity, lipolysis and GLP-1 concentrations in humans". Scientific Reports 9 (2019): https://curis.ku.dk/portal/en/publications/circulating-but-not-faecal-shortchain-fatty-acids-are-related-to-insulin-sensitivity-lipolysis-and-glp1-concentrations-in-humans(c511ced2-ba11-4082-a87a-24fc2f938b0d).html.
    10.1038/s41598-019-48775-0
  167. C. Lundegaard Asferg; U Bjørn Andersen; Linneberg A; Jens Peter Goetze; Jens Juul Holst; J L Jeppesen. "Copeptin, a surrogate marker for arginine vasopressin secretion, is positively associated with glucagon". Diabetic Medicine 36 11 (2019): 1408-1411. https://curis.ku.dk/portal/en/publications/copeptin-a-surrogate-marker-for-arginine-vasopressin-secretion-is-positively-associated-with-glucagon(fc3d1dcb-e229-4e90-896d-50c1b6838293).html.
    10.1111/dme.13820
  168. Nicolai Wewer Albrechtsen; Peter D Mark; Dijana Terzic; Lasse H Hansen; Ulrik Ø Andersen; Bolette Hartmann; Richard D Carr; et al. "Sacubitril/Valsartan Augments Postprandial Plasma Concentrations of Active GLP-1 When Combined With Sitagliptin in Men". Journal of Clinical Endocrinology and Metabolism 104 9 (2019): 3868-3876. https://curis.ku.dk/portal/en/publications/sacubitrilvalsartan-augments-postprandial-plasma-concentrations-of-active-glp1-when-combined-with-sitagliptin-in-men(65447cf2-3a0f-463d-b756-b7b6ac15cd06).html.
    10.1210/jc.2019-00515
  169. Christian Anholm; Preman Kumarathurai; Anders Jurs; Lene Rorholm Pedersen; Olav Wendelboe Nielsen; Ole Peter Kristiansen; Mogens Fenger; et al. "Liraglutide improves the beta-cell function without increasing insulin secretion during a mixed meal in patients, who exhibit well-controlled type 2 diabetes and coronary artery disease". Diabetology & Metabolic Syndrome 11 (2019): https://curis.ku.dk/portal/en/publications/liraglutide-improves-the-betacell-function-without-increasing-insulin-secretion-during-a-mixed-meal-in-patients-who-exhibit-wellcontrolled-type-2-diabetes-and-coronary-artery-disease(03db0f39-30d5-47dd-b742-e3619.
    10.1186/s13098-019-0438-6
  170. Julia Otten; Mats Ryberg; Caroline Mellberg; Tomas Andersson; Elin Chorell; Bernt Lindahl; Christel Larsson; Jens Juul Holst; Tommy Olsson. "Postprandial levels of GLP-1, GIP and glucagon after 2 years of weight loss with a Paleolithic diet: a randomised controlled trial in healthy obese women". European Journal of Endocrinology 180 6 (2019): 417-427. https://curis.ku.dk/portal/en/publications/postprandial-levels-of-glp1-gip-and-glucagon-after-2-years-of-weight-loss-with-a-paleolithic-diet-a-randomised-controlled-trial-in-healthy-obese-women(6045d055-c736-438f-842d-b25a44fbf455).html.
    10.1530/EJE-19-0082
  171. Bo Broberg; Jan L. Madsen; Stefan Fuglsang; Jens Juul Holst; Karl Bang Christensen; Casper Rydahl; Thomas Idorn; Bo Feldt-Rasmussen; Mads Hornum. "Gastrointestinal motility in patients with end-stage renal disease on chronic hemodialysis". Neurogastroenterology and Motility 31 4 (2019): https://curis.ku.dk/portal/en/publications/gastrointestinal-motility-in-patients-with-endstage-renal-disease-on-chronic-hemodialysis(28cfd3e1-9cb1-4ff4-bf42-60929e599b16).html.
    10.1111/nmo.13554
  172. Nithya Sukumar; Christos Bagias; Ilona Goljan; Yonas Weldeselassie; Seley Gharanei; Bee K. Tan; Jens J. Holst; Ponnusamy Saravanan. "Reduced GLP-1 Secretion at 30 Minutes After a 75-g Oral Glucose Load Is Observed in Gestational Diabetes Mellitus: A Prospective Cohort Study". Diabetes 67 12 (2018): 2650-2656. https://doi.org/10.2337/db18-0254.
    10.2337/db18-0254
  173. Mia Demant; Jonatan I Bagger; Malte P Suppli; Asger Lund; Mette Gyldenløve; Katrine B Hansen; Kristine J Hare; et al. "Determinants of Fasting Hyperglucagonemia in Patients with Type 2 Diabetes and Nondiabetic Control Subjects". Metabolic Syndrome and Related Disorders 16 10 (2018): 530-536. https://curis.ku.dk/portal/en/publications/determinants-of-fasting-hyperglucagonemia-in-patients-with-type-2-diabetes-and-nondiabetic-control-subjects(dab8c7ce-3bd0-47d2-a984-924d2289701b).html.
    10.1089/met.2018.0066
  174. Kirstine N. Bojsen-Møller; Anne-Marie Lundsgaard; Sten Madsbad; Bente Kiens; Jens Juul Holst. "Hepatic Insulin Clearance in Regulation of Systemic Insulin Concentrations—Role of Carbohydrate and Energy Availability". Diabetes 67 11 (2018): 2129-2136. https://doi.org/10.2337/db18-0539.
    10.2337/db18-0539
  175. Berit Svendsen; Olav Larsen; Maria Buur Nordskov Gabe; Charlotte Bayer Christiansen; Mette M Rosenkilde; Daniel J Drucker; Jens Juul Holst. "Insulin Secretion Depends on Intra-islet Glucagon Signaling". Cell Reports 25 5 (2018): 1127-1134.E2. https://curis.ku.dk/portal/en/publications/insulin-secretion-depends-on-intraislet-glucagon-signaling(7b6bd9cb-f73b-417b-a7a6-4f12b6d33420).html.
    10.1016/j.celrep.2018.10.018
  176. A. Lautenbach; M. Wernecke; N. Riedel; J. Veigel; J. Yamamura; S. Keller; R. Jung; et al. "Adaptive changes in pancreas post Roux-en-Y gastric bypass induced weight loss". Diabetes - Metabolism: Research and Reviews (Print Edition) 34 7 (2018): 1-8. https://curis.ku.dk/portal/en/publications/adaptive-changes-in-pancreas-post-rouxeny-gastric-bypass-induced-weight-loss(115e2b30-6ffb-476c-a9c3-e01b61139c51).html.
    10.1002/dmrr.3025
  177. Christina M. van der Beek; Emanuel E. Canfora; Anna M. Kip; Stefan H. M. Gorissen; Steven W. M. Olde Damink; Hans M. van Eijk; Jens Juul Holst; et al. "The prebiotic inulin improves substrate metabolism and promotes short-chain fatty acid production in overweight to obese men". Metabolism 87 (2018): 25-35. https://curis.ku.dk/portal/en/publications/the-prebiotic-inulin-improves-substrate-metabolism-and-promotes-shortchain-fatty-acid-production-in-overweight-to-obese-men(33103cc5-7d8b-4ba9-baa5-24f3d52143c0).html.
    10.1016/j.metabol.2018.06.009
  178. Amirsalar Samkani; Mads Skytte; Mads Thomsen; Arne Astrup; Carolyn Deacon; Jens Holst; Sten Madsbad; et al. "Acute Effects of Dietary Carbohydrate Restriction on Glycemia, Lipemia and Appetite Regulating Hormones in Normal-Weight to Obese Subjects". Nutrients 10 9 (2018): 1285-1285. https://doi.org/10.3390/nu10091285.
    10.3390/nu10091285
  179. Emilie S. Andersen; A. Lund; J. I. Bagger; C Andreasen; MF Grøndahl; Carolyn Deacon; Bolette Hartmann; et al. "Is glucagon-like peptide-1 fully protected by the dipeptidyl peptidase 4 inhibitor sitagliptin when administered to patients with type 2 diabetes?". Diabetes, Obesity and Metabolism 20 8 (2018): 1937-1943. https://curis.ku.dk/portal/en/publications/is-glucagonlike-peptide1-fully-protected-by-the-dipeptidyl-peptidase-4-inhibitor-sitagliptin-when-administered-to-patients-with-type-2-diabetes(631116d8-95cf-4875-a468-5b2fbc50d8bb).html.
    10.1111/dom.13321
  180. Andreas Brønden; Kristian Mikkelsen; David P. Sonne; Morten Hansen; Christoffer Våben; Maria Buur Nordskov Gabe; Mette Marie Rosenkilde; et al. "Glucose-lowering effects and mechanisms of the bile acid-sequestering resin sevelamer". Diabetes, Obesity and Metabolism 20 7 (2018): 1623-1631. https://curis.ku.dk/portal/en/publications/glucoselowering-effects-and-mechanisms-of-the-bile-acidsequestering-resin-sevelamer(cd0f7493-ed84-49d0-bd47-a43e3c28ad41).html.
    10.1111/dom.13272
  181. Charlotte Bayer Christiansen; Sara Lind Jepsen; Berit Svendsen; Emilie Balk-Møller; Tina Dahlby; Rune E Kuhre; Bolette Hartmann; et al. "Acute administration of interleukin-6 does not increase secretion of glucagon-like peptide-1 in mice". Physiological Reports 6 13 (2018): 1-8. https://curis.ku.dk/portal/en/publications/acute-administration-of-interleukin6-does-not-increase-secretion-of-glucagonlike-peptide1-in-mice(590abbe5-5642-4239-bad7-5f6bad975228).html.
    10.14814/phy2.13788
  182. Silvia R Coutinho; Jens F Rehfeld; Jens Juul Holst; Bård Kulseng; Catia Martins. "Impact of weight loss achieved through a multidisciplinary intervention on appetite in patients with severe obesity". American Journal of Physiology: Endocrinology and Metabolism 315 1 (2018): E91-E98. https://curis.ku.dk/portal/en/publications/impact-of-weight-loss-achieved-through-a-multidisciplinary-intervention-on-appetite-in-patients-with-severe-obesity(0d748250-f722-40be-b3f6-17c32bd7f794).html.
    10.1152/ajpendo.00322.2017
  183. Magnus F. Grøndahl; Jonatan I. Bagger; Asger Lund; Annesofie Faurschou; Jens F. Rehfeld; Jens J. Holst; Tina Vilsbøll; Filip K. Knop. "Effects of Smoking Versus Nonsmoking on Postprandial Glucose Metabolism in Heavy Smokers Compared With Nonsmokers". Diabetes Care 41 6 (2018): 1260-1267. https://doi.org/10.2337/dc17-1818.
    10.2337/dc17-1818
  184. Rasmus Hytting-Andreasen; Emilie Balk-Møller; Bolette Hartmann; Jens Pedersen; johanne agerlin Windeløv; Jens Juul Holst; Hannelouise Kissow. "Endogenous glucagon-like peptide- 1 and 2 are essential for regeneration after acute intestinal injury in mice". PLoS ONE 13 6 (2018): 1-14. https://curis.ku.dk/portal/en/publications/endogenous-glucagonlike-peptide-1-and-2-are-essential-for-regeneration-after-acute-intestinal-injury-in-mice(e4f1b915-c8f9-4158-92f5-f7b5a81df4dd).html.
    10.1371/journal.pone.0198046
  185. Bodil Just Christensen; Julie Berg Schmidt; Mette Søndergaard Nielsen; Louise Tækker; Lotte Holm; Susanne Lunn; Wender L.P. Bredie; et al. "Patient profiling for success after weight loss surgery (GO Bypass study): An interdisciplinary study protocol". Contemporary Clinical Trials Communications 10 (2018): 121-130. https://doi.org/10.1016/j.conctc.2018.02.002.
    10.1016/j.conctc.2018.02.002
  186. S Veedfald; A Plamboeck; Bolette Hartmann; T Vilsbøll; F K Knop; Carolyn Deacon; L B Svendsen; Jens Juul Holst. "Ghrelin secretion in humans - a role for the vagus nerve?". Neurogastroenterology and Motility 30 6 (2018): https://curis.ku.dk/portal/en/publications/ghrelin-secretion-in-humans--a-role-for-the-vagus-nerve(42515de7-4541-4d41-a263-0207d1a5bcf2).html.
    10.1111/nmo.13295
  187. Jens Juul Holst; Sten Madsbad; Kirstine N Bojsen-Møller; Maria Saur Svane; Nils Bruun Jørgensen; Carsten Dirksen; Christoffer Martinussen. "Mechanisms in bariatric surgery". Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery 14 5 (2018): 708-714. https://curis.ku.dk/portal/en/publications/mechanisms-in-bariatric-surgery(25c14ae7-9fe6-405b-98b7-cc0e64996b51).html.
    10.1016/j.soard.2018.03.003
  188. Ajenthen Ranjan; Kirsten Nørgaard; Rikke Tetzschner; Isabelle Isa Kristin Steineck; Trine Ryberg Clausen; Jens Juul Holst; Sten Madsbad; Signe Schmidt. "Effects of Preceding Ethanol Intake on Glucose Response to Low-Dose Glucagon in Individuals With Type 1 Diabetes: A Randomized, Placebo-Controlled, Crossover Study". Diabetes Care 41 4 (2018): 797-806. https://doi.org/10.2337/dc17-1458.
    10.2337/dc17-1458
  189. Rune Ehrenreich Kuhre; Nicolai Wewer Albrechtsen; Olav Larsen; Sara Lind Jepsen; Emilie Balk-Møller; Daniel Andersen; Carolyn Deacon; et al. "Bile acids are important direct and indirect regulators of the secretion of appetite- and metabolism-regulating hormones from the gut and pancreas.". Molecular Metabolism 11 (2018): 84-95. https://curis.ku.dk/portal/en/publications/bile-acids-are-important-direct-and-indirect-regulators-of-the-secretion-of-appetite-and-metabolismregulating-hormones-from-the-gut-and-pancreas(c3776646-bf4e-4caa-b8e2-487a952caba4).html.
    10.1016/j.molmet.2018.03.007
  190. Line Engelbrechtsen; Yuvaraj Mahendran; Anna Jonsson; Anette P Gjesing; Peter E Weeke; Marit E. Jørgensen; Kristine Færch; et al. "Common variants in the hERG (KCNH2) voltage-gated potassium channel are associated with altered fasting and glucose-stimulated plasma incretin and glucagon responses". B M C Genetics 19 1 (2018): 1-9. https://curis.ku.dk/portal/en/publications/common-variants-in-the-herg-kcnh2-voltagegated-potassium-channel-are-associated-with-altered-fasting-and-glucosestimulated-plasma-incretin-and-glucagon-responses(23421f77-277b-4090-b2ac-a2f676768c3a).html.
    10.1186/s12863-018-0602-2
  191. Christiansen CB; Gabe MBN; Svendsen B; Dragsted LO; Rosenkilde MM; Holst JJ. "The impact of short chain fatty acids on GLP-1 and PYY secretion from the isolated perfused rat colon.". American journal of physiology. Gastrointestinal and liver physiology (2018): http://europepmc.org/abstract/med/29494208.
    10.1152/ajpgi.00346.2017
  192. Anne Grethe Schioldan; Søren Gregersen; Stine Hald; Ann Bjørnshave; Mette Bohl; Bolette Hartmann; Jens Juul Holst; Hans Stødkilde-Jørgensen; Kjeld Hermansen. "Effects of a diet rich in arabinoxylan and resistant starch compared with a diet rich in refined carbohydrates on postprandial metabolism and features of the metabolic syndrome". European Journal of Nutrition 57 2 (2018): 795–807-795–807. https://curis.ku.dk/portal/en/publications/effects-of-a-diet-rich-in-arabinoxylan-and-resistant-starch-compared-with-a-diet-rich-in-refined-carbohydrates-on-postprandial-metabolism-and-features-of-the-metabolic-syndrome(a166eff8-ca41-4ba9-b56c-44bddb97933.
    10.1007/s00394-016-1369-8
  193. Nicolai Wewer Albrechtsen; Kristine Færch; Troels M Jensen; Daniel R Witte; Jens Pedersen; Yuvaraj Mahendran; Anna Jonsson; et al. "Evidence of a liver-alpha cell axis in humans". Diabetologia 61 3 (2018): 671-680. https://curis.ku.dk/portal/en/publications/evidence-of-a-liveralpha-cell-axis-in-humans(5e84c8a3-af4e-4347-8c2a-7f333afde9f4).html.
    10.1007/s00125-017-4535-5
  194. Ajenthen Ranjan; Sabrina L Wendt; Signe Schmidt; Sten Madsbad; Jens Juul Holst; Henrik Madsen; Carsten B Knudsen; John B Jørgensen; Kirsten Nørgaard. "Relationship between Optimum Mini-doses of Glucagon and Insulin Levels when Treating Mild Hypoglycaemia in Patients with Type 1 Diabetes". Basic & Clinical Pharmacology & Toxicology 122 3 (2018): 322-330. https://curis.ku.dk/portal/en/publications/relationship-between-optimum-minidoses-of-glucagon-and-insulin-levels-when-treating-mild-hypoglycaemia-in-patients-with-type-1-diabetes(dfd9155b-c879-4625-beff-55d6f4e1dc22).html.
    10.1111/bcpt.12907
  195. Tina Jorsal; Nicolai A. Rhee; Jens Pedersen; Camilla D. Wahlgren; Brynjulf Mortensen; Sara Lind Jepsen; Jacob Jelsing; et al. "Enteroendocrine K and L cells in healthy and type 2 diabetic individuals". Diabetologia 61 2 (2018): 284-294. https://curis.ku.dk/portal/en/publications/enteroendocrine-k-and-l-cells-in-healthy-and-type-2-diabetic-individuals(6b9e7f54-7bbd-4a77-bf25-2fbded9b5e3b).html.
    10.1007/s00125-017-4450-9
  196. Lærke Smidt Gasbjerg; Mikkel B Christensen; Bolette Hartmann; Amalie R Lanng; Alexander H Sparre-Ulrich; Maria Buur Nordskov Gabe; Flemming Dela; et al. "GIP(3-30)NH2 is an efficacious GIP receptor antagonist in humans". Diabetologia 61 2 (2018): 413-423. https://curis.ku.dk/portal/en/publications/gip330nh2-is-an-efficacious-gip-receptor-antagonist-in-humans(306ea785-4c4f-45e4-a283-77fc4e2a972d).html.
    10.1007/s00125-017-4447-4
  197. Andreas Brønden; Anders Albér; Ulrich Rohde; Lærke Smidt Gasbjerg; Jens F Rehfeld; Jens Juul Holst; Tina Vilsbøll; Filip K Knop. "The bile acid-sequestering resin sevelamer eliminates the acute GLP-1 stimulatory effect of endogenously released bile acids in patients with type 2 diabetes". Diabetes, Obesity and Metabolism 20 2 (2018): 362-369. https://curis.ku.dk/portal/en/publications/the-bile-acidsequestering-resin-sevelamer-eliminates-the-acute-glp1-stimulatory-effect-of-endogenously-released-bile-acids-in-patients-with-type-2-diabetes(edffa756-c54d-4e43-9472-e4c0006faccf).html.
    10.1111/dom.13080
  198. Holst JJ; Albrechtsen NJW; Gabe MBN; Rosenkilde MM. "Oxyntomodulin: Actions and role in diabetes.". Peptides (2018): http://europepmc.org/abstract/med/29412831.
    10.1016/j.peptides.2017.09.018
  199. Lærke Smidt Gasbjerg; Maria Buur Nordskov Gabe; Bolette Hartmann; Mikkel Bring Christensen; Filip Krag Knop; Jens Juul Holst; Mette Marie Rosenkilde. "Glucose-dependent insulinotropic polypeptide (GIP) receptor antagonists as anti-diabetic agents". Peptides 100 (2018): 173-181. https://curis.ku.dk/portal/en/publications/glucosedependent-insulinotropic-polypeptide-gip-receptor-antagonists-as-antidiabetic-agents(a1fe8ce2-79c9-465a-9150-426116f4d442).html.
    10.1016/j.peptides.2017.11.021
  200. Ann Bjørnshave; Jens Juul Holst; Kjeld Hermansen. "Pre-Meal Effect of Whey Proteins on Metabolic Parameters in Subjects with and without Type 2 Diabetes: A Randomized, Crossover Trial". Nutrients (2018): https://doi.org/10.3390/nu10020122.
    10.3390/nu10020122
  201. Emilie S. Andersen; Carolyn F. Deacon; Jens J. Holst. "Do we know the true mechanism of action of the DPP -4 inhibitors?". Diabetes, Obesity and Metabolism 20 1 (2018): 34-41. https://doi.org/10.1111/dom.13018.
    10.1111/dom.13018
  202. Mikkel B Christensen; Asger Lund; Salvatore Calanna; Niklas R Jørgensen; Jens Juul Holst; Tina Vilsbøll; Filip K Knop. "Glucose-Dependent Insulinotropic Polypeptide (GIP) Inhibits Bone Resorption Independently of Insulin and Glycemia". The Journal of clinical endocrinology and metabolism 103 1 (2018): 288-294. https://curis.ku.dk/portal/en/publications/glucosedependent-insulinotropic-polypeptide-gip-inhibits-bone-resorption-independently-of-insulin-and-glycemia(cff6fe60-0b54-4c4b-b70b-d53ccdcac912).html.
    10.1210/jc.2017-01949
  203. Nicolai Wewer Albrechtsen; Anders E Junker; Mette Christensen; Sofie Hædersdal; Flemming Wibrand; Allan M Lund; Katrine Douglas Galsgaard; et al. "Hyperglucagonemia correlates with plasma levels of non-branched-chain amino acids in patients with liver disease independent of type 2 diabetes". American Journal of Physiology: Gastrointestinal and Liver Physiology 314 1 (2018): G91-G96. https://curis.ku.dk/portal/en/publications/hyperglucagonemia-correlates-with-plasma-levels-of-nonbranchedchain-amino-acids-in-patients-with-liver-disease-independent-of-type-2-diabetes(85b29d76-a2e1-414d-bd49-bd3c7d654837).html.
    10.1152/ajpgi.00216.2017
  204. Katrine Douglas Galsgaard; Marie Winther-Sørensen; Cathrine Ørskov; Hannelouise Kissow; Steen Seier Poulsen; Hendrik Vilstrup; Cornelia Prehn; et al. "Disruption of glucagon receptor signaling causes hyperaminoacidemia exposing a possible liver-alpha-cell axis". American Journal of Physiology: Endocrinology and Metabolism 314 1 (2018): E93-E103. https://curis.ku.dk/portal/en/publications/disruption-of-glucagon-receptor-signaling-causes-hyperaminoacidemia-exposing-a-possible-liveralphacell-axis(1637564c-1834-4eea-85c3-81638942af29).html.
    10.1152/ajpendo.00198.2017
  205. Mandøe MJ; Hansen KB; Windeløv JA; Knop FK; Rehfeld JF; Rosenkilde MM; Holst JJ; Hansen HS. "Comparing olive oil and C4-dietary oil, a prodrug for the GPR119 agonist, 2-oleoyl glycerol, less energy intake of the latter is needed to stimulate incretin hormone secretion in overweight subjects with type 2 diabetes.". Nutrition & diabetes (2018): http://europepmc.org/abstract/med/29330461.
    10.1038/s41387-017-0011-z
  206. Gabe MBN; Sparre-Ulrich AH; Pedersen MF; Gasbjerg LS; Inoue A; Bräuner-Osborne H; Hartmann B; Rosenkilde MM. "Human GIP(3-30)NH2 inhibits G protein-dependent as well as G protein-independent signaling and is selective for the GIP receptor with high-affinity binding to primate but not rodent GIP receptors.". Biochemical pharmacology (2018): http://europepmc.org/abstract/med/29378179.
    10.1016/j.bcp.2018.01.040
  207. Signe Frøssing; Malin Nylander; Elizaveta Chabanova; Jan Frystyk; Jens Juul Holst; Caroline Kistorp; Sven O Skouby; Jens Faber. "Effect of liraglutide on ectopic fat in polycystic ovary syndrome". Diabetes, Obesity and Metabolism 20 1 (2018): 215-218. https://curis.ku.dk/portal/en/publications/effect-of-liraglutide-on-ectopic-fat-in-polycystic-ovary-syndrome(edf0ae48-8fcb-4d5a-ae31-0f8b3460abcb).html.
    10.1111/dom.13053
  208. Jens Juul Holst; Sten Madsbad. "Erratum to semaglutide seems to be more effective the other GLP-1Ras". Annals of Translational Medicine 6 3 (2018): 74-74. https://curis.ku.dk/portal/en/publications/erratum-to-semaglutide-seems-to-be-more-effective-the-other-glp1ras(3e26db73-d0c6-4c1d-bcfe-4951d533a2e2).html.
    10.21037/atm.2018.01.20
  209. Kirsten K. Ahring; Allan M. Lund; Erik Jensen; Thomas G. Jensen; Karen Brøndum-Nielsen; Michael Pedersen; Allan Bardow; et al. "Comparison of Glycomacropeptide with Phenylalanine Free-Synthetic Amino Acids in Test Meals to PKU Patients: No Significant Differences in Biomarkers, Including Plasma Phe Levels". Journal of Nutrition and Metabolism (2018): https://doi.org/10.1155/2018/6352919.
    10.1155/2018/6352919
  210. Jakob Starup-Linde; Sidse Westberg-Rasmussen; Simon Lykkeboe; Aase Handberg; Bolette Hartmann; Jens Juul Holst; Kjeld Hermansen; Peter Vestergaard; Søren Gregersen. "Glucose Tolerance Tests and Osteocalcin Responses in Healthy People". Frontiers in Endocrinology 9 (2018): https://curis.ku.dk/portal/en/publications/glucose-tolerance-tests-and-osteocalcin-responses-in-healthy-people(2d6342cf-5748-4c46-a4c9-d1825f0b8d7e).html.
    10.3389/fendo.2018.00356
  211. Amirsalar Samkani; Mads Gustav Juul Skytte; Daniel Kandel; Stine Kjaer; Arne Astrup; Carolyn Deacon; Jens Juul Holst; et al. "A carbohydrate-reduced high-protein diet acutely decreases postprandial and diurnal glucose excursions in type 2 diabetes patients". British Journal of Nutrition 119 8 (2018): 910-917. https://curis.ku.dk/portal/en/publications/a-carbohydratereduced-highprotein-diet-acutely-decreases-postprandial-and-diurnal-glucose-excursions-in-type-2-diabetes-patients(fc216f77-e8b0-4b2d-bccf-eda068c28489).html.
    10.1017/S0007114518000521
  212. Mark Hvistendahl; Christopher Filtenborg Brandt; Siri Tribler; Rahim Mohammad Naimi; Bolette Hartmann; Jens Juul Holst; Jens Frederik Rehfeld; et al. "Effect of liraglutide treatment on jejunostomy output in patients with short bowel syndrome". Journal of Parenteral and Enteral Nutrition 42 1 (2018): 112-121. https://curis.ku.dk/portal/en/publications/effect-of-liraglutide-treatment-on-jejunostomy-output-in-patients-with-short-bowel-syndrome(debdb33d-178d-442f-9a7f-20f51a6f1ef8).html.
    10.1177/0148607116672265
  213. Amirsalar Samkani; Mads Gustav Juul Skytte; Christian Anholm; Arne Astrup; Carolyn Deacon; Jens Juul Holst; Sten Madsbad; et al. "The acute effects of dietary carbohydrate reduction on postprandial responses of non-esterified fatty acids and triglycerides". Lipids in Health and Disease 17 (2018): https://curis.ku.dk/portal/en/publications/the-acute-effects-of-dietary-carbohydrate-reduction-on-postprandial-responses-of-nonesterified-fatty-acids-and-triglycerides(878c00d4-2cbb-4aa9-9cea-b56c053efd31).html.
    10.1186/s12944-018-0953-8
  214. Kristian H. Mikkelsen; Tina Vilsboll; Jens Juul Holst; Bolette Hartmann; Filip K. Knop; Morten Frost. "No changes in levels of bone formation and resorption markers following a broad-spectrum antibiotic course". BMC Endocrine Disorders 18 (2018): https://curis.ku.dk/portal/en/publications/no-changes-in-levels-of-bone-formation-and-resorption-markers-following-a-broadspectrum-antibiotic-course(c709aef7-ba01-424e-8227-82258436014e).html.
    10.1186/s12902-018-0291-x
  215. Md. Abdul Halim; Marie Degerblad; Magnus Sundbom; Urban Karlbom; Jens Juul Holst; Dominic-Luc Webb; Per M. Hellstrom. "Glucagon-Like Peptide-1 Inhibits Prandial Gastrointestinal Motility Through Myenteric Neuronal Mechanisms in Humans". Journal of Clinical Endocrinology & Metabolism 103 2 (2018): 575-585. https://curis.ku.dk/portal/en/publications/glucagonlike-peptide1-inhibits-prandial-gastrointestinal-motility-through-myenteric-neuronal-mechanisms-in-humans(88453a66-48ce-4441-9105-428d3c8ea658).html.
    10.1210/jc.2017-02006
  216. David L. Sigalet; Viona Lam; Mary Brindle; Dana Boctor; Laurie Wallace; Elaine de Heuval; Bolette Hartmann; Jens Juul Holst. "The glucagon like peptide-2 'axis'". Journal of Pediatric Surgery 53 5 (2018): 898-904. https://curis.ku.dk/portal/en/publications/the-glucagon-like-peptide2-axis(15c54a9e-2f60-40b3-b65c-ab9ec8148901).html.
    10.1016/j.jpedsurg.2018.02.012
  217. Emilie Bahne; Emily W L Sun; Richard L Young; Morten Hansen; David P Sonne; Jakob S Hansen; Ulrich Rohde; et al. "Metformin-induced glucagon-like peptide-1 secretion contributes to the actions of metformin in type 2 diabetes". JCI Insight 3 23 (2018): 1-16. https://curis.ku.dk/portal/en/publications/metformininduced-glucagonlike-peptide1-secretion-contributes-to-the-actions-of-metformin-in-type-2-diabetes(cd9f6791-5e6e-42db-8551-e736f309dc59).html.
    10.1172/jci.insight.93936
  218. Simon Veedfald; Tongzhi Wu; Michelle Bound; Jacqueline Grivell; Bolette Hartmann; Jens F. Rehfeld; Carolyn Deacon; et al. "Hyperosmolar Duodenal Saline Infusion Lowers Circulating Ghrelin and Stimulates Intestinal Hormone Release in Young Men". Journal of Clinical Endocrinology & Metabolism 103 12 (2018): 4409-4418. https://curis.ku.dk/portal/en/publications/hyperosmolar-duodenal-saline-infusion-lowers-circulating-ghrelin-and-stimulates-intestinal-hormone-release-in-young-men(3e96f502-3ab4-462f-8b5a-c3342d75198a).html.
    10.1210/jc.2018-00699
  219. Jens F. Rehfeld; Filip K. Knop; Ali Asmar; Sten Madsbad; Jens Juul Holst; Meena Asmar. "Cholecystokinin secretion is suppressed by glucagon-like peptide-1". Scandinavian Journal of Gastroenterology 53 12 (2018): 1429-1432. https://curis.ku.dk/portal/en/publications/cholecystokinin-secretion-is-suppressed-by-glucagonlike-peptide1(9090b7ad-4e7c-4499-a84b-c4b27219d2ed).html.
    10.1080/00365521.2018.1530297
  220. Märta Borghede; Lars Vinter-Jensen; Henrik H Rasmussen; Simon Veedfald; Jens F Rehfeld; Bolette Hartmann; Jens Juul Holst; Filip K Knop; David P Sonne. "Restoration of enteroendocrine and pancreatic function after internal hernia and short bowel syndrome in a young woman with gastric bypass". Physiological Reports 6 9 (2018): https://curis.ku.dk/portal/en/publications/restoration-of-enteroendocrine-and-pancreatic-function-after-internal-hernia-and-short-bowel-syndrome-in-a-young-woman-with-gastric-bypass(790ee659-e1f9-40a5-9c45-c5cdac063351).html.
    10.14814/phy2.13686
  221. José De Jesús Garduno-Garcia; Amalia Gastaldelli; Ralph A DeFronzo; Raweewan Lertwattanarak; Jens Juul Holst; Nicolas Musi. "Older subjects with ß-cell dysfunction have an accentuated incretin release". Journal of Clinical Endocrinology and Metabolism 103 7 (2018): 2613-2619. https://curis.ku.dk/portal/en/publications/older-subjects-with-cell-dysfunction-have-an-accentuated-incretin-release(a1d53193-0f24-402a-8fda-74eba2d610e5).html.
    10.1210/jc.2018-00260
  222. Nicolai Wewer Albrechtsen; Philipp E Geyer; Sophia Doll; Peter V Treit; Kirstine N Bojsen-Møller; Christoffer Martinussen; Nils B Jørgensen; et al. "Plasma Proteome Profiling Reveals Dynamics of Inflammatory and Lipid Homeostasis Markers after Roux-En-Y Gastric Bypass Surgery". Cell Systems 7 6 (2018): 601-612. https://curis.ku.dk/portal/en/publications/plasma-proteome-profiling-reveals-dynamics-of-inflammatory-and-lipid-homeostasis-markers-after-rouxeny-gastric-bypass-surgery(6445e470-eef1-4503-81f8-510861746fbb).html.
    10.1016/j.cels.2018.10.012
  223. Lea Benedicte Skov Hansen; Henrik Munch Roager; Nadja Buus Søndertoft; Rikke Juul Gøbel; Mette Kristensen; Mireia Vallès-Colomer; Sara Vieira-Silva; et al. "A low-gluten diet induces changes in the intestinal microbiome of healthy Danish adults". Nature Communications 9 (2018): https://curis.ku.dk/portal/en/publications/a-lowgluten-diet-induces-changes-in-the-intestinal-microbiome-of-healthy-danish-adults(32f6a287-6b33-4713-9058-05a50fee0140).html.
    10.1038/s41467-018-07019-x
  224. S. Carnell; C. Grillot; T. Ungredda; S. Ellis; N. Mehta; Jens Juul Holst; A. Geliebter. "Morning and afternoon appetite and gut hormone responses to meal and stress challenges in obese individuals with and without binge eating disorder". International Journal of Obesity 42 4 (2018): 841-849. https://curis.ku.dk/portal/en/publications/morning-and-afternoon-appetite-and-gut-hormone-responses-to-meal-and-stress-challenges-in-obese-individuals-with-and-without-binge-eating-disorder(5a8da151-4624-47de-99ee-6034e6d8fc4e).html.
    10.1038/ijo.2017.307
  225. Qing-Run Li; Zi-Ming Wang; Nicolai Wewer Albrechtsen; Dan-Dan Wang; Zhi-Duan Su; Xian-Fu Gao; Qing-Qing Wu; et al. "Systems signatures reveal unique remission-path of Type 2 diabetes following Roux-en-Y gastric bypass surgery". EBioMedicine 28 (2018): 234-240. https://curis.ku.dk/portal/en/publications/systems-signatures-reveal-unique-remissionpath-of-type-2-diabetes-following-rouxeny-gastric-bypass-surgery(02afc2e8-4e62-4a8f-a3e6-5b0e26127bae).html.
    10.1016/j.ebiom.2018.01.018
  226. Natalia Petersen; Thomas Frimruer; Marianne Terndrup Pedersen; Kristoffer Lihme Egerod; Nicolai Wewer Albrechtsen; Jens Juul Holst; Anne Grapin-Botton; Kim Jensen; Thue W. Schwartz. "Inhibiting RHOA Signaling in Mice Increases Glucose Tolerance and Numbers of Enteroendocrine and Other Secretory Cells in the Intestine". Gastroenterology 155 4 (2018): 1164-1176. https://curis.ku.dk/portal/en/publications/inhibiting-rhoa-signaling-in-mice-increases-glucose-tolerance-and-numbers-of-enteroendocrine-and-other-secretory-cells-in-the-intestine(c15034a5-87cd-40f1-986f-c7c49b0cbef0).html.
    10.1053/j.gastro.2018.06.039
  227. Mette S Schmedes; Line Bendtsen; Sisse Gomes; Bjørn Liaset; Jens Juul Holst; Christian Ritz; Søren Reitelseder; et al. "The effect of casein, hydrolyzed casein, and whey proteins on urinary and postprandial plasma metabolites in overweight and moderately obese human subjects". Journal of the Science of Food and Agriculture 98 15 (2018): 5598-5605. https://curis.ku.dk/portal/en/publications/the-effect-of-casein-hydrolyzed-casein-and-whey-proteins-on-urinary-and-postprandial-plasma-metabolites-in-overweight-and-moderately-obese-human-subjects(0e667ccd-5b61-4caa-aa0a-ad1c6a61bc30).html.
    10.1002/jsfa.9103
  228. Louise Lang Lehrskov; Mark Preben Lyngbaek; Line Soederlund; Grit Elster Legaard; Jan Adam Ehses; Sarah Elizabeth Heywood; Nicolai Wewer Albrechtsen; et al. "Interleukin-6 Delays Gastric Emptying in Humans with Direct Effects on Glycemic Control". Cell Metabolism 27 6 (2018): 1201-1211. https://curis.ku.dk/portal/en/publications/interleukin6-delays-gastric-emptying-in-humans-with-direct-effects-on-glycemic-control(303646ea-99da-404c-a430-ee2b7b3ff139).html.
    10.1016/j.cmet.2018.04.008
  229. Eva Winning Iepsen; Jinyi Zhang; Henrik S. Thomsen; Elizaveta L Hansen; Mette Hollensted; Sten Madsbad; Torben Hansen; et al. "Patients with Obesity Caused by Melanocortin-4 Receptor Mutations Can Be Treated with a Glucagon-like Peptide-1 Receptor Agonist". Cell Metabolism 28 1 (2018): 23-32.e3. https://curis.ku.dk/portal/en/publications/patients-with-obesity-caused-by-melanocortin4-receptor-mutations-can-be-treated-with-a-glucagonlike-peptide1-receptor-agonist(13da1155-e04d-4ca8-b247-effd7f585f46).html.
    10.1016/j.cmet.2018.05.008
  230. A D M Koopman; F Rutters; S P Rauh; G Nijpels; Jens Juul Holst; J W Beulens; M. Alssema; J M Dekker. "Incretin responses to oral glucose and mixed meal tests and changes in fasting glucose levels during 7 years of follow-up". PloS one 13 1 (2018): https://curis.ku.dk/portal/en/publications/incretin-responses-to-oral-glucose-and-mixed-meal-tests-and-changes-in-fasting-glucose-levels-during-7-years-of-followup(2cfbfc80-5b9f-4c41-adb5-5c096156765b).html.
    10.1371/journal.pone.0191114
  231. Giovanna Muscogiuri; Giancarlo Balercia; Luigi Barrea; Angelo Cignarelli; Francesco Giorgino; Jens Juul Holst; Daniela Laudisio; et al. "Gut". Critical Reviews in Food Science and Nutrition 58 8 (2018): 1294–1309-1294–1309. https://curis.ku.dk/portal/en/publications/gut(80f7b0d0-f192-4b9c-ac27-9c59b7078ba1).html.
    10.1080/10408398.2016.1252712
  232. Rune Ehrenreich Kuhre; Charlotte Bayer Christiansen; Monika Yosifova Saltiel; Nicolai Wewer Albrechtsen; Jens Juul Holst. "On the relationship between glucose absorption and glucose-stimulated secretion of GLP-1, neurotensin, and PYY from different intestinal segments in the rat". Physiological Reports 5 23 (2017): https://curis.ku.dk/portal/en/publications/on-the-relationship-between-glucose-absorption-and-glucosestimulated-secretion-of-glp1-neurotensin-and-pyy-from-different-intestinal-segments-in-the-rat(703d8603-a142-4aba-9888-2aaefba781f1).html.
    10.14814/phy2.13507
  233. George Tharakan; Preeshila Behary; Nicolai Wewer Albrechtsen; Harvinder Chahal; Julia Kenkre; Alexander D Miras; Ahmed R Ahmed; et al. "Roles of increased glycemic variability, GLP-1 and glucagon in hypoglycaemia after Roux-en-Y gastric bypass". European Journal of Endocrinology 177 (2017): 455-464. https://curis.ku.dk/portal/en/publications/roles-of-increased-glycemic-variability-glp1-and-glucagon-in-hypoglycaemia-after-rouxeny-gastric-bypass(3a2ca882-1d0d-4a0a-b71a-d4f40baf80d9).html.
    10.1530/EJE-17-0446
  234. Jonas Ronn; Elisa P Jensen; Nicolai Wewer Albrechtsen; Jens Juul Holst; Charlotte Mehlin Sørensen. "Glucagon-like peptide-1 acutely affects renal blood flow and urinary flow rate in spontaneously hypertensive rats despite significantly reduced renal expression of GLP-1 receptors". Physiological Reports 5 23 (2017): https://curis.ku.dk/portal/en/publications/glucagonlike-peptide1-acutely-affects-renal-blood-flow-and-urinary-flow-rate-in-spontaneously-hypertensive-rats-despite-significantly-reduced-renal-expression-of-glp1-receptors(bc72dab9-f3ff-4f14-826c-b9556498cfc.
    10.14814/phy2.13503
  235. Line Engelbrechtsen; Jens Lundgren; Nicolai Wewer Albrechtsen; Yuvaraj Mahendran; Eva Winning Iepsen; P. Finocchietto; Anna Jonsson; et al. "Treatment with liraglutide may improve markers of CVD reflected by reduced levels of apoB". Obesity Science & Practice 3 4 (2017): 425-433. https://curis.ku.dk/portal/en/publications/treatment-with-liraglutide-may-improve-markers-of-cvd-reflected-by-reduced-levels-of-apob(e3e7d45b-9c52-45a8-a4d7-22a59392313e).html.
    10.1002/osp4.133
  236. M S Svane; M B Toft-Nielsen; V B Kristiansen; Bolette Hartmann; Jens Juul Holst; S Madsbad; K N Bojsen-Møller. "Nutrient re-routing and altered gut-islet cell crosstalk may explain early relief of severe postprandial hypoglycaemia after reversal of Roux-en-Y gastric bypass". Diabetic Medicine Online 34 12 (2017): 1783-1787. https://curis.ku.dk/portal/en/publications/nutrient-rerouting-and-altered-gutislet-cell-crosstalk-may-explain-early-relief-of-severe-postprandial-hypoglycaemia-after-reversal-of-rouxeny-gastric-bypass(a144e8cd-582e-4c01-ba0e-a6f7198f5462).html.
    10.1111/dme.13443
  237. Bodil Just Christensen; Eva Winning Iepsen; Julie Rehné Lundgren; Lotte Holm; Sten Madsbad; Jens Juul Holst; Signe Torekov. "Instrumentalization of eating improves weight loss maintenance in obesity". Obesity Facts 10 6 (2017): 633-647. https://curis.ku.dk/portal/en/publications/instrumentalization-of-eating-improves-weight-loss-maintenance-in-obesity(49c7e457-96df-4f7e-9dd4-77467fe8c97a).html.
    10.1159/000481138
  238. A. Tura; J. I. Bagger; E. Ferrannini; Jens Juul Holst; F. K. Knop; T. Vilsbøll; A. Mari. "Impaired beta cell sensitivity to incretins in type 2 diabetes is insufficiently compensated by higher incretin response". Nutrition, Metabolism and Cardiovascular Diseases 27 12 (2017): 1123-1129. https://curis.ku.dk/portal/en/publications/impaired-beta-cell-sensitivity-to-incretins-in-type-2-diabetes-is-insufficiently-compensated-by-higher-incretin-response(f1ea5bb2-a54b-4c4c-b05f-7231fbd0069a).html.
    10.1016/j.numecd.2017.10.006
  239. Peter Almgren; Andreas Lindqvist; Ulrika Krus; Liisa Hakaste; Emilia Ottosson-Laakso; Olof Asplund; Emily Sonestedt; et al. "Genetic determinants of circulating GIP and GLP-1 concentrations". JCI insight 2 21 (2017): https://curis.ku.dk/portal/en/publications/genetic-determinants-of-circulating-gip-and-glp1-concentrations(b0c80ccf-f30c-4be6-9cac-13565d52b28c).html.
    10.1172/jci.insight.93306
  240. Sabrina Lyngbye Wendt; Ajenthen Ranjan; Jan Kloppenborg Møller; Signe Schmidt; Carsten Boye Knudsen; Jens Juul Holst; Sten Madsbad; et al. "Cross-Validation of a Glucose-Insulin-Glucagon Pharmacodynamics Model for Simulation Using Data From Patients With Type 1 Diabetes". Journal of Diabetes Science and Technology 11 6 (2017): 1101-1111. https://curis.ku.dk/portal/en/publications/crossvalidation-of-a-glucoseinsulinglucagon-pharmacodynamics-model-for-simulation-using-data-from-patients-with-type-1-diabetes(c411a33f-7b07-4063-8982-702f43d2e805).html.
    10.1177/1932296817693254
  241. Steven E Thiessen; Sarah Derde; Inge Derese; Thomas Dufour; Chloé Albert Vega; Lies Langouche; Chloë Goossens; et al. "Role of Glucagon in Catabolism and Muscle Wasting of Critical Illness and Modulation by Nutrition". American Journal of Respiratory and Critical Care Medicine 196 9 (2017): 1131-1143. https://curis.ku.dk/portal/en/publications/role-of-glucagon-in-catabolism-and-muscle-wasting-of-critical-illness-and-modulation-by-nutrition(ef860e75-cbba-4c63-b605-d6fd8f9e6b55).html.
    10.1164/rccm.201702-0354OC
  242. Nicolai Wewer Albrechtsen; Rune E. Kuhre; Daniel Hornburg; Christian Z. Jensen; Mads Hornum; Carsten Dirksen; Maria Svane; et al. "Circulating Glucagon 1-61 Regulates Blood Glucose by Increasing Insulin Secretion and Hepatic Glucose Production". Cell Reports 21 6 (2017): 1452-1460. https://curis.ku.dk/portal/en/publications/circulating-glucagon-161-regulates-blood-glucose-by-increasing-insulin-secretion-and-hepatic-glucose-production(5de0f9aa-7d95-4884-a486-1ef985f758da).html.
    10.1016/j.celrep.2017.10.034
  243. Andreas Brønden; Anders Albér; Ulrich Rohde; Jens F Rehfeld; Jens Juul Holst; Tina Vilsbøll; Filip K Knop. "Single-Dose Metformin Enhances Bile Acid-Induced Glucagon-Like Peptide-1 Secretion in Patients With Type 2 Diabetes". The Journal of clinical endocrinology and metabolism 102 11 (2017): 4153-4162. https://curis.ku.dk/portal/en/publications/singledose-metformin-enhances-bile-acidinduced-glucagonlike-peptide1-secretion-in-patients-with-type-2-diabetes(a881828d-f36c-49de-9101-6fb012f4be1c).html.
    10.1210/jc.2017-01091
  244. Jennifer S Ten Kulve; Dick J Veltman; Victor E A Gerdes; Liselotte van Bloemendaal; Frederik Barkhof; Carolyn Deacon; Jens Juul Holst; et al. "Elevated Postoperative Endogenous GLP-1 Levels Mediate Effects of Roux-en-Y Gastric Bypass on Neural Responsivity to Food Cues". Diabetes Care 40 11 (2017): 1522-1529. https://curis.ku.dk/portal/en/publications/elevated-postoperative-endogenous-glp1-levels-mediate-effects-of-rouxeny-gastric-bypass-on-neural-responsivity-to-food-cues(88b55633-a5d3-4e23-8f63-db4d766478ca).html.
    10.2337/dc16-2113
  245. Lena Mumme; Thomas G.K. Breuer; Stephan Rohrer; Nina Schenker; Björn A. Menge; Jens J. Holst; Michael A. Nauck; Juris J. Meier. "Defects in a-Cell Function in Patients With Diabetes Due to Chronic Pancreatitis Compared With Patients With Type 2 Diabetes and Healthy Individuals". Diabetes Care (2017): dc170792-dc170792. https://doi.org/10.2337/dc17-0792.
    10.2337/dc17-0792
  246. David L Sigalet; Mary Brindle; Dana Boctor; Linda Casey; Bryan Dicken; Sonia Butterworth; Viona Lam; et al. "Safety and Dosing Study of Glucagon-Like Peptide 2 in Children With Intestinal Failure". Journal of Parenteral and Enteral Nutrition 41 5 (2017): 844-852. https://curis.ku.dk/portal/en/publications/safety-and-dosing-study-of-glucagonlike-peptide-2-in-children-with-intestinal-failure(2eee8c80-1352-491e-a4ee-146e126a8c4e).html.
    10.1177/0148607115609566
  247. Ajenthen Ranjan; Signe Schmidt; Camilla Damm-Frydenberg; Jens Juul Holst; Sten Madsbad; Kirsten Nørgaard. "Short-term effects of a low carbohydrate diet on glycaemic variables and cardiovascular risk markers in patients with type 1 diabetes". Diabetes, Obesity and Metabolism 19 10 (2017): 1479-1484. https://curis.ku.dk/portal/en/publications/shortterm-effects-of-a-low-carbohydrate-diet-on-glycaemic-variables-and-cardiovascular-risk-markers-in-patients-with-type-1-diabetes(585de7a7-cf19-4e61-b017-f0ec84b0b1ed).html.
    10.1111/dom.12953
  248. Ruud S. Kootte; Evgeni Levin; Jarkko Salojärvi; Loek P. Smits; Annick V. Hartstra; Shanti D. Udayappan; Gerben Hermes; et al. "Improvement of Insulin Sensitivity after Lean Donor Feces in Metabolic Syndrome Is Driven by Baseline Intestinal Microbiota Composition". Cell Metabolism 26 4 (2017): 611-619.e6. https://curis.ku.dk/portal/en/publications/improvement-of-insulin-sensitivity-after-lean-donor-feces-in-metabolic-syndrome-is-driven-by-baseline-intestinal-microbiota-composition(c47b215c-191b-4b49-8cd3-975752023673).html.
    10.1016/j.cmet.2017.09.008
  249. Rikke M Røge; Jonatan I Bagger; Oskar Alskär; Niels R Kristensen; Søren Klim; Jens Juul Holst; Steen H Ingwersen; et al. "Mathematical Modelling of Glucose-Dependent Insulinotropic Polypeptide and Glucagon-like Peptide-1 following Ingestion of Glucose". Basic & Clinical Pharmacology & Toxicology 121 4 (2017): 290-297. https://curis.ku.dk/portal/en/publications/mathematical-modelling-of-glucosedependent-insulinotropic-polypeptide-and-glucagonlike-peptide1-following-ingestion-of-glucose(55ac0027-2379-4fd3-8179-466d15afceb7).html.
    10.1111/bcpt.12792
  250. johanne agerlin Windeløv; Nicolai Wewer Albrechtsen; Rune E Kuhre; Sara Lind Jepsen; Daniel Hornburg; Jens Pedersen; Elisa P Jensen; et al. "Why is it so difficult to measure glucagon-like peptide-1 in a mouse?". Diabetologia 60 10 (2017): 2066-2075. https://curis.ku.dk/portal/en/publications/why-is-it-so-difficult-to-measure-glucagonlike-peptide1-in-a-mouse(1c2dfeff-ef51-404e-ba2e-21bc03527a9f).html.
    10.1007/s00125-017-4347-7
  251. Nicolai Wewer Albrechtsen; Ali Asmar; Frederik Jensen; Signe Törang; Lene Simonsen; Rune E Kuhre; Meena Asmar; et al. "A sandwich ELISA for measurement of the primary glucagon-like peptide-1 metabolite". American Journal of Physiology: Endocrinology and Metabolism 313 3 (2017): E284-E291. https://curis.ku.dk/portal/en/publications/a-sandwich-elisa-for-measurement-of-the-primary-glucagonlike-peptide1-metabolite(3c9365ac-1827-4f4d-a5cb-26c8c22273d3).html.
    10.1152/ajpendo.00005.2017
  252. Catia Martins; Irina Aschehoug; Marit Ludviksen; Jens Juul Holst; Graham Finlayson; Ulrik Wisloff; Linda Morgan; Neil King; Bård Kulseng. "High-Intensity Interval Training, Appetite, and Reward Value of Food in the Obese". Medicine and Science in Sports and Exercise 49 9 (2017): 1851-1858. https://curis.ku.dk/portal/en/publications/highintensity-interval-training-appetite-and-reward-value-of-food-in-the-obese(dbfb7a9a-310c-497d-aba6-3b47b5519b24).html.
    10.1249/MSS.0000000000001296
  253. Anne Ørgaard; Jens Juul Holst. "The role of somatostatin in GLP-1-induced inhibition of glucagon secretion in mice". Diabetologia 60 9 (2017): 1731-1739. https://curis.ku.dk/portal/en/publications/the-role-of-somatostatin-in-glp1induced-inhibition-of-glucagon-secretion-in-mice(e5579c4d-e158-455d-adf7-36f547fa0460).html.
    10.1007/s00125-017-4315-2
  254. Meena Asmar; Ali Asmar; Lene Simonsen; Lærke Smidt Gasbjerg; Alexander Hovard Sparre-Ulrich; Mette Marie Rosenkilde; Bolette Hartmann; et al. "The Gluco- and Liporegulatory and Vasodilatory Effects of Glucose-Dependent Insulinotropic Polypeptide (GIP) Are Abolished by an Antagonist of the Human GIP Receptor". Diabetes (2017): db170480-db170480. https://doi.org/10.2337%2Fdb17-0480.
    10.2337/db17-0480
  255. Ursula Kehlet; Josephine Kofod; Jens J Holst; Christian Ritz; Margit D Aaslyng; Anne Raben. "Addition of Rye Bran and Pea Fiber to Pork Meatballs Enhances Subjective Satiety in Healthy Men, but Does Not Change Glycemic or Hormonal Responses: A Randomized Crossover Meal Test Study". The Journal of Nutrition (2017):
    10.3945/jn.117.250332
  256. Stephen J D O'Keefe; Tina Rakitt; Junhai Ou; Ihab I El Hajj; Elizabeth Blaney; Kishore Vipperla; Jens Juul Holst; Jens Rehlfeld. "Pancreatic and Intestinal Function Post Roux-en-Y Gastric Bypass Surgery for Obesity". Clinical and Translational Gastroenterology 8 (2017): https://curis.ku.dk/portal/en/publications/pancreatic-and-intestinal-function-post-rouxeny-gastric-bypass-surgery-for-obesity(5e1cf45c-1fe6-4ddb-8f7c-08e91e09a53a).html.
    10.1038/ctg.2017.39
  257. Louise Hyltén-Cavallius; Eva Winning Iepsen; Michael Christiansen; Claus Graff; Linneberg A; Oluf Pedersen; Jens Juul Holst; et al. "Glucose ingestion causes cardiac repolarization disturbances in type 1 long QT syndrome patients and healthy subjects". Heart Rhythm 14 8 (2017): 1165-1170. https://curis.ku.dk/portal/en/publications/glucose-ingestion-causes-cardiac-repolarization-disturbances-in-type-1-long-qt-syndrome-patients-and-healthy-subjects(e05b4e29-e5ae-4be6-bf4e-08ff961eb11a).html.
    10.1016/j.hrthm.2017.04.018
  258. Julie R Larsen; Louise Vedtofte; Mathilde S L Jakobsen; Hans R Jespersen; Michelle I Jakobsen; Camilla K Svensson; Kamuran Koyuncu; et al. "Effect of Liraglutide Treatment on Prediabetes and Overweight or Obesity in Clozapine- or Olanzapine-Treated Patients With Schizophrenia Spectrum Disorder". J A M A Psychiatry 74 7 (2017): 719-728. https://curis.ku.dk/portal/en/publications/effect-of-liraglutide-treatment-on-prediabetes-and-overweight-or-obesity-in-clozapine-or-olanzapinetreated-patients-with-schizophrenia-spectrum-disorder(8f607aed-ae3b-40d8-ba3a-1dd885542d9e).html.
    10.1001/jamapsychiatry.2017.1220
  259. Tricia Tan; Preeshila Behary; George Tharakan; James Minnion; Werd Al-Najim; Nicolai Wewer Albrechtsen; Jens Juul Holst; Stephen R Bloom. "The effect of a subcutaneous infusion of GLP-1, OXM and PYY on Energy intake and Expenditure in Obese volunteers". The Journal of clinical endocrinology and metabolism 102 7 (2017): 2364-2372. https://curis.ku.dk/portal/en/publications/the-effect-of-a-subcutaneous-infusion-of-glp1-oxm-and-pyy-on-energy-intake-and-expenditure-in-obese-volunteers(22ebce3e-c071-4fa9-bfd5-643cea59cb4a).html.
    10.1210/jc.2017-00469
  260. Signe Foghsgaard; Louise Vedtofte; Camilla Andreasen; Emilie S Andersen; Emilie Bahne; Jonatan I Bagger; Jens A Svare; et al. "Women with prior gestational diabetes mellitus and prediabetes are characterised by a decreased incretin effect". Diabetologia 60 7 (2017): 1344-1353. https://curis.ku.dk/portal/en/publications/women-with-prior-gestational-diabetes-mellitus-and-prediabetes-are-characterised-by-a-decreased-incretin-effect(899f18b0-56ec-40d1-ae37-54080eabde02).html.
    10.1007/s00125-017-4265-8
  261. Emanuel E Canfora; Christina M van der Beek; Gerben D A Hermes; Gijs H Goossens; Johan W E Jocken; Jens Juul Holst; Hans M van Eijk; et al. "Supplementation of Diet With Galacto-oligosaccharides Increases Bifidobacteria, but Not Insulin Sensitivity, in Obese Prediabetic Individuals". Gastroenterology 153 1 (2017): 87-97.e3. https://curis.ku.dk/portal/en/publications/supplementation-of-diet-with-galactooligosaccharides-increases-bifidobacteria-but-not-insulin-sensitivity-inobeseprediabetic-individuals(4a5487a9-8c02-4762-8450-a60555548c1f).html.
    10.1053/j.gastro.2017.03.051
  262. N Matikainen; S Söderlund; E Björnson; L H Bogl; K H Pietiläinen; A Hakkarainen; N Lundbom; et al. "Fructose intervention for 12 weeks does not impair glycemic control or incretin hormone responses during oral glucose or mixed meal tests in obese men". Nutrition, Metabolism & Cardiovascular Diseases 27 6 (2017): 534-542. https://curis.ku.dk/portal/en/publications/fructose-intervention-for-12-weeks-does-not-impair-glycemic-control-or-incretin-hormone-responses-during-oral-glucose-or-mixed-meal-tests-in-obese-men(0d1844e2-6b73-4862-acd8-5cf0d8508713).html.
    10.1016/j.numecd.2017.03.003
  263. Nicolai Wewer Albrechtsen; Kristina W Poulsen; Lærke Ø Svensson; Lasse X Jensen; Jens Juul Holst; Signe Torekov. "Health care professionals from developing countries report educational benefits after an online diabetes course". B M C Medical Education 17 (2017): https://curis.ku.dk/portal/en/publications/health-care-professionals-from-developing-countries-report-educational-benefits-after-an-online-diabetes-course(aedf7522-b3b1-4ff4-85fe-f89ebac7a943).html.
    10.1186/s12909-017-0935-y
  264. Emanuel E Canfora; Christina M van der Beek; Johan W E Jocken; Gijs H Goossens; Jens Juul Holst; Steven W M Olde Damink; Kaatje Lenaerts; Cornelis H C Dejong; Ellen E Blaak. "Colonic infusions of short-chain fatty acid mixtures promote energy metabolism in overweight/obese men". Scientific Reports 7 (2017): https://curis.ku.dk/portal/en/publications/colonic-infusions-of-shortchain-fatty-acid-mixtures-promote-energy-metabolism-in-overweightobese-men(95ee1039-ba3a-4fd7-a7b4-782a048d4ac9).html.
    10.1038/s41598-017-02546-x
  265. Sten Madsbad; Jens Juul Holst. "Glycaemic control and weight loss with semaglutide in type 2 diabetes". The Lancet Diabetes and Endocrinology 5 5 (2017): 315-317. https://curis.ku.dk/portal/en/publications/glycaemic-control-and-weight-loss-with-semaglutide-in-type-2-diabetes(72797d69-5e52-454b-a928-fb376575e765).html.
    10.1016/S2213-8587(17)30094-3
  266. Yongjia Feng; Farok R Demehri; Weidong Xiao; Yu-Hwai Tsai; Jennifer C Jones; Constance D Brindley; David W Threadgill; et al. "Interdependency of EGF and GLP-2 Signaling in Attenuating Mucosal Atrophy in a Mouse Model of Parenteral Nutrition". Cellular and molecular gastroenterology and hepatology 3 3 (2017): 447-468. https://curis.ku.dk/portal/en/publications/interdependency-of-egf-and-glp2-signaling-in-attenuating-mucosal-atrophy-in-a-mouse-model-of-parenteral-nutrition(92f83798-6244-4ced-9958-df680c778774).html.
    10.1016/j.jcmgh.2016.12.005
  267. Janssens R; Mortier A; Boff D; Ruytinx P; Gouwy M; Vantilt B; Larsen O; et al. "Truncation of CXCL12 by CD26 reduces its CXC chemokine receptor 4- and atypical chemokine receptor 3-dependent activity on endothelial cells and lymphocytes.". Biochemical pharmacology (2017): http://europepmc.org/abstract/med/28322746.
    10.1016/j.bcp.2017.03.009
  268. Dorte Glintborg; Hanne Mumm; Jens Juul Holst; Marianne Andersen. "Effect of oral contraceptives and/or metformin on GLP-1 secretion and reactive hypoglycaemia in polycystic ovary syndrome". Endocrine Connections 6 4 (2017): 267-277. https://curis.ku.dk/portal/en/publications/effect-of-oral-contraceptives-andor-metformin-on-glp1-secretion-and-reactive-hypoglycaemia-in-polycystic-ovary-syndrome(d0d63460-d937-45fb-9021-b068586158be).html.
    10.1530/EC-17-0034
  269. Sidse Westberg-Rasmussen; Jakob Starup-Linde; Kjeld Hermansen; Jens Juul Holst; Bolette Hartmann; Peter Vestergaard; Søren Gregersen. "Differential impact of glucose administered intravenously or orally on bone turnover markers in healthy male subjects". Bone 97 (2017): 261-266. https://curis.ku.dk/portal/en/publications/differential-impact-of-glucose-administered-intravenously-or-orally-on-bone-turnover-markers-in-healthy-male-subjects(e217689c-43b8-4128-a139-cfb10eebe46c).html.
    10.1016/j.bone.2017.01.027
  270. Holst, Jens. "Sweet Taste Receptor Activation in the Gut Is of Limited Importance for Glucose-Stimulated GLP-1 and GIP Secretion". Nutrients (2017): http://www.mdpi.com/2072-6643/9/4/418.
    10.3390/nu9040418
  271. Christian Seerup Frandsen; Thomas Fremming Dejgaard; Henrik Ullits Andersen; Jens Juul Holst; Bolette Hartmann; Birger Thorsteinsson; Sten Madsbad. "Liraglutide as adjunct to insulin treatment in type 1 diabetes does not interfere with glycaemic recovery or gastric emptying rate during hypoglycaemia". Diabetes, Obesity and Metabolism 19 6 (2017): 773-782. https://curis.ku.dk/portal/en/publications/liraglutide-as-adjunct-to-insulin-treatment-in-type-1-diabetes-does-not-interfere-with-glycaemic-recovery-or-gastric-emptying-rate-during-hypoglycaemia(46f661b9-c971-47d1-8127-12c8c713befd).html.
    10.1111/dom.12830
  272. S. Y. Morrison; J. J. Pastor; J. C. Quintela; Jens Juul Holst; Bolette Hartmann; J. K. Drackley; I. R. Ipharraguerre. "Short communication". Journal of Dairy Science 100 3 (2017): 1940-1945. https://curis.ku.dk/portal/en/publications/short-communication(3c467714-1039-415b-b925-db90252986cd).html.
    10.3168/jds.2016-11810
  273. Sravan K Thondam; Christina Daousi; John P H Wilding; Jens Juul Holst; Gulizar I Ameen; Chenjing Yang; Catherine Whitmore; Silvia Mora; Daniel J Cuthbertson. "Glucose-dependent insulinotropic polypeptide promotes lipid deposition in subcutaneous adipocytes in obese type 2 diabetes patients". American Journal of Physiology: Endocrinology and Metabolism 312 3 (2017): E224-E233. https://curis.ku.dk/portal/en/publications/glucosedependent-insulinotropic-polypeptide-promotes-lipid-deposition-in-subcutaneous-adipocytes-in-obese-type-2-diabetes-patients(8f540cc8-54b8-4187-8384-99b626060571).html.
    10.1152/ajpendo.00347.2016
  274. Colleen M Craig; Li-Fen Liu; Carolyn Deacon; Jens Juul Holst; Tracey L McLaughlin. "Critical role for GLP-1 in symptomatic post-bariatric hypoglycaemia". Diabetologia 60 3 (2017): 531-540. https://curis.ku.dk/portal/en/publications/critical-role-for-glp1-in-symptomatic-postbariatric-hypoglycaemia(d0b6e223-a06d-467b-9fd9-3a4017ef9c0c).html.
    10.1007/s00125-016-4179-x
  275. Michael A Nauck; Melanie Kahle; Oleg Baranov; Carolyn Deacon; Jens Juul Holst. "Addition of a dipeptidyl peptidase-4 inhibitor, sitagliptin, to ongoing therapy with the glucagon-like peptide-1 receptor agonist liraglutide". Diabetes, Obesity and Metabolism 19 2 (2017): 200-207. https://curis.ku.dk/portal/en/publications/addition-of-a-dipeptidyl-peptidase4-inhibitor-sitagliptin-to-ongoing-therapy-with-the-glucagonlike-peptide1-receptor-agonist-liraglutide(595f285d-a9db-4112-ac63-ed85d03efd04).html.
    10.1111/dom.12802
  276. Lasse Bremholm Hansen; Ulrik B Andersen; Mads Hornum; Linda Hilsted; Simon Veedfald; Bolette Hartmann; Jens Juul Holst. "Acute effects of glucagon-like peptide-1, GLP-19-36 amide, and exenatide on mesenteric blood flow, cardiovascular parameters, and biomarkers in healthy volunteers". Physiological Reports 5 4 (2017): https://curis.ku.dk/portal/en/publications/acute-effects-of-glucagonlike-peptide1-glp1936-amide-and-exenatide-on-mesenteric-blood-flow-cardiovascular-parameters-and-biomarkers-in-healthy-volunteers(0bbf6e49-06bf-4fc7-8557-120adceee6c5).html.
    10.14814/phy2.13102
  277. Ali Asmar; Meena Asmar; Lene Simonsen; Sten Madsbad; Jens Juul Holst; Bolette Hartmann; Charlotte Mehlin Sørensen; Jens Bülow. "Glucagon-like peptide-1 elicits vasodilation in adipose tissue and skeletal muscle in healthy men". Physiological Reports 5 3 (2017): https://curis.ku.dk/portal/en/publications/glucagonlike-peptide1-elicits-vasodilation-in-adipose-tissue-and-skeletal-muscle-in-healthy-men(6469af28-1add-4c94-a867-d6a2bbbfbeef).html.
    10.14814/phy2.13073
  278. Anne-Sophie Sejling; Troels W Kjaer; Ulrik Pedersen-Bjergaard; Line S Remvig; Christian S Frandsen; Linda Hilsted; Jens Faber; et al. "Hypoglycemia-Associated EEG Changes Following Antecedent Hypoglycemia in Type 1 Diabetes Mellitus". Diabetes Technology & Therapeutics 19 2 (2017): 85-90. https://curis.ku.dk/portal/en/publications/hypoglycemiaassociated-eeg-changes-following-antecedent-hypoglycemia-in-type-1-diabetes-mellitus(42ab55e4-5cae-473a-9b7d-0c74e72402d4).html.
    10.1089/dia.2016.0331
  279. Pelle L Ishøy; Filip K Knop; Brian V Broberg; Nikolaj Bak; Ulrik B Andersen; Niklas R Jørgensen; Jens Juul Holst; Birte Y Glenthøj; Bjørn H Ebdrup. "Effect of GLP-1 Receptor Agonist Treatment on Body weight in Obese Antipsychotic-treated Patients with Schizophrenia". Diabetes, Obesity and Metabolism 19 2 (2017): 162-171. https://curis.ku.dk/portal/en/publications/effect-of-glp1-receptor-agonist-treatment-on-body-weight-in-obese-antipsychotictreated-patients-with-schizophrenia(7d3ee1fc-d1c4-4aeb-a54e-aa9f03b1909d).html.
    10.1111/dom.12795
  280. Signe Nielsen; Maria S Svane; Rune E Kuhre; Trine R Clausen; Viggo B Kristiansen; Jens F Rehfeld; Jens Juul Holst; Sten Madsbad; Kirstine N Bojsen-Moller. "Chenodeoxycholic acid stimulates glucagon-like peptide-1 secretion in patients after Roux-en-Y gastric bypass". Physiological Reports 5 3 (2017): https://curis.ku.dk/portal/en/publications/chenodeoxycholic-acid-stimulates-glucagonlike-peptide1-secretion-in-patients-after-rouxeny-gastric-bypass(2ea7400a-3916-46ae-a095-81a9a9c1d7f2).html.
    10.14814/phy2.13140
  281. Ulrich Rohde; Cecilie A Federspiel; Peter Vilmann; Ebbe Langholz; Steffen U Friis; Martin Krakauer; Jens F Rehfeld; et al. "The impact of EndoBarrier gastrointestinal liner in obese patients with normal glucose tolerance and in patients with type 2 diabetes". Diabetes, Obesity and Metabolism 19 2 (2017): 189-199. https://curis.ku.dk/portal/en/publications/the-impact-of-endobarrier-gastrointestinal-liner-in-obese-patients-with-normal-glucose-tolerance-and-in-patients-with-type-2-diabetes(0cb1789f-fc15-4cc8-a4ac-dd91fb3603e1).html.
    10.1111/dom.12800
  282. Jens J. Holst; Nicolai J. Wewer Albrechtsen; Jens Pedersen; Filip K. Knop. "Glucagon and Amino Acids Are Linked in a Mutual Feedback Cycle: The Liver–a-Cell Axis". Diabetes 66 2 (2017): 235-240. https://doi.org/10.2337/db16-0994.
    10.2337/db16-0994
  283. Krishna BA; Spiess K; Poole EL; Lau B; Voigt S; Kledal TN; Rosenkilde MM; Sinclair JH. "Targeting the latent cytomegalovirus reservoir with an antiviral fusion toxin protein.". Nature communications (2017): http://europepmc.org/abstract/med/28148951.
    10.1038/ncomms14321
  284. David L Sigalet; Mary E Brindle; Dana Boctor; Bryan Dicken; Viona Lam; Lily Sia Lu; Elaine de Heuvel; Bolette Hartmann; Jens Juul Holst. "A safety and pharmacokinetic dosing study of glucagon-like peptide 2 in infants with intestinal failure". Journal of Pediatric Surgery 52 5 (2017): 749-754. https://curis.ku.dk/portal/en/publications/a-safety-and-pharmacokinetic-dosing-study-of-glucagonlike-peptide-2-in-infants-with-intestinal-failure(b63e8f93-f3f8-4fcc-8b6d-d1c32e209ebd).html.
    10.1016/j.jpedsurg.2017.01.034
  285. Ajenthen Ranjan; Signe Schmidt; Camilla Damm-Frydenberg; Isabelle Steineck; Trine Ryberg Clausen; Jens Juul Holst; Sten Madsbad; Kirsten Nørgaard. "Low-Carbohydrate Diet Impairs the Effect of Glucagon in the Treatment of Insulin-Induced Mild Hypoglycemia: A Randomized Crossover Study". Diabetes Care (2017): dc161472-dc161472. http://dx.doi.org/10.2337/dc16-1472.
    10.2337/dc16-1472
  286. Helene Johannessen; David Revesz; Yosuke Kodama; Nikki Cassie; Karolina P Skibicka; Perry Barrett; Suzanne Dickson; et al. "Vagal Blocking for Obesity Control". Obesity Surgery 27 1 (2017): 177-185. https://curis.ku.dk/portal/en/publications/vagal-blocking-for-obesity-control(81d16715-c714-47db-8757-42affc8ab80a).html.
    10.1007/s11695-016-2370-2
  287. Sara Gry Vienberg; Siv Hesse Jacobsen; Dorte Worm; Lisbeth Edvardsen Hvolris; Lars Peter Skat Naver; Thomas Peter Almdal; Dorte Lindqvist Hansen; et al. "Increased glucose-stimulated FGF21 response to oral glucose in obese non-diabetic subjects after Roux-en-Y Gastric Bypass". Clinical Endocrinology 86 1 (2017): 156-159. https://curis.ku.dk/portal/en/publications/increased-glucosestimulated-fgf21-response-to-oral-glucose-in-obese-nondiabetic-subjects-after-rouxeny-gastric-bypass(58eb3ac0-be27-4221-a223-965ce5af4287).html.
    10.1111/cen.13241
  288. Signe Foghsgaard; Camilla Andreasen; Louise Vedtofte; Emilie S. Andersen; Emilie Bahne; Charlotte Strandberg; Thora Buhl; et al. "Nonalcoholic Fatty Liver Disease Is Prevalent in Women With Prior Gestational Diabetes Mellitus and Independently Associated With Insulin Resistance and Waist Circumference". Diabetes Care 40 1 (2017): 109-116. https://curis.ku.dk/portal/en/publications/nonalcoholic-fatty-liver-disease-is-prevalent-in-women-with-prior-gestational-diabetes-mellitus-and-independently-associated-with-insulin-resistance-and-waist-circumference(0eedd881-3133-4871-a1e2-9500505b38e8).h.
    10.2337/dc16-1017
  289. Kirstine N Bojsen-Møller; Carsten Dirksen; Maria Saur Svane; Nils B Jørgensen; Jens Juul Holst; Erik A. Richter; Sten Madsbad. "Variable reliability of surrogate measures of insulin sensitivity after Roux-en-Y gastric bypass". American Journal of Physiology: Regulatory, Integrative and Comparative Physiology 312 5 (2017): R797-R805. https://curis.ku.dk/portal/en/publications/variable-reliability-of-surrogate-measures-of-insulin-sensitivity-after-rouxeny-gastric-bypass(3a03cbe4-1cee-4c0b-9b2b-ee05fab67fea).html.
    10.1152/ajpregu.00291.2016
  290. Pernille Mensberg; Signe Nyby; Peter Godsk Jørgensen; H Storgaard; Magnus Thorsten Jensen; J Sivertsen; Jens Juul Holst; et al. "Near-normalization of glycaemic control with glucagon-like peptide-1 receptor agonist treatment combined with exercise in patients with type 2 diabetes". Diabetes, Obesity and Metabolism 19 2 (2017): 172-180. https://curis.ku.dk/portal/en/publications/nearnormalization-of-glycaemic-control-with-glucagonlike-peptide1-receptor-agonist-treatment-combined-with-exercise-in-patients-with-type-2-diabetes(869d73fa-b880-49a6-a6ac-bec4265f46af).html.
    10.1111/dom.12797
  291. Coby Eelderink; Martijn W J Noort; Nesli Sozer; Martijn Koehorst; Jens Juul Holst; Carolyn Deacon; Jens F Rehfeld; et al. "Difference in postprandial GLP-1 response despite similar glucose kinetics after consumption of wheat breads with different particle size in healthy men". European Journal of Nutrition 56 3 (2017): 1063-1076. https://curis.ku.dk/portal/en/publications/difference-in-postprandial-glp1-response-despite-similar-glucose-kinetics-after-consumption-of-wheat-breads-with-different-particle-size-in-healthy-men(848c548e-9f1b-4f2b-b11a-79019b9f9371).html.
    10.1007/s00394-016-1156-6
  292. Anja Böhm; Robert Wagner; Fausto Machicao; Jens Juul Holst; Baptist Gallwitz; Norbert Stefan; Andreas Fritsche; Hans-Ulrich Häring; Harald Staiger. "DPP4 gene variation affects GLP-1 secretion, insulin secretion, and glucose tolerance in humans with high body adiposity". PloS one 12 7 (2017): https://curis.ku.dk/portal/en/publications/dpp4-gene-variation-affects-glp1-secretion-insulin-secretion-and-glucose-tolerance-in-humans-with-high-body-adiposity(06686a6e-a13e-4783-9317-eb1947d945d2).html.
    10.1371/journal.pone.0181880
  293. Toh Peng Yeow; Giovanni Pacini; Andrea Tura; Chee Peng Hor; Shueh Lin Lim; Florence Hui Sieng Tan; Chin Voon Tong; et al. "Preserved glucagon-like peptide-1 responses to oral glucose, but reduced incretin effect, insulin secretion and sensitivity in young Asians with type 2 diabetes mellitus". BMJ open diabetes research & care 5 1 (2017): https://curis.ku.dk/portal/en/publications/preserved-glucagonlike-peptide1-responses-to-oral-glucose-but-reduced-incretin-effect-insulin-secretion-and-sensitivity-in-young-asians-with-type-2-diabetes-mellitus(bf582058-e575-4ef0-a43f-ab5b7a730206).html.
    10.1136/bmjdrc-2016-000352
  294. Sarah W Lai; Elaine de Heuvel; Laurie E Wallace; Bolette Hartmann; Jens Juul Holst; Mary E Brindle; Prasanth K Chelikani; David L Sigalet. "Effects of exogenous glucagon-like peptide-2 and distal bowel resection on intestinal and systemic adaptive responses in rats". PloS one 12 7 (2017): https://curis.ku.dk/portal/en/publications/effects-of-exogenous-glucagonlike-peptide2-and-distal-bowel-resection-on-intestinal-and-systemic-adaptive-responses-in-rats(f9fcadf9-db6f-43c7-968c-3262c3aea0e6).html.
    10.1371/journal.pone.0181453
  295. A H Sparre-Ulrich; Maria Buur Nordskov Gabe; Lærke Smidt Gasbjerg; Charlotte Bayer Christiansen; Berit Svendsen; Bolette Hartmann; Jens Juul Holst; Mette Marie Rosenkilde. "GIP(3-30)NH2 is a potent competitive antagonist of the GIP receptor and effectively inhibits GIP-mediated insulin, glucagon, and somatostatin release". Biochemical Pharmacology 131 (2017): 78-88. https://curis.ku.dk/portal/en/publications/gip330nh2-is-a-potent-competitive-antagonist-of-the-gip-receptor-and-effectively-inhibits-gipmediated-insulin-glucagon-and-somatostatin-release(e3003660-d479-4e00-b8e1-c91aa921b50c).html.
    10.1016/j.bcp.2017.02.012
  296. Louise Hyltén-Cavallius; Eva Winning Iepsen; Nicolai Wewer Albrechtsen; Mathilde Svendstrup; Anniek Frederike Lubberding; Bolette Hartmann; Thomas Jespersen; et al. "Patients with Long QT Syndrome Due to Impaired hERG-encoded Kv11.1 Potassium Channel Have Exaggerated Endocrine Pancreatic and Incretin Function Associated with Reactive Hypoglycemia". Circulation 135 18 (2017): 1705-1719. https://curis.ku.dk/portal/en/publications/patients-with-long-qt-syndrome-due-to-impaired-hergencoded-kv111-potassium-channel-have-exaggerated-endocrine-pancreatic-and-incretin-function-associated-with-reactive-hypoglycemia(b3415700-4dc0-4294-a7bc-f0de156.
    10.1161/CIRCULATIONAHA.116.024279
  297. Karoline Knudsen; Bolette Hartmann; Tatyana D Fedorova; Karen Østergaard; Klaus Krogh; Niels Møller; Jens Juul Holst; Per Borghammer. "Pancreatic Polypeptide in Parkinson's Disease". Journal of Parkinson's Disease 7 4 (2017): 645-652. https://curis.ku.dk/portal/en/publications/pancreatic-polypeptide-in-parkinsons-disease(b86d4aa6-6288-416e-8dea-6680ed541195).html.
    10.3233/JPD-171189
  298. Philipp E Geyer; Nicolai Wewer Albrechtsen; Stefka Tyanova; Niklas Grassl; Eva Winning Iepsen; Julie Lundgren; Sten Madsbad; et al. "Proteomics reveals the effects of sustained weight loss on the human plasma proteome". Molecular Systems Biology 12 (2016): https://curis.ku.dk/portal/en/publications/proteomics-reveals-the-effects-of-sustained-weight-loss-on-the-human-plasma-proteome(d176ebd5-2464-4a66-abe8-82679ca60631).html.
    10.15252/msb.20167357
  299. Line Engelbrechtsen; Eva Winning Iepsen; Ehm Astrid Andersson Galijatovic; Yuvaraj Mahendran; Julie Rehné Lundgren; Anna Jonsson; Sten Madsbad; et al. "Weight loss and weight maintenance obtained with or without GLP-1 analogue treatment decrease branched chain amino acid levels". Metabolomics 12 12 (2016): 1-9. https://curis.ku.dk/portal/en/publications/weight-loss-and-weight-maintenance-obtained-with-or-without-glp1-analogue-treatment-decrease-branched-chain-amino-acid-levels(dd7ae79e-d589-475c-9b4f-462e55febd14).html.
    10.1007/s11306-016-1128-0
  300. Oleg Baranov; Melanie Kahle; Carolyn Deacon; Jens Juul Holst; Michael A Nauck. "Feedback suppression of meal-induced glucagon-like peptide-1 (GLP-1) secretion mediated through elevations in intact GLP-1 caused by dipeptidyl peptidase-4 inhibition". Diabetes, Obesity and Metabolism 18 11 (2016): 1100-1109. https://curis.ku.dk/portal/en/publications/feedback-suppression-of-mealinduced-glucagonlike-peptide1-glp1-secretion-mediated-through-elevations-in-intact-glp1-caused-by-dipeptidyl-peptidase4-inhibition(9d8069f5-7c46-4e7c-bcfc-8abd3c76647f).html.
    10.1111/dom.12706
  301. Asger Lund; Jonatan I Bagger; Mikkel Bring Christensen; Magnus Grøndahl; Gerrit van Hall; Jens Juul Holst; Tina Vilsbøll Lauritsen; Filip K Knop. "Higher Endogenous Glucose Production during OGTT vs Isoglycemic Intravenous Glucose Infusion". The Journal of Clinical Endocrinology & Metabolism 101 11 (2016): 4377-4384. https://curis.ku.dk/portal/en/publications/higher-endogenous-glucose-production-during-ogtt-vs-isoglycemic-intravenous-glucose-infusion(a26a7c2b-e79d-4b69-a98f-0d32335d585f).html.
    10.1210/jc.2016-1948
  302. Christina M van der Beek; Emanuel E Canfora; Kaatje Lenaerts; Freddy J Troost; Steven W M Olde Damink; Jens Juul Holst; Ad A M Masclee; Cornelis H C Dejong; Ellen E Blaak. "Distal, not proximal, colonic acetate infusions promote fat oxidation and improve metabolic markers in overweight/obese men". Clinical Science 130 22 (2016): 2073-2082. https://curis.ku.dk/portal/en/publications/distal-not-proximal-colonic-acetate-infusions-promote-fat-oxidation-and-improve-metabolic-markers-in-overweightobese-men(934f58b1-de98-4fcd-8711-88151f459fd6).html.
    10.1042/CS20160263
  303. Alice E Adriaenssens; Berit Svendsen; Brian Y H Lam; Giles S H Yeo; Jens Juul Holst; Frank Reimann; Fiona M Gribble. "Transcriptomic profiling of pancreatic alpha, beta and delta cell populations identifies delta cells as a principal target for ghrelin in mouse islets". Diabetologia 59 10 (2016): 2156-2165. https://curis.ku.dk/portal/en/publications/transcriptomic-profiling-of-pancreatic-alpha-beta-and-delta-cell-populations-identifies-delta-cells-as-a-principal-target-for-ghrelin-in-mouse-islets(9a125a10-8f44-4938-b9e4-53d09c997373).html.
    10.1007/s00125-016-4033-1
  304. Sofie Sylvest Nielsen; Gitte Lund Christensen; Jens Juul Holst; Nils Billestrup. "Regulation of Pancreatic Alpha Cell Function and Proliferation by Bone Morphogenetic Protein 4 (BMP4) in vitro.". Endocrinology 157 10 (2016): 3809-3820. https://curis.ku.dk/portal/en/publications/regulation-of-pancreatic-alpha-cell-function-and-proliferation-by-bone-morphogenetic-protein-4-bmp4-in-vitro(63e189f2-2b70-4172-b5af-d21c8fa00d0a).html.
    10.1210/en.2016-1163
  305. Nicolai Wewer Albrechtsen; Rune E Kuhre; Jens Pedersen; Filip K Knop; Jens Juul Holst. "The biology of glucagon and the consequences of hyperglucagonemia". Biomarkers in Medicine 10 11 (2016): 1141-1151. https://curis.ku.dk/portal/en/publications/the-biology-of-glucagon-and-the-consequences-of-hyperglucagonemia(5ddadb13-ee6b-4da0-b439-8c1fcff20823).html.
    10.2217/bmm-2016-0090
  306. Cecilia Ratner; Louise J Skov; Zindy Raida; Thomas Bächler; Kathrin Bellmann-Sickert; Christelle Le Foll; Bjørn Sivertsen; et al. "Effects of Peripheral Neurotensin on Appetite Regulation and Its Role in Gastric Bypass Surgery". Endocrinology 157 9 (2016): 3482-92. https://curis.ku.dk/portal/en/publications/effects-of-peripheral-neurotensin-on-appetite-regulation-and-its-role-in-gastric-bypass-surgery(3f79c1c8-398e-42c7-962a-17ec3449d317).html.
    10.1210/en.2016-1329
  307. Carsten Dirksen; Aleksander Eiken; Kirstine N Bojsen-Møller; Maria S Svane; Christoffer Martinussen; Nils B Jørgensen; Jens Juul Holst; Sten Madsbad. "No Islet Cell Hyperfunction, but Altered Gut-Islet Regulation and Postprandial Hypoglycemia in Glucose-Tolerant Patients 3 Years After Gastric Bypass Surgery". Obesity Surgery 26 9 (2016): 2263-7. https://curis.ku.dk/portal/en/publications/no-islet-cell-hyperfunction-but-altered-gutislet-regulation-and-postprandial-hypoglycemia-in-glucosetolerant-patients-3years-after-gastric-bypass-surgery(e4cbeb61-e5f9-472f-a19f-63a25f6ebf90).html.
    10.1007/s11695-016-2197-x
  308. Søren Fisker Schmidt; Jesper Grud Skat Madsen; Kari Østerli Frafjord; Lars la Cour Poulsen; Sofia Salö; Michael Boergesen; Anne Loft; et al. "Integrative Genomics Outlines a Biphasic Glucose Response and a ChREBP-ROR¿ Axis Regulating Proliferation in ß Cells". Cell Reports 16 9 (2016): 2359-72. https://curis.ku.dk/portal/en/publications/integrative-genomics-outlines-a-biphasic-glucose-response-and-a-chrebpror-axis-regulating-proliferation-in--cells(6af2a742-d454-4240-b465-e5a750113604).html.
    10.1016/j.celrep.2016.07.063
  309. M S Svane; Nils B Jørgensen; K N Bojsen-Møller; C Dirksen; S. Nielsen; V B Kristiansen; S Toräng; et al. "Peptide YY and glucagon-like peptide-1 contribute to decreased food intake after Roux-en-Y gastric bypass surgery". International Journal of Obesity 40 (2016): 1699–1706-1699–1706. https://curis.ku.dk/portal/en/publications/peptide-yy-and-glucagonlike-peptide1-contribute-to-decreased-food-intake-after-rouxeny-gastric-bypass-surgery(12663208-8629-454c-920b-d9eeeca9e445).html.
    10.1038/ijo.2016.121
  310. Kristine Faerch; Dorte Vistisen; Giovanni Pacini; Signe Torekov; Nanna Borup Johansen; Daniel R Witte; Anna Jonsson; et al. "Insulin Resistance is Accompanied by Increased Fasting Glucagon and Delayed Glucagon Suppression in Individuals With Normal and Impaired Glucose Regulation". Diabetes 65 11 (2016): 3473-3481. https://curis.ku.dk/portal/en/publications/insulin-resistance-is-accompanied-by-increased-fasting-glucagon-and-delayed-glucagon-suppression-in-individuals-with-normal-and-impaired-glucose-regulation(c6bc6abd-51ae-47e0-ac8a-317b33c6c0e5).html.
    10.2337/db16-0240
  311. Meena Asmar; Lene Simonsen; Ali Asmar; Jens Juul Holst; Flemming Dela; Jens Bülow. "Insulin Plays a Permissive Role for the Vasoactive Effect of GIP Regulating Adipose Tissue Metabolism in Humans". Journal of Clinical Endocrinology and Metabolism 101 8 (2016): 3155-62. https://curis.ku.dk/portal/en/publications/insulin-plays-a-permissive-role-for-the-vasoactive-effect-of-gip-regulating-adipose-tissue-metabolism-in-humans(82e83aa9-470d-43bc-902b-6661ca75e2b2).html.
    10.1210/jc.2016-1933
  312. Dorien Reijnders; Gijs H Goossens; Gerben D A Hermes; Evelien P J G Neis; Christina M van der Beek; Jasper Most; Jens Juul Holst; et al. "Effects of Gut Microbiota Manipulation by Antibiotics on Host Metabolism in Obese Humans". Cell Metabolism 24 1 (2016): 63-74. https://curis.ku.dk/portal/en/publications/effects-of-gut-microbiota-manipulation-by-antibiotics-on-host-metabolism-in-obese-humans(72cc470f-fde8-4fac-be88-2474af359607).html.
    10.1016/j.cmet.2016.06.016
  313. J.J. Castro; S.Y. Morrison; A. Hosseinni; J.J. Loor; J.K. Drackley; I.R. Ipharraguerre; Jens Juul Holst; Bolette Hartmann. "Secretion of glucagon-like peptide-2 responds to nutrient intake but not glucose provision in milk-fed calves". Journal of Dairy Science 99 7 (2016): 5793–5807-5793–5807. https://curis.ku.dk/portal/en/publications/secretion-of-glucagonlike-peptide2-responds-to-nutrient-intake-but-not-glucose-provision-in-milkfed-calves(691db1de-cc0a-4394-9f7f-d4e5679a21b6).html.
    10.3168/jds.2015-10519
  314. Jens Juul Holst; Sten Madsbad. "Mechanisms of surgical control of type 2 diabetes". Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery 12 6 (2016): 1236-42. https://curis.ku.dk/portal/en/publications/mechanisms-of-surgical-control-of-type-2-diabetes(9eaa9584-6927-412b-94c8-74181b7ed7ae).html.
    10.1016/j.soard.2016.02.033
  315. Morten Hansen; Matthijs J Scheltema; David P Sonne; J S Hansen; Michael Sperling; Jens F Rehfeld; Jens Juul Holst; Tina Vilsbøll Lauritsen; Filip K Knop. "Effect of chenodeoxycholic acid and the bile acid sequestrant colesevelam on glucagon-like peptide-1 secretion". Diabetes, Obesity and Metabolism 18 6 (2016): 571-80. https://curis.ku.dk/portal/en/publications/effect-of-chenodeoxycholic-acid-and-the-bile-acid-sequestrant-colesevelam-on-glucagonlike-peptide1-secretion(483346c1-4333-4006-a079-caf1bd7e0342).html.
    10.1111/dom.12648
  316. Eva Winning Iepsen; Julie Lundgren; Jens Juul Holst; Sten Madsbad; Signe Torekov. "Successful weight loss maintenance includes long-term increased meal responses of GLP-1 and PYY3-36". European Journal of Endocrinology 174 6 (2016): 775-784. https://curis.ku.dk/portal/en/publications/successful-weight-loss-maintenance-includes-longterm-increased-meal-responses-of-glp1-and-pyy336(c4090b39-ed30-467c-bfc9-246e0b7a65b7).html.
    10.1530/EJE-15-1116
  317. Jens Juul Holst; Fiona Gribble; Michael Horowitz; Chris K Rayner. "Roles of the Gut in Glucose Homeostasis". Diabetes Care 39 6 (2016): 884-92. https://curis.ku.dk/portal/en/publications/roles-of-the-gut-in-glucose-homeostasis(5b2dfbbd-8f19-4fca-8f4c-bc37de59afff).html.
    10.2337/dc16-0351
  318. johanne agerlin Windeløv; Jens Pedersen; Jens Juul Holst. "Use of anesthesia dramatically alters the oral glucose tolerance and insulin secretion in C57Bl/6 mice". Physiological Reports 4 11 (2016): https://curis.ku.dk/portal/en/publications/use-of-anesthesia-dramatically-alters-the-oral-glucose-tolerance-and-insulin-secretion-in-c57bl6-mice(5a53736c-355b-446b-a4ee-17b82abf9948).html.
    10.14814/phy2.12824
  319. Kirsten M. Hoelmkjaer; Nicolai Wewer Albrechtsen; Jens Juul Holst; Anna M. Cronin; Dorte H. Nielsen; Thomas Mandrup-Poulsen; Charlotte Reinhard Bjørnvad. "A Placebo-Controlled Study on the Effects of the Glucagon-Like Peptide-1 Mimetic, Exenatide, on Insulin Secretion, Body Composition and Adipokines in Obese, Client-Owned Cats". P L o S One 11 5 (2016): https://curis.ku.dk/portal/en/publications/a-placebocontrolled-study-on-the-effects-of-the-glucagonlike-peptide1-mimetic-exenatide-on-insulin-secretion-body-composition-and-adipokines-in-obese-clientowned-cats(8997a2b3-2ce1-4afa-8116-0f970a94bb38).html.
    10.1371/journal.pone.0154727
  320. Ulrich Rohde; David Peick Sonne; Mikkel Christensen; Morten Hansen; Andreas Brønden; Signe Toräng; Jens Frederik Rehfeld; et al. "Cholecystokinin-Induced Gallbladder Emptying and Single-Dose Metformin Elicit Additive Glucagon-Like Peptide-1 Responses". The Journal of clinical endocrinology and metabolism 101 5 (2016): 2076-2083. https://curis.ku.dk/portal/en/publications/cholecystokinininduced-gallbladder-emptying-and-singledose-metformin-elicit-additive-glucagonlike-peptide1-responses(ffef3def-f2de-40b1-8b94-a4e725aa377b).html.
    10.1210/jc.2016-1133
  321. Nicolai Wewer Albrechtsen; Daniel Hornburg; Reidar Albrechtsen; Berit Svendsen; Signe Toräng; Sara Lind Jepsen; Rune E Kuhre; et al. "Oxyntomodulin Identified as a Marker of Type 2 Diabetes and Gastric Bypass Surgery by Mass-spectrometry Based Profiling of Human Plasma". EBioMedicine 7 (2016): 112-120. https://curis.ku.dk/portal/en/publications/oxyntomodulin-identified-as-a-marker-of-type-2-diabetes-and-gastric-bypass-surgery-by-massspectrometry-based-profiling-of-human-plasma(8f4d7938-309d-44a9-919a-cce01f2cb115).html.
    10.1016/j.ebiom.2016.03.034
  322. Ali Asmar; Lene Simonsen; Meena Asmar; Sten Madsbad; Jens Juul Holst; Erik Frandsen; Cedric Moro; et al. "Glucagon-like peptide-1 does not have acute effects on central or renal hemodynamics in patients with type 2 diabetes without nephropathy". American Journal of Physiology: Endocrinology and Metabolism 310 9 (2016): E744-E753. https://curis.ku.dk/portal/en/publications/glucagonlike-peptide1-does-not-have-acute-effects-on-central-or-renal-hemodynamics-in-patients-with-type-2-diabetes-without-nephropathy(b136a58a-9dfb-4b7b-9724-68f868c5dd60).html.
    10.1152/ajpendo.00518.2015
  323. A E Junker; L Gluud; Jens Juul Holst; F K Knop; T Vilsbøll. "Diabetic and nondiabetic patients with nonalcoholic fatty liver disease have an impaired incretin effect and fasting hyperglucagonaemia". Journal of Internal Medicine 279 5 (2016): 485–493-485–493. https://curis.ku.dk/portal/en/publications/diabetic-and-nondiabetic-patients-with-nonalcoholic-fatty-liver-disease-have-an-impaired-incretin-effect-and-fasting-hyperglucagonaemia(bb36067a-cf5d-4c52-9853-624427b331e5).html.
    10.1111/joim.12462
  324. Jens Juul Holst; johanne agerlin Windeløv; Geke Aline Boer; Jens Pedersen; Berit Svendsen; Mikkel Christensen; Signe Torekov; et al. "Searching for the physiological role of glucose-dependent insulinotropic polypeptide". Journal of Diabetes Investigation 7 S1 (2016): 8-12. https://curis.ku.dk/portal/en/publications/searching-for-the-physiological-role-of-glucosedependent-insulinotropic-polypeptide(6f5a85cc-3dde-4fd6-91b8-9ab21cc54aec).html.
    10.1111/jdi.12488
  325. Maria S Svane; Kirstine N Bojsen-Moller; Signe Nielsen; Nils B Jørgensen; Carsten Dirksen; Flemming Bendtsen; Viggo B Kristiansen; et al. "Effects of endogenous GLP-1 and GIP on glucose tolerance after Roux-en-Y gastric bypass surgery". American Journal of Physiology: Endocrinology and Metabolism 310 7 (2016): E505-E514. https://curis.ku.dk/portal/en/publications/effects-of-endogenous-glp1-and-gip-on-glucose-tolerance-after-rouxeny-gastric-bypass-surgery(ee872285-6791-4449-a37a-1f163b723fc5).html.
    10.1152/ajpendo.00471.2015
  326. Anders E Junker; Lise L Gluud; Gerrit van Hall; Jens Juul Holst; Filip K Knop; Tina Vilsbøll Lauritsen. "Effects of glucagon-like peptide-1 on glucagon secretion in patients with non-alcoholic fatty liver disease". Journal of Hepatology 64 4 (2016): 908–915-908–915. https://curis.ku.dk/portal/en/publications/effects-of-glucagonlike-peptide1-on-glucagon-secretion-in-patients-with-nonalcoholic-fatty-liver-disease(b6124672-603c-4960-b511-213eb103076a).html.
    10.1016/j.jhep.2015.11.014
  327. Thomas Fremming Dejgaard; Christian Seerup Frandsen; Jens Juul Holst; Sten Madsbad. "Liraglutide for treating type 1 diabetes". Expert Opinion on Biological Therapy 16 4 (2016): 579-90. https://curis.ku.dk/portal/en/publications/liraglutide-for-treating-type-1-diabetes(f17101d3-5aaa-49cb-91f4-0d44da0d1511).html.
    10.1517/14712598.2016.1160050
  328. Matthew P Gilbert; Michel Marre; Jens Juul Holst; Alan Garber; Florian M M Baeres; Henrik Thomsen; Richard E Pratley. "Comparison of the long-term effects of LIiraglutide and Glimepiride monotherapy on bone mineral density in patients with type 2 diabetes". Endocrine Practice 22 4 (2016): 406-411. https://curis.ku.dk/portal/en/publications/comparison-of-the-longterm-effects-of-liiraglutide-and-glimepiride-monotherapy-on-bone-mineral-density-in-patients-with-type-2-diabetes(238fbf68-5e19-4ac2-95a7-e4dfeb15a4a9).html.
    10.4158/EP15758.OR
  329. Simon Veedfald; Marie Hansen; Louise Wulff Christensen; Sara Agnete Hjort Larsen; Karina Rahr Hjøllund; Astrid Plamboeck; Bolette Hartmann; Carolyn Deacon; Jens Juul Holst. "The insulinotropic effect of exogenous GLP-1 is not affected by acute vagotomy in anaesthetized pigs". Experimental Physiology 101 7 (2016): 895-912. https://curis.ku.dk/portal/en/publications/the-insulinotropic-effect-of-exogenous-glp1-is-not-affected-by-acute-vagotomy-in-anaesthetized-pigs(220341a2-89e2-48d0-95ce-6a0e6d154beb).html.
    10.1113/EP085692
  330. Asger Lund; Jonatan I Bagger; Nicolai Wewer Albrechtsen; Mikkel Christensen; Magnus Grøndahl; Bolette Hartmann; Elisabeth R Mathiesen; et al. "Evidence of Extrapancreatic Glucagon Secretion in Man". Diabetes 65 3 (2016): 585-597. https://curis.ku.dk/portal/en/publications/evidence-of-extrapancreatic-glucagon-secretion-in-man(80fc42d7-8b42-4784-87ee-68023cbe3868).html.
    10.2337/db16-er06
  331. Thomas Fremming Dejgaard; Christian Seerup Frandsen; Tanja Stenbæk Hansen; Thomas Almdal; Søren Urhammer; Ulrik Pedersen-Bjergaard; Tonny Jensen; et al. "Efficacy and safety of liraglutide for overweight adult patients with type 1 diabetes and insufficient glycaemic control (Lira-1)". The Lancet Diabetes & Endocrinology 4 3 (2016): 221–232-221–232. https://curis.ku.dk/portal/en/publications/efficacy-and-safety-of-liraglutide-for-overweight-adult-patients-with-type-1-diabetes-and-insufficient-glycaemic-control-lira1(df678d26-2333-46c3-8da4-b07030dc5d51).html.
    10.1016/S2213-8587(15)00436-2
  332. L S Hansen; A H Sparre-Ulrich; M. Christensen; F K Knop; Bolette Hartmann; Jens Juul Holst; Mette Marie Rosenkilde. "N- and C-terminally truncated forms of glucose-dependent insulinotropic polypeptide are high-affinity competitive antagonists of the human GIP receptor". British Journal of Pharmacology 173 5 (2016): 826-838. https://curis.ku.dk/portal/en/publications/n-and-cterminally-truncated-forms-of-glucosedependent-insulinotropic-polypeptide-are-highaffinity-competitive-antagonists-of-the-human-gip-receptor(5043b16e-d095-4774-b9bd-b42066678e24).html.
    10.1111/bph.13384
  333. Rune Ehrenreich Kuhre; Nicolai Wewer Albrechtsen; Carolyn Deacon; Emilie Balk-Møller; Jens Frederik Rehfeld; Frank Relman; Fiona Mary Gribble; Jens Juul Holst. "Peptide production and secretion in GLUTag, NCI-H716 and STC-1 cells: a comparison to native L-cells.". Journal of Molecular Endocrinology 56 (2016): 201-211. https://curis.ku.dk/portal/en/publications/peptide-production-and-secretion-in-glutag-ncih716-and-stc1-cells-a-comparison-to-native-lcells(da402fda-413e-4e42-b173-d41f6150790f).html.
    10.1530/JME-15-0293
  334. Thea A S Halden; Erlend J Egeland; Anders Åsberg; Anders Hartmann; Karsten Midtvedt; Hassan Z Khiabani; Jens Juul Holst; et al. "GLP-1 Restores Altered Insulin and Glucagon Secretion in Posttransplantation Diabetes". Diabetes Care 39 (2016): 617-24. https://curis.ku.dk/portal/en/publications/glp1-restores-altered-insulin-and-glucagon-secretion-in-posttransplantation-diabetes(893d115c-af33-4271-8e36-c25d4b27ad50).html.
    10.2337/dc15-2383
  335. J. Skov; M. Pedersen; Jens Juul Holst; B Madsen; Jens Peter Goetze; S. Rittig; Thomas Jonassen; et al. "Short-term effects of liraglutide on kidney function and vasoactive hormones in type 2 diabetes". Diabetes, Obesity and Metabolism Online 18 6 (2016): 581-9. https://curis.ku.dk/portal/en/publications/shortterm-effects-of-liraglutide-on-kidney-function-and-vasoactive-hormones-in-type-2-diabetes(782494e1-be5c-4b57-bb32-ee5fc5510e50).html.
    10.1111/dom.12651
  336. Esben Vedel-Larsen; Eva Winning Iepsen; Julie Lundgren; Claus Graff; Johannes J Struijk; Torben Hansen; Jens Juul Holst; et al. "Major rapid weight loss induces changes in cardiac repolarization". Journal of Electrocardiology 49 3 (2016): 467-472. https://curis.ku.dk/portal/en/publications/major-rapid-weight-loss-induces-changes-in-cardiac-repolarization(c5f623dd-1eae-4416-8330-abe90c6a95ac).html.
    10.1016/j.jelectrocard.2016.02.005
  337. Nicolai Wewer Albrechtsen; Rune Ehrenreich Kuhre; Signe Toräng; Jens Juul Holst. "The intestinal distribution pattern of appetite- and glucose regulatory peptides in mice, rats and pigs". BMC Research Notes 9 1 (2016): 1-6. https://curis.ku.dk/portal/en/publications/the-intestinal-distribution-pattern-of-appetite-and-glucose-regulatory-peptides-in-mice-rats-and-pigs(bbf20234-6cba-4e1d-9574-6679ac661f53).html.
    10.1186/s13104-016-1872-2
  338. Elaine W Yu; Marlene Wewalka; Su-Ann Ding; Donald C Simonson; Kathleen Foster; Jens Juul Holst; Ashley Vernon; Allison B Goldfine; Florencia Halperin. "Effects of Gastric Bypass and Gastric Banding on Bone Remodeling in Obese Patients with Type 2 Diabetes". Journal of Clinical Endocrinology and Metabolism 101 2 (2016): 714–722-714–722. https://curis.ku.dk/portal/en/publications/effects-of-gastric-bypass-and-gastric-banding-on-bone-remodeling-in-obese-patients-with-type-2-diabetes(d3aaad99-d6ec-4867-9041-581992043f9a).html.
    10.1210/jc.2015-3437
  339. Joanna Luttikhold; Klaske van Norren; Herman Rijna; Nikki Buijs; Marjolein Ankersmit; Annemieke C Heijboer; Jeannette Gootjes; et al. "Jejunal feeding is followed by a greater rise in plasma cholecystokinin, peptide YY, glucagon-like peptide 1, and glucagon-like peptide 2 concentrations compared with gastric feeding in vivo in humans". The American Journal of Clinical Nutrition 103 2 (2016): 435-43. https://curis.ku.dk/portal/en/publications/jejunal-feeding-is-followed-by-a-greater-rise-in-plasma-cholecystokinin-peptide-yy-glucagonlike-peptide-1-and-glucagonlike-peptide-2-concentrations-compared-with-gastric-feeding-in-vivo-in-humans(5171634e-e0e3-44.
    10.3945/ajcn.115.116251
  340. Carl Frederik Hansen; Thomas Thymann; Anders Daniel Andersen; Jens Juul Holst; Bolette Hartmann; Linda Hilsted; Louise Langhorn; Jacob Jelsing; Per T Sangild. "Rapid gut growth but persistent delay in digestive function in the postnatal period of preterm pigs". American Journal of Physiology: Gastrointestinal and Liver Physiology 310 8 (2016): G550-560. https://curis.ku.dk/portal/en/publications/rapid-gut-growth-but-persistent-delay-in-digestive-function-in-the-postnatal-period-of-preterm-pigs(3fb9355b-b69b-441e-9b42-5ac7d52d3533).html.
    10.1152/ajpgi.00221.2015
  341. Amra Jujic; Peter M Nilsson; Margaretha Persson; Jens Juul Holst; Signe Torekov; Valeriya Lyssenko; Leif Groop; Olle Melander; Martin Magnusson. "Atrial Natriuretic Peptide in the high normal range is associated with lower prevalence of insulin resistance". The Journal of clinical endocrinology and metabolism 101 4 (2016): 1372-1380. https://curis.ku.dk/portal/en/publications/atrial-natriuretic-peptide-in-the-high-normal-range-is-associated-with-lower-prevalence-of-insulin-resistance(94e80f64-9e37-4678-887d-221a28b651cc).html.
    10.1210/jc.2015-3518
  342. Signe Toräng; Kirstine N Bojsen-Møller; Maria S Svane; Bolette Hartmann; Mette Marie Rosenkilde; Sten Madsbad; Jens Juul Holst. "In vivo and in vitro degradation of peptide YY3-36 to inactive peptide YY3-34 in humans". A J P: Regulatory, Integrative and Comparative Physiology (Online) 310 1 (2016): R866-R874. https://curis.ku.dk/portal/en/publications/in-vivo-and-in-vitro-degradation-of-peptide-yy336-to-inactive-peptide-yy334-in-humans(0609d750-1c33-434b-b2ad-f179643f6da1).html.
    10.1152/ajpregu.00394.2015
  343. Ajenthen Ranjan; S Schmidt; Sten Madsbad; Jens Juul Holst; K Nørgaard. "Effects of subcutaneous, low-dose glucagon on insulin-induced mild hypoglycaemia in patients with insulin pump treated type 1 diabetes". Diabetes, Obesity and Metabolism Online 18 4 (2016): 410-418. https://curis.ku.dk/portal/en/publications/effects-of-subcutaneous-lowdose-glucagon-on-insulininduced-mild-hypoglycaemia-in-patients-with-insulin-pump-treated-type-1-diabetes(90402025-19a5-4b4d-9693-54890ccc1952).html.
    10.1111/dom.12627
  344. Nicolai Wewer Albrechtsen; Rune Ehrenreich Kuhre; johanne agerlin Windeløv; Anne Ørgaard; Carolyn Deacon; Hannelouise Kissow; Bolette Hartmann; Jens Juul Holst. "Dynamics of glucagon secretion in mice and rats revealed using a validated sandwich ELISA for small sample volumes.". American Journal of Physiology: Endocrinology and Metabolism 311 2 (2016): E302-E309. https://curis.ku.dk/portal/en/publications/dynamics-of-glucagon-secretion-in-mice-and-rats-revealed-using-a-validated-sandwich-elisa-for-small-sample-volumes(d4fcd5b0-b660-406c-beac-d12bf2e60fe6).html.
    10.1152/ajpendo.00119.2016
  345. Julie Berg Schmidt; Anders Sjödin; Lene Susanne Stevner; Christian Ritz; Natasha B Michaelsen; Anne B Thomsen; Jens Juul Holst; Arne Astrup. "Serum lipase activity and concentration during intravenous infusions of GLP-1 and PYY3-36 and after ad libitum meal ingestion in overweight men". Physiological Reports 4 18 (2016): https://curis.ku.dk/portal/en/publications/serum-lipase-activity-and-concentration-during-intravenous-infusions-of-glp1-and-pyy336-and-after-adlibitum-meal-ingestion-in-overweight-men(32edcc47-8fc0-4a37-8159-25268edbe740).html.
    10.14814/phy2.12980
  346. Nicolai Wewer Albrechtsen; Simon Veedfald; Astrid Plamboeck; Carolyn Deacon; Bolette Hartmann; Filip K Knop; Tina Vilsbøll Lauritsen; Jens Juul Holst. "Inability of Some Commercial Assays to Measure Suppression of Glucagon Secretion". Journal of Diabetes Research 2016 (2016): https://curis.ku.dk/portal/en/publications/inability-of-some-commercial-assays-to-measure-suppression-of-glucagon-secretion(cc11eed9-7767-4372-8f3c-5bff35ed337d).html.
    10.1155/2016/8352957
  347. Nicolai Wewer Albrechtsen; Reidar Albrechtsen; l Bremholm; Berit Svendsen; Rune Ehrenreich Kuhre; Steen Seier Poulsen; Charlotte Bayer Christiansen; et al. "Glucagon-like peptide-1 receptor signaling in acinar cells causes growth dependent release of pancreatic enzymes". Cell Reports 17 11 (2016): 2845-2856. https://curis.ku.dk/portal/en/publications/glucagonlike-peptide1-receptor-signaling-in-acinar-cells-causes-growth-dependent-release-of-pancreatic-enzymes(30ea7f74-bc13-4f7a-90d4-2707c7717512).html.
    10.1016/j.celrep.2016.11.051
  348. Niina Matikainen; Elias Björnson; Sanni Söderlund; Christofer Borén; Björn Eliasson; Kirsi H Pietiläinen; Leonie H Bogl; et al. "Minor Contribution of Endogenous GLP-1 and GLP-2 to Postprandial Lipemia in Obese Men". PLOS ONE 11 1 (2016): 1-15. https://curis.ku.dk/portal/en/publications/minor-contribution-of-endogenous-glp1-and-glp2-to-postprandial-lipemia-in-obese-men(f4068775-cace-465c-b825-cdc935c2c843).html.
    10.1371/journal.pone.0145890
  349. Etienne Larger; Nicolai Wewer Albrechtsen; L.H. Hansen; R.W. Gelling; Jaqueline Capeau; Carolyn Deacon; O.D. Madsen; et al. "Pancreatic a-cell hyperplasia and hyperglucagonemia due to a mutation of the glucagon". Endocrinology, Diabetes & Metabolism Case Reports 2016 (2016): https://curis.ku.dk/portal/en/publications/pancreatic-cell-hyperplasia-and-hyperglucagonemia-due-to-a-mutation-of-the-glucagon(e21f25e6-7633-4d8a-b2f4-fae5c4a58391).html.
    10.1530/EDM-16-0081
  350. H A Hassing; M S Engelstoft; R M Sichlau; A N Madsen; J F Rehfeld; J Pedersen; R M Jones; et al. "Oral 2-oleyl glyceryl ether improves glucose tolerance in mice through the GPR119 receptor". BioFactors 42 6 (2016): 665-673. https://curis.ku.dk/portal/en/publications/oral-2oleyl-glyceryl-ether-improves-glucose-tolerance-in-mice-through-the-gpr119-receptor(3786af38-e946-4cca-979f-9cb492a6915a).html.
    10.1002/biof.1303
  351. Albert Palleja; Alireza Kashani; Kristine Allin; Trine Nielsen; Chenchen Zhang; Yin Li; Thorsten Brach; et al. "Roux-en-Y gastric bypass surgery of morbidly obese patients induces swift and persistent changes of the individual gut microbiota". Genome Medicine 8 (2016): https://curis.ku.dk/portal/en/publications/rouxeny-gastric-bypass-surgery-of-morbidly-obese-patients-induces-swift-and-persistent-changes-of-the-individual-gut-microbiota(509c23f3-cc89-4b29-808a-306ed130f5f5).html.
    10.1186/s13073-016-0312-1
  352. Michael A Nauck; J Kind; Lars D Köthe; Jens Juul Holst; Carolyn Deacon; M Broschag; YL He; L Kjems; J. Foley. "Quantification of the contribution of GLP-1 to mediating insulinotropic effects of DPP-4 inhibition with vildagliptin in healthy subjects and type 2-diabetic patients using exendin [9-39] as a GLP-1 receptor antagonist.". Diabetes 65 8 (2016): 2440-2447. https://curis.ku.dk/portal/en/publications/quantification-of-the-contribution-of-glp1-to-mediating-insulinotropic-effects-of-dpp4-inhibition-with-vildagliptin-in-healthy-subjects-and-type-2diabetic-patients-using-exendin-939-as-a-glp1-recepto(aaaa7c83-ab2.
    10.2337/db16-0107
  353. Peter L Kristensen; Ulrik Pedersen-Bjergaard; Rikke Due-Andersen; Thomas Høi-Hansen; Lise Grimmeshave; Valeriya Lyssenko; Leif Groop; et al. "Impact of the TCF7L2 genotype on risk of hypoglycaemia and glucagon secretion during hypoglycaemia". Endocrine Connections 5 6 (2016): 53-60. https://curis.ku.dk/portal/en/publications/impact-of-the-tcf7l2-genotype-on-risk-of-hypoglycaemia-and-glucagon-secretion-during-hypoglycaemia(d5cecd66-5f2d-40aa-bd54-330937dca83a).html.
    10.1530/EC-16-0050
  354. M Asmar; N Arngrim; L. Simonsen; A Asmar; P Nordby; Jens Juul Holst; Jens Bülow. "The blunted effect of glucose-dependent insulinotropic polypeptide in subcutaneous abdominal adipose tissue in obese subjects is partly reversed by weight loss". Nutrition and Diabetes 6 (2016): https://curis.ku.dk/portal/en/publications/the-blunted-effect-of-glucosedependent-insulinotropic-polypeptide-in-subcutaneous-abdominal-adipose-tissue-in-obese-subjects-is-partly-reversed-by-weight-loss(177a2c27-66f0-4fc6-a8b0-527029a080a3).html.
    10.1038/nutd.2016.15
  355. Vivi R. Steenberg; Signe Marie Jensen; Jens Pedersen; Andreas N. Madsen; johanne agerlin Windeløv; Birgitte Holst; Bjoern Quistorff; Steen Seier Poulsen; Jens Juul Holst. "Acute disruption of glucagon secretion or action does not improve glucose tolerance in an insulin-deficient mouse model of diabetes". Diabetologia 59 2 (2016): 363-370. https://curis.ku.dk/portal/en/publications/acute-disruption-of-glucagon-secretion-or-action-does-not-improve-glucose-tolerance-in-an-insulindeficient-mouse-model-of-diabetes(c9870b44-2d5a-4cb5-a5f7-fd369bf33800).html.
    10.1007/s00125-015-3794-2
  356. Kristian H Mikkelsen; Morten Frost; Martin I Bahl; Tine R Licht; Ulrich S Jensen; Jacob Rosenberg; Oluf Pedersen; et al. "Effect of Antibiotics on Gut Microbiota, Gut Hormones and Glucose Metabolism". PLOS ONE 10 11 (2015): 1-14. https://curis.ku.dk/portal/en/publications/effect-of-antibiotics-on-gut-microbiota-gut-hormones-and-glucose-metabolism(b23638bb-a48a-4ee9-8c05-e39a930b2400).html.
    10.1371/journal.pone.0142352
  357. Egerod KL; Engelstoft MS; Lund ML; Grunddal KV; Zhao M; Barir-Jensen D; Nygaard EB; et al. "Transcriptional and Functional Characterization of the G Protein-Coupled Receptor Repertoire of Gastric Somatostatin Cells.". (2015): http://europepmc.org/abstract/med/26181106.
    10.1210/EN.2015-1388
  358. Keller J; Binnewies U; Rösch M; Juul Holst J; Beglinger C; Andresen V; Layer P. "Gastric emptying and disease activity in inflammatory bowel disease.". (2015): http://europepmc.org/abstract/med/26426315.
    10.1111/eci.12542
  359. Holst JJ; Buse JB; Rodbard HW; Linjawi S; Woo VC; Boesgaard TW; Kvist K; Gough SC. "IDegLira Improves Both Fasting and Postprandial Glucose Control as Demonstrated Using Continuous Glucose Monitoring and a Standardized Meal Test.". (2015): http://europepmc.org/abstract/med/26443290.
    10.1177/1932296815610124
  360. Bagger JI; Holst JJ; Hartmann B; Andersen B; Knop FK; Vilsbøll T. "Effect of Oxyntomodulin, Glucagon, GLP-1 and Combined Glucagon + GLP-1 Infusion on Food Intake, Appetite and Resting Energy Expenditure.". (2015): http://europepmc.org/abstract/med/26445112.
    10.1210/jc.2015-2335
  361. Grunddal KV; Ratner CF; Svendsen B; Sommer F; Engelstoft MS; Madsen AN; Pedersen J; et al. "Neurotensin Is Co-Expressed, Co-Released And Acts Together With Glp-1 And Pyy In Enteroendocrine Control Of Metabolism.". (2015): http://europepmc.org/abstract/med/26469136.
    10.1210/en.2015-1600
  362. Svendsen B; Pais R; Engelstoft MS; Milev NB; Richards P; Christiansen CB; Habib A; et al. "GLP1 and GIP cells rarely overlap and differ by bombesin receptor-2 expression and responsiveness.". (2015): http://europepmc.org/abstract/med/26483393.
    10.1530/JOE-15-0247
  363. Frandsen CS; Dejgaard TF; Holst JJ; Andersen HU; Thorsteinsson B; Madsbad S. "Twelve-Week Treatment With Liraglutide As Add-On to Insulin in Normal-Weight Patients With Poorly Controlled Type 1 Diabetes: A Randomized, Placebo-Controlled, Double-Blinded Parallel Study.". (2015): http://europepmc.org/abstract/med/26486191.
    10.2337/dc15-1037
  364. Rosenkilde M; Morville T; Riis Andersen P; Kjær K; Rasmusen H; Holst JJ; Dela F; et al. "Inability to match energy intake with energy expenditure at sustained near-maximal rates of energy expenditure in older men during a 14-d cycling expedition.". (2015): http://europepmc.org/abstract/med/26490491.
    10.3945/ajcn.115.109918
  365. Veedfald S; Plamboeck A; Deacon CF; Hartmann B; Knop FK; Vilsboll T; Holst JJ. "Cephalic phase secretion of insulin and other entero-pancreatic hormones in humans.". (2015): http://europepmc.org/abstract/med/26492921.
    10.1152/ajpgi.00222.2015
  366. Witte AB; Hilsted L; Holst JJ; Schmidt PT. "Peptide YY3-36 and glucagon-like peptide-1 in functional dyspepsia. Secretion and role in symptom generation.". (2015): http://europepmc.org/abstract/med/26503455.
    10.3109/00365521.2015.1101780
  367. Møller CL; Vistisen D; Færch K; Johansen NB; Witte DR; Jonsson A; Pedersen O; et al. "Glucose-dependent insulinotropic polypeptide (GIP) is associated with lower LDL but unhealthy fat distribution, independent of insulin: The ADDITION-PRO study.". (2015): http://europepmc.org/abstract/med/26505824.
    10.1210/jc.2015-3133
  368. Rhee NA; Wahlgren CD; Pedersen J; Mortensen B; Langholz E; Wandall EP; Friis SU; et al. "Effect of Roux-en-Y gastric bypass on the distribution and hormone expression of small-intestinal enteroendocrine cells in obese patients with type 2 diabetes.". (2015): http://europepmc.org/abstract/med/26186884.
    10.1007/s00125-015-3696-3
  369. Eelderink C; Noort MW; Sozer N; Koehorst M; Holst JJ; Deacon CF; Rehfeld JF; et al. "The structure of wheat bread influences the postprandial metabolic response in healthy men.". (2015): http://europepmc.org/abstract/med/26288992.
    10.1039/c5fo00354g
  370. Reiband HK; Schmidt S; Ranjan A; Holst JJ; Madsbad S; Nørgaard K. "Dual-hormone treatment with insulin and glucagon in patients with type 1 diabetes.". (2015): http://europepmc.org/abstract/med/25533565.
    10.1002/dmrr.2632
  371. Junker AE; Gluud LL; Holst JJ; Knop FK; Vilsbøll T. "Influence of gastrointestinal factors on glucose metabolism in patients with cirrhosis.". (2015): http://europepmc.org/abstract/med/25867498.
    10.1111/jgh.12981
  372. Skovsø S; Damgaard J; Fels JJ; Olsen GS; Wolf XA; Rolin B; Holst JJ. "Effects of insulin therapy on weight gain and fat distribution in the HF/HS-STZ rat model of type 2 diabetes.". (2015): http://europepmc.org/abstract/med/26121961.
    10.1038/ijo.2015.92
  373. Veedfald S; Plamboeck A; Hartmann B; Svendsen LB; Vilsbøll T; Knop FK; Holst JJ. "Pancreatic polypeptide responses to isoglycemic oral and intravenous glucose in humans with and without intact vagal innervation.". (2015): http://europepmc.org/abstract/med/26218807.
    10.1016/j.peptides.2015.07.020
  374. Bojsen-Møller KN; Jacobsen SH; Dirksen C; Jørgensen NB; Reitelseder S; Jensen JE; Kristiansen VB; et al. "Accelerated protein digestion and amino acid absorption after Roux-en-Y gastric bypass.". (2015): http://europepmc.org/abstract/med/26245808.
    10.3945/ajcn.115.109298
  375. Christensen LW; Kuhre RE; Janus C; Svendsen B; Holst JJ. "Vascular, but not luminal, activation of FFAR1 (GPR40) stimulates GLP-1 secretion from isolated perfused rat small intestine.". (2015): http://europepmc.org/abstract/med/26381015.
    10.14814/phy2.12551
  376. Sparre-Ulrich AH; Hansen LS; Svendsen B; Christensen M; Knop FK; Hartmann B; Holst JJ; Rosenkilde MM. "Species-specific action of (Pro3)GIP - an efficacious agonist on human GIP receptor, but partial agonist and competitive antagonist on rat and mouse GIP receptors.". (2015): http://europepmc.org/abstract/med/26359804.
    10.1111/bph.13323
  377. Ten Kulve JS; Veltman DJ; van Bloemendaal L; Barkhof F; Deacon CF; Holst JJ; Konrad RJ; et al. "Endogenous GLP-1 mediates postprandial reductions in activation in central reward and satiety areas in patients with type 2 diabetes.". (2015): http://europepmc.org/abstract/med/26385462.
    10.1007/s00125-015-3754-x
  378. Mandøe MJ; Hansen KB; Hartmann B; Rehfeld JF; Holst JJ; Hansen HS. "The 2-monoacylglycerol moiety of dietary fat appears to be responsible for the fat-induced release of GLP-1 in humans.". (2015): http://europepmc.org/abstract/med/26178726.
    10.3945/ajcn.115.106799
  379. Hansen M; Hjøllund KR; Hartmann B; Plamboeck A; Deacon CF; Wewer Albrechtsen NJ; Holst JJ. "Important species differences regarding lymph contribution to gut hormone responses.". (2015): http://europepmc.org/abstract/med/26048091.
    10.1016/j.peptides.2015.05.008
  380. Plamboeck A; Veedfald S; Deacon CF; Hartmann B; Vilsbøll T; Knop FK; Holst JJ. "The role of efferent cholinergic transmission for the insulinotropic and glucagonostatic effects of GLP-1.". (2015): http://europepmc.org/abstract/med/26136531.
    10.1152/ajpregu.00123.2015
  381. Shen RL; Thymann T; Østergaard MV; Støy AC; Krych L; Nielsen DS; Lauridsen C; et al. "Early gradual feeding with bovine colostrum improves gut function and NEC resistance relative to infant formula in preterm pigs.". (2015): http://europepmc.org/abstract/med/26138468.
    10.1152/ajpgi.00163.2015
  382. Svendsen B; Holst JJ. "Regulation of gut hormone secretion. Studies using isolated perfused intestines.". (2015): http://europepmc.org/abstract/med/26275337.
    10.1016/j.peptides.2015.08.001
  383. Idorn T; Knop FK; Jørgensen MB; Jensen T; Resuli M; Hansen PM; Christensen KB; et al. "Safety and Efficacy of Liraglutide in Patients With Type 2 Diabetes and End-Stage Renal Disease: An Investigator-Initiated, Placebo-Controlled, Double-Blinded, Parallel Group, Randomized Trial.". (2015): http://europepmc.org/abstract/med/26283739.
    10.2337/dc15-1025
  384. Schmidt JB; Pedersen SD; Gregersen NT; Vestergaard L; Nielsen MS; Ritz C; Madsbad S; et al. "Effects of RYGB on energy expenditure, appetite and glycemic control: a randomized controlled clinical trial.". (2015): http://europepmc.org/abstract/med/26303352.
    10.1038/ijo.2015.162
  385. Østoft SH; Bagger JI; Hansen T; Hartmann B; Pedersen O; Holst JJ; Knop FK; Vilsbøll T. "Postprandial incretin and islet hormone responses and dipeptidyl-peptidase 4 enzymatic activity in patients with maturity onset diabetes of the young.". (2015): http://europepmc.org/abstract/med/25953829.
    10.1530/EJE-15-0070
  386. Sejling AS; Lange KH; Frandsen CS; Diemar SS; Tarnow L; Faber J; Holst JJ; et al. "Infrared thermographic assessment of changes in skin temperature during hypoglycaemia in patients with type 1 diabetes.". (2015): http://europepmc.org/abstract/med/25985748.
    10.1007/s00125-015-3616-6
  387. Iepsen EW; Lundgren JR; Hartmann B; Pedersen O; Hansen T; Jørgensen NR; Jensen JE; et al. "GLP-1 Receptor Agonist Treatment Increases Bone Formation and Prevents Bone Loss in Weight-Reduced Obese Women.". (2015): http://europepmc.org/abstract/med/26043228.
    10.1210/jc.2015-1176
  388. Christensen M; Sparre-Ulrich AH; Hartmann B; Grevstad U; Rosenkilde MM; Holst JJ; Vilsbøll T; Knop FK. "Transfer of liraglutide from blood to cerebrospinal fluid is minimal in patients with type 2 diabetes.". (2015): http://europepmc.org/abstract/med/26228460.
    10.1038/ijo.2015.136
  389. Gyldenløve M; Vilsbøll T; Zachariae C; Holst JJ; Knop FK; Skov L. "Impaired incretin effect is an early sign of glucose dysmetabolism in nondiabetic patients with psoriasis.". (2015): http://europepmc.org/abstract/med/26174490.
    10.1111/joim.12388
  390. Lund MT; Hansen M; Skaaby S; Dalby S; Støckel M; Floyd AK; Bech K; et al. "Preoperative ß-cell function in patients with type 2 diabetes is important for the outcome of Roux-en-Y gastric bypass surgery.". (2015): http://europepmc.org/abstract/med/25867961.
    10.1113/JP270264
  391. Toräng S; Veedfald S; Rosenkilde MM; Hartmann B; Holst JJ. "The anorexic hormone Peptide YY3-36 is rapidly metabolized to inactive Peptide YY3-34 in vivo.". (2015): http://europepmc.org/abstract/med/26197931.
    10.14814/phy2.12455
  392. Færch K; Torekov SS; Vistisen D; Johansen NB; Witte DR; Jonsson A; Pedersen O; et al. "GLP-1 Response to Oral Glucose Is Reduced in Prediabetes, Screen-Detected Type 2 Diabetes, and Obesity and Influenced by Sex: The ADDITION-PRO Study.". (2015): http://europepmc.org/abstract/med/25677912.
    10.2337/db14-1751
  393. Christiansen CB; Svendsen B; Holst JJ. "The VGF-Derived Neuropeptide TLQP-21 Shows No Impact on Hormone Secretion in the Isolated Perfused Rat Pancreas.". (2015): http://europepmc.org/abstract/med/25602348.
    10.1055/s-0034-1395615
  394. Kuhre RE; Bechmann LE; Wewer Albrechtsen NJ; Hartmann B; Holst JJ. "Glucose stimulates neurotensin secretion from the rat small intestine by mechanisms involving SGLT1 and GLUT2, leading to cell depolarization and calcium influx.". (2015): http://europepmc.org/abstract/med/25898949.
    10.1152/ajpendo.00012.2015
  395. Schopman JE; Hoekstra JB; Frier BM; Ackermans MT; de Sonnaville JJ; Stades AM; Zwertbroek R; et al. "Effects of sitagliptin on counter-regulatory and incretin hormones during acute hypoglycaemia in patients with type 1 diabetes: a randomized double-blind placebo-controlled crossover study.". (2015): http://europepmc.org/abstract/med/25694217.
    10.1111/dom.12453
  396. Sejling AS; Kjær TW; Pedersen-Bjergaard U; Diemar SS; Frandsen CS; Hilsted L; Faber J; et al. "Hypoglycemia-associated changes in the electroencephalogram in patients with type 1 diabetes and normal hypoglycemia awareness or unawareness.". (2015): http://europepmc.org/abstract/med/25488900.
    10.2337/db14-1359
  397. Iepsen EW; Lundgren J; Dirksen C; Jensen JE; Pedersen O; Hansen T; Madsbad S; Holst JJ; Torekov SS. "Treatment with a GLP-1 receptor agonist diminishes the decrease in free plasma leptin during maintenance of weight loss.". (2015): http://europepmc.org/abstract/med/25287751.
    10.1038/ijo.2014.177
  398. Pedersen J; Pedersen NB; Brix SW; Grunddal KV; Rosenkilde MM; Hartmann B; Ørskov C; Poulsen SS; Holst JJ. "The glucagon-like peptide 2 receptor is expressed in enteric neurons and not in the epithelium of the intestine.". (2015): http://europepmc.org/abstract/med/25748021.
    10.1016/j.peptides.2015.02.007
  399. Eriksen M; Jensen DH; Tribler S; Holst JJ; Madsbad S; Krarup T. "Reduction of insulinotropic properties of GLP-1 and GIP after glucocorticoid-induced insulin resistance.". (2015): http://europepmc.org/abstract/med/25748606.
    10.1007/s00125-015-3522-y
  400. Kelstrup L; Clausen TD; Mathiesen ER; Hansen T; Holst JJ; Damm P. "Incretin and glucagon levels in adult offspring exposed to maternal diabetes in pregnancy.". (2015): http://europepmc.org/abstract/med/25781355.
    10.1210/jc.2014-3978
  401. Sjøberg KA; Rattigan S; Jeppesen JF; Lundsgaard AM; Holst JJ; Kiens B. "Differential effects of glucagon-like peptide-1 on microvascular recruitment and glucose metabolism in short- and long-term insulin resistance.". (2015): http://europepmc.org/abstract/med/25688993.
    10.1113/JP270129
  402. Kuhre RE; Wewer Albrechtsen NJ; Hartmann B; Deacon CF; Holst JJ. "Measurement of the incretin hormones: glucagon-like peptide-1 and glucose-dependent insulinotropic peptide.". (2015): http://europepmc.org/abstract/med/25623632.
    10.1016/j.jdiacomp.2014.12.006
  403. Yabe D; Kuroe A; Watanabe K; Iwasaki M; Hamasaki A; Hamamoto Y; Harada N; et al. "Early phase glucagon and insulin secretory abnormalities, but not incretin secretion, are similarly responsible for hyperglycemia after ingestion of nutrients.". (2015): http://europepmc.org/abstract/med/25613093.
    10.1016/j.jdiacomp.2014.12.010
  404. Fredheim S; Andersen ML; Pörksen S; Nielsen LB; Pipper C; Hansen L; Holst JJ; et al. "The influence of glucagon on postprandial hyperglycaemia in children 5 years after onset of type 1 diabetes.". (2015): http://europepmc.org/abstract/med/25541633.
    10.1007/s00125-014-3486-3
  405. Bohl M; Bjørnshave A; Rasmussen KV; Schioldan AG; Amer B; Larsen MK; Dalsgaard TK; et al. "Dairy proteins, dairy lipids, and postprandial lipemia in persons with abdominal obesity (DairyHealth): a 12-wk, randomized, parallel-controlled, double-blinded, diet intervention study.". (2015): http://europepmc.org/abstract/med/25833983.
    10.3945/ajcn.114.097923
  406. Gyldenløve M; Storgaard H; Holst JJ; Vilsbøll T; Knop FK; Skov L. "Patients with psoriasis are insulin resistant.". (2015): http://europepmc.org/abstract/med/25653028.
    10.1016/j.jaad.2015.01.004
  407. Jensen EP; Poulsen SS; Kissow H; Holstein-Rathlou NH; Deacon CF; Jensen BL; Holst JJ; Sorensen CM. "Activation of GLP-1 receptors on vascular smooth muscle cells reduces the autoregulatory response in afferent arterioles and increases renal blood flow.". (2015): http://europepmc.org/abstract/med/25656368.
    10.1152/ajprenal.00527.2014
  408. Kleberg K; Jacobsen AK; Ferreira JG; Windeløv JA; Rehfeld JF; Holst JJ; de Araujo IE; Hansen HS. "Sensing of triacylglycerol in the gut: different mechanisms for fatty acids and 2-monoacylglycerol.". (2015): http://europepmc.org/abstract/med/25639597.
    10.1113/jphysiol.2014.285635
  409. Asmar A; Simonsen L; Asmar M; Madsbad S; Holst JJ; Frandsen E; Moro C; Jonassen T; Bülow J. "Renal extraction and acute effects of glucagon-like peptide-1 on central and renal hemodynamics in healthy men.". (2015): http://europepmc.org/abstract/med/25670826.
    10.1152/ajpendo.00429.2014
  410. Lehrskov-Schmidt L; Nielsen ST; Holst JJ; Møller K; Solomon TP. "The effects of TNF-a on GLP-1-stimulated plasma glucose kinetics.". (2015): http://europepmc.org/abstract/med/25675385.
    10.1210/jc.2014-4244
  411. Samocha-Bonet D; Chisholm DJ; Holst JJ; Greenfield JR. "L-glutamine and whole protein restore first-phase insulin response and increase glucagon-like peptide-1 in type 2 diabetes patients.". (2015): http://europepmc.org/abstract/med/25811109.
    10.3390/nu7042101
  412. Haahr ME; Hansen DL; Fisher PM; Svarer C; Stenbæk DS; Madsen K; Madsen J; et al. "Central 5-HT neurotransmission modulates weight loss following gastric bypass surgery in obese individuals.". (2015): http://europepmc.org/abstract/med/25855196.
    10.1523/JNEUROSCI.3348-14.2015
  413. Lindgren O; Pacini G; Tura A; Holst JJ; Deacon CF; Ahrén B. "Incretin effect after oral amino acid ingestion in humans.". (2015): http://europepmc.org/abstract/med/25490278.
    10.1210/jc.2014-3865
  414. Jørgensen NB; Dirksen C; Bojsen-Møller KN; Kristiansen VB; Wulff BS; Rainteau D; Humbert L; et al. "Improvements in glucose metabolism early after gastric bypass surgery are not explained by increases in total bile acids and fibroblast growth factor 19 concentrations.". (2015): http://europepmc.org/abstract/med/25536209.
    10.1210/jc.2014-1658
  415. Svendsen B; Pedersen J; Albrechtsen NJ; Hartmann B; Toräng S; Rehfeld JF; Poulsen SS; Holst JJ. "An analysis of cosecretion and coexpression of gut hormones from male rat proximal and distal small intestine.". (2015): http://europepmc.org/abstract/med/25535831.
    10.1210/en.2014-1710
  416. Wewer Albrechtsen NJ; Bak MJ; Hartmann B; Christensen LW; Kuhre RE; Deacon CF; Holst JJ. "Stability of glucagon-like peptide 1 and glucagon in human plasma.". (2015): http://europepmc.org/abstract/med/25596009.
    10.1530/EC-14-0126
  417. Martinussen C; Bojsen-Møller KN; Dirksen C; Jacobsen SH; Jørgensen NB; Kristiansen VB; Holst JJ; Madsbad S. "Immediate enhancement of first-phase insulin secretion and unchanged glucose effectiveness in patients with type 2 diabetes after Roux-en-Y gastric bypass.". (2015): http://europepmc.org/abstract/med/25628424.
    10.1152/ajpendo.00506.2014
  418. Jørgensen MB; Idorn T; Knop FK; Holst JJ; Hornum M; Feldt-Rasmussen B. "Clearance of glucoregulatory peptide hormones during haemodialysis and haemodiafiltration in non-diabetic end-stage renal disease patients.". (2015): http://europepmc.org/abstract/med/25319937.
    10.1093/ndt/gfu327
  419. Bjerg AT; Kristensen M; Ritz C; Stark KD; Holst JJ; Leser TD; Wellejus A; Astrup A. "Four weeks supplementation with Lactobacillus paracasei subsp. paracasei L. casei W8® shows modest effect on triacylglycerol in young healthy adults.". (2015): http://europepmc.org/abstract/med/25245572.
    10.3920/BM2014.0058
  420. Gyldenløve M; Vilsbøll T; Holst JJ; Zachariae C; Skov L; Knop FK. "Disturbed postprandial glucose metabolism and gut hormone responses in non-diabetic patients with psoriasis.". (2015): http://europepmc.org/abstract/med/25819574.
    10.1111/bjd.13789
  421. Knudsen SH; Karstoft K; Winding K; Holst JJ; Pedersen BK; Solomon TP. "Effects of acute exercise on pancreatic endocrine function in subjects with type 2 diabetes.". (2015): http://europepmc.org/abstract/med/25406646.
    10.1111/dom.12413
  422. Kuhre RE; Frost CR; Svendsen B; Holst JJ. "Molecular mechanisms of glucose-stimulated GLP-1 secretion from perfused rat small intestine.". (2015): http://europepmc.org/abstract/med/25157092.
    10.2337/db14-0807
  423. Svane MS; Bojsen-Møller KN; Madsbad S; Holst JJ. "Updates in weight loss surgery and gastrointestinal peptides.". (2015): http://europepmc.org/abstract/med/25517025.
    10.1097/MED.0000000000000131
  424. Catia Martins; Dorthe Stensvold; Graham Finlayson; Jens Juul Holst; Ulrik Wisloff; Bård Kulseng; Linda Morgan; Neil A King. "Effect of moderate- and high-intensity acute exercise on appetite in obese individuals". Medicine and Science in Sports and Exercise 47 1 (2015): 40-8. https://curis.ku.dk/portal/en/publications/effect-of-moderate-and-highintensity-acute-exercise-on-appetite-in-obese-individuals(78b26181-fc5a-4aa4-9742-5bdc52448a75).html.
    10.1249/MSS.0000000000000372
  425. Christensen M; Calanna S; Sparre-Ulrich AH; Kristensen PL; Rosenkilde MM; Faber J; Purrello F; et al. "Glucose-dependent insulinotropic polypeptide augments glucagon responses to hypoglycemia in type 1 diabetes.". (2015): http://europepmc.org/abstract/med/25053587.
    10.2337/db14-0440
  426. Aaboe K; Akram S; Deacon CF; Holst JJ; Madsbad S; Krarup T. "Restoration of the insulinotropic effect of glucose-dependent insulinotropic polypeptide contributes to the antidiabetic effect of dipeptidyl peptidase-4 inhibitors.". (2015): http://europepmc.org/abstract/med/25243647.
    10.1111/dom.12395
  427. CM Craig; C Lamendola; Jens Juul Holst; Carolyn Deacon; TL McLaughlin. "The Use of Gastrostomy Tube for the Long-Term Remission of Hyperinsulinemic Hypoglycemia After Roux-en-y Gastric Bypass". aace clinical case reports 1 2 (2015): e84-e87. https://curis.ku.dk/portal/en/publications/the-use-of-gastrostomy-tube-for-the-longterm-remission-of-hyperinsulinemic-hypoglycemia-after-rouxeny-gastric-bypass(ca829587-70f4-4327-bedd-48c564f31d7e).html.
    10.4158/EP14218.CR
  428. Ralph A DeFronzo; Ele Ferrannini; Leif Groop; Robert R Henry; William H Herman; Jens Juul Holst; Frank B Hu; et al. "Type 2 diabetes mellitus". Nature Reviews. Disease Primers 1 (2015): https://curis.ku.dk/portal/en/publications/type-2-diabetes-mellitus(70f5592d-9963-4fbc-966f-7acab2e4b123).html.
    10.1038/nrdp.2015.19
  429. Pernille Barkholt; Andreas Vegge; Trine Ryberg Clausen; Malene Muusfeldt Birck; Johannes Josef Fels; Mikael Støckel; Ismayil Gögenür; et al. "Post-surgical effects of Roux-En-Y gastric bypass on glucose homeostasis, intestinal morphology and L-cells in obese Göttingen minipigs". Journal of Obesity and Bariatrics 1 1 (2015): https://curis.ku.dk/portal/en/publications/postsurgical-effects-of-rouxeny-gastric-bypass-on-glucose-homeostasis-intestinal-morphology-and-lcells-in-obese-goettingen-minipigs(78dca106-cf95-41d7-a2c6-7c92e8502328).html.
    10.13188/2377-9284.1000004
  430. Marie-Christine Simon; Klaus Strassburger; Bettina Nowotny; Hubert Kolb; Peter Nowotny; Volker Burkart; Fariba Zivehe; et al. "Intake of Lactobacillus reuteri Improves Incretin and Insulin Secretion in Glucose-Tolerant Humans". Diabetes Care 38 10 (2015): 1827-34. https://curis.ku.dk/portal/en/publications/intake-of-lactobacillus-reuteri-improves-incretin-and-insulin-secretion-in-glucosetolerant-humans(b1b2c885-7646-4629-a718-4d15c30e162b).html.
    10.2337/dc14-2690
  431. Gentile CL; Ward E; Holst JJ; Astrup A; Ormsbee MJ; Connelly S; Arciero PJ. "Resistant starch and protein intake enhances fat oxidation and feelings of fullness in lean and overweight/obese women.". (2015): http://europepmc.org/abstract/med/26514213.
    10.1186/s12937-015-0104-2
  432. Rudling M; Camilleri M; Graffner H; Holst JJ; Rikner L. "Specific inhibition of bile acid transport alters plasma lipids and GLP-1.". (2015): http://europepmc.org/abstract/med/26197999.
    10.1186/s12872-015-0070-9
  433. Hofsø D; Birkeland KI; Holst JJ; Bollerslev J; Sandbu R; Røislien J; Hjelmesæth J. "Gastric bypass surgery has a weight-loss independent effect on post-challenge serum glucose levels.". (2015): http://europepmc.org/abstract/med/26300987.
    10.1186/s13098-015-0066-8
  434. Guimarães M; Rodrigues P; Pereira SS; Nora M; Gonçalves G; Albrechtsen NW; Hartmann B; Holst JJ; Monteiro MP. "GLP1 and glucagon co-secreting pancreatic neuroendocrine tumor presenting as hypoglycemia after gastric bypass.". (2015): http://europepmc.org/abstract/med/26266036.
    10.1530/EDM-15-0049
  435. Eva Winning Iepsen; Signe Torekov; Jens Juul Holst. "GLP-1 baseret behandling af diabetes og svær overvægt". BestPractice 9 4 (2015): 10-12. https://curis.ku.dk/portal/en/publications/glp1-baseret-behandling-af-diabetes-og-svaer-overvaegt(3e951962-37c4-49d6-a8b3-d1a9d16741fb).html.
  436. Benjamin G Challis; Nicolai Wewer Albrechtsen; Vishakha Bansiya; Keith Burling; Peter Barker; Bolette Hartmann; Fiona Gribble; et al. "Heterogeneity of glucagonomas due to differential processing of proglucagon-derived peptides". Endocrinology, Diabetes & Metabolism Case Reports 2015 (2015): 1-7. https://curis.ku.dk/portal/en/publications/heterogeneity-of-glucagonomas-due-to-differential-processing-of-proglucagonderived-peptides(4f369ed2-4113-4109-9a75-1f06b8539a2f).html.
    10.1530/EDM-15-0105
  437. Dejgaard TF; Knop FK; Tarnow L; Frandsen CS; Hansen TS; Almdal T; Holst JJ; Madsbad S; Andersen HU. "Efficacy and safety of the glucagon-like peptide-1 receptor agonist liraglutide added to insulin therapy in poorly regulated patients with type 1 diabetes--a protocol for a randomised, double-blind, placebo-controlled study: the Lira-1 study.". (2015): http://europepmc.org/abstract/med/25838513.
    10.1136/bmjopen-2015-007791
  438. Larsen JR; Larsen L; Holst JJ. "Correction. Does a GLP-1 receptor agonist change glucose tolerance in patients treated with antipsychotic medications? Design of a randomised, double-blinded, placebo-controlled clinical trial.". (2015): http://europepmc.org/abstract/med/25948402.
    10.1136/bmjopen-2013-004227corr1
  439. de Diego-Cabero N; Mereu A; Menoyo D; Holst JJ; Ipharraguerre IR. "Bile acid mediated effects on gut integrity and performance of early-weaned piglets.". (2015): http://europepmc.org/abstract/med/25972097.
    10.1186/s12917-015-0425-6
  440. Iepsen EW; Torekov SS; Holst JJ. "Liraglutide for Type 2 diabetes and obesity: a 2015 update.". (2015): http://europepmc.org/abstract/med/26106933.
    10.1586/14779072.2015.1054810
  441. Cheryl A. Brighton; Juraj Rievaj; Rune E. Kuhre; Leslie L. Glass; Kristina Schoonjans; Jens Juul Holst; Fiona M. Gribble; Frank Reimann. "Bile Acids Trigger GLP-1 Release Predominantly by Accessing Basolaterally Located G Protein-Coupled Bile Acid Receptors". Endocrinology 156 11 (2015): 3961-1370. https://curis.ku.dk/portal/en/publications/bile-acids-trigger-glp1-release-predominantly-by-accessing-basolaterally-located-g-proteincoupled-bile-acid-receptors(1576b9a2-7b28-4fb1-b4fe-79294cc1b011).html.
    10.1210/en.2015-1321
  442. Panaro BL; Tough IR; Engelstoft MS; Matthews RT; Digby GJ; Møller CL; Svendsen B; et al. "The melanocortin-4 receptor is expressed in enteroendocrine L cells and regulates the release of peptide YY and glucagon-like peptide 1 in vivo.". (2014): http://europepmc.org/abstract/med/25453189.
    10.1016/j.cmet.2014.10.004
  443. van Poppel PC; van Asseldonk EJ; Holst JJ; Vilsbøll T; Netea MG; Tack CJ. "The interleukin-1 receptor antagonist anakinra improves first-phase insulin secretion and insulinogenic index in subjects with impaired glucose tolerance.". (2014): http://europepmc.org/abstract/med/25039318.
    10.1111/dom.12357
  444. Iepsen EW; Torekov SS; Holst JJ. "Therapies for inter-relating diabetes and obesity - GLP-1 and obesity.". (2014): http://europepmc.org/abstract/med/25260877.
    10.1517/14656566.2014.965678
  445. Sonne DP; Lund A; Faber J; Holst JJ; Vilsbøll T; Knop FK. "On the role of gallbladder emptying and incretin hormones for nutrient-mediated TSH suppression in patients with type 2 diabetes.". (2014): http://europepmc.org/abstract/med/25277744.
    10.1530/EC-14-0088
  446. Nissen A; Christensen M; Knop FK; Vilsbøll T; Holst JJ; Hartmann B. "Glucose-dependent insulinotropic polypeptide inhibits bone resorption in humans.". (2014): http://europepmc.org/abstract/med/25144635.
    10.1210/jc.2014-2547
  447. Bjerg AT; Kristensen M; Ritz C; Holst JJ; Rasmussen C; Leser TD; Wellejus A; Astrup A. "Lactobacillus paracasei subsp paracasei L. casei W8 suppresses energy intake acutely.". (2014): http://europepmc.org/abstract/med/25049132.
    10.1016/j.appet.2014.07.016
  448. Bak MJ; Wewer Albrechtsen NJ; Pedersen J; Knop FK; Vilsbøll T; Jørgensen NB; Hartmann B; et al. "Specificity and sensitivity of commercially available assays for glucagon-like peptide-1 (GLP-1): implications for GLP-1 measurements in clinical studies.". (2014): http://europepmc.org/abstract/med/25041349.
    10.1111/dom.12352
  449. Karstoft K; Winding K; Knudsen SH; James NG; Scheel MM; Olesen J; Holst JJ; Pedersen BK; Solomon TP. "Mechanisms behind the superior effects of interval vs continuous training on glycaemic control in individuals with type 2 diabetes: a randomised controlled trial.". (2014): http://europepmc.org/abstract/med/25099941.
    10.1007/s00125-014-3334-5
  450. Bendtsen LQ; Lorenzen JK; Gomes S; Liaset B; Holst JJ; Ritz C; Reitelseder S; Sjödin A; Astrup A. "Effects of hydrolysed casein, intact casein and intact whey protein on energy expenditure and appetite regulation: a randomised, controlled, cross-over study.". (2014): http://europepmc.org/abstract/med/25191896.
    10.1017/S000711451400213X
  451. Madsbad S; Holst JJ. "GLP-1 as a mediator in the remission of type 2 diabetes after gastric bypass and sleeve gastrectomy surgery.". (2014): http://europepmc.org/abstract/med/25249642.
    10.2337/db14-0935
  452. Sonne DP; Rehfeld JF; Holst JJ; Vilsbøll T; Knop FK. "Postprandial gallbladder emptying in patients with type 2 diabetes: potential implications for bile-induced secretion of glucagon-like peptide 1.". (2014): http://europepmc.org/abstract/med/24986531.
    10.1530/EJE-14-0309
  453. Ebdrup BH; Knop FK; Madsen A; Mortensen HB; Søgaard B; Holst JJ; Szecsi PB; Lublin H. "Glucometabolic hormones and cardiovascular risk markers in antipsychotic-treated patients.". (2014): http://europepmc.org/abstract/med/25295432.
    10.4088/JCP.13m08820
  454. Pietraszek A; Gregersen S; Pedersen SB; Holst JJ; Hermansen K. "Acute effects of monounsaturated fat on postprandial lipemia and gene expression in first-degree relatives of subjects with type 2 diabetes.". (2014): http://europepmc.org/abstract/med/24824014.
    10.1038/ejcn.2014.64
  455. Wewer Albrechtsen NJ; Hartmann B; Veedfald S; Windeløv JA; Plamboeck A; Bojsen-Møller KN; Idorn T; et al. "Hyperglucagonaemia analysed by glucagon sandwich ELISA: nonspecific interference or truly elevated levels?". (2014): http://europepmc.org/abstract/med/24891019.
    10.1007/s00125-014-3283-z
  456. Rhee NA; Østoft SH; Holst JJ; Deacon CF; Vilsbøll T; Knop FK. "The impact of dipeptidyl peptidase 4 inhibition on incretin effect, glucose tolerance, and gastrointestinal-mediated glucose disposal in healthy subjects.". (2014): http://europepmc.org/abstract/med/24935932.
    10.1530/EJE-14-0314
  457. Rhee NA; Vilmann P; Hassan H; Hendel JW; Holst JJ; Vilsbøll T; Knop FK. "The use of double-balloon enteroscopy in retrieving mucosal biopsies from the entire human gastrointestinal tract.". (2014): http://europepmc.org/abstract/med/24998781.
    10.3109/00365521.2014.934912
  458. Itoh K; Moriguchi R; Yamada Y; Fujita M; Yamato T; Oumi M; Holst JJ; Seino Y. "High saturated fatty acid intake induces insulin secretion by elevating gastric inhibitory polypeptide levels in healthy individuals.". (2014): http://europepmc.org/abstract/med/25172378.
    10.1016/j.nutres.2014.07.013
  459. Østoft SH; Bagger JI; Hansen T; Pedersen O; Holst JJ; Knop FK; Vilsbøll T. "Incretin effect and glucagon responses to oral and intravenous glucose in patients with maturity-onset diabetes of the young--type 2 and type 3.". (2014): http://europepmc.org/abstract/med/24677712.
    10.2337/db13-1878
  460. Juhl CB; Bradley U; Holst JJ; Leslie RD; Yderstraede KB; Hunter S; Action LADA Consortium. "Similar weight-adjusted insulin secretion and insulin sensitivity in short-duration late autoimmune diabetes of adulthood (LADA) and type 2 diabetes: Action LADA 9 [corrected].". (2014): http://europepmc.org/abstract/med/24628669.
    10.1111/dme.12434
  461. Bagger JI; Knop FK; Lund A; Holst JJ; Vilsbøll T. "Glucagon responses to increasing oral loads of glucose and corresponding isoglycaemic intravenous glucose infusions in patients with type 2 diabetes and healthy individuals.". (2014): http://europepmc.org/abstract/med/24879388.
    10.1007/s00125-014-3264-2
  462. Færch LH; Thorsteinsson B; Tarnow L; Juul Holst J; Kjær T; Kanters J; Larroude C; Dela F; Pedersen-Bjergaard U. "Effects of angiotensin II receptor blockade on cerebral, cardiovascular, counter-regulatory, and symptomatic responses during hypoglycaemia in patients with type 1 diabetes.". (2014): http://europepmc.org/abstract/med/25070348.
    10.1177/1470320314529356
  463. Idorn T; Knop FK; Jørgensen MB; Christensen M; Holst JJ; Hornum M; Feldt-Rasmussen B. "Elimination and degradation of glucagon-like peptide-1 and glucose-dependent insulinotropic polypeptide in patients with end-stage renal disease.". (2014): http://europepmc.org/abstract/med/24712563.
    10.1210/jc.2013-3809
  464. Østoft SH; Bagger JI; Hansen T; Pedersen O; Faber J; Holst JJ; Knop FK; Vilsbøll T. "Glucose-lowering effects and low risk of hypoglycemia in patients with maturity-onset diabetes of the young when treated with a GLP-1 receptor agonist: a double-blind, randomized, crossover trial.". (2014): http://europepmc.org/abstract/med/24929431.
    10.2337/dc13-3007
  465. Ryo Sueyoshi; Kathleen M Woods Ignatoski; Manabu Okawada; Bolette Hartmann; Jens Juul Holst; Daniel H Teitelbaum. "Stimulation of intestinal growth and function with DPP-IV inhibition in a mouse short bowel syndrome model". American Journal of Physiology: Gastrointestinal and Liver Physiology 307 4 (2014): G410-19. https://curis.ku.dk/portal/en/publications/stimulation-of-intestinal-growth-and-function-with-dppiv-inhibition-in-a-mouse-short-bowel-syndrome-model(10848945-3263-458b-80bc-ba6c0c49a0a4).html.
    10.1152/ajpgi.00363.2013
  466. Schmidt JB; Gregersen NT; Pedersen SD; Arentoft JL; Ritz C; Schwartz TW; Holst JJ; Astrup A; Sjödin A. "Effects of PYY3-36 and GLP-1 on energy intake, energy expenditure, and appetite in overweight men.". (2014): http://europepmc.org/abstract/med/24735885.
    10.1152/ajpendo.00569.2013
  467. Bojsen-Møller KN; Dirksen C; Jørgensen NB; Jacobsen SH; Serup AK; Albers PH; Hansen DL; et al. "Early enhancements of hepatic and later of peripheral insulin sensitivity combined with increased postprandial insulin secretion contribute to improved glycemic control after Roux-en-Y gastric bypass.". (2014): http://europepmc.org/abstract/med/24241533.
    10.2337/db13-1307
  468. Torekov SS; Holst JJ; Ehlers MR. "Dose response of continuous subcutaneous infusion of recombinant glucagon-like peptide-1 in combination with metformin and sulphonylurea over 12¿weeks in patients with type 2 diabetes mellitus.". (2014): http://europepmc.org/abstract/med/24251641.
    10.1111/dom.12240
  469. Kuhre RE; Albrechtsen NW; Windeløv JA; Svendsen B; Hartmann B; Holst JJ. "GLP-1 amidation efficiency along the length of the intestine in mice, rats and pigs and in GLP-1 secreting cell lines.". (2014): http://europepmc.org/abstract/med/24486427.
    10.1016/j.peptides.2014.01.020
  470. Xiao W; Feng Y; Holst JJ; Hartmann B; Yang H; Teitelbaum DH. "Glutamate prevents intestinal atrophy via luminal nutrient sensing in a mouse model of total parenteral nutrition.". (2014): http://europepmc.org/abstract/med/24497581.
    10.1096/fj.13-238311
  471. Hartvigsen ML; Lærke HN; Overgaard A; Holst JJ; Bach Knudsen KE; Hermansen K. "Postprandial effects of test meals including concentrated arabinoxylan and whole grain rye in subjects with the metabolic syndrome: a randomised study.". (2014): http://europepmc.org/abstract/med/24595224.
    10.1038/ejcn.2014.25
  472. Thymann T; Le Huërou-Luron I; Petersen YM; Hedemann MS; Elinf J; Jensen BB; Holst JJ; Hartmann B; Sangild PT. "Glucagon-like peptide 2 treatment may improve intestinal adaptation during weaning.". (2014): http://europepmc.org/abstract/med/24663206.
    10.2527/jas.2013-7015
  473. Vrieze A; Out C; Fuentes S; Jonker L; Reuling I; Kootte RS; van Nood E; et al. "Impact of oral vancomycin on gut microbiota, bile acid metabolism, and insulin sensitivity.". (2014): http://europepmc.org/abstract/med/24316517.
    10.1016/j.jhep.2013.11.034
  474. Torekov SS; Iepsen E; Christiansen M; Linneberg A; Pedersen O; Holst JJ; Kanters JK; Hansen T. "KCNQ1 long QT syndrome patients have hyperinsulinemia and symptomatic hypoglycemia.". (2014): http://europepmc.org/abstract/med/24357532.
    10.2337/db13-1454
  475. Torekov SS; Harsløf T; Rejnmark L; Eiken P; Jensen JB; Herman AP; Hansen T; et al. "A functional amino acid substitution in the glucose-dependent insulinotropic polypeptide receptor (GIPR) gene is associated with lower bone mineral density and increased fracture risk.". (2014): http://europepmc.org/abstract/med/24446656.
    10.1210/jc.2013-3766
  476. Harder-Lauridsen NM; Krogh-Madsen R; Holst JJ; Plomgaard P; Leick L; Pedersen BK; Fischer CP. "Effect of IL-6 on the insulin sensitivity in patients with type 2 diabetes.". (2014): http://europepmc.org/abstract/med/24473436.
    10.1152/ajpendo.00571.2013
  477. Kuhre RE; Gribble FM; Hartmann B; Reimann F; Windeløv JA; Rehfeld JF; Holst JJ. "Fructose stimulates GLP-1 but not GIP secretion in mice, rats, and humans.". (2014): http://europepmc.org/abstract/med/24525020.
    10.1152/ajpgi.00372.2013
  478. Bak MJ; Albrechtsen NW; Pedersen J; Hartmann B; Christensen M; Vilsbøll T; Knop FK; et al. "Specificity and sensitivity of commercially available assays for glucagon and oxyntomodulin measurement in humans.". (2014): http://europepmc.org/abstract/med/24412928.
    10.1530/EJE-13-0941
  479. Mezza T; Muscogiuri G; Sorice GP; Clemente G; Hu J; Pontecorvi A; Holst JJ; Giaccari A; Kulkarni RN. "Insulin resistance alters islet morphology in nondiabetic humans.". (2014): http://europepmc.org/abstract/med/24215793.
    10.2337/db13-1013
  480. Aulinger BA; Bedorf A; Kutscherauer G; de Heer J; Holst JJ; Göke B; Schirra J. "Defining the role of GLP-1 in the enteroinsulinar axis in type 2 diabetes using DPP-4 inhibition and GLP-1 receptor blockade.". (2014): http://europepmc.org/abstract/med/24296715.
    10.2337/db13-1455
  481. Christensen MB; Calanna S; Holst JJ; Vilsbøll T; Knop FK. "Glucose-dependent insulinotropic polypeptide: blood glucose stabilizing effects in patients with type 2 diabetes.". (2014): http://europepmc.org/abstract/med/24423311.
    10.1210/jc.2013-3644
  482. Lund MT; Dalby S; Hartmann B; Helge J; Holst JJ; Dela F. "The incretin effect does not differ in trained and untrained, young, healthy men.". (2014): http://europepmc.org/abstract/med/24354574.
    10.1111/apha.12218
  483. Vardarli I; Arndt E; Deacon CF; Holst JJ; Nauck MA. "Effects of sitagliptin and metformin treatment on incretin hormone and insulin secretory responses to oral and "isoglycemic" intravenous glucose.". (2014): http://europepmc.org/abstract/med/24186866.
    10.2337/db13-0805
  484. Krogh-Madsen R; Pedersen M; Solomon TP; Knudsen SH; Hansen LS; Karstoft K; Lehrskov-Schmidt L; et al. "Normal physical activity obliterates the deleterious effects of a high-caloric intake.". (2014): http://europepmc.org/abstract/med/24201706.
    10.1152/japplphysiol.00155.2013
  485. Sjøberg KA; Holst JJ; Rattigan S; Richter EA; Kiens B. "GLP-1 increases microvascular recruitment but not glucose uptake in human and rat skeletal muscle.". (2014): http://europepmc.org/abstract/med/24302010.
    10.1152/ajpendo.00283.2013
  486. Tamandl D; Sahora K; Prucker J; Schmid R; Holst JJ; Miholic J; Goetzinger P; Gnant M. "Impact of the reconstruction method on delayed gastric emptying after pylorus-preserving pancreaticoduodenectomy: a prospective randomized study.". (2014): http://europepmc.org/abstract/med/24121364.
    10.1007/s00268-013-2274-4
  487. Madsbad S; Dirksen C; Holst JJ. "Mechanisms of changes in glucose metabolism and bodyweight after bariatric surgery.". (2014): http://europepmc.org/abstract/med/24622719.
    10.1016/S2213-8587(13)70218-3
  488. Asmar M; Simonsen L; Arngrim N; Holst JJ; Dela F; Bülow J. "Glucose-dependent insulinotropic polypeptide has impaired effect on abdominal, subcutaneous adipose tissue metabolism in obese subjects.". (2014): http://europepmc.org/abstract/med/23736366.
    10.1038/ijo.2013.73
  489. Nicolai Wewer Albrechtsen; Rune Ehrenreich Kuhre; Carolyn Deacon; Jens Juul Holst. "Targeting the intestinal L-cell for obesity and type 2 diabetes treatment". Expert Review of Endocrinology & Metabolism 9 1 (2014): 61-72. https://curis.ku.dk/portal/en/publications/targeting-the-intestinal-lcell-for-obesity-and-type-2-diabetes-treatment(bab9123d-330b-45b4-a843-00aeb29e8c17).html.
    10.1586/17446651.2014.862152
  490. Hartvigsen ML; Gregersen S; Lærke HN; Holst JJ; Bach Knudsen KE; Hermansen K. "Effects of concentrated arabinoxylan and ß-glucan compared with refined wheat and whole grain rye on glucose and appetite in subjects with the metabolic syndrome: a randomized study.". (2014): http://europepmc.org/abstract/med/24253758.
    10.1038/ejcn.2013.236
  491. Harmuth S; Wewalka M; Holst JJ; Nemecek R; Thalhammer S; Schmid R; Sahora K; Gnant M; Miholic J. "Distal gastrectomy in pancreaticoduodenectomy is associated with accelerated gastric emptying, enhanced postprandial release of GLP-1, and improved insulin sensitivity.". (2014): http://europepmc.org/abstract/med/24002756.
    10.1007/s11605-013-2283-5
  492. Idorn T; Knop FK; Jørgensen M; Holst JJ; Hornum M; Feldt-Rasmussen B. "Postprandial responses of incretin and pancreatic hormones in non-diabetic patients with end-stage renal disease.". (2014): http://europepmc.org/abstract/med/24078334.
    10.1093/ndt/gft353
  493. Sigalet DL; de Heuvel E; Wallace L; Bulloch E; Turner J; Wales PW; Nation P; et al. "Effects of chronic glucagon-like peptide-2 therapy during weaning in neonatal pigs.". (2014): http://europepmc.org/abstract/med/24368164.
    10.1016/j.regpep.2013.12.006
  494. Idorn T; Knop FK; Jørgensen M; Holst JJ; Hornum M; Feldt-Rasmussen B. "The authors reply.". (2014): http://europepmc.org/abstract/med/24380909.
    10.1038/ki.2013.410
  495. Monika judyta Bak; Nicolai Wewer Albrechtsen; Bolette Hartmann; Jens Pedersen; Mikkel Christensen; Tina Vilsboll; Filip Krag Knop; et al. "No Effect of Aprotinin (Trasylol) on Degradation of Exogenous and Endogenous Glucagon in Human, Mouse and Rat Plasma". Journal of Endocrinology and Diabetes 1 1 (2014): 1-5. https://curis.ku.dk/portal/en/publications/no-effect-of-aprotinin-trasylol-on-degradation-of-exogenous-and-endogenous-glucagon-in-human-mouse-and-rat-plasma(1eff7f30-bf0f-4edf-98f4-a4b62d5fbc36).html.
    10.15226/2374-6890/1/1/00101
  496. Samocha-Bonet D; Chisholm DJ; Gribble FM; Coster AC; Carpenter KH; Jones GR; Holst JJ; Greenfield JR. "Glycemic effects and safety of L-Glutamine supplementation with or without sitagliptin in type 2 diabetes patients-a randomized study.". (2014): http://europepmc.org/abstract/med/25412338.
    10.1371/journal.pone.0113366
  497. Junker AE; Gluud LL; Pedersen J; Langhoff JL; Holst JJ; Knop FK; Vilsbøll T. "A 25-year-old woman with type 2 diabetes and liver disease.". (2014): http://europepmc.org/abstract/med/25606030.
    10.1159/000369968
  498. Poulsen MW; Bak MJ; Andersen JM; Monošík R; Giraudi-Futin AC; Holst JJ; Nielsen J; et al. "Effect of dietary advanced glycation end products on postprandial appetite, inflammation, and endothelial activation in healthy overweight individuals.". (2014): http://europepmc.org/abstract/med/23929260.
    10.1007/s00394-013-0574-y
  499. Mark AB; Poulsen MW; Andersen S; Andersen JM; Bak MJ; Ritz C; Holst JJ; et al. "Consumption of a diet low in advanced glycation end products for 4 weeks improves insulin sensitivity in overweight women.". (2014): http://europepmc.org/abstract/med/23959566.
    10.2337/dc13-0842
  500. Matikainen N; Bogl LH; Hakkarainen A; Lundbom J; Lundbom N; Kaprio J; Rissanen A; Holst JJ; Pietiläinen KH. "GLP-1 responses are heritable and blunted in acquired obesity with high liver fat and insulin resistance.". (2014): http://europepmc.org/abstract/med/23990519.
    10.2337/dc13-1283
  501. Larsen JR; Vedtofte L; Holst JJ; Oturai P; Kjær A; Correll CU; Vilsbøll T; Fink-Jensen A. "Does a GLP-1 receptor agonist change glucose tolerance in patients treated with antipsychotic medications? Design of a randomised, double-blinded, placebo-controlled clinical trial.". (2014): http://europepmc.org/abstract/med/24667381.
    10.1136/bmjopen-2013-004227
  502. Knop FK; Lund A; Madsbad S; Holst JJ; Krarup T; Vilsbøll T. "Unprecedented high insulin secretion in a healthy human subject after intravenous glucagon-like peptide-1: a case report.". (2014): http://europepmc.org/abstract/med/24885055.
    10.1186/1756-0500-7-326
  503. Anholm C; Kumarathurai P; Klit MS; Kristiansen OP; Nielsen OW; Ladelund S; Madsbad S; Sajadieh A; Haugaard SB. "Adding liraglutide to the backbone therapy of biguanide in patients with coronary artery disease and newly diagnosed type-2 diabetes (the AddHope2 study): a randomised controlled study protocol.". (2014): http://europepmc.org/abstract/med/25031198.
    10.1136/bmjopen-2014-005942
  504. Gejl M; Lerche S; Mengel A; Møller N; Bibby BM; Smidt K; Brock B; et al. "Influence of GLP-1 on myocardial glucose metabolism in healthy men during normo- or hypoglycemia.". (2014): http://europepmc.org/abstract/med/24400077.
    10.1371/journal.pone.0083758
  505. Skov J; Holst JJ; Gøtze JP; Frøkiær J; Christiansen JS. "Glucagon-like peptide-1: effect on pro-atrial natriuretic peptide in healthy males.". (2014): http://europepmc.org/abstract/med/24327600.
    10.1530/EC-13-0087
  506. Holst JJ. "Enteroendocrine secretion of gut hormones in diabetes, obesity and after bariatric surgery.". (2013): http://europepmc.org/abstract/med/24161809.
    10.1016/j.coph.2013.09.014
  507. Ipharraguerre IR; Tedó G; Menoyo D; de Diego Cabero N; Holst JJ; Nofrarías M; Mereu A; Burrin DG. "Bile acids induce glucagon-like peptide 2 secretion with limited effects on intestinal adaptation in early weaned pigs.". (2013): http://europepmc.org/abstract/med/24047704.
    10.3945/jn.113.177865
  508. Rosenkilde M; Reichkendler MH; Auerbach P; Toräng S; Gram AS; Ploug T; Holst JJ; Sjödin A; Stallknecht B. "Appetite regulation in overweight, sedentary men after different amounts of endurance exercise: a randomized controlled trial.". (2013): http://europepmc.org/abstract/med/24052035.
    10.1152/japplphysiol.00680.2013
  509. Dirksen C; Bojsen-Møller KN; Jørgensen NB; Jacobsen SH; Kristiansen VB; Naver LS; Hansen DL; et al. "Exaggerated release and preserved insulinotropic action of glucagon-like peptide-1 underlie insulin hypersecretion in glucose-tolerant individuals after Roux-en-Y gastric bypass.". (2013): http://europepmc.org/abstract/med/24048673.
    10.1007/s00125-013-3055-1
  510. Kissow H; Hartmann B; Holst JJ; Poulsen SS. "Glucagon-like peptide-1 as a treatment for chemotherapy-induced mucositis.". (2013): http://europepmc.org/abstract/med/23086829.
    10.1136/gutjnl-2012-303280
  511. Nielsen ST; Lehrskov-Schmidt L; Krogh-Madsen R; Solomon TP; Holst JJ; Møller K. "Tumour necrosis factor-alpha infusion produced insulin resistance but no change in the incretin effect in healthy volunteers.". (2013): http://europepmc.org/abstract/med/23904405.
    10.1002/dmrr.2441
  512. Hallundbæk Mikkelsen K; Nielsen MF; Tvede M; Hansen T; Pedersen OB; Holst JJ; Vilsbøll T; Knop FK. "[Gut microbiota may have influence on glucose and lipid metabolism].". (2013): http://europepmc.org/abstract/med/24629316.
  513. Lund MT; Taudorf L; Hartmann B; Helge JW; Holst JJ; Dela F. "Meal induced gut hormone secretion is altered in aerobically trained compared to sedentary young healthy males.". (2013): http://europepmc.org/abstract/med/23979179.
    10.1007/s00421-013-2711-y
  514. Kappe C; Zhang Q; Holst JJ; Nyström T; Sjöholm A. "Evidence for paracrine/autocrine regulation of GLP-1-producing cells.". (2013): http://europepmc.org/abstract/med/23986202.
    10.1152/ajpcell.00227.2013
  515. Camastra S; Muscelli E; Gastaldelli A; Holst JJ; Astiarraga B; Baldi S; Nannipieri M; et al. "Long-term effects of bariatric surgery on meal disposal and ß-cell function in diabetic and nondiabetic patients.". (2013): http://europepmc.org/abstract/med/23835342.
    10.2337/db13-0321
  516. Dirksen C; Jørgensen NB; Bojsen-Møller KN; Kielgast U; Jacobsen SH; Clausen TR; Worm D; et al. "Gut hormones, early dumping and resting energy expenditure in patients with good and poor weight loss response after Roux-en-Y gastric bypass.". (2013): http://europepmc.org/abstract/med/23419600.
    10.1038/ijo.2013.15
  517. Perälä MM; Kajantie E; Valsta LM; Holst JJ; Leiviskä J; Eriksson JG. "Early growth and postprandial appetite regulatory hormone responses.". (2013): http://europepmc.org/abstract/med/23597289.
    10.1017/S0007114513000950
  518. Sigalet DL; Kravarusic D; Butzner D; Hartmann B; Holst JJ; Meddings J. "A pilot study examining the relationship among Crohn disease activity, glucagon-like peptide-2 signalling and intestinal function in pediatric patients.". (2013): http://europepmc.org/abstract/med/24106731.
  519. Alssema M; Rijkelijkhuizen JM; Holst JJ; Teerlink T; Scheffer PG; Eekhoff EM; Gastaldelli A; et al. "Preserved GLP-1 and exaggerated GIP secretion in type 2 diabetes and relationships with triglycerides and ALT.". (2013): http://europepmc.org/abstract/med/23864340.
    10.1530/EJE-13-0487
  520. Calanna S; Christensen M; Holst JJ; Laferrère B; Gluud LL; Vilsbøll T; Knop FK. "Secretion of glucose-dependent insulinotropic polypeptide in patients with type 2 diabetes: systematic review and meta-analysis of clinical studies.". (2013): http://europepmc.org/abstract/med/24065842.
    10.2337/dc13-0465
  521. Knop FK; Konings E; Timmers S; Schrauwen P; Holst JJ; Blaak EE. "Thirty days of resveratrol supplementation does not affect postprandial incretin hormone responses, but suppresses postprandial glucagon in obese subjects.". (2013): http://europepmc.org/abstract/med/23663119.
    10.1111/dme.12231
  522. Jacobsen SH; Bojsen-Møller KN; Dirksen C; Jørgensen NB; Clausen TR; Wulff BS; Kristiansen VB; et al. "Effects of gastric bypass surgery on glucose absorption and metabolism during a mixed meal in glucose-tolerant individuals.". (2013): http://europepmc.org/abstract/med/23893303.
    10.1007/s00125-013-3003-0
  523. Deacon CF; Holst JJ. "Dipeptidyl peptidase-4 inhibitors for the treatment of type 2 diabetes: comparison, efficacy and safety.". (2013): http://europepmc.org/abstract/med/23919507.
    10.1517/14656566.2013.824966
  524. Holst JJ. "Incretin hormones and the satiation signal.". (2013): http://europepmc.org/abstract/med/23295502.
    10.1038/ijo.2012.208
  525. Jørgensen NB; Dirksen C; Bojsen-Møller KN; Jacobsen SH; Worm D; Hansen DL; Kristiansen VB; et al. "Exaggerated glucagon-like peptide 1 response is important for improved ß-cell function and glucose tolerance after Roux-en-Y gastric bypass in patients with type 2 diabetes.". (2013): http://europepmc.org/abstract/med/23649520.
    10.2337/db13-0022
  526. 't Hart LM; Fritsche A; Nijpels G; van Leeuwen N; Donnelly LA; Dekker JM; Alssema M; et al. "The CTRB1/2 locus affects diabetes susceptibility and treatment via the incretin pathway.". (2013): http://europepmc.org/abstract/med/23674605.
    10.2337/db13-0227
  527. Holst JJ. "Pancreatic safety of GLP-1-based therapeutic agents: further insights from rodent studies?". (2013): http://europepmc.org/abstract/med/23820635.
    10.1007/s00125-013-2984-z
  528. Vegge A; Thymann T; Lund P; Stoll B; Bering SB; Hartmann B; Jelsing J; et al. "Glucagon-like peptide-2 induces rapid digestive adaptation following intestinal resection in preterm neonates.". (2013): http://europepmc.org/abstract/med/23764891.
    10.1152/ajpgi.00064.2013
  529. Plamboeck A; Veedfald S; Deacon CF; Hartmann B; Wettergren A; Svendsen LB; Meisner S; et al. "Characterisation of oral and i.v. glucose handling in truncally vagotomised subjects with pyloroplasty.". (2013): http://europepmc.org/abstract/med/23704713.
    10.1530/EJE-13-0264
  530. Bonde L; Vilsbøll T; Nielsen T; Bagger JI; Svare JA; Holst JJ; Larsen S; Knop FK. "Reduced postprandial GLP-1 responses in women with gestational diabetes mellitus.". (2013): http://europepmc.org/abstract/med/23406269.
    10.1111/dom.12082
  531. Murat Mesta; Marco Carvelli; Rein J de Vries; Harm van Eersel; Jeroen J M van der Holst; Matthias Schober; Mauro Furno; et al. "Molecular-scale simulation of electroluminescence in a multilayer white organic light-emitting diode". Nature Materials 12 7 (2013): 652-8. https://curis.ku.dk/portal/en/publications/molecularscale-simulation-of-electroluminescence-in-a-multilayer-white-organic-lightemitting-diode(860a438f-81e7-41fc-ba90-126856691420).html.
    10.1038/nmat3622
  532. Bojsen-Møller KN; Dirksen C; Jørgensen NB; Jacobsen SH; Hansen DL; Worm D; Naver L; et al. "Increased hepatic insulin clearance after Roux-en-Y gastric bypass.". (2013): http://europepmc.org/abstract/med/23609835.
    10.1210/jc.2013-1286
  533. Benight NM; Stoll B; Olutoye OO; Holst JJ; Burrin DG. "GLP-2 delays but does not prevent the onset of necrotizing enterocolitis in preterm pigs.". (2013): http://europepmc.org/abstract/med/23343934.
    10.1097/MPG.0b013e318286891e
  534. Muscogiuri G; Mezza T; Prioletta A; Sorice GP; Clemente G; Sarno G; Nuzzo G; et al. "Removal of duodenum elicits GLP-1 secretion.". (2013): http://europepmc.org/abstract/med/23393218.
    10.2337/dc12-0811
  535. Naimi RM; Madsen KB; Askov-Hansen C; Brandt CF; Hartmann B; Holst JJ; Mortensen PB; Jeppesen PB. "A dose-equivalent comparison of the effects of continuous subcutaneous glucagon-like peptide 2 (GLP-2) infusions versus meal related GLP-2 injections in the treatment of short bowel syndrome (SBS) patients.". (2013): http://europepmc.org/abstract/med/23501043.
    10.1016/j.regpep.2013.03.023
  536. Madsen KB; Askov-Hansen C; Naimi RM; Brandt CF; Hartmann B; Holst JJ; Mortensen PB; Jeppesen PB. "Acute effects of continuous infusions of glucagon-like peptide (GLP)-1, GLP-2 and the combination (GLP-1+GLP-2) on intestinal absorption in short bowel syndrome (SBS) patients. A placebo-controlled study.". (2013): http://europepmc.org/abstract/med/23511332.
    10.1016/j.regpep.2013.03.025
  537. Plamboeck A; Veedfald S; Deacon CF; Hartmann B; Wettergren A; Svendsen LB; Meisner S; et al. "The effect of exogenous GLP-1 on food intake is lost in male truncally vagotomized subjects with pyloroplasty.". (2013): http://europepmc.org/abstract/med/23599045.
    10.1152/ajpgi.00035.2013
  538. Idorn T; Knop FK; Jørgensen M; Holst JJ; Hornum M; Feldt-Rasmussen B. "Gastrointestinal factors contribute to glucometabolic disturbances in nondiabetic patients with end-stage renal disease.". (2013): http://europepmc.org/abstract/med/23325073.
    10.1038/ki.2012.460
  539. Arngrim N; Simonsen L; Holst JJ; Bülow J. "Reduced adipose tissue lymphatic drainage of macromolecules in obese subjects: a possible link between obesity and local tissue inflammation?". (2013): http://europepmc.org/abstract/med/22751255.
    10.1038/ijo.2012.98
  540. Calanna S; Christensen M; Holst JJ; Laferrère B; Gluud LL; Vilsbøll T; Knop FK. "Secretion of glucagon-like peptide-1 in patients with type 2 diabetes mellitus: systematic review and meta-analyses of clinical studies.". (2013): http://europepmc.org/abstract/med/23377698.
    10.1007/s00125-013-2841-0
  541. Belza A; Ritz C; Sørensen MQ; Holst JJ; Rehfeld JF; Astrup A. "Contribution of gastroenteropancreatic appetite hormones to protein-induced satiety.". (2013): http://europepmc.org/abstract/med/23466396.
    10.3945/ajcn.112.047563
  542. van Raalte DH; Kwa KA; van Genugten RE; Tushuizen ME; Holst JJ; Deacon CF; Karemaker JM; et al. "Islet-cell dysfunction induced by glucocorticoid treatment: potential role for altered sympathovagal balance?". (2013): http://europepmc.org/abstract/med/23164480.
    10.1016/j.metabol.2012.10.007
  543. Dirksen C; Damgaard M; Bojsen-Møller KN; Jørgensen NB; Kielgast U; Jacobsen SH; Naver LS; et al. "Fast pouch emptying, delayed small intestinal transit, and exaggerated gut hormone responses after Roux-en-Y gastric bypass.". (2013): http://europepmc.org/abstract/med/23360316.
    10.1111/nmo.12087
  544. Thomsen KL; Jessen N; Møller AB; Aagaard NK; Grønbæk H; Holst JJ; Vilstrup H. "Regulation of urea synthesis during the acute-phase response in rats.". (2013): http://europepmc.org/abstract/med/23392238.
    10.1152/ajpgi.00416.2012
  545. Skov J; Dejgaard A; Frøkiær J; Holst JJ; Jonassen T; Rittig S; Christiansen JS. "Glucagon-like peptide-1 (GLP-1): effect on kidney hemodynamics and renin-angiotensin-aldosterone system in healthy men.". (2013): http://europepmc.org/abstract/med/23463656.
    10.1210/jc.2012-3855
  546. Kappe C; Patrone C; Holst JJ; Zhang Q; Sjöholm A. "Metformin protects against lipoapoptosis and enhances GLP-1 secretion from GLP-1-producing cells.". (2013): http://europepmc.org/abstract/med/22850868.
    10.1007/s00535-012-0637-5
  547. Holst JJ; Deacon CF. "Is there a place for incretin therapies in obesity and prediabetes?". (2013): http://europepmc.org/abstract/med/23415157.
    10.1016/j.tem.2013.01.004
  548. Askov-Hansen C; Jeppesen PB; Lund P; Hartmann B; Holst JJ; Henriksen DB. "Effect of glucagon-like peptide-2 exposure on bone resorption: Effectiveness of high concentration versus prolonged exposure.". (2013): http://europepmc.org/abstract/med/23261963.
    10.1016/j.regpep.2012.11.002
  549. Sonne DP; Hare KJ; Martens P; Rehfeld JF; Holst JJ; Vilsbøll T; Knop FK. "Postprandial gut hormone responses and glucose metabolism in cholecystectomized patients.". (2013): http://europepmc.org/abstract/med/23275610.
    10.1152/ajpgi.00435.2012
  550. Simonsen L; Holst JJ; Madsen K; Deacon CF. "The C-terminal extension of exendin-4 provides additional metabolic stability when added to GLP-1, while there is minimal effect of truncating exendin-4 in anaesthetized pigs.". (2013): http://europepmc.org/abstract/med/23318502.
    10.1016/j.regpep.2012.12.012
  551. Faurschou A; Pedersen J; Gyldenløve M; Poulsen SS; Holst JJ; Thyssen JP; Zachariae C; et al. "Increased expression of glucagon-like peptide-1 receptors in psoriasis plaques.". (2013): http://europepmc.org/abstract/med/23362875.
    10.1111/exd.12081
  552. Pedersen J; Ugleholdt RK; Jørgensen SM; Windeløv JA; Grunddal KV; Schwartz TW; Füchtbauer EM; et al. "Glucose metabolism is altered after loss of L cells and a-cells but not influenced by loss of K cells.". (2013): http://europepmc.org/abstract/med/23115082.
    10.1152/ajpendo.00547.2011
  553. Holmer-Jensen J; Mortensen LS; Astrup A; de Vrese M; Holst JJ; Thomsen C; Hermansen K. "Acute differential effects of dietary protein quality on postprandial lipemia in obese non-diabetic subjects.". (2013): http://europepmc.org/abstract/med/23351408.
    10.1016/j.nutres.2012.11.004
  554. Holst JJ; Vilsbøll T. "Combining GLP-1 receptor agonists with insulin: therapeutic rationales and clinical findings.". (2013): http://europepmc.org/abstract/med/22646532.
    10.1111/j.1463-1326.2012.01628.x
  555. Færch K; Pilgaard K; Knop FK; Hansen T; Pedersen O; Jørgensen T; Holst JJ. "Incretin and pancreatic hormone secretion in Caucasian non-diabetic carriers of the TCF7L2 rs7903146 risk T allele.". (2013): http://europepmc.org/abstract/med/22862926.
    10.1111/j.1463-1326.2012.01675.x
  556. Sanela Smajilovic; Christoffer Clemmensen; Lars Dan Johansen; Petrine Wellendorph; Jens Juul Holst; Peter Grevsen Thams; Egbuna Ogo; Hans Bräuner-Osborne. "The L-alpha-amino acid receptor GPRC6A is expressed in the islets of Langerhans but is not involved in L-arginine-induced insulin release". Amino Acids 44 2 (2013): 383-390. https://curis.ku.dk/portal/en/publications/the-lalphaamino-acid-receptor-gprc6a-is-expressed-in-the-islets-of-langerhans-but-is-not-involved-in-larginineinduced-insulin-release(2af34d3c-6519-4f75-ab5c-b91adad70dba).html.
    10.1007/s00726-012-1341-8
  557. J. I. Bagger; S. H. Ostoft; T. Hansen; O. Pedersen; Jens Juul Holst; F. K. Knop; T. Vilsboll. "Preserved postprandial GLP-1 and GIP responses in patients with maturity onset diabetes of the young". Diabetologia 56 (2013): S152-S152. https://curis.ku.dk/portal/en/publications/preserved-postprandial-glp1-and-gip-responses-in-patients-with-maturity-onset-diabetes-of-the-young(80aa3b76-d34b-40b1-8a43-b7a6daed0416).html.
  558. Morten Damgaard; Jesper Graff; Stefan Fuglsang; Jens Juul Holst; Jens F. Rehfeld; Jan Lysgård Madsen. "Effects of oleic acid and olive oil on gastric emptying, gut hormone secretion and appetite in lean and overweight or obese males". e - S P E N Journal 8 1 (2013): e8-e14. https://curis.ku.dk/portal/en/publications/effects-of-oleic-acid-and-olive-oil-on-gastric-emptying-gut-hormone-secretion-and-appetite-in-lean-and-overweight-or-obese-males(1c9ddc58-6c17-47eb-91b1-28af3affda56).html.
    10.1016/j.clnme.2012.10.004
  559. Foghsgaard S; Vedtofte L; Mathiesen ER; Svare JA; Gluud LL; Holst JJ; Damm P; Knop FK; Vilsbøll T. "The effect of a glucagon-like peptide-1 receptor agonist on glucose tolerance in women with previous gestational diabetes mellitus: protocol for an investigator-initiated, randomised, placebo-controlled, double-blinded, parallel intervention trial.". (2013): http://europepmc.org/abstract/med/24176797.
    10.1136/bmjopen-2013-003834
  560. Pedersen LR; Olsen RH; Frederiksen M; Astrup A; Chabanova E; Hasbak P; Holst JJ; et al. "Copenhagen study of overweight patients with coronary artery disease undergoing low energy diet or interval training: the randomized CUT-IT trial protocol.". (2013): http://europepmc.org/abstract/med/24252596.
    10.1186/1471-2261-13-106
  561. Mari A; Bagger JI; Ferrannini E; Holst JJ; Knop FK; Vilsbøll T. "Mechanisms of the incretin effect in subjects with normal glucose tolerance and patients with type 2 diabetes.". (2013): http://europepmc.org/abstract/med/24019903.
    10.1371/journal.pone.0073154
  562. Bryant EJ; King NA; Falkén Y; Hellström PM; Holst JJ; Blundell JE; Näslund E. "Relationships among tonic and episodic aspects of motivation to eat, gut peptides, and weight before and after bariatric surgery.". (2013): http://europepmc.org/abstract/med/23260807.
    10.1016/j.soard.2012.09.011
  563. Idorn T; Knop FK; Jørgensen M; Jensen T; Resuli M; Hansen PM; Christensen KB; et al. "Safety and efficacy of liraglutide in patients with type 2 diabetes and end-stage renal disease: protocol for an investigator-initiated prospective, randomised, placebo-controlled, double-blinded, parallel intervention study.". (2013): http://europepmc.org/abstract/med/23624993.
    10.1136/bmjopen-2013-002764
  564. Pietraszek A; Hermansen K; Pedersen SB; Langdahl BL; Holst JJ; Gregersen S. "Effects of a meal rich in medium-chain saturated fat on postprandial lipemia in relatives of type 2 diabetics.". (2013): http://europepmc.org/abstract/med/23644012.
    10.1016/j.nut.2013.01.018
  565. Dirksen C; Jacobsen SH; Bojsen-Møller KN; Jørgensen NB; Naver LS; Hvolris LE; Worm D; et al. "Reduction in cardiovascular risk factors and insulin dose, but no beta-cell regeneration 1 year after Roux-en-Y gastric bypass in an obese patient with type 1 diabetes: a case report.". (2013): http://europepmc.org/abstract/med/24306154.
    10.1016/j.orcp.2012.01.002
  566. Hoggard N; Cruickshank M; Moar KM; Bestwick C; Holst JJ; Russell W; Horgan G. "A single supplement of a standardised bilberry (Vaccinium myrtillus L.) extract (36 % wet weight anthocyanins) modifies glycaemic response in individuals with type 2 diabetes controlled by diet and lifestyle.". (2013): http://europepmc.org/abstract/med/25191571.
    10.1017/jns.2013.16
  567. Gejl M; Lerche S; Egefjord L; Brock B; Møller N; Vang K; Rodell AB; et al. "Glucagon-like peptide-1 (GLP-1) raises blood-brain glucose transfer capacity and hexokinase activity in human brain.". (2013): http://europepmc.org/abstract/med/23543638.
    10.3389/fnene.2013.00002
  568. Kristensen PL; Pedersen-Bjergaard U; Kjær TW; Olsen NV; Dela F; Holst JJ; Faber J; Tarnow L; Thorsteinsson B. "Influence of erythropoietin on cognitive performance during experimental hypoglycemia in patients with type 1 diabetes mellitus: a randomized cross-over trial.". (2013): http://europepmc.org/abstract/med/23577069.
    10.1371/journal.pone.0059672
  569. Solomon TP; Knudsen SH; Karstoft K; Winding K; Holst JJ; Pedersen BK. "Examining the effects of hyperglycemia on pancreatic endocrine function in humans: evidence for in vivo glucotoxicity.". (2012): http://europepmc.org/abstract/med/23043193.
    10.1210/jc.2012-2097
  570. Egerod KL; Engelstoft MS; Grunddal KV; Nøhr MK; Secher A; Sakata I; Pedersen J; et al. "A major lineage of enteroendocrine cells coexpress CCK, secretin, GIP, GLP-1, PYY, and neurotensin but not somatostatin.". (2012): http://europepmc.org/abstract/med/23064014.
    10.1210/en.2012-1595
  571. van der Meer Y; Gerrits WJ; van den Bosch M; Holst JJ; Moreto M; Buurman WA; Kulik W; van Kempen TA. "Chenodeoxycholic acid reduces intestinal permeability in newly weaned piglets.". (2012): http://europepmc.org/abstract/med/23365361.
    10.2527/jas.50998
  572. Gejl M; Egefjord L; Lerche S; Vang K; Bibby BM; Holst JJ; Mengel A; et al. "Glucagon-like peptide-1 decreases intracerebral glucose content by activating hexokinase and changing glucose clearance during hyperglycemia.". (2012): http://europepmc.org/abstract/med/22929437.
    10.1038/jcbfm.2012.118
  573. Frost M; Petersen I; Brixen K; Beck-Nielsen H; Holst JJ; Christiansen L; Højlund K; Christensen K. "Adult glucose metabolism in extremely birthweight-discordant monozygotic twins.". (2012): http://europepmc.org/abstract/med/22955993.
    10.1007/s00125-012-2695-x
  574. Verbrugghe A; Hesta M; Daminet S; Polis I; Holst JJ; Buyse J; Wuyts B; Janssens GP. "Propionate absorbed from the colon acts as gluconeogenic substrate in a strict carnivore, the domestic cat (Felis catus).". (2012): http://europepmc.org/abstract/med/21895780.
    10.1111/j.1439-0396.2011.01220.x
  575. Taylor-Edwards CC; Burrin DG; Kristensen NB; Holst JJ; McLeod KR; Harmon DL. "Glucagon-like peptide-2 (GLP-2) increases net amino acid utilization by the portal-drained viscera of ruminating calves.". (2012): http://europepmc.org/abstract/med/23031436.
    10.1017/S175173111200095X
  576. Rauch T; Graefe-Mody U; Deacon CF; Ring A; Holst JJ; Woerle HJ; Dugi KA; Heise T. "Linagliptin increases incretin levels, lowers glucagon, and improves glycemic control in type 2 diabetes mellitus.". (2012): http://europepmc.org/abstract/med/22986920.
    10.1007/s13300-012-0010-y
  577. Kissow H; Hartmann B; Holst JJ; Viby NE; Hansen LS; Rosenkilde MM; Hare KJ; Poulsen SS. "Glucagon-like peptide-1 (GLP-1) receptor agonism or DPP-4 inhibition does not accelerate neoplasia in carcinogen treated mice.". (2012): http://europepmc.org/abstract/med/22989472.
    10.1016/j.regpep.2012.08.016
  578. Blaak EE; Antoine JM; Benton D; Björck I; Bozzetto L; Brouns F; Diamant M; et al. "Impact of postprandial glycaemia on health and prevention of disease.". (2012): http://europepmc.org/abstract/med/22780564.
    10.1111/j.1467-789X.2012.01011.x
  579. Kappe C; Holst JJ; Zhang Q; Sjöholm A. "Molecular mechanisms of lipoapoptosis and metformin protection in GLP-1 secreting cells.". (2012): http://europepmc.org/abstract/med/22982676.
    10.1016/j.bbrc.2012.09.010
  580. Ekholm E; Shaat N; Holst JJ. "Characterization of beta cell and incretin function in patients with MODY1 (HNF4A MODY) and MODY3 (HNF1A MODY) in a Swedish patient collection.". (2012): http://europepmc.org/abstract/med/21761282.
    10.1007/s00592-011-0312-y
  581. Svendsen PF; Jensen FK; Holst JJ; Haugaard SB; Nilas L; Madsbad S. "The effect of a very low calorie diet on insulin sensitivity, beta cell function, insulin clearance, incretin hormone secretion, androgen levels and body composition in obese young women.". (2012): http://europepmc.org/abstract/med/22708619.
    10.3109/00365513.2012.691542
  582. Brinkman AS; Murali SG; Hitt S; Solverson PM; Holst JJ; Ney DM. "Enteral nutrients potentiate glucagon-like peptide-2 action and reduce dependence on parenteral nutrition in a rat model of human intestinal failure.". (2012): http://europepmc.org/abstract/med/22744334.
    10.1152/ajpgi.00184.2012
  583. Lund P; Sangild PT; Aunsholt L; Hartmann B; Holst JJ; Mortensen J; Mortensen PB; Jeppesen PB. "Randomised controlled trial of colostrum to improve intestinal function in patients with short bowel syndrome.". (2012): http://europepmc.org/abstract/med/22828734.
    10.1038/ejcn.2012.93
  584. Barnes JL; Hartmann B; Holst JJ; Tappenden KA. "Intestinal adaptation is stimulated by partial enteral nutrition supplemented with the prebiotic short-chain fructooligosaccharide in a neonatal intestinal failure piglet model.". (2012): http://europepmc.org/abstract/med/22517051.
    10.1177/0148607112444131
  585. Stoll B; Puiman PJ; Cui L; Chang X; Benight NM; Bauchart-Thevret C; Hartmann B; Holst JJ; Burrin DG. "Continuous parenteral and enteral nutrition induces metabolic dysfunction in neonatal pigs.". (2012): http://europepmc.org/abstract/med/22549765.
    10.1177/0148607112444756
  586. Elza Muscelli; Arturo Casolaro; Amalia Gastaldelli; Andrea Mari; Giuseppe Seghieri; Brenno Astiarraga; Yu Chen; et al. "Mechanisms for the antihyperglycemic effect of sitagliptin in patients with type 2 diabetes". Journal of Clinical Endocrinology and Metabolism 97 8 (2012): 2818-26. https://curis.ku.dk/portal/en/publications/mechanisms-for-the-antihyperglycemic-effect-of-sitagliptin-in-patients-with-type-2-diabetes(21a5a06b-e11e-49d8-82de-35936916db36).html.
    10.1210/jc.2012-1205
  587. Jacobsen SH; Olesen SC; Dirksen C; Jørgensen NB; Bojsen-Møller KN; Kielgast U; Worm D; et al. "Changes in gastrointestinal hormone responses, insulin sensitivity, and beta-cell function within 2 weeks after gastric bypass in non-diabetic subjects.". (2012): http://europepmc.org/abstract/med/22359255.
    10.1007/s11695-012-0621-4
  588. Jørgensen NB; Jacobsen SH; Dirksen C; Bojsen-Møller KN; Naver L; Hvolris L; Clausen TR; et al. "Acute and long-term effects of Roux-en-Y gastric bypass on glucose metabolism in subjects with Type 2 diabetes and normal glucose tolerance.". (2012): http://europepmc.org/abstract/med/22535748.
    10.1152/ajpendo.00073.2012
  589. Dirksen C; Jørgensen NB; Bojsen-Møller KN; Jacobsen SH; Hansen DL; Worm D; Holst JJ; Madsbad S. "Mechanisms of improved glycaemic control after Roux-en-Y gastric bypass.". (2012): http://europepmc.org/abstract/med/22538359.
    10.1007/s00125-012-2556-7
  590. Hansen HS; Rosenkilde MM; Holst JJ; Schwartz TW. "GPR119 as a fat sensor.". (2012): http://europepmc.org/abstract/med/22560300.
    10.1016/j.tips.2012.03.014
  591. Mortensen LS; Holmer-Jensen J; Hartvigsen ML; Jensen VK; Astrup A; de Vrese M; Holst JJ; Thomsen C; Hermansen K. "Effects of different fractions of whey protein on postprandial lipid and hormone responses in type 2 diabetes.". (2012): http://europepmc.org/abstract/med/22588635.
    10.1038/ejcn.2012.48
  592. Kissow H; Viby NE; Hartmann B; Holst JJ; Timm M; Thim L; Poulsen SS. "Exogenous glucagon-like peptide-2 (GLP-2) prevents chemotherapy-induced mucositis in rat small intestine.". (2012): http://europepmc.org/abstract/med/22729158.
    10.1007/s00280-012-1882-2
  593. Mickiewicz M; Zabielski R; Grenier B; Le Normand L; Savary G; Holst JJ; Oswald IP; Metges CC; Guilloteau P. "Structural and functional development of small intestine in intrauterine growth retarded porcine offspring born to gilts fed diets with differing protein ratios throughout pregnancy.". (2012): http://europepmc.org/abstract/med/22791636.
  594. Lønborg J; Vejlstrup N; Kelbæk H; Bøtker HE; Kim WY; Mathiasen AB; Jørgensen E; et al. "Exenatide reduces reperfusion injury in patients with ST-segment elevation myocardial infarction.". (2012): http://europepmc.org/abstract/med/21920963.
    10.1093/eurheartj/ehr309
  595. Knop FK; Aaboe K; Vilsbøll T; Vølund A; Holst JJ; Krarup T; Madsbad S. "Impaired incretin effect and fasting hyperglucagonaemia characterizing type 2 diabetic subjects are early signs of dysmetabolism in obesity.". (2012): http://europepmc.org/abstract/med/22171657.
    10.1111/j.1463-1326.2011.01549.x
  596. Gjesing AP; Ekstrøm CT; Eiberg H; Urhammer SA; Holst JJ; Pedersen O; Hansen T. "Fasting and oral glucose-stimulated levels of glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) are highly familial traits.". (2012): http://europepmc.org/abstract/med/22349073.
    10.1007/s00125-012-2484-6
  597. Rohrer S; Menge BA; Grüber L; Deacon CF; Schmidt WE; Veldhuis JD; Holst JJ; Meier JJ. "Impaired crosstalk between pulsatile insulin and glucagon secretion in prediabetic individuals.". (2012): http://europepmc.org/abstract/med/22399501.
    10.1210/jc.2011-3439
  598. Myint KS; Greenfield JR; Farooqi IS; Henning E; Holst JJ; Finer N. "Prolonged successful therapy for hyperinsulinaemic hypoglycaemia after gastric bypass: the pathophysiological role of GLP1 and its response to a somatostatin analogue.". (2012): http://europepmc.org/abstract/med/22408121.
    10.1530/EJE-11-1065
  599. Nielsen R; Wiggers H; Halbirk M; Bøtker H; Holst JJ; Schmitz O; Frandsen E; et al. "Metabolic effects of short-term GLP-1 treatment in insulin resistant heart failure patients.". (2012): http://europepmc.org/abstract/med/22421983.
    10.1055/s-0032-1304605
  600. Jensen DH; Aaboe K; Henriksen JE; Vølund A; Holst JJ; Madsbad S; Krarup T. "Steroid-induced insulin resistance and impaired glucose tolerance are both associated with a progressive decline of incretin effect in first-degree relatives of patients with type 2 diabetes.". (2012): http://europepmc.org/abstract/med/22286551.
    10.1007/s00125-012-2459-7
  601. Hansen KB; Vilsbøll T; Bagger JI; Holst JJ; Knop FK. "Impaired incretin-induced amplification of insulin secretion after glucose homeostatic dysregulation in healthy subjects.". (2012): http://europepmc.org/abstract/med/22319034.
    10.1210/jc.2011-2594
  602. Maersk M; Belza A; Holst JJ; Fenger-Grøn M; Pedersen SB; Astrup A; Richelsen B. "Satiety scores and satiety hormone response after sucrose-sweetened soft drink compared with isocaloric semi-skimmed milk and with non-caloric soft drink: a controlled trial.". (2012): http://europepmc.org/abstract/med/22252107.
    10.1038/ejcn.2011.223
  603. Shang Q; Liu MK; Saumoy M; Holst JJ; Salen G; Xu G. "The combination of colesevelam with sitagliptin enhances glycemic control in diabetic ZDF rat model.". (2012): http://europepmc.org/abstract/med/22281473.
    10.1152/ajpgi.00295.2011
  604. Sivertsen J; Rosenmeier J; Holst JJ; Vilsbøll T. "The effect of glucagon-like peptide 1 on cardiovascular risk.". (2012): http://europepmc.org/abstract/med/22290234.
    10.1038/nrcardio.2011.211
  605. Holst JJ. "Incretin based therapies: do they hold their promise?". (2012): http://europepmc.org/abstract/med/22248344.
    10.1111/j.1753-0407.2012.00186.x
  606. Schmidt S; Finan DA; Duun-Henriksen AK; Jørgensen JB; Madsen H; Bengtsson H; Holst JJ; Madsbad S; Nørgaard K. "Effects of everyday life events on glucose, insulin, and glucagon dynamics in continuous subcutaneous insulin infusion-treated type 1 diabetes: collection of clinical data for glucose modeling.". (2012): http://europepmc.org/abstract/med/22023376.
    10.1089/dia.2011.0101
  607. Nørholk LM; Holst JJ; Jeppesen PB. "Treatment of adult short bowel syndrome patients with teduglutide.". (2012): http://europepmc.org/abstract/med/22224470.
    10.1517/14656566.2012.644787
  608. Holmer-Jensen J; Hartvigsen ML; Mortensen LS; Astrup A; de Vrese M; Holst JJ; Thomsen C; Hermansen K. "Acute differential effects of milk-derived dietary proteins on postprandial lipaemia in obese non-diabetic subjects.". (2012): http://europepmc.org/abstract/med/21792215.
    10.1038/ejcn.2011.142
  609. Jain AK; Stoll B; Burrin DG; Holst JJ; Moore DD. "Enteral bile acid treatment improves parenteral nutrition-related liver disease and intestinal mucosal atrophy in neonatal pigs.". (2012): http://europepmc.org/abstract/med/22094603.
    10.1152/ajpgi.00280.2011
  610. Holst JJ; McGill MA. "Potential new approaches to modifying intestinal GLP-1 secretion in patients with type 2 diabetes mellitus: focus on bile acid sequestrants.". (2012): http://europepmc.org/abstract/med/21958333.
    10.2165/11595370-000000000-00000
  611. S. H. Ostoft; J. I. Bagger; T. Hansen; O. Pedersen; Jens Juul Holst; F. Knop; T. Vilsboll. "The incretin effect in patients with maturity onset diabetes of the young". Diabetologia 55 (2012): S144-S144. https://curis.ku.dk/portal/en/publications/the-incretin-effect-in-patients-with-maturity-onset-diabetes-of-the-young(e3f006a6-5756-4489-94ee-2da22fef3f46).html.
  612. Gunnerud UJ; Heinzle C; Holst JJ; Östman EM; Björck IM. "Effects of pre-meal drinks with protein and amino acids on glycemic and metabolic responses at a subsequent composite meal.". (2012): http://europepmc.org/abstract/med/23028596.
    10.1371/journal.pone.0044731
  613. Gunnerud U; Holst JJ; Östman E; Björck I. "The glycemic, insulinemic and plasma amino acid responses to equi-carbohydrate milk meals, a pilot- study of bovine and human milk.". (2012): http://europepmc.org/abstract/med/23057765.
    10.1186/1475-2891-11-83
  614. Salehi A; Gunnerud U; Muhammed SJ; Ostman E; Holst JJ; Björck I; Rorsman P. "The insulinogenic effect of whey protein is partially mediated by a direct effect of amino acids and GIP on ß-cells.". (2012): http://europepmc.org/abstract/med/22647249.
    10.1186/1743-7075-9-48
  615. Calissendorff J; Gustafsson T; Holst JJ; Brismar K; Röjdmark S. "Alcohol intake and its effect on some appetite-regulating hormones in man: influence of gastroprotection with sucralfate.". (2012): http://europepmc.org/abstract/med/22621425.
    10.3109/07435800.2012.662662
  616. Eva Winning Iepsen; Signe Torekov; Jens Juul Holst. "Leptin og dens betydning for vægtvedligeholdelse". Klinisk biokemi i Norden 24 4 (2012): 8-15. https://curis.ku.dk/portal/en/publications/leptin-og-dens-betydning-for-vaegtvedligeholdelse(7a83db22-77bf-451e-ab63-149c422a880f).html.
  617. Møller JB; Jusko WJ; Gao W; Hansen T; Pedersen O; Holst JJ; Overgaard RV; Madsen H; Ingwersen SH. "Mechanism-based population modelling for assessment of L-cell function based on total GLP-1 response following an oral glucose tolerance test.". (2011): http://europepmc.org/abstract/med/21922329.
    10.1007/s10928-011-9216-2
  618. Christensen M; Vedtofte L; Holst JJ; Vilsbøll T; Knop FK. "Glucose-dependent insulinotropic polypeptide: a bifunctional glucose-dependent regulator of glucagon and insulin secretion in humans.". (2011): http://europepmc.org/abstract/med/21984584.
    10.2337/db11-0979
  619. Ugleholdt R; Pedersen J; Bassi MR; Füchtbauer EM; Jørgensen SM; Kissow HL; Nytofte N; et al. "Transgenic rescue of adipocyte glucose-dependent insulinotropic polypeptide receptor expression restores high fat diet-induced body weight gain.". (2011): http://europepmc.org/abstract/med/22027838.
    10.1074/jbc.M111.311779
  620. C S Tam; H-R Berthoud; M Bueter; M V Chakravarthy; A Geliebter; A Hajnal; Jens Juul Holst; et al. "Could the mechanisms of bariatric surgery hold the key for novel therapies?". Obesity Reviews 12 11 (2011): 984-94. https://curis.ku.dk/portal/en/publications/could-the-mechanisms-of-bariatric-surgery-hold-the-key-for-novel-therapies(6b89096f-0c22-4979-8162-1d8d68bf321f).html.
    10.1111/j.1467-789X.2011.00902.x
  621. Torekov SS; Ma L; Grarup N; Hartmann B; Hainerová IA; Kielgast U; Kissow H; et al. "Homozygous carriers of the G allele of rs4664447 of the glucagon gene (GCG) are characterised by decreased fasting and stimulated levels of insulin, glucagon and glucagon-like peptide (GLP)-1.". (2011): http://europepmc.org/abstract/med/21822931.
    10.1007/s00125-011-2265-7
  622. Stephens JW; Bodvarsdottir TB; Wareham K; Prior SL; Bracken RM; Lowe GD; Rumley A; et al. "Effects of short-term therapy with glibenclamide and repaglinide on incretin hormones and oxidative damage associated with postprandial hyperglycaemia in people with type 2 diabetes mellitus.". (2011): http://europepmc.org/abstract/med/21835486.
    10.1016/j.diabres.2011.07.014
  623. Jorgensen NB; Dirksen C; Holst JJ; Madsbad S. "Gastric bypass and duodenal and gastric feeding: a comment to Hansen et al.". (2011): http://europepmc.org/abstract/med/22039038.
    10.1152/ajpgi.00228.2011
  624. Górka P; Kowalski ZM; Pietrzak P; Kotunia A; Jagusiak W; Holst JJ; Guilloteau P; Zabielski R. "Effect of method of delivery of sodium butyrate on rumen development in newborn calves.". (2011): http://europepmc.org/abstract/med/22032381.
    10.3168/jds.2011-4166
  625. Bagger JI; Knop FK; Holst JJ; Vilsbøll T. "Glucagon antagonism as a potential therapeutic target in type 2 diabetes.". (2011): http://europepmc.org/abstract/med/21615669.
    10.1111/j.1463-1326.2011.01427.x
  626. Naessén S; Carlström K; Holst JJ; Hellström PM; Hirschberg AL. "Women with bulimia nervosa exhibit attenuated secretion of glucagon-like peptide 1, pancreatic polypeptide, and insulin in response to a meal.". (2011): http://europepmc.org/abstract/med/21813805.
    10.3945/ajcn.111.014837
  627. Pedersen J; Holst JJ. "Glucagon like-peptide 1 receptor and the liver.". (2011): http://europepmc.org/abstract/med/22093450.
    10.1111/j.1478-3231.2011.02626.x
  628. Holst JJ; Christensen M; Lund A; de Heer J; Svendsen B; Kielgast U; Knop FK. "Regulation of glucagon secretion by incretins.". (2011): http://europepmc.org/abstract/med/21824261.
    10.1111/j.1463-1326.2011.01452.x
  629. Jensen PB; Larsen PJ; Karlsen C; Jensen HI; Holst JJ; Madsen OD. "Foetal proglucagon processing in relation to adult appetite control: lessons from a transplantable rat glucagonoma with severe anorexia.". (2011): http://europepmc.org/abstract/med/21824258.
    10.1111/j.1463-1326.2011.01439.x
  630. Vermeulen MA; Richir MC; Garretsen MK; van Schie A; Ghatei MA; Holst JJ; Heijboer AC; et al. "Gastric emptying, glucose metabolism and gut hormones: evaluation of a common preoperative carbohydrate beverage.". (2011): http://europepmc.org/abstract/med/21255977.
    10.1016/j.nut.2010.10.001
  631. Ketterer C; Müssig K; Heni M; Dudziak K; Randrianarisoa E; Wagner R; Machicao F; et al. "Genetic variation within the TRPM5 locus associates with prediabetic phenotypes in subjects at increased risk for type 2 diabetes.". (2011): http://europepmc.org/abstract/med/21489577.
    10.1016/j.metabol.2011.02.002
  632. Holst JJ. "Postprandial insulin secretion after gastric bypass surgery: the role of glucagon-like peptide 1.". (2011): http://europepmc.org/abstract/med/21868790.
    10.2337/db11-0798
  633. Lindgren O; Carr RD; Holst JJ; Deacon CF; Ahrén B. "Dissociated incretin hormone response to protein versus fat ingestion in obese subjects.". (2011): http://europepmc.org/abstract/med/21554523.
    10.1111/j.1463-1326.2011.01420.x
  634. Henry RR; Smith SR; Schwartz SL; Mudaliar SR; Deacon CF; Holst JJ; Duan RY; Chen RS; List JF. "Effects of saxagliptin on ß-cell stimulation and insulin secretion in patients with type 2 diabetes.". (2011): http://europepmc.org/abstract/med/21554520.
    10.1111/j.1463-1326.2011.01417.x
  635. Krog-Mikkelsen I; Sloth B; Dimitrov D; Tetens I; Björck I; Flint A; Holst JJ; et al. "A low glycemic index diet does not affect postprandial energy metabolism but decreases postprandial insulinemia and increases fullness ratings in healthy women.". (2011): http://europepmc.org/abstract/med/21775528.
    10.3945/jn.110.134627
  636. Hansen KB; Rosenkilde MM; Knop FK; Wellner N; Diep TA; Rehfeld JF; Andersen UB; Holst JJ; Hansen HS. "2-Oleoyl glycerol is a GPR119 agonist and signals GLP-1 release in humans.". (2011): http://europepmc.org/abstract/med/21778222.
    10.1210/jc.2011-0647
  637. Torekov SS; Madsbad S; Holst JJ. "Obesity - an indication for GLP-1 treatment? Obesity pathophysiology and GLP-1 treatment potential.". (2011): http://europepmc.org/abstract/med/21401851.
    10.1111/j.1467-789X.2011.00860.x
  638. Lindgren O; Carr RD; Deacon CF; Holst JJ; Pacini G; Mari A; Ahrén B. "Incretin hormone and insulin responses to oral versus intravenous lipid administration in humans.". (2011): http://europepmc.org/abstract/med/21593115.
    10.1210/jc.2011-0266
  639. Hjøllund KR; Deacon CF; Holst JJ. "Dipeptidyl peptidase-4 inhibition increases portal concentrations of intact glucagon-like peptide-1 (GLP-1) to a greater extent than peripheral concentrations in anaesthetised pigs.". (2011): http://europepmc.org/abstract/med/21604085.
    10.1007/s00125-011-2168-7
  640. Waget A; Cabou C; Masseboeuf M; Cattan P; Armanet M; Karaca M; Castel J; et al. "Physiological and pharmacological mechanisms through which the DPP-4 inhibitor sitagliptin regulates glycemia in mice.". (2011): http://europepmc.org/abstract/med/21673098.
    10.1210/en.2011-0286
  641. Krog-Mikkelsen I; Hels O; Tetens I; Holst JJ; Andersen JR; Bukhave K. "The effects of L-arabinose on intestinal sucrase activity: dose-response studies in vitro and in humans.". (2011): http://europepmc.org/abstract/med/21677059.
    10.3945/ajcn.111.014225
  642. Menge BA; Grüber L; Jørgensen SM; Deacon CF; Schmidt WE; Veldhuis JD; Holst JJ; Meier JJ. "Loss of inverse relationship between pulsatile insulin and glucagon secretion in patients with type 2 diabetes.". (2011): http://europepmc.org/abstract/med/21677283.
    10.2337/db11-0251
  643. Okawada M; Holst JJ; Teitelbaum DH. "Administration of a dipeptidyl peptidase IV inhibitor enhances the intestinal adaptation in a mouse model of short bowel syndrome.". (2011): http://europepmc.org/abstract/med/21719060.
    10.1016/j.surg.2011.05.013
  644. Falkén Y; Hellström PM; Holst JJ; Näslund E. "Changes in glucose homeostasis after Roux-en-Y gastric bypass surgery for obesity at day three, two months, and one year after surgery: role of gut peptides.". (2011): http://europepmc.org/abstract/med/21543426.
    10.1210/jc.2010-2876
  645. Kielgast U; Krarup T; Holst JJ; Madsbad S. "Four weeks of treatment with liraglutide reduces insulin dose without loss of glycemic control in type 1 diabetic patients with and without residual beta-cell function.". (2011): http://europepmc.org/abstract/med/21593296.
    10.2337/dc11-0096
  646. Samocha-Bonet D; Wong O; Synnott EL; Piyaratna N; Douglas A; Gribble FM; Holst JJ; Chisholm DJ; Greenfield JR. "Glutamine reduces postprandial glycemia and augments the glucagon-like peptide-1 response in type 2 diabetes patients.". (2011): http://europepmc.org/abstract/med/21593352.
    10.3945/jn.111.139824
  647. Torekov SS; Kipnes MS; Harley RE; Holst JJ; Ehlers MR. "Dose response of subcutaneous GLP-1 infusion in patients with type 2 diabetes.". (2011): http://europepmc.org/abstract/med/21362122.
    10.1111/j.1463-1326.2011.01388.x
  648. Brock Jacobsen I; Vind BF; Korsholm L; Flyvbjerg A; Frystyk J; Holst JJ; Beck-Nielsen H; Henriksen JE. "Counter-regulatory hormone responses to spontaneous hypoglycaemia during treatment with insulin Aspart or human soluble insulin: a double-blinded randomized cross-over study.". (2011): http://europepmc.org/abstract/med/21481195.
    10.1111/j.1748-1716.2011.02307.x
  649. Morten Hansen; Kristine Juul Hare; Jens Juul Holst; Filip Krag Knop. "Inhibition of glucagon secretion by GLP-1 agonists and DPP4 inhibitors". Journal of Clinical Metabolism & Diabetes 2 2 (2011): 7-13. https://curis.ku.dk/portal/en/publications/inhibition-of-glucagon-secretion-by-glp1-agonists-and-dpp4-inhibitors(7a83e000-5962-4573-8080-e59d412a8666).html.
  650. Hansen AM; Bödvarsdottir TB; Nordestgaard DN; Heller RS; Gotfredsen CF; Maedler K; Fels JJ; Holst JJ; Karlsen AE. "Upregulation of alpha cell glucagon-like peptide 1 (GLP-1) in Psammomys obesus--an adaptive response to hyperglycaemia?". (2011): http://europepmc.org/abstract/med/21347622.
    10.1007/s00125-011-2080-1
  651. Lund A; Vilsbøll T; Bagger JI; Holst JJ; Knop FK. "The separate and combined impact of the intestinal hormones, GIP, GLP-1, and GLP-2, on glucagon secretion in type 2 diabetes.". (2011): http://europepmc.org/abstract/med/21386059.
    10.1152/ajpendo.00665.2010
  652. Bremholm L; Hornum M; Andersen UB; Hartmann B; Holst JJ; Jeppesen PB. "The effect of Glucagon-Like Peptide-2 on mesenteric blood flow and cardiac parameters in end-jejunostomy short bowel patients.". (2011): http://europepmc.org/abstract/med/21421014.
    10.1016/j.regpep.2011.03.003
  653. Nauck MA; Kemmeries G; Holst JJ; Meier JJ. "Rapid tachyphylaxis of the glucagon-like peptide 1-induced deceleration of gastric emptying in humans.". (2011): http://europepmc.org/abstract/med/21430088.
    10.2337/db10-0474
  654. Kielgast U; Holst JJ; Madsbad S. "Antidiabetic actions of endogenous and exogenous GLP-1 in type 1 diabetic patients with and without residual ß-cell function.". (2011): http://europepmc.org/abstract/med/21441444.
    10.2337/db10-1790
  655. Holst JJ; Knop FK; Vilsbøll T; Krarup T; Madsbad S. "Loss of incretin effect is a specific, important, and early characteristic of type 2 diabetes.". (2011): http://europepmc.org/abstract/med/21525464.
    10.2337/dc11-s227
  656. Usinger L; Hansen KB; Kristiansen VB; Larsen S; Holst JJ; Knop FK. "Gastric emptying of orally administered glucose solutions and incretin hormone responses are unaffected by laparoscopic adjustable gastric banding.". (2011): http://europepmc.org/abstract/med/21287292.
    10.1007/s11695-011-0362-9
  657. Madsbad S; Kielgast U; Asmar M; Deacon CF; Torekov SS; Holst JJ. "An overview of once-weekly glucagon-like peptide-1 receptor agonists--available efficacy and safety data and perspectives for the future.". (2011): http://europepmc.org/abstract/med/21208359.
    10.1111/j.1463-1326.2011.01357.x
  658. Morten Hansen; Filip Krag Knop; Jens Juul Holst. "Inhibition de la sécrétion du glucagon par les antagonistes du GLP-1 et les inhibiteurs de la DPP-4". Medecine des Maladies Metaboliques 5 2 (2011): https://curis.ku.dk/portal/en/publications/inhibition-de-la-secretion-du-glucagon-par-les-antagonistes-du-glp1-et-les-inhibiteurs-de-la-dpp4(a11dd05e-ab91-45fd-a49b-071647313825).html.
  659. Mentis N; Vardarli I; Köthe LD; Holst JJ; Deacon CF; Theodorakis M; Meier JJ; Nauck MA. "GIP does not potentiate the antidiabetic effects of GLP-1 in hyperglycemic patients with type 2 diabetes.". (2011): http://europepmc.org/abstract/med/21330636.
    10.2337/db10-1332
  660. Christensen M; Knop FK; Vilsbøll T; Holst JJ. "Lixisenatide for type 2 diabetes mellitus.". (2011): http://europepmc.org/abstract/med/21391833.
    10.1517/13543784.2011.562191
  661. Witte AB; Grybäck P; Jacobsson H; Näslund E; Hellström PM; Holst JJ; Hilsted L; Schmidt PT. "Involvement of endogenous glucagon-like peptide-1 in regulation of gastric motility and pancreatic endocrine secretion.". (2011): http://europepmc.org/abstract/med/21114428.
    10.3109/00365521.2010.537680
  662. Thomsen KL; Aagaard NK; Grønbæk H; Holst JJ; Jessen N; Frystyk J; Vilstrup H. "IL-6 has no acute effect on the regulation of urea synthesis in vivo in rats.". (2011): http://europepmc.org/abstract/med/21190512.
    10.3109/00365513.2010.547213
  663. Vardarli I; Nauck MA; Köthe LD; Deacon CF; Holst JJ; Schweizer A; Foley JE. "Inhibition of DPP-4 with vildagliptin improved insulin secretion in response to oral as well as "isoglycemic" intravenous glucose without numerically changing the incretin effect in patients with type 2 diabetes.". (2011): http://europepmc.org/abstract/med/21239518.
    10.1210/jc.2010-2178
  664. Nathanson D; Zethelius B; Berne C; Lind L; Andrén B; Ingelsson E; Holst JJ; Nyström T. "Plasma levels of glucagon like peptide-1 associate with diastolic function in elderly men.". (2011): http://europepmc.org/abstract/med/21309838.
    10.1111/j.1464-5491.2010.03207.x
  665. Holst JJ; Burcelin R; Nathanson E. "Neuroprotective properties of GLP-1: theoretical and practical applications.". (2011): http://europepmc.org/abstract/med/21222567.
    10.1185/03007995.2010.549466
  666. Bagger JI; Knop FK; Lund A; Vestergaard H; Holst JJ; Vilsbøll T. "Impaired regulation of the incretin effect in patients with type 2 diabetes.". (2011): http://europepmc.org/abstract/med/21252240.
    10.1210/jc.2010-2435
  667. Taylor-Edwards CC; Burrin DG; Holst JJ; McLeod KR; Harmon DL. "Glucagon-like peptide-2 (GLP-2) increases small intestinal blood flow and mucosal growth in ruminating calves.". (2011): http://europepmc.org/abstract/med/21257057.
    10.3168/jds.2010-3540
  668. Hansen KB; Vilsbøll T; Bagger JI; Holst JJ; Knop FK. "Increased postprandial GIP and glucagon responses, but unaltered GLP-1 response after intervention with steroid hormone, relative physical inactivity, and high-calorie diet in healthy subjects.". (2011): http://europepmc.org/abstract/med/21047927.
    10.1210/jc.2010-1605
  669. Nauck MA; Vardarli I; Deacon CF; Holst JJ; Meier JJ. "Secretion of glucagon-like peptide-1 (GLP-1) in type 2 diabetes: what is up, what is down?". (2011): http://europepmc.org/abstract/med/20871975.
    10.1007/s00125-010-1896-4
  670. Gjesing AP; Kjems LL; Vestmar MA; Grarup N; Linneberg A; Deacon CF; Holst JJ; Pedersen O; Hansen T. "Carriers of the TCF7L2 rs7903146 TT genotype have elevated levels of plasma glucose, serum proinsulin and plasma gastric inhibitory polypeptide (GIP) during a meal test.". (2011): http://europepmc.org/abstract/med/20957343.
    10.1007/s00125-010-1940-4
  671. Qian Wang; Charles G Bailey; Cynthia Ng; Jessamy Tiffen; Annora Thoeng; Vineet Minhas; Melanie L Lehman; et al. "Androgen receptor and nutrient signaling pathways coordinate the demand for increased amino acid transport during prostate cancer progression". Cancer Research 71 24 (2011): 7525-7536. https://curis.ku.dk/portal/en/publications/androgen-receptor-and-nutrient-signaling-pathways-coordinate-the-demand-for-increased-amino-acid-transport-during-prostate-cancer-progression(03a0d37c-da2e-4902-b968-172b979606c1).html.
    10.1158/0008-5472.CAN-11-1821
  672. John B Buse; Alan Garber; Julio Rosenstock; Wolfgang E Schmidt; Jason H Brett; Nicoline Videbæk; Jens Juul Holst; Michael Nauck. "Liraglutide Treatment Is Associated with a Low Frequency and Magnitude of Antibody Formation with No Apparent Impact on Glycemic Response or Increased Frequency of Adverse Events". Journal of Clinical Endocrinology and Metabolism 96 6 (2011): 1695-702. https://curis.ku.dk/portal/en/publications/liraglutide-treatment-is-associated-with-a-low-frequency-and-magnitude-of-antibody-formation-with-no-apparent-impact-on-glycemic-response-or-increased-frequency-of-adverse-events(699a827c-9cc4-4c3a-bd2a-9ce56c766.
    10.1210/jc.2010-2822
  673. Hjerrild BE; Holst JJ; Juhl CB; Christiansen JS; Schmitz O; Gravholt CH. "Delayed ß-cell response and glucose intolerance in young women with Turner syndrome.". (2011): http://europepmc.org/abstract/med/21406078.
    10.1186/1472-6823-11-6
  674. Gjesing AP; Vestmar MA; Jørgensen T; Heni M; Holst JJ; Witte DR; Hansen T; Pedersen O. "The effect of PCSK1 variants on waist, waist-hip ratio and glucose metabolism is modified by sex and glucose tolerance status.". (2011): http://europepmc.org/abstract/med/21935364.
    10.1371/journal.pone.0023907
  675. Pedersen MH; Mølgaard C; Hellgren LI; Matthiessen J; Holst JJ; Lauritzen L. "The Effect of Dietary Fish Oil in addition to Lifestyle Counselling on Lipid Oxidation and Body Composition in Slightly Overweight Teenage Boys.". (2011): http://europepmc.org/abstract/med/21773017.
    10.1155/2011/348368
  676. Raben A; Møller BK; Flint A; Vasilaris TH; Christina Møller A; Juul Holst J; Astrup A. "Increased postprandial glycaemia, insulinemia, and lipidemia after 10 weeks' sucrose-rich diet compared to an artificially sweetened diet: a randomised controlled trial.". (2011): http://europepmc.org/abstract/med/21799667.
    10.3402/fnr.v55i0.5961
  677. Koopmann MC; Chen X; Holst JJ; Ney DM. "Sustained glucagon-like peptide-2 infusion is required for intestinal adaptation, and cessation reverses increased cellularity in rats with intestinal failure.". (2010): http://europepmc.org/abstract/med/20864657.
    10.1152/ajpgi.00367.2010
  678. Migoya EM; Bergeron R; Miller JL; Snyder RN; Tanen M; Hilliard D; Weiss B; et al. "Dipeptidyl peptidase-4 inhibitors administered in combination with metformin result in an additive increase in the plasma concentration of active GLP-1.". (2010): http://europepmc.org/abstract/med/21048706.
    10.1038/clpt.2010.184
  679. Nilsson AC; Östman EM; Knudsen KE; Holst JJ; Björck IM. "A cereal-based evening meal rich in indigestible carbohydrates increases plasma butyrate the next morning.". (2010): http://europepmc.org/abstract/med/20810606.
    10.3945/jn.110.123604
  680. Edholm T; Degerblad M; Grybäck P; Hilsted L; Holst JJ; Jacobsson H; Efendic S; Schmidt PT; Hellström PM. "Differential incretin effects of GIP and GLP-1 on gastric emptying, appetite, and insulin-glucose homeostasis.". (2010): http://europepmc.org/abstract/med/20584260.
    10.1111/j.1365-2982.2010.01554.x
  681. Taylor-Edwards CC; Burrin DG; Matthews JC; McLeod KR; Holst JJ; Harmon DL. "Expression of mRNA for proglucagon and glucagon-like peptide-2 (GLP-2) receptor in the ruminant gastrointestinal tract and the influence of energy intake.". (2010): http://europepmc.org/abstract/med/20688461.
    10.1016/j.domaniend.2010.05.002
  682. Rasmussen AR; Viby NE; Hare KJ; Hartmann B; Thim L; Holst JJ; Poulsen SS. "The intestinotrophic peptide, GLP-2, counteracts the gastrointestinal atrophy in mice induced by the epidermal growth factor receptor inhibitor, erlotinib, and cisplatin.". (2010): http://europepmc.org/abstract/med/20112065.
    10.1007/s10620-009-1104-x
  683. Holst JJ. "[Cardiac effects of glucagon-like peptide 1].". (2010): http://europepmc.org/abstract/med/20961500.
  684. Knop FK; Vilsbøll T; Larsen S; Madsbad S; Holst JJ; Krarup T. "Glucagon suppression during OGTT worsens while suppression during IVGTT sustains alongside development of glucose intolerance in patients with chronic pancreatitis.". (2010): http://europepmc.org/abstract/med/20573586.
    10.1016/j.regpep.2010.05.011
  685. Asmar M; Simonsen L; Madsbad S; Stallknecht B; Holst JJ; Bülow J. "Glucose-dependent insulinotropic polypeptide may enhance fatty acid re-esterification in subcutaneous abdominal adipose tissue in lean humans.". (2010): http://europepmc.org/abstract/med/20547981.
    10.2337/db10-0098
  686. Ellrichmann M; Boehm ID; Ritter PR; Holst JJ; Schmidt WE; Otte JM; Meier JJ. "Appetite reduction and weight loss during antiviral therapy for hepatitis C are associated with impaired gastric emptying and altered gastrointestinal hormone secretion.". (2010): http://europepmc.org/abstract/med/26009447.
    10.1016/j.regpep.2010.07.119
  687. Holst JJ. "Incretin physiology and pathophysiology.". (2010): http://europepmc.org/abstract/med/26009378.
    10.1016/j.regpep.2010.07.145
  688. Lapauw B; Ouwens M; 't Hart LM; Wuyts B; Holst JJ; T'Sjoen G; Kaufman JM; Ruige JB. "Sex steroids affect triglyceride handling, glucose-dependent insulinotropic polypeptide, and insulin sensitivity: a 1-week randomized clinical trial in healthy young men.". (2010): http://europepmc.org/abstract/med/20484128.
    10.2337/dc10-0515
  689. Christensen M; Knop FK; Vilsbøll T; Aaboe K; Holst JJ; Madsbad S; Krarup T. "Glucagon-like peptide-2, but not glucose-dependent insulinotropic polypeptide, stimulates glucagon release in patients with type 1 diabetes.". (2010): http://europepmc.org/abstract/med/20580750.
    10.1016/j.regpep.2010.05.004
  690. Meier JJ; Ritter PR; Jacob A; Menge BA; Deacon CF; Schmidt WE; Nauck MA; Holst JJ. "Impact of exogenous hyperglucagonemia on postprandial concentrations of gastric inhibitory polypeptide and glucagon-like peptide-1 in humans.". (2010): http://europepmc.org/abstract/med/20501678.
    10.1210/jc.2010-0550
  691. Yazbeck R; Sulda ML; Howarth GS; Bleich A; Raber K; von Hörsten S; Holst JJ; Abbott CA. "Dipeptidyl peptidase expression during experimental colitis in mice.". (2010): http://europepmc.org/abstract/med/20186930.
    10.1002/ibd.21241
  692. Bock G; Dalla Man C; Micheletto F; Basu R; Giesler PD; Laugen J; Deacon CF; et al. "The effect of DPP-4 inhibition with sitagliptin on incretin secretion and on fasting and postprandial glucose turnover in subjects with impaired fasting glucose.". (2010): http://europepmc.org/abstract/med/20039889.
    10.1111/j.1365-2265.2009.03764.x
  693. Hansen KB; Vilsbøll T; Bagger JI; Holst JJ; Knop FK. "Reduced glucose tolerance and insulin resistance induced by steroid treatment, relative physical inactivity, and high-calorie diet impairs the incretin effect in healthy subjects.". (2010): http://europepmc.org/abstract/med/20410219.
    10.1210/jc.2010-0119
  694. Hare KJ; Vilsbøll T; Asmar M; Deacon CF; Knop FK; Holst JJ. "The glucagonostatic and insulinotropic effects of glucagon-like peptide 1 contribute equally to its glucose-lowering action.". (2010): http://europepmc.org/abstract/med/20150286.
    10.2337/db09-1414
  695. Larnkjaer A; Schack-Nielsen L; Mølgaard C; Ingstrup HK; Holst JJ; Michaelsen KF. "Effect of growth in infancy on body composition, insulin resistance, and concentration of appetite hormones in adolescence.". (2010): http://europepmc.org/abstract/med/20410092.
    10.3945/ajcn.2009.27956
  696. Falkén Y; Hellström PM; Sanger GJ; Dewit O; Dukes G; Grybäck P; Holst JJ; Näslund E. "Actions of prolonged ghrelin infusion on gastrointestinal transit and glucose homeostasis in humans.". (2010): http://europepmc.org/abstract/med/20100281.
    10.1111/j.1365-2982.2009.01463.x
  697. Taqi E; Wallace LE; de Heuvel E; Chelikani PK; Zheng H; Berthoud HR; Holst JJ; Sigalet DL. "The influence of nutrients, biliary-pancreatic secretions, and systemic trophic hormones on intestinal adaptation in a Roux-en-Y bypass model.". (2010): http://europepmc.org/abstract/med/20438940.
    10.1016/j.jpedsurg.2010.02.036
  698. Asmar M; Bache M; Knop FK; Madsbad S; Holst JJ. "Do the actions of glucagon-like peptide-1 on gastric emptying, appetite, and food intake involve release of amylin in humans?". (2010): http://europepmc.org/abstract/med/20194711.
    10.1210/jc.2009-2133
  699. Kielgast U; Asmar M; Madsbad S; Holst JJ. "Effect of glucagon-like peptide-1 on alpha- and beta-cell function in C-peptide-negative type 1 diabetic patients.". (2010): http://europepmc.org/abstract/med/20207828.
    10.1210/jc.2009-2440
  700. Yabe D; Kuroe A; Lee S; Watanabe K; Hyo T; Hishizawa M; Kurose T; et al. "Little enhancement of meal-induced glucagon-like peptide 1 secretion in Japanese: Comparison of type 2 diabetes patients and healthy controls.". (2010): http://europepmc.org/abstract/med/24843409.
    10.1111/j.2040-1124.2010.00010.x
  701. Aaboe K; Knop FK; Vilsbøll T; Deacon CF; Holst JJ; Madsbad S; Krarup T. "Twelve weeks treatment with the DPP-4 inhibitor, sitagliptin, prevents degradation of peptide YY and improves glucose and non-glucose induced insulin secretion in patients with type 2 diabetes mellitus.". (2010): http://europepmc.org/abstract/med/20380653.
    10.1111/j.1463-1326.2009.01167.x
  702. Juhl CB; Højlund K; Elsborg R; Poulsen MK; Selmar PE; Holst JJ; Christiansen C; Beck-Nielsen H. "Automated detection of hypoglycemia-induced EEG changes recorded by subcutaneous electrodes in subjects with type 1 diabetes--the brain as a biosensor.". (2010): http://europepmc.org/abstract/med/20074827.
    10.1016/j.diabres.2010.01.007
  703. Hare KJ; Vilsbøll T; Holst JJ; Knop FK. "Inappropriate glucagon response after oral compared with isoglycemic intravenous glucose administration in patients with type 1 diabetes.". (2010): http://europepmc.org/abstract/med/20103744.
    10.1152/ajpendo.00700.2009
  704. Alibegovic AC; Sonne MP; Højbjerre L; Hansen T; Pedersen O; van Hall G; Holst JJ; et al. "The T-allele of TCF7L2 rs7903146 associates with a reduced compensation of insulin secretion for insulin resistance induced by 9 days of bed rest.". (2010): http://europepmc.org/abstract/med/20107109.
    10.2337/db09-0918
  705. Martins C; Kulseng B; King NA; Holst JJ; Blundell JE. "The effects of exercise-induced weight loss on appetite-related peptides and motivation to eat.". (2010): http://europepmc.org/abstract/med/20150577.
    10.1210/jc.2009-2082
  706. Rijkelijkhuizen JM; McQuarrie K; Girman CJ; Stein PP; Mari A; Holst JJ; Nijpels G; Dekker JM. "Effects of meal size and composition on incretin, alpha-cell, and beta-cell responses.". (2010): http://europepmc.org/abstract/med/19846181.
    10.1016/j.metabol.2009.07.039
  707. McLaughlin T; Peck M; Holst J; Deacon C. "Reversible hyperinsulinemic hypoglycemia after gastric bypass: a consequence of altered nutrient delivery.". (2010): http://europepmc.org/abstract/med/20133462.
    10.1210/jc.2009-1628
  708. Halbirk M; Nørrelund H; Møller N; Holst JJ; Schmitz O; Nielsen R; Nielsen-Kudsk JE; et al. "Cardiovascular and metabolic effects of 48-h glucagon-like peptide-1 infusion in compensated chronic patients with heart failure.". (2010): http://europepmc.org/abstract/med/20081109.
    10.1152/ajpheart.00930.2009
  709. Kozawa J; Okita K; Imagawa A; Iwahashi H; Holst JJ; Yamagata K; Shimomura I. "Similar incretin secretion in obese and non-obese Japanese subjects with type 2 diabetes.". (2010): http://europepmc.org/abstract/med/20138827.
    10.1016/j.bbrc.2010.01.134
  710. Asmar M; Tangaa W; Madsbad S; Hare K; Astrup A; Flint A; Bülow J; Holst JJ. "On the role of glucose-dependent insulintropic polypeptide in postprandial metabolism in humans.". (2010): http://europepmc.org/abstract/med/19996386.
    10.1152/ajpendo.00639.2009
  711. Shang Q; Saumoy M; Holst JJ; Salen G; Xu G. "Colesevelam improves insulin resistance in a diet-induced obesity (F-DIO) rat model by increasing the release of GLP-1.". (2010): http://europepmc.org/abstract/med/20044510.
    10.1152/ajpgi.00362.2009
  712. Asmar M; Højberg PV; Deacon CF; Hare K; Holst JJ; Madsbad S. "Pancreatic beta-cell responses to GLP-1 after near-normalization of blood glucose in patients with type 2 diabetes.". (2010): http://europepmc.org/abstract/med/20005261.
    10.1016/j.regpep.2009.12.004
  713. Asmar M; Holst JJ. "Glucagon-like peptide 1 and glucose-dependent insulinotropic polypeptide: new advances.". (2010): http://europepmc.org/abstract/med/19881341.
    10.1097/MED.0b013e3283339051
  714. Brader L; Holm L; Mortensen L; Thomsen C; Astrup A; Holst JJ; de Vrese M; Schrezenmeir J; Hermansen K. "Acute effects of casein on postprandial lipemia and incretin responses in type 2 diabetic subjects.". (2010): http://europepmc.org/abstract/med/19473824.
    10.1016/j.numecd.2009.03.019
  715. Dirksen C; Hansen DL; Madsbad S; Hvolris LE; Naver LS; Holst JJ; Worm D. "Postprandial diabetic glucose tolerance is normalized by gastric bypass feeding as opposed to gastric feeding and is associated with exaggerated GLP-1 secretion: a case report.". (2010): http://europepmc.org/abstract/med/19918005.
    http://dx.doi.org/10.2337/dc09-1374
  716. Nathanson D; Zethelius B; Berne C; Holst JJ; Sjöholm A; Nyström T. "Reduced plasma levels of glucagon-like peptide-1 in elderly men are associated with impaired glucose tolerance but not with coronary heart disease.". (2010): http://europepmc.org/abstract/med/19936703.
    10.1007/s00125-009-1596-0
  717. Carr RD; Larsen MO; Jelic K; Lindgren O; Vikman J; Holst JJ; Deacon CF; Ahrén B. "Secretion and dipeptidyl peptidase-4-mediated metabolism of incretin hormones after a mixed meal or glucose ingestion in obese compared to lean, nondiabetic men.". (2010): http://europepmc.org/abstract/med/20008019.
    10.1210/jc.2009-2054
  718. Deacon CF; Holst JJ. "Linagliptin, a xanthine-based dipeptidyl peptidase-4 inhibitor with an unusual profile for the treatment of type 2 diabetes.". (2010): http://europepmc.org/abstract/med/19947894.
    10.1517/13543780903463862
  719. Bremholm L; Hornum M; Andersen UB; Holst JJ. "The effect of glucagon-like peptide-2 on arterial blood flow and cardiac parameters.". (2010): http://europepmc.org/abstract/med/19900491.
    10.1016/j.regpep.2009.11.001
  720. Vidarsdottir S; Roelfsema F; Streefland T; Holst JJ; Rehfeld JF; Pijl H. "Short-term treatment with olanzapine does not modulate gut hormone secretion: olanzapine disintegrating versus standard tablets.". (2010): http://europepmc.org/abstract/med/19779025.
    10.1530/EJE-09-0433
  721. Meena Asmar; Patricia Højberg; Carolyn Deacon; Kristine Hare; Jens Juul Holst; Sten Madsbad. "Pancreatic ß-cell responses to GLP-1 after near-normalization of blood glucose in patients with type 2 diabetes". Regulatory Peptides 160 1-3 (2010): 175-180. https://curis.ku.dk/portal/en/publications/pancreatic-sscell-responses-to-glp1-after-nearnormalization-of-blood-glucose-in-patients-with-type-2-diabetes(75ea89c8-9a5c-440a-8bba-615204fa4a87).html.
  722. Lodefalk M; Carlsson-Skwirut C; Holst JJ; Aman J; Bang P. "Effects of fat supplementation on postprandial GIP, GLP-1, ghrelin and IGFBP-1 levels: a pilot study on adolescents with type 1 diabetes.". (2010): http://europepmc.org/abstract/med/20389106.
    10.1159/000308168
  723. Hornum M; Pedersen JF; Larsen S; Olsen O; Holst JJ; Knop FK. "Increased postprandial response of glucagon-like peptide-2 in patients with chronic pancreatitis and pancreatic exocrine insufficiency.". (2010): http://europepmc.org/abstract/med/20460948.
    10.1159/000243729
  724. Holst JJ. "Glucagon and glucagon-like peptides 1 and 2.". (2010): http://europepmc.org/abstract/med/19960378.
    10.1007/400_2009_35
  725. Knop FK; Vilsbøll T; Lund A; Krarup T; Holst JJ; Hornum M. "The impact of pancreatic enzyme supplementation on postprandial responses of glucagon-like Peptide-2 in patients with chronic pancreatitis and pancreatic exocrine insufficiency.". (2010): http://europepmc.org/abstract/med/20818126.
  726. Redstone HA; Buie WD; Hart DA; Wallace L; Hornby PJ; Sague S; Holst JJ; Sigalet DL. "The effect of glucagon-like Peptide-2 receptor agonists on colonic anastomotic wound healing.". (2010): http://europepmc.org/abstract/med/20953406.
    10.1155/2010/672453
  727. Høi-Hansen T; Pedersen-Bjergaard U; Andersen RD; Kristensen PL; Thomsen C; Kjaer T; Høgenhaven H; et al. "Cognitive performance, symptoms and counter-regulation during hypoglycaemia in patients with type 1 diabetes and high or low renin-angiotensin system activity.". (2009): http://europepmc.org/abstract/med/19717500.
    10.1177/1470320309343007
  728. Müssig K; Staiger H; Machicao F; Machann J; Schick F; Schäfer SA; Claussen CD; et al. "Preliminary report: genetic variation within the GPBAR1 gene is not associated with metabolic traits in white subjects at an increased risk for type 2 diabetes mellitus.". (2009): http://europepmc.org/abstract/med/19716570.
    10.1016/j.metabol.2009.06.012
  729. Hare KJ; Knop FK; Asmar M; Madsbad S; Deacon CF; Holst JJ; Vilsbøll T. "Preserved inhibitory potency of GLP-1 on glucagon secretion in type 2 diabetes mellitus.". (2009): http://europepmc.org/abstract/med/19837930.
    10.1210/jc.2009-0921
  730. Liu X; Murali SG; Holst JJ; Ney DM. "Whey protein potentiates the intestinotrophic action of glucagon-like peptide-2 in parenterally fed rats.". (2009): http://europepmc.org/abstract/med/19776251.
    10.1152/ajpregu.00423.2009
  731. Kielgast U; Holst JJ; Madsbad S. "Treatment of type 1 diabetic patients with glucagon-like peptide-1 (GLP-1) and GLP-1R agonists.". (2009): http://europepmc.org/abstract/med/19925391.
    10.2174/157339909789804413
  732. Keller J; Beglinger C; Holst JJ; Andresen V; Layer P. "Mechanisms of gastric emptying disturbances in chronic and acute inflammation of the distal gastrointestinal tract.". (2009): http://europepmc.org/abstract/med/20501434.
    10.1152/ajpgi.00145.2009
  733. Le Gall M; Gallois M; Sève B; Louveau I; Holst JJ; Oswald IP; Lallès JP; Guilloteau P. "Comparative effect of orally administered sodium butyrate before or after weaning on growth and several indices of gastrointestinal biology of piglets.". (2009): http://europepmc.org/abstract/med/19480733.
    10.1017/S0007114509990213
  734. Simonsen L; Pilgaard S; Carr RD; Kanstrup AB; Holst JJ; Deacon CF. "Inhibition of neutral endopeptidase 24.11 does not potentiate the improvement in glycemic control obtained with dipeptidyl peptidase-4 inhibition in diabetic Goto-Kakizaki rats.". (2009): http://europepmc.org/abstract/med/19579179.
    10.1055/s-0029-1225609
  735. Guldstrand M; Ahrén B; Näslund E; Holst JJ; Adamson U. "Dissociated incretin response to oral glucose at 1 year after restrictive vs. malabsorptive bariatric surgery.". (2009): http://europepmc.org/abstract/med/19614945.
    10.1111/j.1463-1326.2009.01089.x
  736. Henriksen DB; Alexandersen P; Hartmann B; Adrian CL; Byrjalsen I; Bone HG; Holst JJ; Christiansen C. "Four-month treatment with GLP-2 significantly increases hip BMD: a randomized, placebo-controlled, dose-ranging study in postmenopausal women with low BMD.". (2009): http://europepmc.org/abstract/med/19631303.
    10.1016/j.bone.2009.07.008
  737. Witte AB; Grybäck P; Holst JJ; Hilsted L; Hellström PM; Jacobsson H; Schmidt PT. "Differential effect of PYY1-36 and PYY3-36 on gastric emptying in man.". (2009): http://europepmc.org/abstract/med/19651163.
    10.1016/j.regpep.2009.07.013
  738. Lerche S; Soendergaard L; Rungby J; Moeller N; Holst JJ; Schmitz OE; Brock B. "No increased risk of hypoglycaemic episodes during 48 h of subcutaneous glucagon-like-peptide-1 administration in fasting healthy subjects.". (2009): http://europepmc.org/abstract/med/19094067.
    10.1111/j.1365-2265.2008.03510.x
  739. Gorka P; Kowalski ZM; Pietrzak P; Kotunia A; Kiljanczyk R; Flaga J; Holst JJ; Guilloteau P; Zabielski R. "Effect of sodium butyrate supplementation in milk replacer and starter diet on rumen development in calves.". (2009): http://europepmc.org/abstract/med/19996481.
  740. Patti ME; Houten SM; Bianco AC; Bernier R; Larsen PR; Holst JJ; Badman MK; et al. "Serum bile acids are higher in humans with prior gastric bypass: potential contribution to improved glucose and lipid metabolism.". (2009): http://europepmc.org/abstract/med/19360006.
    10.1038/oby.2009.102
  741. Bucinskaite V; Tolessa T; Pedersen J; Rydqvist B; Zerihun L; Holst JJ; Hellström PM. "Receptor-mediated activation of gastric vagal afferents by glucagon-like peptide-1 in the rat.". (2009): http://europepmc.org/abstract/med/19453518.
    10.1111/j.1365-2982.2009.01317.x
  742. Simonsen L; Pilgaard S; Orskov C; Hartmann B; Holst JJ; Deacon CF. "Long-term exendin-4 treatment delays natural deterioration of glycaemic control in diabetic Goto-Kakizaki rats.". (2009): http://europepmc.org/abstract/med/19508463.
    10.1111/j.1463-1326.2009.01066.x
  743. Faerch K; Borch-Johnsen K; Holst JJ; Vaag A. "Pathophysiology and aetiology of impaired fasting glycaemia and impaired glucose tolerance: does it matter for prevention and treatment of type 2 diabetes?". (2009): http://europepmc.org/abstract/med/19590846.
    10.1007/s00125-009-1443-3
  744. Gelling RW; Vuguin PM; Du XQ; Cui L; Rømer J; Pederson RA; Leiser M; et al. "Pancreatic beta-cell overexpression of the glucagon receptor gene results in enhanced beta-cell function and mass.". (2009): http://europepmc.org/abstract/med/19602585.
    10.1152/ajpendo.00082.2009
  745. Schrader H; Menge BA; Breuer TG; Ritter PR; Uhl W; Schmidt WE; Holst JJ; Meier JJ. "Impaired glucose-induced glucagon suppression after partial pancreatectomy.". (2009): http://europepmc.org/abstract/med/19491219.
    10.1210/jc.2009-0826
  746. Bonuccelli S; Muscelli E; Gastaldelli A; Barsotti E; Astiarraga BD; Holst JJ; Mari A; Ferrannini E. "Improved tolerance to sequential glucose loading (Staub-Traugott effect): size and mechanisms.". (2009): http://europepmc.org/abstract/med/19531643.
    10.1152/ajpendo.00127.2009
  747. Hansen KB; Knop FK; Holst JJ; Vilsbøll T. "Treatment of type 2 diabetes with glucagon-like peptide-1 receptor agonists.". (2009): http://europepmc.org/abstract/med/19624785.
    10.1111/j.1742-1241.2009.02086.x
  748. Christensen M; Knop FK; Holst JJ; Vilsboll T. "Lixisenatide, a novel GLP-1 receptor agonist for the treatment of type 2 diabetes mellitus.". (2009): http://europepmc.org/abstract/med/19629885.
  749. Deacon CF; Holst JJ. "Immunoassays for the incretin hormones GIP and GLP-1.". (2009): http://europepmc.org/abstract/med/19748060.
    10.1016/j.beem.2009.03.006
  750. Vilsbøll T; Holst JJ; Knop FK. "The spectrum of antidiabetic actions of GLP-1 in patients with diabetes.". (2009): http://europepmc.org/abstract/med/19748063.
    10.1016/j.beem.2009.03.011
  751. Ozer EA; Holst JJ; Duman N; Kumral A; Ozkan H. "The relationship between glucagon-like peptide 2 and feeding intolerance in preterm infants.". (2009): http://europepmc.org/abstract/med/18499738.
    10.1093/tropej/fmn033
  752. Pilgaard K; Jensen CB; Schou JH; Lyssenko V; Wegner L; Brøns C; Vilsbøll T; et al. "The T allele of rs7903146 TCF7L2 is associated with impaired insulinotropic action of incretin hormones, reduced 24 h profiles of plasma insulin and glucagon, and increased hepatic glucose production in young healthy men.". (2009): http://europepmc.org/abstract/med/19288077.
    10.1007/s00125-009-1307-x
  753. Holst JJ; Seino Y. "GLP-1 receptor agonists: targeting both hyperglycaemia and disease processes in diabetes.". (2009): http://europepmc.org/abstract/med/19299027.
    10.1016/j.diabres.2009.02.017
  754. Müssig K; Staiger H; Machicao F; Kirchhoff K; Guthoff M; Schäfer SA; Kantartzis K; et al. "Association of type 2 diabetes candidate polymorphisms in KCNQ1 with incretin and insulin secretion.". (2009): http://europepmc.org/abstract/med/19366866.
    10.2337/db08-1589
  755. Mortensen LS; Hartvigsen ML; Brader LJ; Astrup A; Schrezenmeir J; Holst JJ; Thomsen C; Hermansen K. "Differential effects of protein quality on postprandial lipemia in response to a fat-rich meal in type 2 diabetes: comparison of whey, casein, gluten, and cod protein.". (2009): http://europepmc.org/abstract/med/19458012.
    10.3945/ajcn.2008.27281
  756. Bosch G; Verbrugghe A; Hesta M; Holst JJ; van der Poel AF; Janssens GP; Hendriks WH. "The effects of dietary fibre type on satiety-related hormones and voluntary food intake in dogs.". (2009): http://europepmc.org/abstract/med/19144213.
    10.1017/S0007114508149194
  757. Holst B; Egerod KL; Jin C; Petersen PS; Østergaard MV; Hald J; Sprinkel AM; et al. "G protein-coupled receptor 39 deficiency is associated with pancreatic islet dysfunction.". (2009): http://europepmc.org/abstract/med/19213833.
    10.1210/en.2008-1250
  758. Bie-Olsen LG; Kjaer TW; Pedersen-Bjergaard U; Lonsdale MN; Holst JJ; Law I; Thorsteinsson B. "Changes of cognition and regional cerebral activity during acute hypoglycemia in normal subjects: A H2 15O positron emission tomographic study.". (2009): http://europepmc.org/abstract/med/19170163.
    10.1002/jnr.22002
  759. Sloth B; Due A; Larsen TM; Holst JJ; Heding A; Astrup A. "The effect of a high-MUFA, low-glycaemic index diet and a low-fat diet on appetite and glucose metabolism during a 6-month weight maintenance period.". (2009): http://europepmc.org/abstract/med/19079942.
    10.1017/S0007114508137710
  760. Mingrone G; Nolfe G; Gissey GC; Iaconelli A; Leccesi L; Guidone C; Nanni G; Holst JJ. "Circadian rhythms of GIP and GLP1 in glucose-tolerant and in type 2 diabetic patients after biliopancreatic diversion.". (2009): http://europepmc.org/abstract/med/19229515.
    10.1007/s00125-009-1288-9
  761. Svendsen PF; Nilas L; Madsbad S; Holst JJ. "Incretin hormone secretion in women with polycystic ovary syndrome: roles of obesity, insulin sensitivity, and treatment with metformin.". (2009): http://europepmc.org/abstract/med/19375579.
    10.1016/j.metabol.2008.11.009
  762. Deacon CF; Holst JJ. "Saxagliptin: a new dipeptidyl peptidase-4 inhibitor for the treatment of type 2 diabetes.". (2009): http://europepmc.org/abstract/med/19444391.
    10.1007/s12325-009-0030-9
  763. Vollmer K; Gardiwal H; Menge BA; Goetze O; Deacon CF; Schmidt WE; Holst JJ; Meier JJ. "Hyperglycemia acutely lowers the postprandial excursions of glucagon-like Peptide-1 and gastric inhibitory polypeptide in humans.". (2009): http://europepmc.org/abstract/med/19174495.
    10.1210/jc.2008-2197
  764. Zijlstra N; Mars M; de Wijk RA; Westerterp-Plantenga MS; Holst JJ; de Graaf C. "Effect of viscosity on appetite and gastro-intestinal hormones.". (2009): http://europepmc.org/abstract/med/19419670.
    10.1016/j.physbeh.2009.02.001
  765. Kaji T; Tanaka H; Redstone H; Wallace LE; Holst JJ; Sigalet DL. "Temporal changes in the intestinal growth promoting effects of glucagon-like peptide 2 following intestinal resection.". (2009): http://europepmc.org/abstract/med/19062041.
    10.1016/j.jss.2008.05.007
  766. Kalaitzakis E; Sadik R; Holst JJ; Ohman L; Björnsson E. "Gut transit is associated with gastrointestinal symptoms and gut hormone profile in patients with cirrhosis.". (2009): http://europepmc.org/abstract/med/19200458.
    10.1016/j.cgh.2008.11.022
  767. Faerch K; Vaag A; Holst JJ; Hansen T; Jørgensen T; Borch-Johnsen K. "Natural history of insulin sensitivity and insulin secretion in the progression from normal glucose tolerance to impaired fasting glycemia and impaired glucose tolerance: the Inter99 study.". (2009): http://europepmc.org/abstract/med/19056613.
    10.2337/dc08-1195
  768. Enç FY; Ones T; Akin HL; Dede F; Turoglu HT; Ulfer G; Bekiroglu N; et al. "Orlistat accelerates gastric emptying and attenuates GIP release in healthy subjects.". (2009): http://europepmc.org/abstract/med/19109408.
    10.1152/ajpgi.90209.2008
  769. Hlebowicz J; Hlebowicz A; Lindstedt S; Björgell O; Höglund P; Holst JJ; Darwiche G; Almér LO. "Effects of 1 and 3 g cinnamon on gastric emptying, satiety, and postprandial blood glucose, insulin, glucose-dependent insulinotropic polypeptide, glucagon-like peptide 1, and ghrelin concentrations in healthy subjects.". (2009): http://europepmc.org/abstract/med/19158209.
    10.3945/ajcn.2008.26807
  770. Olesen SC; Hansen DL; Almdal T; Bendtsen F; Nordgaard I; Hvolris LE; Holst JJ; Naver L; Madsbad S. "[Surgical treatment of diabetes mellitus type 2].". (2009): http://europepmc.org/abstract/med/19284908.
  771. Knop FK; Vilsbøll T; Holst JJ. "Incretin-based therapy of type 2 diabetes mellitus.". (2009): http://europepmc.org/abstract/med/19275672.
    10.2174/138920309787315158
  772. Højberg PV; Vilsbøll T; Rabøl R; Knop FK; Bache M; Krarup T; Holst JJ; Madsbad S. "Four weeks of near-normalisation of blood glucose improves the insulin response to glucagon-like peptide-1 and glucose-dependent insulinotropic polypeptide in patients with type 2 diabetes.". (2009): http://europepmc.org/abstract/med/19037628.
    10.1007/s00125-008-1195-5
  773. Aaboe K; Knop FK; Vilsboll T; Vølund A; Simonsen U; Deacon CF; Madsbad S; Holst JJ; Krarup T. "KATP channel closure ameliorates the impaired insulinotropic effect of glucose-dependent insulinotropic polypeptide in patients with type 2 diabetes.". (2009): http://europepmc.org/abstract/med/19050053.
    10.1210/jc.2008-1731
  774. Murphy R; Tura A; Clark PM; Holst JJ; Mari A; Hattersley AT. "Glucokinase, the pancreatic glucose sensor, is not the gut glucose sensor.". (2009): http://europepmc.org/abstract/med/18974968.
    10.1007/s00125-008-1183-9
  775. Greenfield JR; Farooqi IS; Keogh JM; Henning E; Habib AM; Blackwood A; Reimann F; Holst JJ; Gribble FM. "Oral glutamine increases circulating glucagon-like peptide 1, glucagon, and insulin concentrations in lean, obese, and type 2 diabetic subjects.". (2009): http://europepmc.org/abstract/med/19056578.
    10.3945/ajcn.2008.26362
  776. Holst JJ; Vilsbøll T; Deacon CF. "The incretin system and its role in type 2 diabetes mellitus.". (2009): http://europepmc.org/abstract/med/18786605.
    10.1016/j.mce.2008.08.012
  777. Kasper Aaboe; Filip Krag Knop; Tina Vilsbøll; A Vølund; U Simonsen; Carolyn Deacon; Sten Madsbad; Jens Juul Holst; Thure Krarup. "KATP channel closure ameliorates the impaired insulinotropic effect of glucose-dependent insulinotropic polypeptide (GIP) in patients with type 2 diabetes". Journal of Clinical Endocrinology and Metabolism 94 2 (2009): 603-608. https://curis.ku.dk/portal/en/publications/katp-channel-closure-ameliorates-the-impaired-insulinotropic-effect-of-glucosedependent-insulinotropic-polypeptide-gip-in-patients-with-type-2-diabetes(6d1149d0-9005-11df-928f-000ea68e967b).html.
  778. Siv Jacobsen; Dorte Lindqvist Hansen; Dorte Worm; Sten Madsbad; Lisbeth Edvardsen Hvolris; Lars Peter Skat Naver; Jens Juul Holst. "Remission af type 2-diabetes efter gastric bypass-kirurgi". Behandlerbladet (2009): 20-29. https://curis.ku.dk/portal/en/publications/remission-af-type-2diabetes-efter-gastric-bypasskirurgi(d4053b90-c27a-4cc6-b9e2-5ae0d366ee5d).html.
    http://dx.doi.org/http://www.diabetes.dk/Rundt_om_diabetes/Paa_tryk/~/media/Files/Diabetes.dk/Rundt_om_diabetes/paa_tryk/Behandlerbladet/Behandlerblad%20nr.28.ashx
  779. Tatsuru Kaji; Hiroaki Tanaka; Laurie E Wallace; Dragan Kravarusic; Jens Juul Holst; David L Sigalet. "Nutritional effects of the serial transverse enteroplasty procedure in experimental short bowel syndrome". European Journal of Pediatric Surgery. Supplement 44 8 (2009): 1552-9. https://curis.ku.dk/portal/en/publications/nutritional-effects-of-the-serial-transverse-enteroplasty-procedure-in-experimental-short-bowel-syndrome(50c07d42-09e4-4b6a-9279-70e2ded5b3dd).html.
    10.1016/j.jpedsurg.2008.10.001
  780. Bremholm L; Hornum M; Henriksen BM; Larsen S; Holst JJ. "Glucagon-like peptide-2 increases mesenteric blood flow in humans.". (2009): http://europepmc.org/abstract/med/19005872.
    10.1080/00365520802538195
  781. Jeppesen PB; Lund P; Gottschalck IB; Nielsen HB; Holst JJ; Mortensen J; Poulsen SS; Quistorff B; Mortensen PB. "Short bowel patients treated for two years with glucagon-like Peptide 2: effects on intestinal morphology and absorption, renal function, bone and body composition, and muscle function.". (2009): http://europepmc.org/abstract/med/19707516.
    10.1155/2009/616054
  782. Jeppesen PB; Lund P; Gottschalck IB; Nielsen HB; Holst JJ; Mortensen J; Poulsen SS; Quistorff B; Mortensen PB. "Short bowel patients treated for two years with glucagon-like peptide 2 (GLP-2): compliance, safety, and effects on quality of life.". (2009): http://europepmc.org/abstract/med/19590736.
    10.1155/2009/425759
  783. Koopmann MC; Liu X; Boehler CJ; Murali SG; Holst JJ; Ney DM. "Colonic GLP-2 is not sufficient to promote jejunal adaptation in a PN-dependent rat model of human short bowel syndrome.". (2009): http://europepmc.org/abstract/med/19644131.
    10.1177/0148607109336597
  784. de Heer J; Rasmussen C; Coy DH; Holst JJ. "Glucagon-like peptide-1, but not glucose-dependent insulinotropic peptide, inhibits glucagon secretion via somatostatin (receptor subtype 2) in the perfused rat pancreas.". (2008): http://europepmc.org/abstract/med/18795252.
    10.1007/s00125-008-1149-y
  785. Liu X; Murali SG; Holst JJ; Ney DM. "Enteral nutrients potentiate the intestinotrophic action of glucagon-like peptide-2 in association with increased insulin-like growth factor-I responses in rats.". (2008): http://europepmc.org/abstract/med/18832087.
    10.1152/ajpregu.90616.2008
  786. Højberg PV; Vilsbøll T; Zander M; Knop FK; Krarup T; Vølund A; Holst JJ; Madsbad S. "Four weeks of near-normalization of blood glucose has no effect on postprandial GLP-1 and GIP secretion, but augments pancreatic B-cell responsiveness to a meal in patients with Type 2 diabetes.". (2008): http://europepmc.org/abstract/med/19046215.
    10.1111/j.1464-5491.2008.02579.x
  787. Aaboe K; Krarup T; Madsbad S; Holst JJ. "GLP-1: physiological effects and potential therapeutic applications.". (2008): http://europepmc.org/abstract/med/18435775.
    10.1111/j.1463-1326.2008.00853.x
  788. Foley JE; Ligueros-Saylan M; He YL; Holst JJ; Deacon CF; Dunning BE; Leone-Jones A; Yu T; Kelley DE. "Effect of vildagliptin on glucagon concentration during meals in patients with type 1 diabetes.". (2008): http://europepmc.org/abstract/med/18597213.
    10.1055/s-2008-1078754
  789. Ellrichmann M; Kapelle M; Ritter PR; Holst JJ; Herzig KH; Schmidt WE; Schmitz F; Meier JJ. "Orlistat inhibition of intestinal lipase acutely increases appetite and attenuates postprandial glucagon-like peptide-1-(7-36)-amide-1, cholecystokinin, and peptide YY concentrations.". (2008): http://europepmc.org/abstract/med/18647814.
    10.1210/jc.2008-0924
  790. Kaji T; Tanaka H; Holst JJ; Redstone H; Wallace L; de Heuval E; Sigalet DL. "The effects of variations in dose and method of administration on glucagon like peptide-2 activity in the rat.". (2008): http://europepmc.org/abstract/med/18762180.
    10.1016/j.ejphar.2008.07.070
  791. Müssig K; Oncü A; Lindauer P; Heininger A; Aebert H; Unertl K; Ziemer G; et al. "Effects of intravenous glucagon-like peptide-1 on glucose control and hemodynamics after coronary artery bypass surgery in patients with type 2 diabetes.". (2008): http://europepmc.org/abstract/med/18721530.
    10.1016/j.amjcard.2008.06.029
  792. Gottschalck IB; Jeppesen PB; Holst JJ; Henriksen DB. "Reduction in bone resorption by exogenous glucagon-like peptide-2 administration requires an intact gastrointestinal tract.". (2008): http://europepmc.org/abstract/med/19086164.
    10.1080/00365520801965381
  793. Blundell JE; Levin F; King NA; Barkeling B; Gustafsson T; Hellstrom PM; Holst JJ; Naslund E. "Overconsumption and obesity: peptides and susceptibility to weight gain.". (2008): http://europepmc.org/abstract/med/18534696.
    10.1016/j.regpep.2007.10.009
  794. Madsbad S; Krarup T; Deacon CF; Holst JJ. "Glucagon-like peptide receptor agonists and dipeptidyl peptidase-4 inhibitors in the treatment of diabetes: a review of clinical trials.". (2008): http://europepmc.org/abstract/med/18542012.
    http://dx.doi.org/10.1097/MCO.0b013e328302f414
  795. Knop FK; Holst JJ; Vilsbøll T. "Replacing SUs with incretin-based therapies for type 2 diabetes mellitus: challenges and feasibility.". (2008): http://europepmc.org/abstract/med/18600596.
  796. Robertson MA; Sigalet DL; Holst JJ; Meddings JB; Wood J; Sharkey KA. "Intestinal permeability and glucagon-like peptide-2 in children with autism: a controlled pilot study.". (2008): http://europepmc.org/abstract/med/18311517.
    10.1007/s10803-007-0482-1
  797. Hellström PM; Näslund E; Edholm T; Schmidt PT; Kristensen J; Theodorsson E; Holst JJ; Efendic S. "GLP-1 suppresses gastrointestinal motility and inhibits the migrating motor complex in healthy subjects and patients with irritable bowel syndrome.". (2008): http://europepmc.org/abstract/med/18298441.
    10.1111/j.1365-2982.2007.01079.x
  798. Faerch K; Vaag A; Holst JJ; Glümer C; Pedersen O; Borch-Johnsen K. "Impaired fasting glycaemia vs impaired glucose tolerance: similar impairment of pancreatic alpha and beta cell function but differential roles of incretin hormones and insulin action.". (2008): http://europepmc.org/abstract/med/18317726.
    10.1007/s00125-008-0951-x
  799. Sørensen LB; Cueto HT; Andersen MT; Bitz C; Holst JJ; Rehfeld JF; Astrup A. "The effect of salatrim, a low-calorie modified triacylglycerol, on appetite and energy intake.". (2008): http://europepmc.org/abstract/med/18469235.
  800. Muscelli E; Mari A; Casolaro A; Camastra S; Seghieri G; Gastaldelli A; Holst JJ; Ferrannini E. "Separate impact of obesity and glucose tolerance on the incretin effect in normal subjects and type 2 diabetic patients.". (2008): http://europepmc.org/abstract/med/18162504.
    10.2337/db07-1315
  801. Nelson DW; Murali SG; Liu X; Koopmann MC; Holst JJ; Ney DM. "Insulin-like growth factor I and glucagon-like peptide-2 responses to fasting followed by controlled or ad libitum refeeding in rats.". (2008): http://europepmc.org/abstract/med/18256135.
    10.1152/ajpregu.00238.2007
  802. Højberg PV; Zander M; Vilsbøll T; Knop FK; Krarup T; Vølund A; Holst JJ; Madsbad S. "Near normalisation of blood glucose improves the potentiating effect of GLP-1 on glucose-induced insulin secretion in patients with type 2 diabetes.". (2008): http://europepmc.org/abstract/med/18292985.
    10.1007/s00125-008-0943-x
  803. Holst JJ; Deacon CF; Vilsbøll T; Krarup T; Madsbad S. "Glucagon-like peptide-1, glucose homeostasis and diabetes.". (2008): http://europepmc.org/abstract/med/18353723.
    10.1016/j.molmed.2008.01.003
  804. Nilsson AC; Ostman EM; Holst JJ; Björck IM. "Including indigestible carbohydrates in the evening meal of healthy subjects improves glucose tolerance, lowers inflammatory markers, and increases satiety after a subsequent standardized breakfast.". (2008): http://europepmc.org/abstract/med/18356328.
  805. Due A; Larsen TM; Hermansen K; Stender S; Holst JJ; Toubro S; Martinussen T; Astrup A. "Comparison of the effects on insulin resistance and glucose tolerance of 6-mo high-monounsaturated-fat, low-fat, and control diets.". (2008): http://europepmc.org/abstract/med/18400707.
  806. Pedersen-Bjergaard U; Thomsen CE; Høgenhaven H; Smed A; Kjaer TW; Holst JJ; Dela F; et al. "Angiotensin-converting enzyme activity and cognitive impairment during hypoglycaemia in healthy humans.". (2008): http://europepmc.org/abstract/med/18404608.
    10.3317/jraas.2008.001
  807. Vollmer K; Holst JJ; Baller B; Ellrichmann M; Nauck MA; Schmidt WE; Meier JJ. "Predictors of incretin concentrations in subjects with normal, impaired, and diabetic glucose tolerance.". (2008): http://europepmc.org/abstract/med/18057091.
    10.2337/db07-1124
  808. Laakso M; Zilinskaite J; Hansen T; Boesgaard TW; Vänttinen M; Stancáková A; Jansson PA; et al. "Insulin sensitivity, insulin release and glucagon-like peptide-1 levels in persons with impaired fasting glucose and/or impaired glucose tolerance in the EUGENE2 study.". (2008): http://europepmc.org/abstract/med/18080106.
    10.1007/s00125-007-0899-2
  809. Lerche S; Brock B; Rungby J; Bøtker HE; Møller N; Rodell A; Bibby BM; et al. "Glucagon-like peptide-1 inhibits blood-brain glucose transfer in humans.". (2008): http://europepmc.org/abstract/med/17991759.
    10.2337/db07-1162
  810. Vestergaard ET; Djurhuus CB; Gjedsted J; Nielsen S; Møller N; Holst JJ; Jørgensen JO; Schmitz O. "Acute effects of ghrelin administration on glucose and lipid metabolism.". (2008): http://europepmc.org/abstract/med/18042651.
    10.1210/jc.2007-2018
  811. Azuma K; Rádiková Z; Mancino J; Toledo FG; Thomas E; Kangani C; Dalla Man C; et al. "Measurements of islet function and glucose metabolism with the dipeptidyl peptidase 4 inhibitor vildagliptin in patients with type 2 diabetes.". (2008): http://europepmc.org/abstract/med/18042650.
    10.1210/jc.2007-1369
  812. Pedersen NB; Hjollund KR; Johnsen AH; Orskov C; Rosenkilde MM; Hartmann B; Holst JJ. "Porcine glucagon-like peptide-2: structure, signaling, metabolism and effects.". (2008): http://europepmc.org/abstract/med/18164496.
    10.1016/j.regpep.2007.11.003
  813. Dynesen AW; Bardow A; Astrup A; Petersson B; Holst JJ; Nauntofte B. "Meal-induced compositional changes in blood and saliva in persons with bulimia nervosa.". (2008): http://europepmc.org/abstract/med/18175732.
  814. Pereira-Fantini PM; Nagy ES; Thomas SL; Taylor RG; Sourial M; Paris MC; Holst JJ; Fuller PJ; Bines JE. "GLP-2 administration results in increased proliferation but paradoxically an adverse outcome in a juvenile piglet model of short bowel syndrome.". (2008): http://europepmc.org/abstract/med/18162829.
    10.1097/01.mpg.0000313833.47207.47
  815. Utzschneider KM; Tong J; Montgomery B; Udayasankar J; Gerchman F; Marcovina SM; Watson CE; et al. "The dipeptidyl peptidase-4 inhibitor vildagliptin improves beta-cell function and insulin sensitivity in subjects with impaired fasting glucose.". (2008): http://europepmc.org/abstract/med/17909087.
    10.2337/dc07-1441
  816. Rosenstock J; Foley JE; Rendell M; Landin-Olsson M; Holst JJ; Deacon CF; Rochotte E; Baron MA. "Effects of the dipeptidyl peptidase-IV inhibitor vildagliptin on incretin hormones, islet function, and postprandial glycemia in subjects with impaired glucose tolerance.". (2008): http://europepmc.org/abstract/med/17947341.
    10.2337/dc07-1616
  817. Amin H; Holst JJ; Hartmann B; Wallace L; Wright J; Sigalet DL. "Functional ontogeny of the proglucagon-derived peptide axis in the premature human neonate.". (2008): http://europepmc.org/abstract/med/18166537.
    10.1542/peds.2007-1461
  818. Birgitte Sloth; Jens Juul Holst. "Appetitregulering". Perspektiv : tidsskrift om ernæring 1 (2008): 4-8. https://curis.ku.dk/portal/en/publications/appetitregulering(189e4370-a1c4-11dd-b6ae-000ea68e967b).html.
  819. Anette Pia Due; Thomas Meinert Larsen; Kjeld Hermansen; steen stender; Jens Juul Holst; Søren Toubro; Torben Martinussen; Arne Astrup. "Comparison of the effects on insulin resistance and glucose tolerance of 6-mo high-monosaturated-fat, low-fat, and control diets". American Journal of Clinical Nutrition 87 4 (2008): 855-862. https://curis.ku.dk/portal/en/publications/comparison-of-the-effects-on-insulin-resistance-and-glucose-tolerance-of-6mo-highmonosaturatedfat-lowfat-and-control-diets(47bc2f00-a1c4-11dd-b6ae-000ea68e967b).html.
  820. B Sloth; Jens Juul Holst. "Appetitregulering: et komplekst system". Perspektiv 1 8 (2008): https://curis.ku.dk/portal/en/publications/appetitregulering-et-komplekst-system(d10cc740-60bb-11de-8bc9-000ea68e967b).html.
  821. K. Mussig; A. Oncu; P. Lindauer; A. Heininger; H. Aebert; K. Unertl; G. Ziemer; et al. "Effects of intravenous glucagon-like peptide-1 on glucose control and hemodynamics after coronary artery bypass surgery in patients with type 2 diabetes". Journal of the American College of Cardiology 102 5 (2008): 646-647. https://curis.ku.dk/portal/en/publications/effects-of-intravenous-glucagonlike-peptide1-on-glucose-control-and-hemodynamics-after-coronary-artery-bypass-surgery-in-patients-with-type-2-diabetes(e45fb290-de5b-11dd-b5fc-000ea68e967b).html.
  822. J.E. Foley; M. Ligueros-Saylan; Y.L. He; Jens Juul Holst; Carolyn F. Deacon; B.E. Dunning; A. Leone-Jones; T. Yu; D.E. Kelley. "Effect of Vildagliptin on Glucagon Concentration During Meals in Patients with Type 1 Diabetes". Hormone and Metabolic Research 40 10 (2008): 727-730. https://curis.ku.dk/portal/en/publications/effect-of-vildagliptin-on-glucagon-concentration-during-meals-in-patients-with-type-1-diabetes(5b8afa50-dd80-11dd-b5fc-000ea68e967b).html.
  823. P.M. Pereira-Fantini; T.S. Nagy; S.L. Thomas; R.G. Taylor; M. Sourial; M.C.J. Paris; J.J. Holst; et al. "GLP-2 administration results in increased proliferation but paradoxically an adverse outcome in a juvenile piglet model of short bowel syndrome". Journal of Pediatric Gastroenterology and Nutrition 46 1 (2008): 20-28. https://curis.ku.dk/portal/en/publications/glp2-administration-results-in-increased-proliferation-but-paradoxically-an-adverse-outcome-in-a-juvenile-piglet-model-of-short-bowel-syndrome(a3ef2930-dd8d-11dd-b5fc-000ea68e967b).html.
  824. Heer J. de; C. Rasmussen; D.H. Coy; Jens Juul Holst. "Glucagon-like peptide-1, but not glucose-dependent insulinotropic peptide, inhibits glucagon secretion via somatostatin (receptor subtype 2) in the perfused rat pancreas". Diabetologia 51 12 (2008): 2263-2270. https://curis.ku.dk/portal/en/publications/glucagonlike-peptide1-but-not-glucosedependent-insulinotropic-peptide-inhibits-glucagon-secretion-via-somatostatin-receptor-subtype-2-in-the-perfused-rat-pancreas(dd984630-de5a-11dd-b5fc-000ea68e967b).html.
  825. I.B. Gottschalck; Palle Bekker Jeppesen; B. Hartmann; Jens Juul Holst; D.B. Henriksen. "Effects of treatment with glucagon-like peptide-2 on bone resorption in colectomized patients with distal ileostomy or jejunostomy and short-bowel syndrome". Scandinavian Journal of Gastroenterology 43 11 (2008): 1304-1310. https://curis.ku.dk/portal/en/publications/effects-of-treatment-with-glucagonlike-peptide2-on-bone-resorption-in-colectomized-patients-with-distal-ileostomy-or-jejunostomy-and-shortbowel-syndrome(d183e890-05a1-11de-b05e-000ea68e967b).html.
  826. M.C. Koopmann; D.W. Nelson; S.G. Murali; X.W. Liu; M.S. Brownfield; Jens Juul Holst; D.M. Ney. "Exogenous glucagon-like peptide-2 (GLP-2) augments GLP-2 receptor mRNA and maintains proglucagon mRNA levels in resected rats". Journal of Parenteral and Enteral Nutrition 32 3 (2008): 254-265. https://curis.ku.dk/portal/en/publications/exogenous-glucagonlike-peptide2-glp2-augments-glp2-receptor-mrna-and-maintains-proglucagon-mrna-levels-in-resected-rats(e943b6d0-dd89-11dd-b5fc-000ea68e967b).html.
  827. H. Amin; Jens Juul Holst; B. Hartmann; L. Wallace; J. Wright; D.L. Sigalet. "Functional ontogeny of the proglucagon-derived peptide axis in the premature human neonate". Pediatrics 121 1 (2008): E180-E186. https://curis.ku.dk/portal/en/publications/functional-ontogeny-of-the-proglucagonderived-peptide-axis-in-the-premature-human-neonate(134f2b40-dd84-11dd-b5fc-000ea68e967b).html.
  828. P.M. Hellstrom; E. Naslund; T. Edholm; P.T. Schmidt; J. Kristensen; E. Theodorsson; Jens Juul Holst; S. Efendic. "GLP-1 suppresses gastrointestinal motility and inhibits the migrating motor complex in healthy subjects and patients with irritable bowel syndrome". Neurogastroenterology and Motility 20 6 (2008): 649-659. https://curis.ku.dk/portal/en/publications/glp1-suppresses-gastrointestinal-motility-and-inhibits-the-migrating-motor-complex-in-healthy-subjects-and-patients-with-irritable-bowel-syndrome(b5318420-dd7b-11dd-b5fc-000ea68e967b).html.
  829. J.E. Blundell; F. Levin; N.A. King; B. Barkeling; T. Gustafson; P.M. Hellstrom; Jens Juul Holst; E. Naslund. "Overconsumption and obesity: Peptides and susceptibility to weight gain". Regulatory Peptides 149 1-3 (2008): 32-38. https://curis.ku.dk/portal/en/publications/overconsumption-and-obesity-peptides-and-susceptibility-to-weight-gain(4a853100-dd83-11dd-b5fc-000ea68e967b).html.
  830. Jens Juul Holst; JR Lasalle. "Overview of incretin hormones.". Journal of Family Practice 57 9 (2008): 53-59. https://curis.ku.dk/portal/en/publications/overview-of-incretin-hormones(ec4f4d10-fb6d-11dd-b219-000ea68e967b).html.
  831. A.C. Nilsson; E.M. Ostman; Jens Juul Holst; I.M. Bjorck. "Including indigestible carbohydrates in the evening meal of healthy subjects improves glucose tolerance, lowers inflammatory markers, and increases satiety after a subsequent standardized breakfast". Journal of Nutrition 138 4 (2008): 732-739. https://curis.ku.dk/portal/en/publications/including-indigestible-carbohydrates-in-the-evening-meal-of-healthy-subjects-improves-glucose-tolerance-lowers-inflammatory-markers-and-increases-satiety-after-a-subsequent-standardized-breakfast(03837fd0-de5c-11.
  832. D.W. Nelson; S.G. Murali; X.W. Liu; M.C. Koopmann; Jens Juul Holst; D.M. Ney. "Insulin-like growth factor I and glucagon-like peptide-2 responses to fasting followed by controlled or ad libitum refeeding in rats". American Journal of Physiology: Regulatory, Integrative and Comparative Physiology 294 4 (2008): R1175-R1184. https://curis.ku.dk/portal/en/publications/insulinlike-growth-factor-i-and-glucagonlike-peptide2-responses-to-fasting-followed-by-controlled-or-ad-libitum-refeeding-in-rats(ed2cc5f0-dd8b-11dd-b5fc-000ea68e967b).html.
  833. M.A. Robertson; D.L. Sigalet; Jens Juul Holst; J.B. Meddings; J. Wood; K.A. Sharkey. "Intestinal permeability and glucagon-like peptide-2 in children with autism: a controlled pilot study". Journal of Autism and Developmental Disorders 38 6 (2008): 1066-1071. https://curis.ku.dk/portal/en/publications/intestinal-permeability-and-glucagonlike-peptide2-in-children-with-autism-a-controlled-pilot-study(3a00ee80-de5c-11dd-b5fc-000ea68e967b).html.
  834. Anja Weirsøe Dynesen; Allan Bardow Jensen; Arne Astrup; Birgit Petersson; Jens Juul Holst; Birgitte Nauntofte. "Meal-induced compositional changes in blood and saliva in persons with bulimia nervosa". American Journal of Clinical Nutrition 87 1 (2008): 12-22. https://curis.ku.dk/portal/en/publications/mealinduced-compositional-changes-in-blood-and-saliva-in-persons-with-bulimia-nervosa(8aa5d110-b16c-11dd-b04f-000ea68e967b).html.
  835. T. Kaji; H. Tanaka; Jens Juul Holst; H. Redstone; L. Wallace; E. de Heuval; D.L. Sigalet. "The effects of variations in dose and method of administration on glucagon like peptide-2 activity in the rat". European Journal of Pharmacology 596 1-3 (2008): 138-145. https://curis.ku.dk/portal/en/publications/the-effects-of-variations-in-dose-and-method-of-administration-on-glucagon-like-peptide2-activity-in-the-rat(f91470a0-dd88-11dd-b5fc-000ea68e967b).html.
  836. Lone Brinkmann Sørensen; Heidi Theresa Cueto; Maja Troest Andersen; Christian Bitz; Jens Juul Holst; Jens Frederik Rehfeld; Arne Astrup. "The effect of salatrim, a low-calorie modified triacylglycerol, on appetite and energy intake". American Journal of Clinical Nutrition 87 5 (2008): 1163-1169. https://curis.ku.dk/portal/en/publications/the-effect-of-salatrim-a-lowcalorie-modified-triacylglycerol-on-appetite-and-energy-intake(48ba8c30-a1c4-11dd-b6ae-000ea68e967b).html.
  837. Jens Juul Holst. "The physiology and pharmacology of incretins in type 2 diabetes mellitus". Diabetes, Obesity and Metabolism 10 Suppl. 3 (2008): 14-21. https://curis.ku.dk/portal/en/publications/the-physiology-and-pharmacology-of-incretins-in-type-2-diabetes-mellitus(1ee0c280-dd88-11dd-b5fc-000ea68e967b).html.
    10.1111/j.1463-1326.2008.00920.x
  838. K. Faerch; A. Vaag; Jens Juul Holst; O. Pedersen; C. Glumer; K. Borch-Johnsen. "Progression from normal glucose tolerance to impaired fasting glycaemia and impaired glucose tolerance: differential roles of insulin resistance and beta cell dysfunction". Diabetologia 51 Suppl. 1 (2008): S85-S86. https://curis.ku.dk/portal/en/publications/progression-from-normal-glucose-tolerance-to-impaired-fasting-glycaemia-and-impaired-glucose-tolerance-differential-roles-of-insulin-resistance-and-beta-cell-dysfunction(ae74f2c0-0251-11de-b05e-000ea68e967b).html.
  839. K. Vollmer; Jens Juul Holst; B. Baher; M. Ellrichmann; M.A. Nauck; W.E. Schmidt; J.J. Meier. "Predictors of incretin concentrations in subjects with normal, impaired, and diabetic glucose tolerance". Diabetes 57 3 (2008): 678-687. https://curis.ku.dk/portal/en/publications/predictors-of-incretin-concentrations-in-subjects-with-normal-impaired-and-diabetic-glucose-tolerance(f917e450-dd8e-11dd-b5fc-000ea68e967b).html.
  840. F.K. Knop; Jens Juul Holst; Tina Vilsbøll. "Replacing SUs with incretin-based therapies for type 2 diabetes mellitus: Challenges and feasibility". IDrugs. The Investigational Drugs Journal 11 7 (2008): 497-501. https://curis.ku.dk/portal/en/publications/replacing-sus-with-incretinbased-therapies-for-type-2-diabetes-mellitus-challenges-and-feasibility(3b368630-dd89-11dd-b5fc-000ea68e967b).html.
  841. E. Muscelli; A. Mari; A. Casolaro; S. Camastra; G. Seghieri; A. Gastaldelli; Jens Juul Holst; E. Ferrannini. "Separate impact of obesity and glucose tolerance on the incretin effect in normal subjects and type 2 diabetic patients". Diabetes 57 5 (2008): 1340-1348. https://curis.ku.dk/portal/en/publications/separate-impact-of-obesity-and-glucose-tolerance-on-the-incretin-effect-in-normal-subjects-and-type-2-diabetic-patients(5d700d00-dd8b-11dd-b5fc-000ea68e967b).html.
  842. Valeur J; Øines E; Morken MH; Holst JJ; Berstad A. "Plasma glucagon-like peptide 1 and peptide YY levels are not altered in symptomatic fructose-sorbitol malabsorption.". (2008): http://europepmc.org/abstract/med/18609141.
    10.1080/00365520802116448
  843. Koopmann MC; Nelson DW; Murali SG; Liu X; Brownfield MS; Holst JJ; Ney DM. "Exogenous glucagon-like peptide-2 (GLP-2) augments GLP-2 receptor mRNA and maintains proglucagon mRNA levels in resected rats.". (2008): http://europepmc.org/abstract/med/18443137.
    10.1177/0148607108316198
  844. Gottschalck IB; Jeppesen PB; Hartmann B; Holst JJ; Henriksen DB. "Effects of treatment with glucagon-like peptide-2 on bone resorption in colectomized patients with distal ileostomy or jejunostomy and short-bowel syndrome.". (2008): http://europepmc.org/abstract/med/18609184.
    10.1080/00365520802200028
  845. Deacon CF; Carr RD; Holst JJ. "DPP-4 inhibitor therapy: new directions in the treatment of type 2 diabetes.". (2008): http://europepmc.org/abstract/med/17981667.
    10.2741/2799
  846. Goldfine AB; Mun EC; Devine E; Bernier R; Baz-Hecht M; Jones DB; Schneider BE; Holst JJ; Patti ME. "Patients with neuroglycopenia after gastric bypass surgery have exaggerated incretin and insulin secretory responses to a mixed meal.". (2007): http://europepmc.org/abstract/med/17895322.
    10.1210/jc.2007-0918
  847. Sangild PT; Malo C; Schmidt M; Petersen YM; Elnif J; Holst JJ; Buddington RK. "Glucagon-like peptide 2 has limited efficacy to increase nutrient absorption in fetal and preterm pigs.". (2007): http://europepmc.org/abstract/med/17898120.
    10.1152/ajpregu.00395.2007
  848. Knop FK; Vilsbøll T; Højberg PV; Larsen S; Madsbad S; Holst JJ; Krarup T. "The insulinotropic effect of GIP is impaired in patients with chronic pancreatitis and secondary diabetes mellitus as compared to patients with chronic pancreatitis and normal glucose tolerance.". (2007): http://europepmc.org/abstract/med/17692937.
    10.1016/j.regpep.2007.07.002
  849. Schäfer SA; Tschritter O; Machicao F; Thamer C; Stefan N; Gallwitz B; Holst JJ; et al. "Impaired glucagon-like peptide-1-induced insulin secretion in carriers of transcription factor 7-like 2 (TCF7L2) gene polymorphisms.". (2007): http://europepmc.org/abstract/med/17661009.
    10.1007/s00125-007-0753-6
  850. McClean PL; Irwin N; Cassidy RS; Holst JJ; Gault VA; Flatt PR. "GIP receptor antagonism reverses obesity, insulin resistance, and associated metabolic disturbances induced in mice by prolonged consumption of high-fat diet.". (2007): http://europepmc.org/abstract/med/17848629.
    10.1152/ajpendo.00460.2007
  851. El-Ouaghlidi A; Rehring E; Holst JJ; Schweizer A; Foley J; Holmes D; Nauck MA. "The dipeptidyl peptidase 4 inhibitor vildagliptin does not accentuate glibenclamide-induced hypoglycemia but reduces glucose-induced glucagon-like peptide 1 and gastric inhibitory polypeptide secretion.". (2007): http://europepmc.org/abstract/med/17698900.
    10.1210/jc.2006-1932
  852. Hagemann D; Holst JJ; Gethmann A; Banasch M; Schmidt WE; Meier JJ. "Glucagon-like peptide 1 (GLP-1) suppresses ghrelin levels in humans via increased insulin secretion.". (2007): http://europepmc.org/abstract/med/17434608.
    10.1016/j.regpep.2007.03.002
  853. Holst JJ. "The physiology of glucagon-like peptide 1.". (2007): http://europepmc.org/abstract/med/17928588.
    10.1152/physrev.00034.2006
  854. Teng M; Johnson MD; Thomas C; Kiel D; Lakis JN; Kercher T; Aytes S; et al. "Small molecule ago-allosteric modulators of the human glucagon-like peptide-1 (hGLP-1) receptor.". (2007): http://europepmc.org/abstract/med/17827014.
    10.1016/j.bmcl.2007.06.086
  855. de Heer J; Pedersen J; Orskov C; Holst JJ. "The alpha cell expresses glucagon-like peptide-2 receptors and glucagon-like peptide-2 stimulates glucagon secretion from the rat pancreas.". (2007): http://europepmc.org/abstract/med/17676310.
    10.1007/s00125-007-0761-6
  856. Cani PD; Holst JJ; Drucker DJ; Delzenne NM; Thorens B; Burcelin R; Knauf C. "GLUT2 and the incretin receptors are involved in glucose-induced incretin secretion.". (2007): http://europepmc.org/abstract/med/17681422.
    10.1016/j.mce.2007.06.003
  857. Meier JJ; Holst JJ; Schmidt WE; Nauck MA. "Reduction of hepatic insulin clearance after oral glucose ingestion is not mediated by glucagon-like peptide 1 or gastric inhibitory polypeptide in humans.". (2007): http://europepmc.org/abstract/med/17609256.
    10.1152/ajpendo.00289.2007
  858. Hare KJ; Hartmann B; Kissow H; Holst JJ; Poulsen SS. "The intestinotrophic peptide, glp-2, counteracts intestinal atrophy in mice induced by the epidermal growth factor receptor inhibitor, gefitinib.". (2007): http://europepmc.org/abstract/med/17785573.
    10.1158/1078-0432.CCR-07-0574
  859. Knop FK; Vilsbøll T; Højberg PV; Larsen S; Madsbad S; Vølund A; Holst JJ; Krarup T. "Reduced incretin effect in type 2 diabetes: cause or consequence of the diabetic state?". (2007): http://europepmc.org/abstract/med/17513701.
    10.2337/db07-0100
  860. Pörksen S; Nielsen LB; Kaas A; Kocova M; Chiarelli F; Orskov C; Holst JJ; et al. "Meal-stimulated glucagon release is associated with postprandial blood glucose level and does not interfere with glycemic control in children and adolescents with new-onset type 1 diabetes.". (2007): http://europepmc.org/abstract/med/17519307.
    10.1210/jc.2007-0244
  861. Sloth B; Davidsen L; Holst JJ; Flint A; Astrup A. "Effect of subcutaneous injections of PYY1-36 and PYY3-36 on appetite, ad libitum energy intake, and plasma free fatty acid concentration in obese males.". (2007): http://europepmc.org/abstract/med/17566112.
    10.1152/ajpendo.00153.2007
  862. Sigalet DL; Wallace LE; Holst JJ; Martin GR; Kaji T; Tanaka H; Sharkey KA. "Enteric neural pathways mediate the anti-inflammatory actions of glucagon-like peptide 2.". (2007): http://europepmc.org/abstract/med/17395898.
    10.1152/ajpgi.00530.2006
  863. Simonsen L; Pilgaard S; Orskov C; Rosenkilde MM; Hartmann B; Holst JJ; Deacon CF. "Exendin-4, but not dipeptidyl peptidase IV inhibition, increases small intestinal mass in GK rats.". (2007): http://europepmc.org/abstract/med/17431213.
    10.1152/ajpgi.00453.2006
  864. Holst JJ; Hartmann B; Gottschalck IB; Jeppesen PB; Miholic J; Henriksen DB. "Bone resorption is decreased postprandially by intestinal factors and glucagon-like peptide-2 is a possible candidate.". (2007): http://europepmc.org/abstract/med/17558904.
    10.1080/00365520601137272
  865. Nielsen LB; Ploug KB; Swift P; Ørskov C; Jansen-Olesen I; Chiarelli F; Holst JJ; et al. "Co-localisation of the Kir6.2/SUR1 channel complex with glucagon-like peptide-1 and glucose-dependent insulinotrophic polypeptide expression in human ileal cells and implications for glycaemic control in new onset type 1 diabetes.". (2007): http://europepmc.org/abstract/med/17535866.
    10.1530/EJE-06-0756
  866. Staehr P; Hother-Nielsen O; Beck-Nielsen H; Roden M; Stingl H; Holst JJ; Jones PK; Chandramouli V; Landau BR. "Hepatic autoregulation: response of glucose production and gluconeogenesis to increased glycogenolysis.". (2007): http://europepmc.org/abstract/med/17213474.
    10.1152/ajpendo.00411.2006
  867. He YL; Wang Y; Bullock JM; Deacon CF; Holst JJ; Dunning BE; Ligueros-Saylan M; Foley JE. "Pharmacodynamics of vildagliptin in patients with type 2 diabetes during OGTT.". (2007): http://europepmc.org/abstract/med/17442688.
    10.1177/0091270006299137
  868. F.K. Knop; Tina Vilsbøll Lauritsen; Sten Madsbad; Jens Juul Holst; T. Krarup; F K Knop; Tina Vilsbøll; et al. "Inappropriate suppression of glucagon during OGTT but not during isoglycaemic i.v. glucose infusion contributes to the reduced incretin effect in type 2 diabetes mellitus". Diabetologia 50 4 (2007): 797-805. https://curis.ku.dk/portal/en/publications/inappropriate-suppression-of-glucagon-during-ogtt-but-not-during-isoglycaemic-iv-glucose-infusion-contributes-to-the-reduced-incretin-effect-in-type-2-diabetes-mellitus(334e67d0-20ec-11dd-bc23-000ea68e967b).html.
    http://dx.doi.org/10.1007/s00125-006-0566-z
  869. Knop FK; Vilsbøll T; Madsbad S; Holst JJ; Krarup T. "Inappropriate suppression of glucagon during OGTT but not during isoglycaemic i.v. glucose infusion contributes to the reduced incretin effect in type 2 diabetes mellitus.". (2007): http://europepmc.org/abstract/med/17225124.
    10.1007/s00125-006-0566-z
  870. Balas B; Baig MR; Watson C; Dunning BE; Ligueros-Saylan M; Wang Y; He YL; et al. "The dipeptidyl peptidase IV inhibitor vildagliptin suppresses endogenous glucose production and enhances islet function after single-dose administration in type 2 diabetic patients.". (2007): http://europepmc.org/abstract/med/17244786.
    10.1210/jc.2006-1882
  871. Meier JJ; Deacon CF; Schmidt WE; Holst JJ; Nauck MA. "Suppression of glucagon secretion is lower after oral glucose administration than during intravenous glucose administration in human subjects.". (2007): http://europepmc.org/abstract/med/17334652.
    10.1007/s00125-007-0598-z
  872. Nilsson M; Holst JJ; Björck IM. "Metabolic effects of amino acid mixtures and whey protein in healthy subjects: studies using glucose-equivalent drinks.". (2007): http://europepmc.org/abstract/med/17413098.
  873. Kien CL; Blauwiekel R; Bunn JY; Jetton TL; Frankel WL; Holst JJ. "Cecal infusion of butyrate increases intestinal cell proliferation in piglets.". (2007): http://europepmc.org/abstract/med/17374654.
  874. Sloth B; Holst JJ; Flint A; Gregersen NT; Astrup A. "Effects of PYY1-36 and PYY3-36 on appetite, energy intake, energy expenditure, glucose and fat metabolism in obese and lean subjects.". (2007): http://europepmc.org/abstract/med/17148749.
    10.1152/ajpendo.00450.2006
  875. Lorenzen JK; Nielsen S; Holst JJ; Tetens I; Rehfeld JF; Astrup A. "Effect of dairy calcium or supplementary calcium intake on postprandial fat metabolism, appetite, and subsequent energy intake.". (2007): http://europepmc.org/abstract/med/17344487.
  876. Henriksen DB; Alexandersen P; Hartmann B; Adrian CL; Byrjalsen I; Bone HG; Holst JJ; Christiansen C. "Disassociation of bone resorption and formation by GLP-2: a 14-day study in healthy postmenopausal women.". (2007): http://europepmc.org/abstract/med/17081815.
    10.1016/j.bone.2006.09.025
  877. Miholic J; Hoffmann M; Holst JJ; Lenglinger J; Mittlböck M; Bergmann H; Stacher G. "Gastric emptying of glucose solution and associated plasma concentrations of GLP-1, GIP, and PYY before and after fundoplication.". (2007): http://europepmc.org/abstract/med/17200910.
    10.1007/s00464-005-0804-3
  878. de Heer J; Holst JJ. "Sulfonylurea compounds uncouple the glucose dependence of the insulinotropic effect of glucagon-like peptide 1.". (2007): http://europepmc.org/abstract/med/17259389.
    10.2337/db06-0738
  879. Ritzel RA; Kleine N; Holst JJ; Willms B; Schmiegel W; Nauck MA. "Preserved GLP-1 effects in a diabetic patient with Cushing's disease.". (2007): http://europepmc.org/abstract/med/17318778.
    10.1055/s-2007-955096
  880. Hansen L; Hare KJ; Hartmann B; Deacon CF; Ugleholdt RK; Plamboeck A; Holst JJ. "Metabolism of glucagon-like peptide-2 in pigs: role of dipeptidyl peptidase IV.". (2007): http://europepmc.org/abstract/med/17107718.
    10.1016/j.regpep.2006.08.012
  881. Nagell CF; Pedersen JF; Holst JJ. "The antagonistic metabolite of GLP-1, GLP-1 (9-36)amide, does not influence gastric emptying and hunger sensations in man.". (2007): http://europepmc.org/abstract/med/17190759.
    10.1080/00365520600780262
  882. Cypryk K; Vilsbøll T; Nadel I; Smyczynska J; Holst JJ; Lewinski A. "Normal secretion of the incretin hormones glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1 during gestational diabetes mellitus.". (2007): http://europepmc.org/abstract/med/17484514.
    10.1080/09513590601137004
  883. Knudsen LB; Kiel D; Teng M; Behrens C; Bhumralkar D; Kodra JT; Holst JJ; et al. "Small-molecule agonists for the glucagon-like peptide 1 receptor.". (2007): http://europepmc.org/abstract/med/17213325.
    10.1073/pnas.0605701104
  884. Knop FK; Vilsbøll T; Larsen S; Højberg PV; Vølund A; Madsbad S; Holst JJ; Krarup T. "Increased postprandial responses of GLP-1 and GIP in patients with chronic pancreatitis and steatorrhea following pancreatic enzyme substitution.". (2007): http://europepmc.org/abstract/med/16954337.
    10.1152/ajpendo.00059.2006
  885. C.L. Kien; R. Blauwiekel; J.Y. Bunn; T.L. Jetton; W.L. Frankel; Jens Juul Holst. "Cecal infusion of butyrate increases intestinal cell proliferation in piglets". Journal of Nutrition 137 4 (2007): 916-922. https://curis.ku.dk/portal/en/publications/cecal-infusion-of-butyrate-increases-intestinal-cell-proliferation-in-piglets(31564150-20ec-11dd-bc23-000ea68e967b).html.
  886. Jens Juul Holst; B. Hartmann; I.B. Gottschalck; P.B. Jeppesen; J. Miholic; D.B. Henriksen. "Bone resorption is decreased postprandially by intestinal factors and glucagon-like peptide-2 is a possible candidate". Scandinavian Journal of Gastroenterology 42 7 (2007): 814-820. https://curis.ku.dk/portal/en/publications/bone-resorption-is-decreased-postprandially-by-intestinal-factors-and-glucagonlike-peptide2-is-a-possible-candidate(28277c70-20ec-11dd-bc23-000ea68e967b).html.
  887. P.L. McClean; N. Irwin; R.S. Cassidy; Jens Juul Holst; V.A. Gault; P.R. Flatt. "GIP receptor antagonism reverses obesity, insulin resistance, and associated metabolic disturbances induced in mice by prolonged consumption of high-fat diet". American Journal of Physiology: Endocrinology and Metabolism 293 6 (2007): E1746-E1755. https://curis.ku.dk/portal/en/publications/gip-receptor-antagonism-reverses-obesity-insulin-resistance-and-associated-metabolic-disturbances-induced-in-mice-by-prolonged-consumption-of-highfat-diet(3dd43130-20ec-11dd-bc23-000ea68e967b).html.
  888. D. Hagemann; Jens Juul Holst; A. Gethmann; M. Banasch; W.E. Schmidt; J.J. Meier. "Glucagon-like peptide 1 (GLP-1) suppresses ghrelin levels in humans via increased insulin secretion". Regulatory Peptides 143 1-3 (2007): 64-68. https://curis.ku.dk/portal/en/publications/glucagonlike-peptide-1-glp1-suppresses-ghrelin-levels-in-humans-via-increased-insulin-secretion(21519bb0-20ec-11dd-bc23-000ea68e967b).html.
  889. P.D. Cani; Jens Juul Holst; D.J. Drucker; N.M. Delzenne; B. Thorens; R. Burcelin; C. Knauf. "GLUT2 and the incretin receptors are involved in glucose-induced incretin secretion". Molecular and Cellular Endocrinology 276 1-2 (2007): 18-23. https://curis.ku.dk/portal/en/publications/glut2-and-the-incretin-receptors-are-involved-in-glucoseinduced-incretin-secretion(10c59da0-20ec-11dd-bc23-000ea68e967b).html.
  890. S. Bode; B. Hartmann; Jens Juul Holst; Gorm Ole Greisen. "Glucagon-like peptide-2 in umbilical cord blood from mature infants". Neonatology 91 1 (2007): 49-53. https://curis.ku.dk/portal/en/publications/glucagonlike-peptide2-in-umbilical-cord-blood-from-mature-infants(0cd550a0-20ec-11dd-bc23-000ea68e967b).html.
  891. S.A. Schafer; O. Tschritter; F. Machicao; C. Thamer; N. Stefan; B. Gallwitz; Jens Juul Holst; et al. "Impaired glucagon-like peptide-1-induced insulin secretion in carriers of transcription factor 7-like 2 (TCF7L2) gene polymorphisms". Diabetologia 50 12 (2007): 2443-2450. https://curis.ku.dk/portal/en/publications/impaired-glucagonlike-peptide1induced-insulin-secretion-in-carriers-of-transcription-factor-7like-2-tcf7l2-gene-polymorphisms(4f196d20-20ec-11dd-bc23-000ea68e967b).html.
  892. Peter Anton Stæhr; O. Hother-Nielsen; H. Beck-Nielsen; M. Roden; H. Stingl; Jens Juul Holst; P.K. Jones; V. Chandramouli; B.R. Landau. "Hepatic autoregulation: response of glucose production and gluconeogenesis to increased glycogenolysis". American Journal of Physiology: Endocrinology and Metabolism 292 5 (2007): E1265-E1269. https://curis.ku.dk/portal/en/publications/hepatic-autoregulation-response-of-glucose-production-and-gluconeogenesis-to-increased-glycogenolysis(55e73790-20ec-11dd-bc23-000ea68e967b).html.
  893. D.B. Henriksen; P. Alexandersen; B. Hartmann; C.L. Adrian; I. Byrjalsen; H.G. Bone; Jens Juul Holst; C. Christiansen. "Disassociation of bone resorption and formation by GLP-2 - A 14-day study in healthy postmenopausal women". Bone 40 3 (2007): 723-729. https://curis.ku.dk/portal/en/publications/disassociation-of-bone-resorption-and-formation-by-glp2--a-14day-study-in-healthy-postmenopausal-women(25594140-20ec-11dd-bc23-000ea68e967b).html.
  894. Lars Bo Nielsen; K.B. Ploug; P. Swift; Cathrine Ørskov; I. Jansen-Olesen; F. Chiarelli; Jens Juul Holst; et al. "Co-localisation of the Kir6.2/SUR1 channel complex with glucagon-like peptide-1 and glucose-dependent insulinotrophic polypeptide expression in human ileal cells and implications for glycaemic control in new onset type 1 diabetes". European Journal of Endocrinology 156 6 (2007): 663-71. https://curis.ku.dk/portal/en/publications/colocalisation-of-the-kir62sur1-channel-complex-with-glucagonlike-peptide1-and-glucosedependent-insulinotrophic-polypeptide-expression-in-human-ileal-cells-and-implications-for-glycaemic-control-in-n(43db0220-20e.
    http://dx.doi.org/10.1530/EJE-06-0756
  895. Janne Kunchel Lorenzen; Sanne Nielsen; Jens Juul Holst; Inge Tetens; Jens Frederik Rehfeld; Arne Astrup. "Effect of dairy calcium or supplementary calcium on postprandial fat metabolism, appetite, and subsequent energy intake". American Journal of Clinical Nutrition 85 3 (2007): 678-687. https://curis.ku.dk/portal/en/publications/effect-of-dairy-calcium-or-supplementary-calcium-on-postprandial-fat-metabolism-appetite-and-subsequent-energy-intake(8c4914f0-a1c2-11dd-b6ae-000ea68e967b).html.
  896. D.L. Sigalet; L.E. Wallace; Jens Juul Holst; G.R. Martin; T. Kaji; H. Tanaka; K.A. Sharkey. "Enteric neural pathways mediate the anti-inflammatory actions of glucagon-like peptide 2". American Journal of Physiology: Gastrointestinal and Liver Physiology 293 1 (2007): G211-G221. https://curis.ku.dk/portal/en/publications/enteric-neural-pathways-mediate-the-antiinflammatory-actions-of-glucagonlike-peptide-2(527dcdd0-20ec-11dd-bc23-000ea68e967b).html.
  897. J. Miholic; M. Hoffmann; Jens Juul Holst; J. Lenglinger; M. Mittlbock; H. Bergmann; G. Stacher. "Gastric emptying of glucose solution and associated plasma concentrations of GLP-1, GIP, and PYY before and after fundoplication". Surgical Endoscopy and Other Interventional Techniques 21 2 (2007): 309-314. https://curis.ku.dk/portal/en/publications/gastric-emptying-of-glucose-solution-and-associated-plasma-concentrations-of-glp1-gip-and-pyy-before-and-after-fundoplication(3f2a2440-20ec-11dd-bc23-000ea68e967b).html.
  898. R.A. Ritzel; N. Kleine; Jens Juul Holst; B. Willms; W. Schmiegel; M.A. Nauck. "Preserved GLP-1 effects in a diabetic patient with Cushing's disease". Experimental and Clinical Endocrinology and Diabetes 115 2 (2007): 146-150. https://curis.ku.dk/portal/en/publications/preserved-glp1-effects-in-a-diabetic-patient-with-cushings-disease(4d4aeeb0-20ec-11dd-bc23-000ea68e967b).html.
  899. J.J. Meier; Jens Juul Holst; Wolfgang E. Schmidt; M.A. Nauck. "Reduction of hepatic insulin clearance after oral glucose ingestion is not mediated by glucagon-like peptide 1 or gastric inhibitory polypeptide in humans". American Journal of Physiology: Endocrinology and Metabolism 293 3 (2007): E849-E856. https://curis.ku.dk/portal/en/publications/reduction-of-hepatic-insulin-clearance-after-oral-glucose-ingestion-is-not-mediated-by-glucagonlike-peptide-1-or-gastric-inhibitory-polypeptide-in-humans(3e395ba0-20ec-11dd-bc23-000ea68e967b).html.
  900. M. Teng; M.D. Johnson; C. Thomas; D. Kiel; J.N. Lakis; T. Kercher; S. Aytes; et al. "Small molecule ago-allosteric modulators of the human glucagon-like peptide-1 (hGLP-1) receptor". Bioorganic & Medicinal Chemistry Letters 17 19 (2007): 5472-5478. https://curis.ku.dk/portal/en/publications/small-molecule-agoallosteric-modulators-of-the-human-glucagonlike-peptide1-hglp1-receptor(59701030-20ec-11dd-bc23-000ea68e967b).html.
  901. J.J. Meier; Carolyn Deacon; Wolfgang E. Schmidt; Jens Juul Holst; M.A. Nauck. "Suppression of glucagon secretion is lower after oral glucose administration than during intravenous glucose administration in human subjects". Diabetologia 50 4 (2007): 806-813. https://curis.ku.dk/portal/en/publications/suppression-of-glucagon-secretion-is-lower-after-oral-glucose-administration-than-during-intravenous-glucose-administration-in-human-subjects(3e1ecec0-20ec-11dd-bc23-000ea68e967b).html.
  902. S. Porksen; L.B. Nielsen; A. Kaas; M. Kocova; F. Chiarelli; C. Orskov; Jens Juul Holst; et al. "Meal-stimulated glucagon release is associated with postprandial blood glucose level and does not interfere with glycemic control in children and adolescents with new-onset type 1 diabetes". Journal of Clinical Endocrinology and Metabolism 92 8 (2007): 2910-2916. https://curis.ku.dk/portal/en/publications/mealstimulated-glucagon-release-is-associated-with-postprandial-blood-glucose-level-and-does-not-interfere-with-glycemic-control-in-children-and-adolescents-with-newonset-type-1-diabetes(4a248160-20ec-11dd-bc23-0.
  903. Jens Juul Holst; Carolyn Deacon. "New horizons in diabetes therapy". Immunology, Endocrine and Metabolic Agents in Medicinal Chemistry 7 1 (2007): 49-55. https://curis.ku.dk/portal/en/publications/new-horizons-in-diabetes-therapy(285cbd40-20ec-11dd-bc23-000ea68e967b).html.
  904. M. Nilsson; Jens Juul Holst; I.M.E. Bjorck. "Metabolic effects of amino acid mixtures and whey protein in healthy subjects: studies using glucose-equivalent drinks". American Journal of Clinical Nutrition 85 4 (2007): 996-1004. https://curis.ku.dk/portal/en/publications/metabolic-effects-of-amino-acid-mixtures-and-whey-protein-in-healthy-subjects-studies-using-glucoseequivalent-drinks(44e80550-20ec-11dd-bc23-000ea68e967b).html.
  905. A.B. Goldfine; E.C. Mun; E. Devine; R. Bernier; M. Baz-Hecht; D.B. Jones; B.E. Schneider; Jens Juul Holst; M.E. Patti. "Patients with neuroglycopenia after gastric bypass surgery have exaggerated incretin and insulin secretory responses to a mixed meal". Journal of Clinical Endocrinology and Metabolism 92 12 (2007): 4678-4685. https://curis.ku.dk/portal/en/publications/patients-with-neuroglycopenia-after-gastric-bypass-surgery-have-exaggerated-incretin-and-insulin-secretory-responses-to-a-mixed-meal(1eaf5280-20ec-11dd-bc23-000ea68e967b).html.
  906. A. El Ouaghlidi; E. Rehring; Jens Juul Holst; A. Schweizer; J. Foley; D. Holmes; M.A. Nauck. "The dipeptidyl peptidase 4 inhibitor vildagliptin does not accentuate glibenclamide-induced hypoglycemia but reduces glucose-induced glucagon-like peptide 1 and gastric inhibitory polypeptide secretion". Journal of Clinical Endocrinology and Metabolism 92 11 (2007): 4165-4171. https://curis.ku.dk/portal/en/publications/the-dipeptidyl-peptidase-4-inhibitor-vildagliptin-does-not-accentuate-glibenclamideinduced-hypoglycemia-but-reduces-glucoseinduced-glucagonlike-peptide-1-and-gastric-inhibitory-polypeptide-secretion(1851d610-20ec.
  907. Thorstenson A; Jacobsson H; Onelöv E; Holst JJ; Hellström PM; Kinn AC. "Gastrointestinal function and metabolic control after construction of an orthotopic ileal neobladder in bladder cancer.". (2007): http://europepmc.org/abstract/med/17366097.
    10.1080/00365590600911217
  908. Bodé S; Hartmann B; Holst JJ; Greisen G. "Glucagon-like peptide-2 in umbilical cord blood from mature infants.". (2007): http://europepmc.org/abstract/med/17344652.
  909. He YL; Serra D; Wang Y; Campestrini J; Riviere GJ; Deacon CF; Holst JJ; et al. "Pharmacokinetics and pharmacodynamics of vildagliptin in patients with type 2 diabetes mellitus.". (2007): http://europepmc.org/abstract/med/17596103.
    10.2165/00003088-200746070-00003
  910. Korner J; Bessler M; Inabnet W; Taveras C; Holst JJ. "Exaggerated glucagon-like peptide-1 and blunted glucose-dependent insulinotropic peptide secretion are associated with Roux-en-Y gastric bypass but not adjustable gastric banding.". (2007): http://europepmc.org/abstract/med/17936091.
    10.1016/j.soard.2007.08.004
  911. Banasch M; Bulut K; Hagemann D; Schrader H; Holst JJ; Schmidt WE; Meier JJ. "Glucagon-like peptide 2 inhibits ghrelin secretion in humans.". (2006): http://europepmc.org/abstract/med/16928403.
    10.1016/j.regpep.2006.07.009
  912. Vilsbøll T; Agersø H; Lauritsen T; Deacon CF; Aaboe K; Madsbad S; Krarup T; Holst JJ. "The elimination rates of intact GIP as well as its primary metabolite, GIP 3-42, are similar in type 2 diabetic patients and healthy subjects.". (2006): http://europepmc.org/abstract/med/16934887.
    10.1016/j.regpep.2006.07.007
  913. Flint A; Møller BK; Raben A; Sloth B; Pedersen D; Tetens I; Holst JJ; Astrup A. "Glycemic and insulinemic responses as determinants of appetite in humans.". (2006): http://europepmc.org/abstract/med/17158418.
  914. Muscelli E; Mari A; Natali A; Astiarraga BD; Camastra S; Frascerra S; Holst JJ; Ferrannini E. "Impact of incretin hormones on beta-cell function in subjects with normal or impaired glucose tolerance.". (2006): http://europepmc.org/abstract/med/16478775.
    10.1152/ajpendo.00571.2005
  915. Herman GA; Bergman A; Stevens C; Kotey P; Yi B; Zhao P; Dietrich B; et al. "Effect of single oral doses of sitagliptin, a dipeptidyl peptidase-4 inhibitor, on incretin and plasma glucose levels after an oral glucose tolerance test in patients with type 2 diabetes.". (2006): http://europepmc.org/abstract/med/16912128.
    10.1210/jc.2006-1009
  916. Weickert MO; Spranger J; Holst JJ; Otto B; Koebnick C; Möhlig M; Pfeiffer AF. "Wheat-fibre-induced changes of postprandial peptide YY and ghrelin responses are not associated with acute alterations of satiety.". (2006): http://europepmc.org/abstract/med/17092365.
    10.1017/BJN20061902
  917. Liu X; Nelson DW; Holst JJ; Ney DM. "Synergistic effect of supplemental enteral nutrients and exogenous glucagon-like peptide 2 on intestinal adaptation in a rat model of short bowel syndrome.". (2006): http://europepmc.org/abstract/med/17093168.
  918. Nelson DW; Liu X; Holst JJ; Raybould HE; Ney DM. "Vagal afferents are essential for maximal resection-induced intestinal adaptive growth in orally fed rats.". (2006): http://europepmc.org/abstract/med/17028287.
    10.1152/ajpregu.00247.2006
  919. Sørensen H; Brand CL; Neschen S; Holst JJ; Fosgerau K; Nishimura E; Shulman GI. "Immunoneutralization of endogenous glucagon reduces hepatic glucose output and improves long-term glycemic control in diabetic ob/ob mice.". (2006): http://europepmc.org/abstract/med/17003351.
    10.2337/db06-0222
  920. Jakob Ryskjaer; Carolyn Deacon; Richard D Carr; Thure Krarup; Sten Madsbad; Jens Juul Holst; Tina Vilsbøll; Carolyn F. Deacon. "Plasma dipeptidyl peptidase-IV activity in patients with type-2 diabetes mellitus correlates positively with HbAlc levels, but is not acutely affected by food intake". European Journal of Endocrinology 155 3 (2006): 485-93. https://curis.ku.dk/portal/en/publications/plasma-dipeptidyl-peptidaseiv-activity-in-patients-with-type2-diabetes-mellitus-correlates-positively-with-hbalc-levels-but-is-not-acutely-affected-by-food-intake(63d6eeb0-ab4b-11dd-b5e9-000ea68e967b).html.
    http://dx.doi.org/10.1530/eje.1.02221
  921. Levin F; Edholm T; Schmidt PT; Grybäck P; Jacobsson H; Degerblad M; Höybye C; et al. "Ghrelin stimulates gastric emptying and hunger in normal-weight humans.". (2006): http://europepmc.org/abstract/med/16772353.
    10.1210/jc.2005-2638
  922. Deacon CF; Plamboeck A; Rosenkilde MM; de Heer J; Holst JJ. "GIP-(3-42) does not antagonize insulinotropic effects of GIP at physiological concentrations.". (2006): http://europepmc.org/abstract/med/16608883.
    10.1152/ajpendo.00577.2005
  923. Pearson ER; Flechtner I; Njølstad PR; Malecki MT; Flanagan SE; Larkin B; Ashcroft FM; et al. "Switching from insulin to oral sulfonylureas in patients with diabetes due to Kir6.2 mutations.". (2006): http://europepmc.org/abstract/med/16885550.
    10.1056/NEJMoa061759
  924. Meier JJ; Gethmann A; Nauck MA; Götze O; Schmitz F; Deacon CF; Gallwitz B; Schmidt WE; Holst JJ. "The glucagon-like peptide-1 metabolite GLP-1-(9-36) amide reduces postprandial glycemia independently of gastric emptying and insulin secretion in humans.". (2006): http://europepmc.org/abstract/med/16403774.
    10.1152/ajpendo.00576.2005
  925. Nagell CF; Wettergren A; Ørskov C; Holst JJ. "Inhibitory effect of GLP-1 on gastric motility persists after vagal deafferentation in pigs.". (2006): http://europepmc.org/abstract/med/16716964.
    10.1080/00365520500408253
  926. Wachters-Hagedoorn RE; Priebe MG; Heimweg JA; Heiner AM; Englyst KN; Holst JJ; Stellaard F; Vonk RJ. "The rate of intestinal glucose absorption is correlated with plasma glucose-dependent insulinotropic polypeptide concentrations in healthy men.". (2006): http://europepmc.org/abstract/med/16702313.
  927. Buemann B; Astrup A; Pedersen O; Black E; Holst C; Toubro S; Echwald S; et al. "Possible role of adiponectin and insulin sensitivity in mediating the favorable effects of lower body fat mass on blood lipids.". (2006): http://europepmc.org/abstract/med/16478823.
    10.1210/jc.2005-1062
  928. Sangild PT; Siggers RH; Schmidt M; Elnif J; Bjornvad CR; Thymann T; Grondahl ML; et al. "Diet- and colonization-dependent intestinal dysfunction predisposes to necrotizing enterocolitis in preterm pigs.". (2006): http://europepmc.org/abstract/med/16697741.
    10.1053/j.gastro.2006.02.026
  929. Keller J; Holst JJ; Layer P. "Inhibition of human pancreatic and biliary output but not intestinal motility by physiological intraileal lipid loads.". (2006): http://europepmc.org/abstract/med/16322090.
    10.1152/ajpgi.00411.2005
  930. Simonsen L; Holst JJ; Deacon CF. "Exendin-4, but not glucagon-like peptide-1, is cleared exclusively by glomerular filtration in anaesthetised pigs.". (2006): http://europepmc.org/abstract/med/16447056.
    10.1007/s00125-005-0128-9
  931. Ugleholdt R; Poulsen ML; Holst PJ; Irminger JC; Orskov C; Pedersen J; Rosenkilde MM; et al. "Prohormone convertase 1/3 is essential for processing of the glucose-dependent insulinotropic polypeptide precursor.". (2006): http://europepmc.org/abstract/med/16476726.
    10.1074/jbc.M601203200
  932. Haugaard SB; Andersen O; Pedersen SB; Dela F; Deacon CF; Holst JJ; Iversen J; Madsbad S. "Glucose-stimulated prehepatic insulin secretion is associated with circulating alanine, triglyceride, glucagon, lactate and TNF-alpha in patients with HIV-lipodystrophy.". (2006): http://europepmc.org/abstract/med/16494630.
    10.1111/j.1468-1293.2006.00364.x
  933. Meier JJ; Gethmann A; Götze O; Gallwitz B; Holst JJ; Schmidt WE; Nauck MA. "Glucagon-like peptide 1 abolishes the postprandial rise in triglyceride concentrations and lowers levels of non-esterified fatty acids in humans.". (2006): http://europepmc.org/abstract/med/16447057.
    10.1007/s00125-005-0126-y
  934. Meier JJ; Nauck MA; Kask B; Holst JJ; Deacon CF; Schmidt WE; Gallwitz B. "Influence of gastric inhibitory polypeptide on pentagastrin-stimulated gastric acid secretion in patients with type 2 diabetes and healthy controls.". (2006): http://europepmc.org/abstract/med/16609993.
  935. Zander M; Madsbad S; Deacon CF; Holst JJ. "The metabolite generated by dipeptidyl-peptidase 4 metabolism of glucagon-like peptide-1 has no influence on plasma glucose levels in patients with type 2 diabetes.". (2006): http://europepmc.org/abstract/med/16385384.
    10.1007/s00125-005-0098-y
  936. Holst JJ. "Glucagon-like peptide-1: from extract to agent. The Claude Bernard Lecture, 2005.". (2006): http://europepmc.org/abstract/med/16416146.
    10.1007/s00125-005-0107-1
  937. Blom WA; Lluch A; Stafleu A; Vinoy S; Holst JJ; Schaafsma G; Hendriks HF. "Effect of a high-protein breakfast on the postprandial ghrelin response.". (2006): http://europepmc.org/abstract/med/16469977.
  938. Blom WA; Lluch A; Vinoy S; Stafleu A; van den Berg R; Holst JJ; Kok FJ; Hendriks HF. "Effects of gastric emptying on the postprandial ghrelin response.". (2006): http://europepmc.org/abstract/med/16188911.
    10.1152/ajpendo.00238.2005
  939. Meier JJ; Nauck MA; Pott A; Heinze K; Goetze O; Bulut K; Schmidt WE; Gallwitz B; Holst JJ. "Glucagon-like peptide 2 stimulates glucagon secretion, enhances lipid absorption, and inhibits gastric acid secretion in humans.". (2006): http://europepmc.org/abstract/med/16401467.
    10.1053/j.gastro.2005.10.004
  940. Guan X; Karpen HE; Stephens J; Bukowski JT; Niu S; Zhang G; Stoll B; et al. "GLP-2 receptor localizes to enteric neurons and endocrine cells expressing vasoactive peptides and mediates increased blood flow.". (2006): http://europepmc.org/abstract/med/16401478.
    10.1053/j.gastro.2005.11.005
  941. W.A.M. Blom; A. Lluch; A. Stafleu; S. Vinoy; Jens Juul Holst; G. Schaafsma; H.F.J. Hendriks. "Effect of a high-protein breakfast on the postprandial ghrelin response". American Journal of Clinical Nutrition 83 2 (2006): 211-220. https://curis.ku.dk/portal/en/publications/effect-of-a-highprotein-breakfast-on-the-postprandial-ghrelin-response(c972c640-70eb-11dc-bee9-02004c4f4f50).html.
  942. W.A.M. Blom; A. Lluch; S. Vinoy; A. Stafleu; R. van den Berg; Jens Juul Holst; F.J. Kok; H.F.J. Hendriks. "Effects of gastric emptying on the postprandial ghrelin response". American Journal of Physiology: Endocrinology and Metabolism 290 2 (2006): E389-E395. https://curis.ku.dk/portal/en/publications/effects-of-gastric-emptying-on-the-postprandial-ghrelin-response(c9a288d0-70eb-11dc-bee9-02004c4f4f50).html.
  943. Anne Flint; Bente Kramer Møller; Anne Raben; Birgitte Sloth; Dorthe Pedersen; Inge Tetens; Jens Juul Holst; Arne Astrup. "Glycemic and insulinemic responses as determinants of appetite in humans". American Journal of Clinical Nutrition 84 6 (2006): 1365-1373. https://curis.ku.dk/portal/en/publications/glycemic-and-insulinemic-responses-as-determinants-of-appetite-in-humans(678ff2b0-a1c1-11dd-b6ae-000ea68e967b).html.
  944. E. Muscelli; A. Mari; A. Natali; B.D. Astiarraga; S. Camastra; S. Frascerra; Jens Juul Holst; E. Ferrannini. "Impact of incretin hormones on beta-cell function in subjects with normal or impaired glucose tolerance". American Journal of Physiology: Endocrinology and Metabolism 291 6 (2006): E1144-E1150. https://curis.ku.dk/portal/en/publications/impact-of-incretin-hormones-on-betacell-function-in-subjects-with-normal-or-impaired-glucose-tolerance(06fe15a0-70ec-11dc-bee9-02004c4f4f50).html.
  945. B. Stoll; P.T. Price; P.J. Reeds; X. Chang; J.F. Henry; J.B. van Goudoever; Jens Juul Holst; D.G. Burrin. "Feeding an elemental diet vs a milk-based formula does not decrease intestinal mucosal growth in infant pigs". Journal of Parenteral and Enteral Nutrition 30 1 (2006): 32-39. https://curis.ku.dk/portal/en/publications/feeding-an-elemental-diet-vs-a-milkbased-formula-does-not-decrease-intestinal-mucosal-growth-in-infant-pigs(262edb30-70ec-11dc-bee9-02004c4f4f50).html.
  946. L. Simonsen; Jens Juul Holst; C.F. Deacon. "Exendin-4, but not glucagon-like peptide-1, is cleared exclusively by glomerular filtration in anaesthetised pigs". Diabetologia 49 4 (2006): 706-712. https://curis.ku.dk/portal/en/publications/exendin4-but-not-glucagonlike-peptide1-is-cleared-exclusively-by-glomerular-filtration-in-anaesthetised-pigs(21aab2a0-70ec-11dc-bee9-02004c4f4f50).html.
  947. F. Levin; T. Edholm; P.T. Schmidt; P. Gryback; H. Jacobsson; M. Degerblad; C. Hoybye; et al. "Ghrelin stimulates gastric emptying and hunger in normal-weight humans". Journal of Clinical Endocrinology and Metabolism 91 9 (2006): 3296-3302. https://curis.ku.dk/portal/en/publications/ghrelin-stimulates-gastric-emptying-and-hunger-in-normalweight-humans(fc6d01a0-70eb-11dc-bee9-02004c4f4f50).html.
  948. J.J. Meier; A. Gethmann; O. Gotze; B. Gallwitz; Jens Juul Holst; W.E. Schmidt; M.A. Nauck. "Glucagon-like peptide 1 abolishes the postprandial rise in triglyceride concentrations and lowers levels of non-esterified fatty acids in humans". Diabetologia 49 3 (2006): 452-458. https://curis.ku.dk/portal/en/publications/glucagonlike-peptide-1-abolishes-the-postprandial-rise-in-triglyceride-concentrations-and-lowers-levels-of-nonesterified-fatty-acids-in-humans(01ceb8f0-70ec-11dc-bee9-02004c4f4f50).html.
  949. X.F. Guan; H.E. Karpen; J. Stephens; J.T. Bukowski; S.Y. Niu; G.C. Zhang; B. Stoll; et al. "GLP-2 receptor localizes to enteric neurons and endocrine cells expressing vasoactive peptides and mediates increased blood flow". Today in Medicine. Gastroenterology 130 1 (2006): 150-164. https://curis.ku.dk/portal/en/publications/glp2-receptor-localizes-to-enteric-neurons-and-endocrine-cells-expressing-vasoactive-peptides-and-mediates-increased-blood-flow(e0188100-70eb-11dc-bee9-02004c4f4f50).html.
  950. Jens Juul Holst. "Glucagon-like peptide-1: From extract to agent. The Claude Bernard Lecture, 2005". Diabetologia 49 2 (2006): 253-260. https://curis.ku.dk/portal/en/publications/glucagonlike-peptide1-from-extract-to-agent-the-claude-bernard-lecture-2005(e8815dd0-70eb-11dc-bee9-02004c4f4f50).html.
  951. J.J. Meier; M.A. Nauck; A. Pott; K. Heinze; O. Goetze; K. Bulut; W.E. Schmidt; B. Gallwitz; Jens Juul Holst. "Glucagon-like peptide 2 stimulates glucagon secretion, enhances lipid absorption, and inhibits gastric acid secretion in humans". Today in Medicine. Gastroenterology 130 1 (2006): 44-54. https://curis.ku.dk/portal/en/publications/glucagonlike-peptide-2-stimulates-glucagon-secretion-enhances-lipid-absorption-and-inhibits-gastric-acid-secretion-in-humans(01eca130-70ec-11dc-bee9-02004c4f4f50).html.
  952. R.E. Wachters-Hagedoorn; M.G. Priebe; J.A.J. Heimweg; A.M. Heiner; K.N. Englyst; Jens Juul Holst; F. Stellaard; R.J. Vonk. "The rate of intestinal glucose absorption is correlated with plasma glucose-dependent insulinotropic polypeptide concentrations in healthy men". Journal of Nutrition 136 6 (2006): 1511-1516. https://curis.ku.dk/portal/en/publications/the-rate-of-intestinal-glucose-absorption-is-correlated-with-plasma-glucosedependent-insulinotropic-polypeptide-concentrations-in-healthy-men(2e8827a0-70ec-11dc-bee9-02004c4f4f50).html.
  953. M. Zander; S. Madsbad; C.F. Deacon; Jens Juul Holst. "The metabolite generated by dipeptidyl-peptidase 4 metabolism of glucagon-like peptide-1 has no influence on plasma glucose levels in patients with type 2 diabetes". Diabetologia 49 2 (2006): 369-374. https://curis.ku.dk/portal/en/publications/the-metabolite-generated-by-dipeptidylpeptidase-4-metabolism-of-glucagonlike-peptide1-has-no-influence-on-plasma-glucose-levels-in-patients-with-type-2-diabetes(30ce4710-70ec-11dc-bee9-02004c4f4f50).html.
  954. J. Meier; M.A. Nauck; A. Pott; K. Heinze; O. Götze; K. Bulut; W.E. Schmidt; B. Gallwitz; Jens Juul Holst. "Stimulation of glucagon secretion and inhibition of gastric acid secretion by glucagon-like peptide-2 (GLP-2) in healthy human subjects". Today in Medicine. Gastroenterology 130 (2006): 44-54. https://curis.ku.dk/portal/en/publications/stimulation-of-glucagon-secretion-and-inhibition-of-gastric-acid-secretion-by-glucagonlike-peptide2-glp2-in-healthy-human-subjects(6de0ce10-6c38-11dc-bee9-02004c4f4f50).html.
  955. M.O. Weickert; J. Spranger; Jens Juul Holst; B. Otto; C. Koebnick; M. Moehlig; A.F.H. Pfeiffer. "Wheat-fibre-induced changes of postprandial peptide YY and ghrelin responses are not associated with acute alterations of satiety". British Journal of Nutrition 96 5 (2006): 795-798. https://curis.ku.dk/portal/en/publications/wheatfibreinduced-changes-of-postprandial-peptide-yy-and-ghrelin-responses-are-not-associated-with-acute-alterations-of-satiety(2f458430-70ec-11dc-bee9-02004c4f4f50).html.
  956. D.W. Nelson; X.W. Liu; Jens Juul Holst; H.E. Raybould; D.M. Ney. "Vagal afferents are essential for maximal resection-induced intestinal adaptive growth in orally fed rats". American Journal of Physiology: Regulatory, Integrative and Comparative Physiology 291 5 (2006): R1256-R1264. https://curis.ku.dk/portal/en/publications/vagal-afferents-are-essential-for-maximal-resectioninduced-intestinal-adaptive-growth-in-orally-fed-rats(08656dd0-70ec-11dc-bee9-02004c4f4f50).html.
  957. Jens Juul Holst; Carolyn Deacon. "Role of GLP-1 analogues and DDP-IV inhibitors in the treatment of type 2 diabetes". Avances en Diabetologia 22 2 (2006): 115-125. https://curis.ku.dk/portal/en/publications/role-of-glp1-analogues-and-ddpiv-inhibitors-in-the-treatment-of-type-2-diabetes(e8d54a30-70eb-11dc-bee9-02004c4f4f50).html.
  958. X.W. Liu; D.W. Nelson; Jens Juul Holst; D.M. Ney. "Synergistic effect of supplemental enteral nutrients and exogenous glucagon-like peptide 2 on intestinal adaptation in a rat model of short bowel syndrome". American Journal of Clinical Nutrition 84 5 (2006): 1142-1150. https://curis.ku.dk/portal/en/publications/synergistic-effect-of-supplemental-enteral-nutrients-and-exogenous-glucagonlike-peptide-2-on-intestinal-adaptation-in-a-rat-model-of-short-bowel-syndrome(fd4debc0-70eb-11dc-bee9-02004c4f4f50).html.
  959. E.R. Pearson; I. Flechtner; P.R. Njolstad; M.T. Malecki; S.E. Flanagan; B. Larkin; F.M. Ashcroft; et al. "Switching from insulin to oral sulfonylureas in patients with diabetes due to Kir6.2 mutations". New England Journal of Medicine 355 5 (2006): 467-477. https://curis.ku.dk/portal/en/publications/switching-from-insulin-to-oral-sulfonylureas-in-patients-with-diabetes-due-to-kir62-mutations(10200940-70ec-11dc-bee9-02004c4f4f50).html.
  960. E.R. Pearson; I. Flechtner; P.R. Njølståd; M.T. Malecki; S. Flanagan; B. Larkin; F.M. Ashcroft; et al. "The successful transfer of insulin treated patients with diabetes due to Kir6.2 (KCNJ11) mutations to oral sulfonylureas". N. Engl. J. Med. 355 (2006): 467-477. https://curis.ku.dk/portal/en/publications/the-successful-transfer-of-insulin-treated-patients-with-diabetes-due-to-kir62-kcnj11-mutations-to-oral-sulfonylureas(74173a80-6c38-11dc-bee9-02004c4f4f50).html.
  961. W.A.M. Blom; A. Lluch; A. Stafleu; S. Vinoy; Jens Juul Holst; G. Schaafsma; H.F.K. Hendriks. "The effect o a high protein dairy breakfast on the postprandial ghrelin response". Am. J. Clin. Nutr. 83 (2006): 211-220. https://curis.ku.dk/portal/en/publications/the-effect-o-a-high-protein-dairy-breakfast-on-the-postprandial-ghrelin-response(75b64480-6c38-11dc-bee9-02004c4f4f50).html.
  962. Stoll B; Price PT; Reeds PJ; Chang X; Henry JF; van Goudoever JB; Holst JJ; Burrin DG. "Feeding an elemental diet vs a milk-based formula does not decrease intestinal mucosal growth in infant pigs.". (2006): http://europepmc.org/abstract/med/16387897.
    10.1177/014860710603000132
  963. Deacon CF; Holst JJ. "Dipeptidyl peptidase IV inhibitors: a promising new therapeutic approach for the management of type 2 diabetes.". (2006): http://europepmc.org/abstract/med/16242377.
    10.1016/j.biocel.2005.09.011
  964. Kaushik N; Pietraszewski M; Holst JJ; O'Keefe SJ. "Enteral feeding without pancreatic stimulation.". (2005): http://europepmc.org/abstract/med/16258370.
    10.1097/01.mpa.0000183374.11919.e5
  965. Fehse F; Trautmann M; Holst JJ; Halseth AE; Nanayakkara N; Nielsen LL; Fineman MS; Kim DD; Nauck MA. "Exenatide augments first- and second-phase insulin secretion in response to intravenous glucose in subjects with type 2 diabetes.". (2005): http://europepmc.org/abstract/med/16144950.
    10.1210/jc.2005-1093
  966. Weickert MO; Mohlig M; Koebnick C; Holst JJ; Namsolleck P; Ristow M; Osterhoff M; et al. "Impact of cereal fibre on glucose-regulating factors.". (2005): http://europepmc.org/abstract/med/16172868.
    10.1007/s00125-005-1941-x
  967. Patti ME; McMahon G; Mun EC; Bitton A; Holst JJ; Goldsmith J; Hanto DW; et al. "Severe hypoglycaemia post-gastric bypass requiring partial pancreatectomy: evidence for inappropriate insulin secretion and pancreatic islet hyperplasia.". (2005): http://europepmc.org/abstract/med/16195867.
    10.1007/s00125-005-1933-x
  968. Jensen CB; Storgaard H; Holst JJ; Dela F; Madsbad S; Vaag A. "Young, low-birth-weight men are not more susceptible to the diabetogenic effects of a prolonged free fatty acid exposure than matched controls.". (2005): http://europepmc.org/abstract/med/16154442.
    10.1016/j.metabol.2005.05.005
  969. Schmidt PT; Näslund E; Grybäck P; Jacobsson H; Holst JJ; Hilsted L; Hellström PM. "A role for pancreatic polypeptide in the regulation of gastric emptying and short-term metabolic control.". (2005): http://europepmc.org/abstract/med/15998783.
    10.1210/jc.2004-2089
  970. Meier JJ; Gallwitz B; Askenas M; Vollmer K; Deacon CF; Holst JJ; Schmidt WE; Nauck MA. "Secretion of incretin hormones and the insulinotropic effect of gastric inhibitory polypeptide in women with a history of gestational diabetes.". (2005): http://europepmc.org/abstract/med/16010522.
    10.1007/s00125-005-1863-7
  971. Plamboeck A; Holst JJ; Carr RD; Deacon CF. "Neutral endopeptidase 24.11 and dipeptidyl peptidase IV are both mediators of the degradation of glucagon-like peptide 1 in the anaesthetised pig.". (2005): http://europepmc.org/abstract/med/16025254.
    10.1007/s00125-005-1847-7
  972. Mari A; Sallas WM; He YL; Watson C; Ligueros-Saylan M; Dunning BE; Deacon CF; Holst JJ; Foley JE. "Vildagliptin, a dipeptidyl peptidase-IV inhibitor, improves model-assessed beta-cell function in patients with type 2 diabetes.". (2005): http://europepmc.org/abstract/med/15886245.
    10.1210/jc.2004-2460
  973. Schou JH; Pilgaard K; Vilsbøll T; Jensen CB; Deacon CF; Holst JJ; Vølund A; Madsbad S; Vaag AA. "Normal secretion and action of the gut incretin hormones glucagon-like peptide-1 and glucose-dependent insulinotropic polypeptide in young men with low birth weight.". (2005): http://europepmc.org/abstract/med/15899957.
    10.1210/jc.2005-0382
  974. Frid AH; Nilsson M; Holst JJ; Björck IM. "Effect of whey on blood glucose and insulin responses to composite breakfast and lunch meals in type 2 diabetic subjects.". (2005): http://europepmc.org/abstract/med/16002802.
  975. Torekov SS; Larsen LH; Glümer C; Borch-Johnsen K; Jørgensen T; Holst JJ; Madsen OD; Hansen T; Pedersen O. "Evidence of an association between the Arg72 allele of the peptide YY and increased risk of type 2 diabetes.". (2005): http://europepmc.org/abstract/med/15983231.
    10.2337/diabetes.54.7.2261
  976. Flint A; Møller BK; Raben A; Tetens I; Holst JJ; Astrup A. "The use of glycaemic index tables to predict glycaemic index of breakfast meals.". (2005): http://europepmc.org/abstract/med/16115343.
    10.1079/BJN20041424
  977. Hermansen K; Hansen B; Jacobsen R; Clausen P; Dalgaard M; Dinesen B; Holst JJ; Pedersen E; Astrup A. "Effects of soy supplementation on blood lipids and arterial function in hypercholesterolaemic subjects.". (2005): http://europepmc.org/abstract/med/15900307.
    10.1038/sj.ejcn.1602151
  978. Meier JJ; Kemmeries G; Holst JJ; Nauck MA. "Erythromycin antagonizes the deceleration of gastric emptying by glucagon-like peptide 1 and unmasks its insulinotropic effect in healthy subjects.". (2005): http://europepmc.org/abstract/med/15983224.
    10.2337/diabetes.54.7.2212
  979. Buemann B; Sørensen TI; Pedersen O; Black E; Holst C; Toubro S; Echwald S; et al. "Lower-body fat mass as an independent marker of insulin sensitivity--the role of adiponectin.". (2005): http://europepmc.org/abstract/med/15824752.
    10.1038/sj.ijo.0802929
  980. Larsen PJ; Holst JJ. "Glucagon-related peptide 1 (GLP-1): hormone and neurotransmitter.". (2005): http://europepmc.org/abstract/med/15780429.
    10.1016/j.regpep.2004.08.026
  981. Grånäs C; Lundholt BK; Heydorn A; Linde V; Pedersen HC; Krog-Jensen C; Rosenkilde MM; Pagliaro L. "High content screening for G protein-coupled receptors using cell-based protein translocation assays.". Combinatorial chemistry & high throughput screening (2005): http://europepmc.org/abstract/med/16101006.
    10.2174/1386207054020741
  982. Holst JJ; Deacon CF. "Glucagon-like peptide-1 mediates the therapeutic actions of DPP-IV inhibitors.". (2005): http://europepmc.org/abstract/med/15759106.
    10.1007/s00125-005-1705-7
  983. Miki T; Minami K; Shinozaki H; Matsumura K; Saraya A; Ikeda H; Yamada Y; Holst JJ; Seino S. "Distinct effects of glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1 on insulin secretion and gut motility.". (2005): http://europepmc.org/abstract/med/15793244.
    10.2337/diabetes.54.4.1056
  984. Hücking K; Kostic Z; Pox C; Ritzel R; Holst JJ; Schmiegel W; Nauck MA. "alpha-Glucosidase inhibition (acarbose) fails to enhance secretion of glucagon-like peptide 1 (7-36 amide) and to delay gastric emptying in Type 2 diabetic patients.". (2005): http://europepmc.org/abstract/med/15787675.
    10.1111/j.1464-5491.2005.01451.x
  985. Martin GR; Wallace LE; Hartmann B; Holst JJ; Demchyshyn L; Toney K; Sigalet DL. "Nutrient-stimulated GLP-2 release and crypt cell proliferation in experimental short bowel syndrome.". (2005): http://europepmc.org/abstract/med/15388486.
    10.1152/ajpgi.00242.2004
  986. Andersen O; Haugaard SB; Holst JJ; Deacon CF; Iversen J; Andersen UB; Nielsen JO; Madsbad S. "Enhanced glucagon-like peptide-1 (GLP-1) response to oral glucose in glucose-intolerant HIV-infected patients on antiretroviral therapy.". (2005): http://europepmc.org/abstract/med/15807714.
    10.1111/j.1468-1293.2005.00270.x
  987. Schmidt PT; Ljung T; Hartmann B; Hare KJ; Holst JJ; Hellström PM. "Tissue levels and post-prandial secretion of the intestinal growth factor, glucagon-like peptide-2, in controls and inflammatory bowel disease: comparison with peptide YY.". (2005): http://europepmc.org/abstract/med/15674099.
    10.1097/00042737-200502000-00012
  988. Burrin DG; Stoll B; Guan X; Cui L; Chang X; Holst JJ. "Glucagon-like peptide 2 dose-dependently activates intestinal cell survival and proliferation in neonatal piglets.". (2005): http://europepmc.org/abstract/med/15486229.
    10.1210/en.2004-1119
  989. Haugaard SB; Andersen O; Dela F; Holst JJ; Storgaard H; Fenger M; Iversen J; Madsbad S. "Defective glucose and lipid metabolism in human immunodeficiency virus-infected patients with lipodystrophy involve liver, muscle tissue and pancreatic beta-cells.". (2005): http://europepmc.org/abstract/med/15762193.
    10.1530/eje.1.01835
  990. Andreassen BU; Paerregaard A; Schmiegelow K; Rechnitzer C; Heilman C; Hartmann B; Holst JJ; Michaelsen KF. "Glucagon-like peptide-2 (GLP-2) response to enteral intake in children during anti-cancer treatment.". (2005): http://europepmc.org/abstract/med/15625426.
    10.1097/00005176-200501000-00009
  991. Ørskov C; Hartmann B; Poulsen SS; Thulesen J; Hare KJ; Holst JJ. "GLP-2 stimulates colonic growth via KGF, released by subepithelial myofibroblasts with GLP-2 receptors.". (2005): http://europepmc.org/abstract/med/15544847.
    10.1016/j.regpep.2004.07.009
  992. Anne Flint; Bente Kramer Møller; Anne Raben; Inge Tetens; Jens Juul Holst; Arne Astrup. "The use of glycaemic index tables to predict glycaemic index of breakfast meals". British Journal of Nutrition 94 1 (2005): 135-136. https://curis.ku.dk/portal/en/publications/the-use-of-glycaemic-index-tables-to-predict-glycaemic-index-of-breakfast-meals(e0e95870-a1be-11dd-b6ae-000ea68e967b).html.
  993. B. Buemann; E. Black; Thorkild I.A. Sørensen; C. Holst; S. Toubro; O. Pedersen; Jens Juul Holst; C. Rasmussen; Arne Astrup. "Lower-body fat mass as an independent marker of insulin sensitivity - the role of adiponectin?". International Journal of Obesity 29 (2005): 624-631. https://curis.ku.dk/portal/en/publications/lowerbody-fat-mass-as-an-independent-marker-of-insulin-sensitivity--the-role-of-adiponectin(30c6eef0-74c3-11db-bee9-02004c4f4f50).html.
  994. A. Mari; W.M. Sallas; Y.L. He; C. Watson; M. Ligueros-Saylan; B.E. Duning; Carolyn F. Deacon; Jens Juul Holst; J.E. Foley. "Vildagliptin, a dipeptidyl peptidase-IV inhibitor improves model-assessed beta-cell function in patients with type 2 diabetes". J. Clin. Endocrinol. Metab. 90 (2005): 4888-4894. https://curis.ku.dk/portal/en/publications/vildagliptin-a-dipeptidyl-peptidaseiv-inhibitor-improves-modelassessed-betacell-function-in-patients-with-type-2-diabetes(151ed060-74c2-11db-bee9-02004c4f4f50).html.
  995. F. Fehse; M. Trautmann; Jens Juul Holst; A.E. Halseth; N. Nanyakkara; L. Nielsen; M.S.D. Fineman; D.D. Kim; M.A. Nauck. "Exenatide augments first and second phase insulin secretion in response to intravenous glucose in subjects with type 2 diabetes". J. Clin. Endocrinol. Metab. 90 (2005): 5991-5997. https://curis.ku.dk/portal/en/publications/exenatide-augments-first-and-second-phase-insulin-secretion-in-response-to-intravenous-glucose-in-subjects-with-type-2-diabetes(74e4eac0-6c38-11dc-bee9-02004c4f4f50).html.
  996. B.U. Andreassen; A. Pærregaard; K. Schmiegelow; C. Rechnitzer; Bolette Hartmann; Jens Juul Holst; K.F. Michaelsen. "Glucagon-like-peptide-2 (GLP-2) response to enteral intake in children during anticancer treatment". Journal of Pediatric Gastroenterology and Nutrition 40 (2005): 48-53. https://curis.ku.dk/portal/en/publications/glucagonlikepeptide2-glp2-response-to-enteral-intake-in-children-during-anticancer-treatment(1da71c10-74c2-11db-bee9-02004c4f4f50).html.
  997. Jens Juul Holst; Carolyn F. Deacon. "Glucagon-like peptide-1 mediates the therapeutic actions of Dpp-IV inhibitors". Diabetologia 48 (2005): 612-615. https://curis.ku.dk/portal/en/publications/glucagonlike-peptide1-mediates-the-therapeutic-actions-of-dppiv-inhibitors(1771c110-74c2-11db-bee9-02004c4f4f50).html.
  998. J.J. Meier; G. Kemmeries; Jens Juul Holst; M.A. Nauck. "Erythromycin antagonises the deceleration of gastric emptying by glucagon-like peptide-1 (GLP)-1 and unmasks its insulinotropic effect in healthy subjects". Diabetes 54 (2005): 2212-2218. https://curis.ku.dk/portal/en/publications/erythromycin-antagonises-the-deceleration-of-gastric-emptying-by-glucagonlike-peptide1-glp1-and-unmasks-its-insulinotropic-effect-in-healthy-subjects(17afb470-74c2-11db-bee9-02004c4f4f50).html.
  999. Jens Juul Holst. "Glucagon-like peptide 1: physiology and therapeutic potential". Endocrinology and Diabetes 12 (2005): 56-62. https://curis.ku.dk/portal/en/publications/glucagonlike-peptide-1-physiology-and-therapeutic-potential(1581d7f0-74c2-11db-bee9-02004c4f4f50).html.
  1000. P.T. Schmidt; T. Ljung; Bolette Hartmann; K.J. Hare; Jens Juul Holst; P.M. Hëllstrøm. "Tissue levels and postprandial secretion of the intestinal growth factor, GLP-2 in inflammatory bowels disease: comparison with PYY". European Journal of Gastroenterology and Hepathology 17 (2005): 207-212. https://curis.ku.dk/portal/en/publications/tissue-levels-and-postprandial-secretion-of-the-intestinal-growth-factor-glp2-in-inflammatory-bowels-disease-comparison-with-pyy(12718ab0-74c2-11db-bee9-02004c4f4f50).html.
  1001. P.T. Schmidt; E. Näslund; P. Grybäck; H. Jacobsson; Jens Juul Holst; L. Hilsted; P.M. Hellström. "Evidence for an endocrine pancreatico-gastric axis: The role of pancreatic polypeptide in gastric emptying and short term metabolic control". J. Clin. Endocrinol. Metab. 90 (2005): 5241-5246. https://curis.ku.dk/portal/en/publications/evidence-for-an-endocrine-pancreaticogastric-axis-the-role-of-pancreatic-polypeptide-in-gastric-emptying-and-short-term-metabolic-control(c6926930-6c36-11dc-bee9-02004c4f4f50).html.
  1002. M.E. Patti; E.C. Mun; Jens Juul Holst; D.W. Hanto; J. Goldsmith; R. Arky; V. Nose; S. Bonner-Weir; A.B. Goldfine. "Severe hypoglycemia post-gastric bypass requiring partial pancreatectomy: Evidence for inappropriate insulin secretion and pancreatic islet cell hyperplasia". Diabetologia 48 (2005): 2236-2240. https://curis.ku.dk/portal/en/publications/severe-hypoglycemia-postgastric-bypass-requiring-partial-pancreatectomy-evidence-for-inappropriate-insulin-secretion-and-pancreatic-islet-cell-hyperplasia(754bc2e0-6c38-11dc-bee9-02004c4f4f50).html.
  1003. Jens Juul Holst. "GLP-1 receptor argonists for the treatment of diabetes". International Diabetes Monitor 17 (2005): 11-18. https://curis.ku.dk/portal/en/publications/glp1-receptor-argonists-for-the-treatment-of-diabetes(74ba5850-6c38-11dc-bee9-02004c4f4f50).html.
  1004. J.J. Meier; B. Gallwitz; M. Askenas; K. Vollmer; Carolyn Deacon; Jens Juul Holst; W.E. Schmidt; M.A. Nauck. "Insulinotropic effect of gastric inhibitory polypeptide (GIP) in women with a history of gestational diabetes". Diabetologia 48 (2005): 1872-1881. https://curis.ku.dk/portal/en/publications/insulinotropic-effect-of-gastric-inhibitory-polypeptide-gip-in-women-with-a-history-of-gestational-diabetes(7b1b0910-6c38-11dc-bee9-02004c4f4f50).html.
  1005. Steen B Haugaard; Ove Andersen; Flemming Dela; Jens Juul Holst; Heidi Storgaard; Mogens Fenger; Johan Iversen; Sten Madsbad. "Defective glucose and lipid metabolism in human immunodeficiency virus-infected patients with lipodystrophy involve liver, muscle tissue and pancreatic beta-cells.". European Journal of Endocrinology 152 1 (2005): 103-112. https://curis.ku.dk/portal/en/publications/defective-glucose-and-lipid-metabolism-in-human-immunodeficiency-virusinfected-patients-with-lipodystrophy-involve-liver-muscle-tissue-and-pancreatic-betacells(d02ec040-5f2f-11de-a8de-000ea68e967b).html.
  1006. S.S. Torekov; L.H. Larsen; C. Glümer; K. Borch-Johnsen; T. Jørgensen; Jens Juul Holst; O.D. Madsen; T. Hansen; O. Pedersen. "Evidence of an association between the Arg72-allele of the peptide YY (PYY) and increased risk of type 2 diabetes". Diabetes 54 (2005): 2261-2265. https://curis.ku.dk/portal/en/publications/evidence-of-an-association-between-the-arg72allele-of-the-peptide-yy-pyy-and-increased-risk-of-type-2-diabetes(1532cd90-74c2-11db-bee9-02004c4f4f50).html.
  1007. D.G. Burrin; B. Stoll; X. Guan; L. Cui; X. Chang; Jens Juul Holst. "GLP-2 dose-dependently activates intestinal cell survival and proliferation in neonatal piglets". Endokrinologiya 146 (2005): 22-32. https://curis.ku.dk/portal/en/publications/glp2-dosedependently-activates-intestinal-cell-survival-and-proliferation-in-neonatal-piglets(15d9e300-74c2-11db-bee9-02004c4f4f50).html.
  1008. K. Hücking; Z. Kostic; C. Pox; R. Ritzel; Jens Juul Holst; W. Schmiegel; M.A. Nauck. "Alpha-Glucosidase inhibition (Acarbose) fails to enhance secretion of glucagons-like peptide 1(7-36 amide) and to delay gastric emptying in type 2 diabetic patients". Diabet. Med. 22 (2005): 470-476. https://curis.ku.dk/portal/en/publications/alphaglucosidase-inhibition-acarbose-fails-to-enhance-secretion-of-glucagonslike-peptide-1736-amide-and-to-delay-gastric-emptying-in-type-2-diabetic-patients(150554f0-74c2-11db-bee9-02004c4f4f50).html.
  1009. O. Andersen; S.B. Haugaard; Jens Juul Holst; Carolyn F. Deacon; J. Iversen; U.B. Andersen; J.O. Nielsen; S. Madsbad. "Enhanced glucagon-like peptide- 1 (GLP-1) response to oral glucose in glucose intolerant HIV-infected patients on antiretroviral therapy". HIV Medicine 6 (2005): 91-98. https://curis.ku.dk/portal/en/publications/enhanced-glucagonlike-peptide-1-glp1-response-to-oral-glucose-in-glucose-intolerant-hivinfected-patients-on-antiretroviral-therapy(33c7c850-74c2-11db-bee9-02004c4f4f50).html.
  1010. P.B. Jeppesen; E.L. Sanguinetti; A. Buckman; L. Howard; J.S. Scolapio; T.R. Ziegler; M. Gregory; et al. "Teduglutide (ALX-0600), a dipeptidyl-peptidase-IV resistant glucagon-like-2 analog improves intestinal function in short bowel syndrome patients". Gut 54 (2005): 1224-1231. https://curis.ku.dk/portal/en/publications/teduglutide-alx0600-a-dipeptidylpeptidaseiv-resistant-glucagonlike2-analog-improves-intestinal-function-in-short-bowel-syndrome-patients(153f77c0-74c2-11db-bee9-02004c4f4f50).html.
  1011. Jens Juul Holst; Carolyn Deacon. "For debate: Are antidiabetic actions of DPP-IV inhibitors mediated by glucagon-like peptide- 1?". Diabetologia 48 (2005): 612-615. https://curis.ku.dk/portal/en/publications/for-debate-are-antidiabetic-actions-of-dppiv-inhibitors-mediated-by-glucagonlike-peptide-1(33b94960-74c2-11db-bee9-02004c4f4f50).html.
  1012. Nyström T; Gutniak MK; Zhang Q; Zhang F; Holst JJ; Ahrén B; Sjöholm A. "Effects of glucagon-like peptide-1 on endothelial function in type 2 diabetes patients with stable coronary artery disease.". (2004): http://europepmc.org/abstract/med/15353407.
    10.1152/ajpendo.00237.2004
  1013. Holst JJ; Deacon CF. "Glucagon-like peptide 1 and inhibitors of dipeptidyl peptidase IV in the treatment of type 2 diabetes mellitus.". (2004): http://europepmc.org/abstract/med/15525549.
    10.1016/j.coph.2004.08.005
  1014. Meier JJ; Gallwitz B; Kask B; Deacon CF; Holst JJ; Schmidt WE; Nauck MA. "Stimulation of insulin secretion by intravenous bolus injection and continuous infusion of gastric inhibitory polypeptide in patients with type 2 diabetes and healthy control subjects.". (2004): http://europepmc.org/abstract/med/15561915.
    10.2337/diabetes.53.suppl_3.S220
  1015. Holst JJ; Orskov C. "The incretin approach for diabetes treatment: modulation of islet hormone release by GLP-1 agonism.". (2004): http://europepmc.org/abstract/med/15561911.
    10.2337/diabetes.53.suppl_3.S197
  1016. Nauck MA; El-Ouaghlidi A; Gabrys B; Hücking K; Holst JJ; Deacon CF; Gallwitz B; Schmidt WE; Meier JJ. "Secretion of incretin hormones (GIP and GLP-1) and incretin effect after oral glucose in first-degree relatives of patients with type 2 diabetes.". (2004): http://europepmc.org/abstract/med/15491793.
    10.1016/j.regpep.2004.06.020
  1017. Nilsson M; Stenberg M; Frid AH; Holst JJ; Björck IM. "Glycemia and insulinemia in healthy subjects after lactose-equivalent meals of milk and other food proteins: the role of plasma amino acids and incretins.". (2004): http://europepmc.org/abstract/med/15531672.
  1018. Hansen L; Lampert S; Mineo H; Holst JJ. "Neural regulation of glucagon-like peptide-1 secretion in pigs.". (2004): http://europepmc.org/abstract/med/15475512.
    10.1152/ajpendo.00197.2004
  1019. Larsen MO; Rolin B; Gotfredsen CF; Carr RD; Holst JJ. "Reduction of beta cell mass: partial insulin secretory compensation from the residual beta cell population in the nicotinamide-streptozotocin Gottingen minipig after oral glucose in vivo and in the perfused pancreas.". (2004): http://europepmc.org/abstract/med/15565374.
    10.1007/s00125-004-1546-9
  1020. Paris MC; Fuller PJ; Carstensen B; Nagy E; Taylor RG; Sourial M; Holst JJ; Hartmann B; Binesm JE. "Plasma GLP-2 levels and intestinal markers in the juvenile pig during intestinal adaptation: effects of different diet regimens.". (2004): http://europepmc.org/abstract/med/15573929.
    10.1023/B:DDAS.0000043388.52260.2f
  1021. Haugaard SB; Andersen O; Storgaard H; Dela F; Holst JJ; Iversen J; Nielsen JO; Madsbad S. "Insulin secretion in lipodystrophic HIV-infected patients is associated with high levels of nonglucose secretagogues and insulin resistance of beta-cells.". (2004): http://europepmc.org/abstract/med/15149949.
    10.1152/ajpendo.00009.2004
  1022. Sigalet DL; Martin G; Meddings J; Hartman B; Holst JJ. "GLP-2 levels in infants with intestinal dysfunction.". (2004): http://europepmc.org/abstract/med/15201402.
    10.1203/01.PDR.0000134250.80492.EC
  1023. Cayé-Thomasen P; Schmidt PT; Hermansson A; Holst JJ; Thomsen J. "Depletion of mucosal substance P in acute otitis media.". (2004): http://europepmc.org/abstract/med/15370562.
    10.1080/00016480410017972
  1024. Degerman E; Manganiello V; Holst JJ; Ahrén B. "Milrinone efficiently potentiates insulin secretion induced by orally but not intravenously administered glucose in C57BL6J mice.". (2004): http://europepmc.org/abstract/med/15364011.
    10.1016/j.ejphar.2004.07.096
  1025. Deacon CF; Ahrén B; Holst JJ. "Inhibitors of dipeptidyl peptidase IV: a novel approach for the prevention and treatment of Type 2 diabetes?". (2004): http://europepmc.org/abstract/med/15330741.
    10.1517/13543784.13.9.1091
  1026. Sanggaard KM; Holst JJ; Rehfeld JF; Sandström B; Raben A; Tholstrup T. "Different effects of whole milk and a fermented milk with the same fat and lactose content on gastric emptying and postprandial lipaemia, but not on glycaemic response and appetite.". (2004): http://europepmc.org/abstract/med/15469648.
    10.1079/BJN20041219
  1027. Trebbien R; Klarskov L; Olesen M; Holst JJ; Carr RD; Deacon CF. "Neutral endopeptidase 24.11 is important for the degradation of both endogenous and exogenous glucagon in anesthetized pigs.". (2004): http://europepmc.org/abstract/med/15126240.
    10.1152/ajpendo.00353.2003
  1028. Zander M; Christiansen A; Madsbad S; Holst JJ. "Additive effects of glucagon-like peptide 1 and pioglitazone in patients with type 2 diabetes.". (2004): http://europepmc.org/abstract/med/15277416.
    10.2337/diacare.27.8.1910
  1029. Holst JJ; Gromada J. "Role of incretin hormones in the regulation of insulin secretion in diabetic and nondiabetic humans.". (2004): http://europepmc.org/abstract/med/15271645.
    10.1152/ajpendo.00545.2003
  1030. Thulesen J; Hartmann B; Hare KJ; Kissow H; Ørskov C; Holst JJ; Poulsen SS. "Glucagon-like peptide 2 (GLP-2) accelerates the growth of colonic neoplasms in mice.". (2004): http://europepmc.org/abstract/med/15247183.
    10.1136/gut.2003.035212
  1031. Niinikoski H; Stoll B; Guan X; Kansagra K; Lambert BD; Stephens J; Hartmann B; Holst JJ; Burrin DG. "Onset of small intestinal atrophy is associated with reduced intestinal blood flow in TPN-fed neonatal piglets.". (2004): http://europepmc.org/abstract/med/15173413.
  1032. Calbet JA; Holst JJ. "Gastric emptying, gastric secretion and enterogastrone response after administration of milk proteins or their peptide hydrolysates in humans.". (2004): http://europepmc.org/abstract/med/15168035.
    10.1007/s00394-004-0448-4
  1033. Flint A; Møller BK; Raben A; Pedersen D; Tetens I; Holst JJ; Astrup A. "The use of glycaemic index tables to predict glycaemic index of composite breakfast meals.". (2004): http://europepmc.org/abstract/med/15182401.
    10.1079/BJN20041124
  1034. Rask E; Olsson T; Söderberg S; Holst Jj J; Tura A; Pacini G; Ahrén B. "Insulin secretion and incretin hormones after oral glucose in non-obese subjects with impaired glucose tolerance.". (2004): http://europepmc.org/abstract/med/15131768.
    10.1016/j.metabol.2003.11.011
  1035. Hansotia T; Baggio LL; Delmeire D; Hinke SA; Yamada Y; Tsukiyama K; Seino Y; et al. "Double incretin receptor knockout (DIRKO) mice reveal an essential role for the enteroinsular axis in transducing the glucoregulatory actions of DPP-IV inhibitors.". (2004): http://europepmc.org/abstract/med/15111503.
    10.2337/diabetes.53.5.1326
  1036. Holst JJ. "Treatment of type 2 diabetes mellitus with agonists of the GLP-1 receptor or DPP-IV inhibitors.". (2004): http://europepmc.org/abstract/med/15155141.
    10.1517/eoed.9.1.155.32952
  1037. Meier JJ; Goetze O; Anstipp J; Hagemann D; Holst JJ; Schmidt WE; Gallwitz B; Nauck MA. "Gastric inhibitory polypeptide does not inhibit gastric emptying in humans.". (2004): http://europepmc.org/abstract/med/14678954.
    10.1152/ajpendo.00499.2003
  1038. Hansen L; Hartmann B; Mineo H; Holst JJ. "Glucagon-like peptide-1 secretion is influenced by perfusate glucose concentration and by a feedback mechanism involving somatostatin in isolated perfused porcine ileum.". (2004): http://europepmc.org/abstract/med/14759551.
    10.1016/j.regpep.2003.10.021
  1039. Nagell CF; Wettergren A; Pedersen JF; Mortensen D; Holst JJ. "Glucagon-like peptide-2 inhibits antral emptying in man, but is not as potent as glucagon-like peptide-1.". (2004): http://europepmc.org/abstract/med/15125467.
    10.1080/00365520410004424
  1040. Nauck MA; Walberg J; Vethacke A; El-Ouaghlidi A; Senkal M; Holst JJ; Gallwitz B; Schmidt WE; Schmiegel W. "Blood glucose control in healthy subject and patients receiving intravenous glucose infusion or total parenteral nutrition using glucagon-like peptide 1.". (2004): http://europepmc.org/abstract/med/14759561.
    10.1016/j.regpep.2003.11.003
  1041. Ugleholdt R; Zhu X; Deacon CF; Ørskov C; Steiner DF; Holst JJ. "Impaired intestinal proglucagon processing in mice lacking prohormone convertase 1.". (2004): http://europepmc.org/abstract/med/14630721.
    10.1210/en.2003-0801
  1042. Vilsbøll T; Holst JJ. "Incretins, insulin secretion and Type 2 diabetes mellitus.". (2004): http://europepmc.org/abstract/med/14968296.
    10.1007/s00125-004-1342-6
  1043. Meier JJ; Weyhe D; Michaely M; Senkal M; Zumtobel V; Nauck MA; Holst JJ; Schmidt WE; Gallwitz B. "Intravenous glucagon-like peptide 1 normalizes blood glucose after major surgery in patients with type 2 diabetes.". (2004): http://europepmc.org/abstract/med/15090972.
    10.1097/01.CCM.0000114811.60629.B5
  1044. Schmidt PT; Hansen L; Hilsted L; Holst JJ. "Cholecystokinin inhibits gastrin secretion independently of paracrine somatostatin secretion in the pig.". (2004): http://europepmc.org/abstract/med/15074389.
    10.1080/00365520310007602
  1045. Näslund E; King N; Mansten S; Adner N; Holst JJ; Gutniak M; Hellström PM. "Prandial subcutaneous injections of glucagon-like peptide-1 cause weight loss in obese human subjects.". (2004): http://europepmc.org/abstract/med/15005830.
    10.1079/BJN20031064
  1046. Meier JJ; Nauck MA; Kranz D; Holst JJ; Deacon CF; Gaeckler D; Schmidt WE; Gallwitz B. "Secretion, degradation, and elimination of glucagon-like peptide 1 and gastric inhibitory polypeptide in patients with chronic renal insufficiency and healthy control subjects.". (2004): http://europepmc.org/abstract/med/14988249.
    10.2337/diabetes.53.3.654
  1047. Gregersen S; Jeppesen PB; Holst JJ; Hermansen K. "Antihyperglycemic effects of stevioside in type 2 diabetic subjects.". (2004): http://europepmc.org/abstract/med/14681845.
    10.1016/j.metabol.2003.07.013
  1048. Henriksen DB; Alexandersen P; Byrjalsen I; Hartmann B; Bone HG; Christiansen C; Holst JJ. "Reduction of nocturnal rise in bone resorption by subcutaneous GLP-2.". (2004): http://europepmc.org/abstract/med/14751571.
    10.1016/j.bone.2003.09.009
  1049. Dalgaard M; Thomsen C; Rasmussen BM; Holst JJ; Hermansen K. "Ethanol with a mixed meal decreases the incretin levels early postprandially and increases postprandial lipemia in type 2 diabetic patients.". (2004): http://europepmc.org/abstract/med/14681846.
    10.1016/j.metabol.2003.08.011
  1050. Anne Flint; Bente Kramer Møller; Anne Raben; D. Pedersen; I. Tetens; Jens Juul Holst; Arne Astrup. "The ¤use of glycaemic index tables to predict glycaemic index of composite breakfast meals". British Journal of Nutrition 91 6 (2004): 979-989. https://curis.ku.dk/portal/en/publications/the-use-of-glycaemic-index-tables-to-predict-glycaemic-index-of-composite-breakfast-meals(875023d0-a1bd-11dd-b6ae-000ea68e967b).html.
  1051. H. Niinikoski; B. Stoll; X. Guam; K. Kansagra; B. Lambert; B. Hartmann; Jens Juul Holst; D.G. Burrin. "Onset of small intestinal atrophy is associated with reduced intestinal blod flow in TNP-fed neonatal piglets". Journal of Nutrition 134 (2004): 1467-1474. https://curis.ku.dk/portal/en/publications/onset-of-small-intestinal-atrophy-is-associated-with-reduced-intestinal-blod-flow-in-tnpfed-neonatal-piglets(194584c0-74c4-11db-bee9-02004c4f4f50).html.
  1052. D.L. Sigalet; G. Martin; J. Meddings; B. Hartmann; Jens Juul Holst. "GLP-2 levels in human infants with intestinal dysfunction". Pediatric Research 56 (2004): 371-376. https://curis.ku.dk/portal/en/publications/glp2-levels-in-human-infants-with-intestinal-dysfunction(176c7f00-74c4-11db-bee9-02004c4f4f50).html.
  1053. E. Degerman; V. Manganiello; Jens Juul Holst; B. Ahren. "Milrinone efficiently potentiates insulin secretion induced by orally but not intravenously administered glucose in C57BL6J mice". Eur. J. Pharmacol. 498 (2004): 319-323. https://curis.ku.dk/portal/en/publications/milrinone-efficiently-potentiates-insulin-secretion-induced-by-orally-but-not-intravenously-administered-glucose-in-c57bl6j-mice(15d404b0-74c4-11db-bee9-02004c4f4f50).html.
  1054. M. Dalgaard; C. Thomsen; B.M. Rasmussen; Jens Juul Holst; K. Hermansen. "Ethanol with a mixed meal decreases the incretin levels early postprandially and increases postprandial lipemia in type 2 diabetic patients". Metabolism 53 (2004): 77-83. https://curis.ku.dk/portal/en/publications/ethanol-with-a-mixed-meal-decreases-the-incretin-levels-early-postprandially-and-increases-postprandial-lipemia-in-type-2-diabetic-patients(2c9b5130-74c4-11db-bee9-02004c4f4f50).html.
  1055. K.M. Sanggaard; Jens Juul Holst; J.F. Rehfeld; B. Sandström; T. Tholstrup. "Different effects of whole milk and a fermented milk with the same fat and lactose content on gastric emptying and postprandial lipaemia, but not on glycaemic response and appetite". Br.J.Nutr. 92 92 (2004): 447-459. https://curis.ku.dk/portal/en/publications/different-effects-of-whole-milk-and-a-fermented-milk-with-the-same-fat-and-lactose-content-on-gastric-emptying-and-postprandial-lipaemia-but-not-on-glycaemic-response-and-appetite(17a03930-74c4-11db-bee9-02004c4f.
  1056. J.A.L. Calbet; Jens Juul Holst. "Similar gastric emptying but greater gastric secretion and GIP release after the ingestion of peptide hydrolysates in man". Eur J Nutrition 43 (2004): 127-139. https://curis.ku.dk/portal/en/publications/similar-gastric-emptying-but-greater-gastric-secretion-and-gip-release-after-the-ingestion-of-peptide-hydrolysates-in-man(2cb45770-74c4-11db-bee9-02004c4f4f50).html.
  1057. C.F. Nagell; A. Wettergren; J. Fog Pedersen; D. Mortensen; Jens Juul Holst. "Glucagon-like peptide-2 (GLP-2) inhibits gastric emptying and promotes satiety in man, but is not as potent as Glucagon-like peptide-1 (GLP-1)". Scandinavian Journal of Gastroenterology 39 (2004): 353-358. https://curis.ku.dk/portal/en/publications/glucagonlike-peptide2-glp2-inhibits-gastric-emptying-and-promotes-satiety-in-man-but-is-not-as-potent-as-glucagonlike-peptide1-glp1(2ca82270-74c4-11db-bee9-02004c4f4f50).html.
  1058. M.C.J. Paris; P.J. Fuller; R.G. Taylor; E. Nagy; M. Sourial; T. Catto-Smith; Bolette Hartmann; Jens Juul Holst; J.E. Bines. "Plasma GLP-2 levels and intestinal markers in the juvenile pig during intestinal adaptation: effects of different diet regimens". Dig. Dis. Sci. 49 (2004): 1688-1695. https://curis.ku.dk/portal/en/publications/plasma-glp2-levels-and-intestinal-markers-in-the-juvenile-pig-during-intestinal-adaptation-effects-of-different-diet-regimens(129f2a60-74c2-11db-bee9-02004c4f4f50).html.
  1059. E. Näslund; N. King; S. Mansten; N. Adner; Jens Juul Holst; M. Gutniak; P. Hellström. "Prandial subcutaneous injections of glucagons-like peptide- 1 cause weight loss in obese human subjects". Br.J.Nutr. 91 (2004): 439-446. https://curis.ku.dk/portal/en/publications/prandial-subcutaneous-injections-of-glucagonslike-peptide-1-cause-weight-loss-in-obese-human-subjects(19b1db20-74c4-11db-bee9-02004c4f4f50).html.
  1060. J.J. Meier; D. Weyhe; M. Michaely; M. Senkal; V. Zumtobel; M.A. Nauck; Jens Juul Holst; W.E. Schmidt; B. Gallwitz. "Intravenous glucagon-like peptide 1 (GLP-1) normalizes blood glucose after major surgery in patients with type 2 diabetes". Critical Care Medicine 32 (2004): 848-851. https://curis.ku.dk/portal/en/publications/intravenous-glucagonlike-peptide-1-glp1-normalizes-blood-glucose-after-major-surgery-in-patients-with-type-2-diabetes(18e5ffa0-74c4-11db-bee9-02004c4f4f50).html.
  1061. M.O. Larsen; B. Rolin; C.F. Gotfredsen; R.D. Carr; Jens Juul Holst. "Reduction of beta cell mass: partial insulin secretory compensation from the residual beta cell population in the nicotinamide-streptozotocin Göttingen minipig after oral glucose in vivo and in the perfused pancreas". Diabetologia 47 (2004): 1873-1878. https://curis.ku.dk/portal/en/publications/reduction-of-beta-cell-mass-partial-insulin-secretory-compensation-from-the-residual-beta-cell-population-in-the-nicotinamidestreptozotocin-goettingen-minipig-after-oral-glucose-in-vivo-and-in-the-pe(12644440-74c.
  1062. A.L. Bartholome; D.M. Albin; D.H. Baker; Jens Juul Holst; K.A. Tappenden. "Supplementation of total parenteral nutrition with butyrate acutely increases structural aspects of intestinal adaptation following and 80% jejunoileal resection in neonatal pigs". J Parenter Enteral Nutr 28 (2004): 210-223. https://curis.ku.dk/portal/en/publications/supplementation-of-total-parenteral-nutrition-with-butyrate-acutely-increases-structural-aspects-of-intestinal-adaptation-following-and-80-jejunoileal-resection-in-neonatal-pigs(15a41b10-74c4-11db-bee9-02004c4f4f.
  1063. Jens Juul Holst. "Enhancing insulin secretion: novel approaches to glucose control". Diabetes Voice 49 (2004): 20-22. https://curis.ku.dk/portal/en/publications/enhancing-insulin-secretion-novel-approaches-to-glucose-control(159c8be0-74c2-11db-bee9-02004c4f4f50).html.
  1064. P.T. Schmidt; L. Hansen; L. Hilsted; Jens Juul Holst. "Cholecystokinin inhibits gastrin secretion independent of paracrine somatostatin secretion in the pig". Scandinavian Journal of Gastroenterology 39 (2004): 217-221. https://curis.ku.dk/portal/en/publications/cholecystokinin-inhibits-gastrin-secretion-independent-of-paracrine-somatostatin-secretion-in-the-pig(19341fa0-74c4-11db-bee9-02004c4f4f50).html.
  1065. L. Hansen; B. Hartmann; H. Mineo; Jens Juul Holst. "Glucagon-like peptide- 1 secretion is influenced by perfusate glucose concentration and a feedback mechanism involving somatostatin in isolated perfused porcine ileum". Regul. Pept. 118 (2004): 11-18. https://curis.ku.dk/portal/en/publications/glucagonlike-peptide-1-secretion-is-influenced-by-perfusate-glucose-concentration-and-a-feedback-mechanism-involving-somatostatin-in-isolated-perfused-porcine-ileum(4a22d390-74c4-11db-bee9-02004c4f4f50).html.
  1066. Bartholome AL; Albin DM; Baker DH; Holst JJ; Tappenden KA. "Supplementation of total parenteral nutrition with butyrate acutely increases structural aspects of intestinal adaptation after an 80% jejunoileal resection in neonatal piglets.". (2004): http://europepmc.org/abstract/med/15291402.
    10.1177/0148607104028004210
  1067. Carstensen M; Thomsen C; Gotzsche O; Holst JJ; Schrezenmeir J; Hermansen K. "Differential postprandial lipoprotein responses in type 2 diabetic men with and without clinical evidence of a former myocardial infarction.". (2004): http://europepmc.org/abstract/med/17491702.
    10.1900/RDS.2004.1.175
  1068. Holst JJ. "On the physiology of GIP and GLP-1.". (2004): http://europepmc.org/abstract/med/15655703.
    10.1055/s-2004-826158
  1069. Dennis B Henriksen; Peter Alexandersen; Nina H Bjarnason; Tina Vilsbøll; Bolette Hartmann; Eva E G Henriksen; Inger Byrjalsen; et al. "Role of gastrointestinal hormones in postprandial reduction of bone resorption". J Bone Miner Res 18 12 (2003): 2180-2190. https://curis.ku.dk/portal/en/publications/role-of-gastrointestinal-hormones-in-postprandial-reduction-of-bone-resorption(a30d9530-74c4-11db-bee9-02004c4f4f50).html.
    http://dx.doi.org/10.1359/jbmr.2003.18.12.2180
  1070. Henriksen DB; Alexandersen P; Bjarnason NH; Vilsbøll T; Hartmann B; Henriksen EE; Byrjalsen I; et al. "Role of gastrointestinal hormones in postprandial reduction of bone resorption.". (2003): http://europepmc.org/abstract/med/14672353.
    10.1359/jbmr.2003.18.12.2180
  1071. Meier JJ; Nauck MA; Siepmann N; Greulich M; Holst JJ; Deacon CF; Schmidt WE; Gallwitz B. "Similar insulin secretory response to a gastric inhibitory polypeptide bolus injection at euglycemia in first-degree relatives of patients with type 2 diabetes and control subjects.". (2003): http://europepmc.org/abstract/med/14669159.
    10.1016/S0026-0495(03)00327-5
  1072. Jackson RS; Creemers JW; Farooqi IS; Raffin-Sanson ML; Varro A; Dockray GJ; Holst JJ; et al. "Small-intestinal dysfunction accompanies the complex endocrinopathy of human proprotein convertase 1 deficiency.". (2003): http://europepmc.org/abstract/med/14617756.
    10.1172/JCI18784
  1073. Schmidt PT; Näslund E; Grybäck P; Jacobsson H; Hartmann B; Holst JJ; Hellström PM. "Peripheral administration of GLP-2 to humans has no effect on gastric emptying or satiety.". (2003): http://europepmc.org/abstract/med/14599711.
    10.1016/S0167-0115(03)00175-7
  1074. Juntunen KS; Laaksonen DE; Autio K; Niskanen LK; Holst JJ; Savolainen KE; Liukkonen KH; Poutanen KS; Mykkänen HM. "Structural differences between rye and wheat breads but not total fiber content may explain the lower postprandial insulin response to rye bread.". (2003): http://europepmc.org/abstract/med/14594782.
  1075. Vilsbøll T; Knop FK; Krarup T; Johansen A; Madsbad S; Larsen S; Hansen T; Pedersen O; Holst JJ. "The pathophysiology of diabetes involves a defective amplification of the late-phase insulin response to glucose by glucose-dependent insulinotropic polypeptide-regardless of etiology and phenotype.". (2003): http://europepmc.org/abstract/med/14557471.
    10.1210/jc.2003-030738
  1076. Zimmermann-Belsing T; Brabant G; Holst JJ; Feldt-Rasmussen U. "Circulating leptin and thyroid dysfunction.". (2003): http://europepmc.org/abstract/med/14514340.
    10.1530/eje.0.1490257
  1077. Ahrén B; Holst JJ; Mari A. "Characterization of GLP-1 effects on beta-cell function after meal ingestion in humans.". (2003): http://europepmc.org/abstract/med/14514592.
    10.2337/diacare.26.10.2860
  1078. Staehr P; Hojlund K; Hother-Nielsen O; Holst JJ; Beck-Nielsen H. "Does overnight normalization of plasma glucose by insulin infusion affect assessment of glucose metabolism in Type 2 diabetes?". (2003): http://europepmc.org/abstract/med/14510862.
    10.1046/j.1464-5491.2003.01004.x
  1079. Bakhøj S; Flint A; Holst JJ; Tetens I. "Lower glucose-dependent insulinotropic polypeptide (GIP) response but similar glucagon-like peptide 1 (GLP-1), glycaemic, and insulinaemic response to ancient wheat compared to modern wheat depends on processing.". (2003): http://europepmc.org/abstract/med/14506486.
    10.1038/sj.ejcn.1601680
  1080. Knop FK; Vilsbøll T; Larsen S; Madsbad S; Holst JJ; Krarup T. "No hypoglycemia after subcutaneous administration of glucagon-like peptide-1 in lean type 2 diabetic patients and in patients with diabetes secondary to chronic pancreatitis.". (2003): http://europepmc.org/abstract/med/12941722.
    10.2337/diacare.26.9.2581
  1081. Deacon CF; Kelstrup M; Trebbien R; Klarskov L; Olesen M; Holst JJ. "Differential regional metabolism of glucagon in anesthetized pigs.". (2003): http://europepmc.org/abstract/med/12759222.
    10.1152/ajpendo.00125.2003
  1082. Møller LN; Stidsen CE; Hartmann B; Holst JJ. "Somatostatin receptors.". (2003): http://europepmc.org/abstract/med/14507421.
    10.1016/S0005-2736(03)00235-9
  1083. Schmidt PT; Orskov C; Rasmussen TN; Holst JJ. "Nitric oxide has tonic inhibitory effect, but is not involved in the vagal control or VIP effects on motility of the porcine antrum.". (2003): http://europepmc.org/abstract/med/14531532.
    10.1080/00365520310004452
  1084. Meier S; Hücking K; Ritzel R; Holst JJ; Schmiegel WH; Nauck MA. "Absence of a memory effect for the insulinotropic action of glucagon-like peptide 1 (GLP-1) in healthy volunteers.". (2003): http://europepmc.org/abstract/med/14517773.
    10.1055/s-2003-42658
  1085. Vilsbøll T; Krarup T; Madsbad S; Holst JJ. "Both GLP-1 and GIP are insulinotropic at basal and postprandial glucose levels and contribute nearly equally to the incretin effect of a meal in healthy subjects.". (2003): http://europepmc.org/abstract/med/12832099.
    10.1016/S0167-0115(03)00111-3
  1086. Mortensen K; Christensen LL; Holst JJ; Orskov C. "GLP-1 and GIP are colocalized in a subset of endocrine cells in the small intestine.". (2003): http://europepmc.org/abstract/med/12832109.
    10.1016/S0167-0115(03)00125-3
  1087. Guan X; Stoll B; Lu X; Tappenden KA; Holst JJ; Hartmann B; Burrin DG. "GLP-2-mediated up-regulation of intestinal blood flow and glucose uptake is nitric oxide-dependent in TPN-fed piglets 1.". (2003): http://europepmc.org/abstract/med/12851879.
    10.1016/S0016-5085(03)00667-X
  1088. Meier JJ; Gallwitz B; Siepmann N; Holst JJ; Deacon CF; Schmidt WE; Nauck MA. "Gastric inhibitory polypeptide (GIP) dose-dependently stimulates glucagon secretion in healthy human subjects at euglycaemia.". (2003): http://europepmc.org/abstract/med/12764578.
    10.1007/s00125-003-1103-y
  1089. Vilsbøll T; Krarup T; Sonne J; Madsbad S; Vølund A; Juul AG; Holst JJ. "Incretin secretion in relation to meal size and body weight in healthy subjects and people with type 1 and type 2 diabetes mellitus.". (2003): http://europepmc.org/abstract/med/12788877.
    10.1210/jc.2002-021873
  1090. Petersen YM; Hartmann B; Holst JJ; Le Huerou-Luron I; Bjørnvad CR; Sangild PT. "Introduction of enteral food increases plasma GLP-2 and decreases GLP-2 receptor mRNA abundance during pig development.". (2003): http://europepmc.org/abstract/med/12771317.
  1091. Jensen CB; Storgaard H; Holst JJ; Dela F; Madsbad S; Vaag AA. "Insulin secretion and cellular glucose metabolism after prolonged low-grade intralipid infusion in young men.". (2003): http://europepmc.org/abstract/med/12788887.
    10.1210/jc.2002-021430
  1092. Meier JJ; Gallwitz B; Salmen S; Goetze O; Holst JJ; Schmidt WE; Nauck MA. "Normalization of glucose concentrations and deceleration of gastric emptying after solid meals during intravenous glucagon-like peptide 1 in patients with type 2 diabetes.". (2003): http://europepmc.org/abstract/med/12788879.
    10.1210/jc.2003-030049
  1093. Meier JJ; Gallwitz B; Siepmann N; Holst JJ; Deacon CF; Schmidt WE; Nauck MA. "The reduction in hepatic insulin clearance after oral glucose is not mediated by gastric inhibitory polypeptide (GIP).". (2003): http://europepmc.org/abstract/med/12686467.
    10.1016/S0167-0115(02)00297-5
  1094. Dahly EM; Gillingham MB; Guo Z; Murali SG; Nelson DW; Holst JJ; Ney DM. "Role of luminal nutrients and endogenous GLP-2 in intestinal adaptation to mid-small bowel resection.". (2003): http://europepmc.org/abstract/med/12505881.
    10.1152/ajpgi.00293.2002
  1095. Piche T; des Varannes SB; Sacher-Huvelin S; Holst JJ; Cuber JC; Galmiche JP. "Colonic fermentation influences lower esophageal sphincter function in gastroesophageal reflux disease.". (2003): http://europepmc.org/abstract/med/12671885.
    10.1053/gast.2003.50159
  1096. Sørensen LB; Flint A; Raben A; Hartmann B; Holst JJ; Astrup A. "No effect of physiological concentrations of glucagon-like peptide-2 on appetite and energy intake in normal weight subjects.". (2003): http://europepmc.org/abstract/med/12664078.
    10.1038/sj.ijo.0802247
  1097. Thomsen C; Storm H; Holst JJ; Hermansen K. "Differential effects of saturated and monounsaturated fats on postprandial lipemia and glucagon-like peptide 1 responses in patients with type 2 diabetes.". (2003): http://europepmc.org/abstract/med/12600850.
  1098. Larsen PJ; Seier V; Fink-Jensen A; Holst JJ; Warberg J; Vrang N. "Cocaine- and amphetamine-regulated transcript is present in hypothalamic neuroendocrine neurones and is released to the hypothalamic-pituitary portal circuit.". (2003): http://europepmc.org/abstract/med/12588509.
    10.1046/j.1365-2826.2003.00960.x
  1099. Gelling RW; Du XQ; Dichmann DS; Romer J; Huang H; Cui L; Obici S; et al. "Lower blood glucose, hyperglucagonemia, and pancreatic alpha cell hyperplasia in glucagon receptor knockout mice.". (2003): http://europepmc.org/abstract/med/12552113.
    10.1073/pnas.0237106100
  1100. Staehr P; Hother-Nielsen O; Landau BR; Chandramouli V; Holst JJ; Beck-Nielsen H. "Effects of free fatty acids per se on glucose production, gluconeogenesis, and glycogenolysis.". (2003): http://europepmc.org/abstract/med/12540595.
    10.2337/diabetes.52.2.260
  1101. Kjems LL; Holst JJ; Vølund A; Madsbad S. "The influence of GLP-1 on glucose-stimulated insulin secretion: effects on beta-cell sensitivity in type 2 and nondiabetic subjects.". (2003): http://europepmc.org/abstract/med/12540611.
    10.2337/diabetes.52.2.380
  1102. Mersebach H; Svendsen OL; Holst JJ; Astrup A; Feldt-Rasmussen U. "Comparisons of leptin, incretins and body composition in obese and lean patients with hypopituitarism and healthy individuals.". (2003): http://europepmc.org/abstract/med/12519414.
    10.1046/j.1365-2265.2003.01675.x
  1103. Vilsbøll T; Agersø H; Krarup T; Holst JJ. "Similar elimination rates of glucagon-like peptide-1 in obese type 2 diabetic patients and healthy subjects.". (2003): http://europepmc.org/abstract/med/12519856.
    10.1210/jc.2002-021053
  1104. Raben A; Agerholm-Larsen L; Flint A; Holst JJ; Astrup A. "Meals with similar energy densities but rich in protein, fat, carbohydrate, or alcohol have different effects on energy expenditure and substrate metabolism but not on appetite and energy intake.". (2003): http://europepmc.org/abstract/med/12499328.
  1105. Lone Brinkmann Sørensen; A. Flint; A. B. Raben; B. Hartmann; Jens Juul Holst; Arne Astrup. "No effect of physiological concentrations of glucagon-like peptide-2 on appetite and energy intake in normal weight subjects". International Journal of Obesity 27 4 (2003): 450-456. https://curis.ku.dk/portal/en/publications/no-effect-of-physiological-concentrations-of-glucagonlike-peptide2-on-appetite-and-energy-intake-in-normal-weight-subjects(65cfbe60-a1bc-11dd-b6ae-000ea68e967b).html.
  1106. Y. M. Petersen; B. Hartmann; Jens Juul Holst; I. Le Huërou-Luron; C. R. Bjørnvad; P. T. Sangild. "Introduction of enteral food increases plasma GLP-2 and decreases GLP-2 receptor mRNA abundance during pig development". Journal of Nutrition 133 6 (2003): 1781-1786. https://curis.ku.dk/portal/en/publications/introduction-of-enteral-food-increases-plasma-glp2-and-decreases-glp2-receptor-mrna-abundance-during-pig-development(128fd590-a1bd-11dd-b6ae-000ea68e967b).html.
  1107. A. B. Raben; L. Agerholm-Larsen; Anne Flint; Jens Juul Holst; Arne Astrup. "Meals with similar energy densities but rich in protein, fat, carbohydrate, or alcohol have different effects on energy expenditure and substrate metabolism but not on appetite and energy intake". American Journal of Clinical Nutrition 77 1 (2003): 91-100. https://curis.ku.dk/portal/en/publications/meals-with-similar-energy-densities-but-rich-in-protein-fat-carbohydrate-or-alcohol-have-different-effects-on-energy-expenditure-and-substrate-metabolism-but-not-on-appetite-and-energy-intake(59b09050-a1bc-11dd-b.
  1108. L.L. Kjems; Jens Juul Holst; A.A. Vølund; S. Madsbad. "The influence of GLP-1 on glucose-induced insulin secretion: effect on ß-cells sensitivity in type 2 and non-diabetic subjects". Diabetes 52 (2003): 380-386. https://curis.ku.dk/portal/en/publications/the-influence-of-glp1-on-glucoseinduced-insulin-secretion-effect-on-sscells-sensitivity-in-type-2-and-nondiabetic-subjects(c7772d50-74c4-11db-bee9-02004c4f4f50).html.
  1109. X. Guan; B. Stoll; X. Lu; K. Tappenden; Jens Juul Holst; Bolette Hartmann; D.G. Burrin. "GLP-2 mediated up-regulation of intestinal blood flow and glucose uptake is nitric oxide-dependent in TNP-fed piglets". Today in Medicine. Gastroenterology 125 (2003): 136-147. https://curis.ku.dk/portal/en/publications/glp2-mediated-upregulation-of-intestinal-blood-flow-and-glucose-uptake-is-nitric-oxidedependent-in-tnpfed-piglets(a0c41a60-74c4-11db-bee9-02004c4f4f50).html.
  1110. J.J. Meier; N. Gallwitz; N. Siepmann; Jens Juul Holst; C.F. Deacon; W.E. Schmidt; M.A. Nauck. "Gastric inhibitory polypeptide (GIP) dose-dependently stimulates glucagon secretion in healthy human subjects at euglycaemia". Diabetologia 46 (2003): 798-801. https://curis.ku.dk/portal/en/publications/gastric-inhibitory-polypeptide-gip-dosedependently-stimulates-glucagon-secretion-in-healthy-human-subjects-at-euglycaemia(d0eee210-74c4-11db-bee9-02004c4f4f50).html.
  1111. P. Staehr; K. Højlund; O. Hother-Nielsen; Jens Juul Holst; H. Beck-Nielsen. "Does overnight normalization of plasma glucose by insulin infusion affect assessment of glucose metabolism in type 2 diabetes". Diabetic Medicine 20 (2003): 816-822. https://curis.ku.dk/portal/en/publications/does-overnight-normalization-of-plasma-glucose-by-insulin-infusion-affect-assessment-of-glucose-metabolism-in-type-2-diabetes(c747dff0-74c4-11db-bee9-02004c4f4f50).html.
  1112. R.W. Gelling; X.Q. Du; D.S. Dichmann; J. Rømer; H. Huan; L. Cui; B.L. Tang; et al. "Lower blood glucose, hyperglucagonemia and pancreatic alpha cell hyperplasia in glucagon receptor knockout mice". Proc Natl Sci 100 (2003): 1438-1443. https://curis.ku.dk/portal/en/publications/lower-blood-glucose-hyperglucagonemia-and-pancreatic-alpha-cell-hyperplasia-in-glucagon-receptor-knockout-mice(a19db180-74c4-11db-bee9-02004c4f4f50).html.
  1113. T. Vilsbøll; T. Krarup; J. Sonne; S. Madsbad; A. Vølund; A.G. Juul; Jens Juul Holst. "Incretin secretion in relation to meal size and body weight in healthy subjects and in people with type 1 and type 2 diabetes mellitus". J. Clin. Endocrinol. Metab. 88 (2003): 2706-2713. https://curis.ku.dk/portal/en/publications/incretin-secretion-in-relation-to-meal-size-and-body-weight-in-healthy-subjects-and-in-people-with-type-1-and-type-2-diabetes-mellitus(a01b0920-74c4-11db-bee9-02004c4f4f50).html.
  1114. C. Thomsen; H. Storm; Jens Juul Holst; K. Hermansen. "Differential effects of saturated and monounsaturated fat on postprandial lipemia and incretin responses in type 2 diabetic subjects". Am. J. Clin. Nutr. 77 (2003): 605-611. https://curis.ku.dk/portal/en/publications/differential-effects-of-saturated-and-monounsaturated-fat-on-postprandial-lipemia-and-incretin-responses-in-type-2-diabetic-subjects(c6f07120-74c4-11db-bee9-02004c4f4f50).html.
  1115. P.J. Larsen; V. Seier; A. Fink-Jensen; Jens Juul Holst; Jørgen Warberg; N. Vrang. "Cocaine and amphetamine-regulated transcript (CART) is present in hypothalamic neuroendocrine neurons and is related to the hypothalamo-pituitary portal circuit". Journal of Neuroendocrinology 15 (2003): 219-226. https://curis.ku.dk/portal/en/publications/cocaine-and-amphetamineregulated-transcript-cart-is-present-in-hypothalamic-neuroendocrine-neurons-and-is-related-to-the-hypothalamopituitary-portal-circuit(eb849bb0-74c4-11db-bee9-02004c4f4f50).html.
  1116. S. Meier; K. Hücking; R. Ritzelt; Jens Juul Holst; W.H. Schmiegel; M.A. Nauck. "Absence of a memory effect for the insulinotropic action of glucagon-like peptide 1(GLP-1) in healthy volunteers". Horm Metab Res 35 (2003): 551-556. https://curis.ku.dk/portal/en/publications/absence-of-a-memory-effect-for-the-insulinotropic-action-of-glucagonlike-peptide-1glp1-in-healthy-volunteers(c76aaa30-74c4-11db-bee9-02004c4f4f50).html.
  1117. Jens Juul Holst. "Will GLP-1 treatment increase blood pressure? Summary and comment". Diabetes Monitor 15 (2003): 15-17. https://curis.ku.dk/portal/en/publications/will-glp1-treatment-increase-blood-pressure-summary-and-comment(9f9e5f10-74c4-11db-bee9-02004c4f4f50).html.
  1118. F. Knop; T. Vilsbøll; S. Larsen; Jens Juul Holst; T. Krarup. "No reactive hypoglycaemia after subcutaneous administrations of GLP-1 in lean type 2 diabetic patients and in patients with diabeties secondary to chronic pancreatitis". Diabetes Care 26 (2003): 2581-2587. https://curis.ku.dk/portal/en/publications/no-reactive-hypoglycaemia-after-subcutaneous-administrations-of-glp1-in-lean-type-2-diabetic-patients-and-in-patients-with-diabeties-secondary-to-chronic-pancreatitis(9f73a590-74c4-11db-bee9-02004c4f4f50).html.
  1119. J.M. Meier; O. Goetze; J. Anstipp; D. Hagemann; Jens Juul Holst; W.E. Schmidt; B. Gallwitz; M.A. Nauck. "Gastric inhibitory polypeptide (GIP) does not inhibit gastric emptying in man". Am. J. Physiol. 16 (2003): E621-E625. https://curis.ku.dk/portal/en/publications/gastric-inhibitory-polypeptide-gip-does-not-inhibit-gastric-emptying-in-man(17509290-74c4-11db-bee9-02004c4f4f50).html.
  1120. T. Vilsbøll; F. Knop; T. Krarup; A. Johansen; S. Madsbad; S. Larsen; T. Hansen; O. Pedersen; Jens Juul Holst. "The pathogenesis of diabetes involves a defective amplication of the late phase insulin response to glucose by GIP - regardless of aetiology and phenotype". J. Clin. Endocrinol. Metab. 88 (2003): 4897-4903. https://curis.ku.dk/portal/en/publications/the-pathogenesis-of-diabetes-involves-a-defective-amplication-of-the-late-phase-insulin-response-to-glucose-by-gip--regardless-of-aetiology-and-phenotype(a0e7f610-74c4-11db-bee9-02004c4f4f50).html.
  1121. J.J. Meier; B. Gallwitz; S. Salmen; O. Goetze; Jens Juul Holst; W.E. Schmidt. "Normalisation of glucose concentrations and deceleration of gastric emptying of solid meals during intravenous glucagon-like peptide-1 (GLP-1) in patients with type 2 diabetes". J. Clin. Endocrinol. Metab. 88 (2003): 2719-2725. https://curis.ku.dk/portal/en/publications/normalisation-of-glucose-concentrations-and-deceleration-of-gastric-emptying-of-solid-meals-during-intravenous-glucagonlike-peptide1-glp1-in-patients-with-type-2-diabetes(a03fa820-74c4-11db-bee9-02004c4f4f50).htm.
  1122. P.T. Schmidt; C. Ørskov; T.N. Rasmussen; Jens Juul Holst. "NO has tonic inhibitory, but is not involved in the vagal control or VIP effects on motility of the porcine antrum". Scandinavian Journal of Gastroenterology 38 (2003): 955-961. https://curis.ku.dk/portal/en/publications/no-has-tonic-inhibitory-but-is-not-involved-in-the-vagal-control-or-vip-effects-on-motility-of-the-porcine-antrum(c75e4e20-74c4-11db-bee9-02004c4f4f50).html.
  1123. K.S. Juntunen; D.E. Laaksonen; K. Aitio; L.K. Niskanen; Jens Juul Holst; K.E. Savolainen; K.H. Liukkonen; K.S. Poutanen; H.M. Mykkänen. "Structural differences between rye and wheat bread but not total fiber content may explain the lower postprandial insulin response to rye bread". AM. J. Clin. Nutr. 78 (2003): 957-964. https://curis.ku.dk/portal/en/publications/structural-differences-between-rye-and-wheat-bread-but-not-total-fiber-content-may-explain-the-lower-postprandial-insulin-response-to-rye-bread(17c6fb10-74c4-11db-bee9-02004c4f4f50).html.
  1124. H. Mersebach; Ole Lander Svendsen; Jens Juul Holst; Arne Astrup; Ulla Feldt-Rasmussen. "Comparisons of leptin, incretins and body composition in obese and lean patients with hypopituitarism and healthy individuals". Clinical Endocrinology 58 1 (2003): 65-71. https://curis.ku.dk/portal/en/publications/comparisons-of-leptin-incretins-and-body-composition-in-obese-and-lean-patients-with-hypopituitarism-and-healthy-individuals(5af25f20-a1bc-11dd-b6ae-000ea68e967b).html.
  1125. Nielsen TB; Yderstraede KB; Schrøder HD; Holst JJ; Brusgaard K; Beck-Nielsen H. "Functional and immunohistochemical evaluation of porcine neonatal islet-like cell clusters.". (2003): http://europepmc.org/abstract/med/12693660.
    10.3727/000000003783985142
  1126. Plamboeck A; Holst JJ; Carr RD; Deacon CF. "Neutral endopeptidase 24.11 and dipeptidyl peptidase IV are both involved in regulating the metabolic stability of glucagon-like peptide-1 in vivo.". (2003): http://europepmc.org/abstract/med/12675252.
  1127. Holst JJ. "Implementation of GLP-1 based therapy of type 2 diabetes mellitus using DPP-IV inhibitors.". (2003): http://europepmc.org/abstract/med/12675249.
  1128. Cejvan K; Coy DH; Holst JJ; Cerasi E; Efendic S. "Gliclazide directly inhibits arginine-induced glucagon release.". (2002): http://europepmc.org/abstract/med/12475779.
    10.2337/diabetes.51.2007.S381
  1129. Hansen L; Holst JJ. "The effects of duodenal peptides on glucagon-like peptide-1 secretion from the ileum. A duodeno--ileal loop?". (2002): http://europepmc.org/abstract/med/12468108.
    10.1016/S0167-0115(02)00157-X
  1130. Krogsgaard Thomsen M; Bokvist K; Høy M; Buschard K; Holst JJ; Lindström P; Gromada J. "Repaglinide at a cellular level.". (2002): http://europepmc.org/abstract/med/12702003.
  1131. Gregersen G; Holst JJ; Trankjaer A; Stadil F; Mogensen AM. "Case report: somatostatin producing teratoma, causing rapidly alternating extreme hyperglycemia and hypoglycemia, and ovarian somatostatinoma.". (2002): http://europepmc.org/abstract/med/12200764.
    10.1053/meta.2002.34710
  1132. Ahrén B; Adner N; Svartberg J; Petrella E; Holst JJ; Gutniak MK. "Anti-diabetogenic effect of the human amylin analogue, pramlintide, in Type 1 diabetes is not mediated by GLP-1.". (2002): http://europepmc.org/abstract/med/12207819.
    10.1046/j.1464-5491.2002.00657_1.x
  1133. Vilsbøll T; Krarup T; Madsbad S; Holst JJ. "Defective amplification of the late phase insulin response to glucose by GIP in obese Type II diabetic patients.". (2002): http://europepmc.org/abstract/med/12189441.
    10.1007/s00125-002-0878-6
  1134. Zhu X; Zhou A; Dey A; Norrbom C; Carroll R; Zhang C; Laurent V; et al. "Disruption of PC1/3 expression in mice causes dwarfism and multiple neuroendocrine peptide processing defects.". (2002): http://europepmc.org/abstract/med/12145326.
    10.1073/pnas.162352599
  1135. Miyawaki K; Yamada Y; Ban N; Ihara Y; Tsukiyama K; Zhou H; Fujimoto S; et al. "Inhibition of gastric inhibitory polypeptide signaling prevents obesity.". (2002): http://europepmc.org/abstract/med/12068290.
    10.1038/nm727
  1136. Bozkurt A; Näslund E; Holst JJ; Hellström PM. "GLP-1 and GLP-2 act in concert to inhibit fasted, but not fed, small bowel motility in the rat.". (2002): http://europepmc.org/abstract/med/12137975.
    10.1016/S0167-0115(02)00095-2
  1137. Djurhuus CB; Hansen TK; Gravholt C; Ørskov L; Hosoda H; Kangawa K; Jørgensen JO; Holst JJ; Schmitz O. "Circulating levels of ghrelin and GLP-1 are inversely related during glucose ingestion.". (2002): http://europepmc.org/abstract/med/12189591.
    10.1055/s-2002-33475
  1138. Djurhuus CB; Hansen TK; Holst JJ; Schmitz O. "Feast or famine - are GLP-1 and ghrelin secretion intertwined?". (2002): http://europepmc.org/abstract/med/12189580.
    10.1055/s-2002-33477
  1139. Deacon CF; Holst JJ. "Dipeptidyl peptidase IV inhibition as an approach to the treatment and prevention of type 2 diabetes: a historical perspective.". (2002): http://europepmc.org/abstract/med/12054731.
    10.1016/S0006-291X(02)00359-5
  1140. Hannibal J; Fahrenkrug J; Holst JJ. "[A newly discovered photopigment in the retina, melanopsin, directs the biological clocks of the brain].". (2002): http://europepmc.org/abstract/med/12025714.
  1141. Reimer MK; Holst JJ; Ahrén B. "Long-term inhibition of dipeptidyl peptidase IV improves glucose tolerance and preserves islet function in mice.". (2002): http://europepmc.org/abstract/med/11980629.
    10.1530/eje.0.1460717
  1142. Hartmann B; Thulesen J; Hare KJ; Kissow H; Orskov C; Poulsen SS; Holst JJ. "Immunoneutralization of endogenous glucagon-like peptide-2 reduces adaptive intestinal growth in diabetic rats.". (2002): http://europepmc.org/abstract/med/11959371.
    10.1016/S0167-0115(02)00013-7
  1143. Jensen CB; Storgaard H; Dela F; Holst JJ; Madsbad S; Vaag AA. "Early differential defects of insulin secretion and action in 19-year-old caucasian men who had low birth weight.". (2002): http://europepmc.org/abstract/med/11916955.
    10.2337/diabetes.51.4.1271
  1144. Deacon CF; Plamboeck A; Møller S; Holst JJ. "GLP-1-(9-36) amide reduces blood glucose in anesthetized pigs by a mechanism that does not involve insulin secretion.". (2002): http://europepmc.org/abstract/med/11882507.
    10.1152/ajpendo.00452.2001
  1145. Haderslev KV; Jeppesen PB; Hartmann B; Thulesen J; Sorensen HA; Graff J; Hansen BS; et al. "Short-term administration of glucagon-like peptide-2. Effects on bone mineral density and markers of bone turnover in short-bowel patients with no colon.". (2002): http://europepmc.org/abstract/med/11989828.
    10.1080/003655202317316006
  1146. Holst JJ; Binderup M. "[Fatty tissue and insulin resistance: resistin and adiponectin].". (2002): http://europepmc.org/abstract/med/11989064.
  1147. Hillingsø JG; Kjeldsen J; Schmidt PT; Rasmussen TN; Fisher-Hansen B; Holst JJ; Lauristen K; Bukhave K; Rask-Madsen J. "Effects of topical ropivacaine on eicosanoids and neurotransmitters in the rectum of patients with distal ulcerative colitis.". (2002): http://europepmc.org/abstract/med/11916195.
    10.1080/003655202317284237
  1148. Nauck MA; Heimesaat MM; Behle K; Holst JJ; Nauck MS; Ritzel R; Hüfner M; Schmiegel WH. "Effects of glucagon-like peptide 1 on counterregulatory hormone responses, cognitive functions, and insulin secretion during hyperinsulinemic, stepped hypoglycemic clamp experiments in healthy volunteers.". (2002): http://europepmc.org/abstract/med/11889194.
    10.1210/jcem.87.3.8355
  1149. Zander M; Madsbad S; Madsen JL; Holst JJ. "Effect of 6-week course of glucagon-like peptide 1 on glycaemic control, insulin sensitivity, and beta-cell function in type 2 diabetes: a parallel-group study.". (2002): http://europepmc.org/abstract/med/11897280.
    10.1016/S0140-6736(02)07952-7
  1150. Johansson A; Olsson T; Cederquist K; Forsberg H; Holst JJ; Seckl JR; Ahren B. "Abnormal release of incretins and cortisol after oral glucose in subjects with insulin-resistant myotonic dystrophy.". (2002): http://europepmc.org/abstract/med/11888847.
    10.1530/eje.0.1460397
  1151. Deacon CF; Wamberg S; Bie P; Hughes TE; Holst JJ. "Preservation of active incretin hormones by inhibition of dipeptidyl peptidase IV suppresses meal-induced incretin secretion in dogs.". (2002): http://europepmc.org/abstract/med/11834453.
    10.1677/joe.0.1720355
  1152. Juntunen KS; Niskanen LK; Liukkonen KH; Poutanen KS; Holst JJ; Mykkänen HM. "Postprandial glucose, insulin, and incretin responses to grain products in healthy subjects.". (2002): http://europepmc.org/abstract/med/11815315.
  1153. Thulesen J; Knudsen LB; Hartmann B; Hastrup S; Kissow H; Jeppesen PB; Ørskov C; Holst JJ; Poulsen SS. "The truncated metabolite GLP-2 (3-33) interacts with the GLP-2 receptor as a partial agonist.". (2002): http://europepmc.org/abstract/med/11738243.
    10.1016/S0167-0115(01)00316-0
  1154. J.G. Hillingsøe; J. Kjeldsen; P.T. Schmidt; T.N. Rasmussen; E. Arlander; B. Fischer-Hansen; Jens Juul Holst; et al. "Preservation of active Effects of topical ropivacaine om eicosanoids and neurotransmitters in the rectum of patients with distal ulcerative colitis". Scandinavian Journal of Gastroenterology 37 (2002): 325-329. https://curis.ku.dk/portal/en/publications/preservation-of-active-effects-of-topical-ropivacaine-om-eicosanoids-and-neurotransmitters-in-the-rectum-of-patients-with-distal-ulcerative-colitis(2f43fba0-74c7-11db-bee9-02004c4f4f50).html.
  1155. K.S. Juntunen; H.K. Lioukkonen; S.K. Poutanen; K.L. Niskanen; Jens Juul Holst; M.H. Mykkänen. "Postprandial glucose, insulin and incretin responses to grain products in healthy subjects". Am. J. Clin. Nutr. 75 (2002): 254-262. https://curis.ku.dk/portal/en/publications/postprandial-glucose-insulin-and-incretin-responses-to-grain-products-in-healthy-subjects(2f80b680-74c7-11db-bee9-02004c4f4f50).html.
  1156. M.A. Nauck; M.M. Heimesaat; K. Behle; Jens Juul Holst; M.S. Nauck; M. Hüfner; W.H. Schmiegel. "Effects of glucagon-like peptide-1 (GLP-1) on counterregulatory hormone responses, cognitive functions and insulin secretion during hyperinsulinaemic, stepped hypoglycaemic clamp experiments in healthy volunteers". J. Clin. Endocrinol. Metab. 87 (2002): 1239-1246. https://curis.ku.dk/portal/en/publications/effects-of-glucagonlike-peptide1-glp1-on-counterregulatory-hormone-responses-cognitive-functions-and-insulin-secretion-during-hyperinsulinaemic-stepped-hypoglycaemic-clamp-experiments-in-healthy-volu(2f9c7be0-74c.
  1157. K.V. Haderslev; P.B. Jeppesen; B. Hartmann; Jesper Thulesen; H.A. Sørensen; J. Graff; B.S. Hansen; et al. "Short-term administration of Glucagon-like peptide-2. Effects on bone mass density and markers of bone remodelling in short bowel patients with no colon". Scandinavian Journal of Gastroenterology vol. 37 (2002): 392-398. https://curis.ku.dk/portal/en/publications/shortterm-administration-of-glucagonlike-peptide2-effects-on-bone-mass-density-and-markers-of-bone-remodelling-in-short-bowel-patients-with-no-colon(4c51a500-74c5-11db-bee9-02004c4f4f50).html.
  1158. Holst JJ. "Therapy of type 2 diabetes mellitus based on the actions of glucagon-like peptide-1.". (2002): http://europepmc.org/abstract/med/12469357.
    10.1002/dmrr.328
  1159. Holst JJ. "Gastric inhibitory polypeptide analogues: do they have a therapeutic role in diabetes mellitus similar to that of glucagon-like Peptide-1?". (2002): http://europepmc.org/abstract/med/12102645.
    10.2165/00063030-200216030-00002
  1160. Meier JJ; Hücking K; Holst JJ; Deacon CF; Schmiegel WH; Nauck MA. "Reduced insulinotropic effect of gastric inhibitory polypeptide in first-degree relatives of patients with type 2 diabetes.". (2001): http://europepmc.org/abstract/med/11679427.
    10.2337/diabetes.50.11.2497
  1161. Verdich C; Flint A; Gutzwiller JP; Näslund E; Beglinger C; Hellström PM; Long SJ; et al. "A meta-analysis of the effect of glucagon-like peptide-1 (7-36) amide on ad libitum energy intake in humans.". (2001): http://europepmc.org/abstract/med/11549680.
    10.1210/jc.86.9.4382
  1162. Gebhard B; Holst JJ; Biegelmayer C; Miholic J. "Postprandial GLP-1, norepinephrine, and reactive hypoglycemia in dumping syndrome.". (2001): http://europepmc.org/abstract/med/11575444.
    10.1023/A:1010635131228
  1163. Rask E; Olsson T; Söderberg S; Johnson O; Seckl J; Holst JJ; Ahrén B; Northern Sweden Monitoring of Trends and Determinants in Cardiovascular Disease (MONICA). "Impaired incretin response after a mixed meal is associated with insulin resistance in nondiabetic men.". (2001): http://europepmc.org/abstract/med/11522713.
    10.2337/diacare.24.9.1640
  1164. Tornøe K; Hannibal J; Georg B; Schmidt PT; Hilsted L; Fahrenkrug J; Holst JJ. "PACAP 1-38 as neurotransmitter in the porcine antrum.". (2001): http://europepmc.org/abstract/med/11495686.
    10.1016/S0167-0115(01)00276-2
  1165. Ljungmann K; Hartmann B; Kissmeyer-Nielsen P; Flyvbjerg A; Holst JJ; Laurberg S. "Time-dependent intestinal adaptation and GLP-2 alterations after small bowel resection in rats.". (2001): http://europepmc.org/abstract/med/11518690.
  1166. Enç FY; Imeryüz N; Akin L; Turoglu T; Dede F; Haklar G; Tekesin N; et al. "Inhibition of gastric emptying by acarbose is correlated with GLP-1 response and accompanied by CCK release.". (2001): http://europepmc.org/abstract/med/11518688.
  1167. Rasmussen TN; Schmidt P; Poulsen SS; Holst JJ. "Effect of calcitonin gene-related peptide (CGRP) on motility and on the release of substance P, neurokinin A, somatostatin and gastrin in the isolated perfused porcine antrum.". (2001): http://europepmc.org/abstract/med/11576394.
    10.1046/j.1365-2982.2001.00274.x
  1168. Verdich C; Toubro S; Buemann B; Holst JJ; Bülow J; Simonsen L; Søndergaard SB; Christensen NJ; Astrup A. "Leptin levels are associated with fat oxidation and dietary-induced weight loss in obesity.". (2001): http://europepmc.org/abstract/med/11500525.
    10.1038/oby.2001.59
  1169. Toft-Nielsen MB; Madsbad S; Holst JJ. "Determinants of the effectiveness of glucagon-like peptide-1 in type 2 diabetes.". (2001): http://europepmc.org/abstract/med/11502823.
    10.1210/jc.86.8.3853
  1170. Toft-Nielsen MB; Damholt MB; Madsbad S; Hilsted LM; Hughes TE; Michelsen BK; Holst JJ. "Determinants of the impaired secretion of glucagon-like peptide-1 in type 2 diabetic patients.". (2001): http://europepmc.org/abstract/med/11502801.
    10.1210/jc.86.8.3717
  1171. Gutniak MK; Svartberg J; Hellström PM; Holst JJ; Adner N; Ahrén B. "Antidiabetogenic action of glucagon-like peptide-1 related to administration relative to meal intake in subjects with type 2 diabetes.". (2001): http://europepmc.org/abstract/med/11454146.
    10.1046/j.1365-2796.2001.00862.x
  1172. Rönnblom A; Hellström PM; Holst JJ; Theodorsson E; Danielsson A. "Gastric myoelectrical activity and gut hormone secretion in myotonic dystrophy.". (2001): http://europepmc.org/abstract/med/11474313.
    10.1097/00042737-200107000-00011
  1173. Zimmermann-Belsing T; Feldt-Rasmussen U; Holst JJ. "[Determination of free and bound leptin in serum: important during thyroid disease?]". (2001): http://europepmc.org/abstract/med/11466993.
  1174. Deacon CF; Danielsen P; Klarskov L; Olesen M; Holst JJ. "Dipeptidyl peptidase IV inhibition reduces the degradation and clearance of GIP and potentiates its insulinotropic and antihyperglycemic effects in anesthetized pigs.". (2001): http://europepmc.org/abstract/med/11423480.
    10.2337/diabetes.50.7.1588
  1175. Staehr P; Hother-Nielsen O; Levin K; Holst JJ; Beck-Nielsen H. "Assessment of hepatic insulin action in obese type 2 diabetic patients.". (2001): http://europepmc.org/abstract/med/11375337.
    10.2337/diabetes.50.6.1363
  1176. Flint A; Raben A; Ersbøll AK; Holst JJ; Astrup A. "The effect of physiological levels of glucagon-like peptide-1 on appetite, gastric emptying, energy and substrate metabolism in obesity.". (2001): http://europepmc.org/abstract/med/11439290.
    10.1038/sj.ijo.0801627
  1177. Friis-Hansen L; Lacourse KA; Samuelson LC; Holst JJ. "Attenuated processing of proglucagon and glucagon-like peptide-1 in carboxypeptidase E-deficient mice.". (2001): http://europepmc.org/abstract/med/11375130.
    10.1677/joe.0.1690595
  1178. Ahrén B; Holst JJ. "The cephalic insulin response to meal ingestion in humans is dependent on both cholinergic and noncholinergic mechanisms and is important for postprandial glycemia.". (2001): http://europepmc.org/abstract/med/11334405.
    10.2337/diabetes.50.5.1030
  1179. Holst JJ. "[Appetite regulation--leptin and other signal substances]". (2001): http://europepmc.org/abstract/med/11402969.
  1180. Zander M; Taskiran M; Toft-Nielsen MB; Madsbad S; Holst JJ. "Additive glucose-lowering effects of glucagon-like peptide-1 and metformin in type 2 diabetes.". (2001): http://europepmc.org/abstract/med/11315837.
    10.2337/diacare.24.4.720
  1181. Ritzel R; Schulte M; Pørksen N; Nauck MS; Holst JJ; Juhl C; März W; et al. "Glucagon-like peptide 1 increases secretory burst mass of pulsatile insulin secretion in patients with type 2 diabetes and impaired glucose tolerance.". (2001): http://europepmc.org/abstract/med/11289042.
    10.2337/diabetes.50.4.776
  1182. Rasmussen TN; Schmidt P; Poulsen SS; Holst JJ. "Localisation and neural control of the release of calcitonin gene-related peptide (CGRP) from the isolated perfused porcine ileum.". (2001): http://europepmc.org/abstract/med/11231043.
    10.1016/S0167-0115(00)00242-1
  1183. Vella A; Shah P; Basu R; Basu A; Camilleri M; Schwenk FW; Holst JJ; Rizza RA. "Effect of glucagon-like peptide-1(7-36)-amide on initial splanchnic glucose uptake and insulin action in humans with type 1 diabetes.". (2001): http://europepmc.org/abstract/med/11246876.
    10.2337/diabetes.50.3.565
  1184. Vilsbøll T; Krarup T; Deacon CF; Madsbad S; Holst JJ. "Reduced postprandial concentrations of intact biologically active glucagon-like peptide 1 in type 2 diabetic patients.". (2001): http://europepmc.org/abstract/med/11246881.
    10.2337/diabetes.50.3.609
  1185. Jeppesen PB; Hartmann B; Thulesen J; Graff J; Lohmann J; Hansen BS; Tofteng F; et al. "Glucagon-like peptide 2 improves nutrient absorption and nutritional status in short-bowel patients with no colon.". (2001): http://europepmc.org/abstract/med/11231933.
    10.1053/gast.2001.22555
  1186. van Goudoever JB; Stoll B; Hartmann B; Holst JJ; Reeds PJ; Burrin DG. "Secretion of trophic gut peptides is not different in bolus- and continuously fed piglets.". (2001): http://europepmc.org/abstract/med/11238751.
  1187. Tina Vilsbøll; T Krarup; S Madsbad; Jens Juul Holst. "No reactive hypoglycaemia in type 2 diabetic patients after subcutaneous administration of GLP-1 and intravenous glucose". Diabetic Medicine 18 2 (2001): 144-149. https://curis.ku.dk/portal/en/publications/no-reactive-hypoglycaemia-in-type-2-diabetic-patients-after-subcutaneous-administration-of-glp1-and-intravenous-glucose(867e9c40-74c7-11db-bee9-02004c4f4f50).html.
  1188. Vilsbøll T; Krarup T; Madsbad S; Holst JJ. "No reactive hypoglycaemia in Type 2 diabetic patients after subcutaneous administration of GLP-1 and intravenous glucose.". (2001): http://europepmc.org/abstract/med/11251679.
    10.1046/j.1464-5491.2001.00424.x
  1189. Thulesen J; Hartmann B; Kissow H; Jeppesen PB; Orskov C; Holst JJ; Poulsen SS. "Intestinal growth adaptation and glucagon-like peptide 2 in rats with ileal--jejunal transposition or small bowel resection.". (2001): http://europepmc.org/abstract/med/11281189.
    10.1023/A:1005572832571
  1190. Näslund E; Bogefors J; Grybäck P; Bjellerup P; Jacobsson H; Holst JJ; Hellström PM. "GLP-1 inhibits gastric emptying of water but does not influence plasma.". (2001): http://europepmc.org/abstract/med/11252407.
    10.1080/003655201750065906
  1191. Raben A; Holst JJ; Madsen J; Astrup A. "Diurnal metabolic profiles after 14 d of an ad libitum high-starch, high-sucrose, or high-fat diet in normal-weight never-obese and postobese women.". (2001): http://europepmc.org/abstract/med/11157312.
  1192. Hojlund K; Wildner-Christensen M; Eshøj O; Skjaerbaek C; Holst JJ; Koldkjaer O; Møller Jensen D; Beck-Nielsen H. "Reference intervals for glucose, beta-cell polypeptides, and counterregulatory factors during prolonged fasting.". (2001): http://europepmc.org/abstract/med/11120658.
  1193. A. Raben; Jens Juul Holst; J. Madsen; Arne Astrup. "Diurnal metabolic profiles after 14 d of an ad libitum high-starch, high-sucrose, or high-fat diet in normal-weight never-obese and postobese women". American Journal of Clinical Nutrition 73 (2001): 177-89. https://curis.ku.dk/portal/en/publications/diurnal-metabolic-profiles-after-14-d-of-an-ad-libitum-highstarch-highsucrose-or-highfat-diet-in-normalweight-neverobese-and-postobese-women(68b5d940-a1ba-11dd-b6ae-000ea68e967b).html.
  1194. R. Ritzel; M. Schulte; N. Porksen; Jens Juul Holst. "Glucagon-like peptide 1 increases secretory burst mass of pulsatile insulin secretion in patients with type 2 diabetes and impaired glucose tolerance". Diabetes 50 (2001): 776-784. https://curis.ku.dk/portal/en/publications/glucagonlike-peptide-1-increases-secretory-burst-mass-of-pulsatile-insulin-secretion-in-patients-with-type-2-diabetes-and-impaired-glucose-tolerance(83c102e0-74c7-11db-bee9-02004c4f4f50).html.
  1195. M B Toft-Nielsen; M B Damholt; Sten Madsbad; L M Hilsted; T E Hughes; B K Michelsen; Jens Juul Holst. "Determinants of the impaired secretion of glucagon-like peptide-1 in type 2 diabetic patients". Journal of Clinical Endocrinology and Metabolism 86 8 (2001): 3717-3723. https://curis.ku.dk/portal/en/publications/determinants-of-the-impaired-secretion-of-glucagonlike-peptide1-in-type-2-diabetic-patients(a8c81380-74c7-11db-bee9-02004c4f4f50).html.
  1196. Holst JJ; Orskov C. "Incretin hormones--an update.". (2001): http://europepmc.org/abstract/med/11713984.
  1197. Jens H. Henriksen; Jens Juul Holst; S. Moller. "Elevated ciculating leptin levels in arterial hypertension: relationship to arteriovenous overflow and extraction of leptin". Clin.Sci. 99 (2001): 527-534. https://curis.ku.dk/portal/en/publications/elevated-ciculating-leptin-levels-in-arterial-hypertension-relationship-to-arteriovenous-overflow-and-extraction-of-leptin(80452290-74c7-11db-bee9-02004c4f4f50).html.
  1198. K. Ljungmann; Bolette Hartmann; P. Kissmeyer-Nielsen; Jens Juul Holst. "Time-dependent intestinal adaptation and GLP-2 alterations after small bowel resection in rats". Am J Physiol-Gastr L 281 (2001): G779-G785. https://curis.ku.dk/portal/en/publications/timedependent-intestinal-adaptation-and-glp2-alterations-after-small-bowel-resection-in-rats(ad413f90-74c7-11db-bee9-02004c4f4f50).html.
  1199. E. Rask; T. Olsson; S. Soderberg; Jens Juul Holst. "Impaired incretin response after a mixed meal is associated with insulin resistance in nondiabetic men". Diabetes Care 24 (2001): 1640-1645. https://curis.ku.dk/portal/en/publications/impaired-incretin-response-after-a-mixed-meal-is-associated-with-insulin-resistance-in-nondiabetic-men(ad01eca0-74c7-11db-bee9-02004c4f4f50).html.
  1200. Bo Ahrén; Jens Juul Holst. "The cephalic insulin response to meal ingestion in humans is dependent on both cholinergic and noncholinergic mechanisms and is important for postprandial glycemia". Diabetes 50 (2001): 1030-1038. https://curis.ku.dk/portal/en/publications/the-cephalic-insulin-response-to-meal-ingestion-in-humans-is-dependent-on-both-cholinergic-and-noncholinergic-mechanisms-and-is-important-for-postprandial-glycemia(86c0ae50-74c7-11db-bee9-02004c4f4f50).html.
  1201. K. Tornoe; J. Hannibal; Birgitte Georg; Jens Juul Holst. "PACAP 1-38 as neurotransmitter in the porcine antrum". Regulatory Peptides 101 (2001): 109-121. https://curis.ku.dk/portal/en/publications/pacap-138-as-neurotransmitter-in-the-porcine-antrum(ad2245e0-74c7-11db-bee9-02004c4f4f50).html.
  1202. Jens Juul Holst; C. Orskov. "Incretin hormones - an update". Scand J Clin Lab Inv 61 Suppl. (2001): 75-85. https://curis.ku.dk/portal/en/publications/incretin-hormones--an-update(acf62cd0-74c7-11db-bee9-02004c4f4f50).html.
  1203. M.K. Gutniak; J. Svartberg; P.M. Hellstrom; Jens Juul Holst. "Antidiabetogenic action of glucagon-like peptide- 1 related to administration relative to meal intake in subjects with type 2 diabetes". J Intern Med 250 (2001): 81-87. https://curis.ku.dk/portal/en/publications/antidiabetogenic-action-of-glucagonlike-peptide-1-related-to-administration-relative-to-meal-intake-in-subjects-with-type-2-diabetes(a89df640-74c7-11db-bee9-02004c4f4f50).html.
  1204. K. Højlund; O. Eshøj; M.W. Christensen; C. Skjærbæk; J. Frystyk; Jens Juul Holst; O. Koldkjær; D. Møller J.; Henning Beck-Nielsen. "Reference intervals for plasma glucose, insulin, proinsulin, C-peptide and counterregulatory factors during a 72-hour fast in healthy human subjects". American Journal of Physiology. 280 (2001): E50-E58. https://curis.ku.dk/portal/en/publications/reference-intervals-for-plasma-glucose-insulin-proinsulin-cpeptide-and-counterregulatory-factors-during-a-72hour-fast-in-healthy-human-subjects(d5e04400-74c7-11db-bee9-02004c4f4f50).html.
  1205. P.B. Jeppesen; Bolette Hartmann; J. Thulesen; J. Graff; J. Lohmann; B.S. Hansen; F. Tofteng; et al. "Treatment of short bowel patients with glucagon-like peptide-2 (GLP-2), a newly discovered intestinotrophic, anti-secretory, and transit modulating peptide". Today in Medicine. Gastroenterology 120 (2001): 806-815. https://curis.ku.dk/portal/en/publications/treatment-of-short-bowel-patients-with-glucagonlike-peptide2-glp2-a-newly-discovered-intestinotrophic-antisecretory-and-transit-modulating-peptide(d5d1c510-74c7-11db-bee9-02004c4f4f50).html.
  1206. Van Goudoever; B. Stoll; Bolette Hartmann; Jens Juul Holst; P.J. Reeds; D.G. Burrin. "Secretion of trophic gut peptides is not different in bolus- and continuously fed piglets". J Nutr. 131 (2001): 729-732. https://curis.ku.dk/portal/en/publications/secretion-of-trophic-gut-peptides-is-not-different-in-bolus-and-continuously-fed-piglets(d5b626c0-74c7-11db-bee9-02004c4f4f50).html.
  1207. A. Ronnblom; P.M. Hellstrom; Jens Juul Holst. "Gastric myoelectrical activity and gut hormone secretion in myotonic dystrophy". Eur J Gastroen Hepat 13 (2001): 825-831. https://curis.ku.dk/portal/en/publications/gastric-myoelectrical-activity-and-gut-hormone-secretion-in-myotonic-dystrophy(a5edca60-74c7-11db-bee9-02004c4f4f50).html.
  1208. B. Gebhard; Jens Juul Holst; C. Biegelmayer. "Postprandial GLP-1, norepinephrine, and reactive hypoglycemia in dumping syndrome". Digest Dis Sci 46 (2001): 1915-1923. https://curis.ku.dk/portal/en/publications/postprandial-glp1-norepinephrine-and-reactive-hypoglycemia-in-dumping-syndrome(8c690b90-74c7-11db-bee9-02004c4f4f50).html.
  1209. E. Naslund; J. Bogefors; P. Gryback; Jens Juul Holst. "GLP-1 inhibits gastric emptying of water but does not influence plasma vasopressin, sodium, or osmolality". Scand J Gastroentero 36 (2001): 156-162. https://curis.ku.dk/portal/en/publications/glp1-inhibits-gastric-emptying-of-water-but-does-not-influence-plasma-vasopressin-sodium-or-osmolality(80f5ade0-74c7-11db-bee9-02004c4f4f50).html.
  1210. Carolyn Deacon; P. Danielsen; L. Klarskov; Jens Juul Holst; M. Olesen. "Dipeptidyl peptidase IV inhibition reduces the degradation and clearance of GIP and potentiates its insulinotropic and antihyperglycemic effects in anesthetized pigs". Diabetes 50 (2001): 1588-1597. https://curis.ku.dk/portal/en/publications/dipeptidyl-peptidase-iv-inhibition-reduces-the-degradation-and-clearance-of-gip-and-potentiates-its-insulinotropic-and-antihyperglycemic-effects-in-anesthetized-pigs(a5b52e30-74c7-11db-bee9-02004c4f4f50).html.
  1211. D.G. Burrin; B. Stoll; R. Jiang; Jens Juul Holst. "GLP-2 stimulates intestinal growth in premature TPN-fed pigs by suppressing proteolysis and apoptosis". Am J Physiol-Gastr L 279 (2001): G1249-G1256. https://curis.ku.dk/portal/en/publications/glp2-stimulates-intestinal-growth-in-premature-tpnfed-pigs-by-suppressing-proteolysis-and-apoptosis(807de5d0-74c7-11db-bee9-02004c4f4f50).html.
  1212. A. Vella; P. Shah; R. Basu; Jens Juul Holst. "Effect of glucagon-like peptide- 1 (7-36)-amide on initial splanchnic glucose uptake and insulin action in humans with type 1 diabetes". Diabetes 50 (2001): 565-572. https://curis.ku.dk/portal/en/publications/effect-of-glucagonlike-peptide-1-736amide-on-initial-splanchnic-glucose-uptake-and-insulin-action-in-humans-with-type-1-diabetes(8301aa80-74c7-11db-bee9-02004c4f4f50).html.
  1213. K. Hojlund; M. Wildner-Christensen; O. Eshoj; Jens Juul Holst. "Reference intervals for glucose, beta-cell polypeptides, and counterregulatory factors during prolonged fasting". Am J Physiol-Endoc M 280 (2001): E50-E58. https://curis.ku.dk/portal/en/publications/reference-intervals-for-glucose-betacell-polypeptides-and-counterregulatory-factors-during-prolonged-fasting(7f2d9810-74c7-11db-bee9-02004c4f4f50).html.
  1214. L. Friis-Hansen; K.A. Lacourse; L.C. Samuelson; Jens Juul Holst. "Attenuated processing of proglucagon and glucagon-like peptide- 1 in carboxypeptidase E-deficient mice". J. Endocrinol. 169 (2001): 595-602. https://curis.ku.dk/portal/en/publications/attenuated-processing-of-proglucagon-and-glucagonlike-peptide-1-in-carboxypeptidase-edeficient-mice(9c846d80-74c7-11db-bee9-02004c4f4f50).html.
  1215. L.B. Knudsen; H. Agerso; C. Bjenning; Jens Juul Holst. "GLP-1 derivatives as novel compounds for the treatment of type 2 diabetes: selection of NN2211 for clinical development". Drug Future 26 (2001): 677-685. https://curis.ku.dk/portal/en/publications/glp1-derivatives-as-novel-compounds-for-the-treatment-of-type-2-diabetes-selection-of-nn2211-for-clinical-development(91cf56c0-74c7-11db-bee9-02004c4f4f50).html.
  1216. P. Staehr; Ole Hother-Nielsen; K. Levin; Jens Juul Holst. "Assesment of hepatic insulin action in obese type 2 diabetic patients". Diabetes 50 (2001): 1363-1370. https://curis.ku.dk/portal/en/publications/assesment-of-hepatic-insulin-action-in-obese-type-2-diabetic-patients(87336d50-74c7-11db-bee9-02004c4f4f50).html.
  1217. M. Zander; M. Taskiran; M.B. Toft-Nielsen; Jens Juul Holst. "Additive glucose-lowering effects of glucagon-like peptide- 1 and metformin type 2 diabetes". Diabetes Care 24 (2001): 720-725. https://curis.ku.dk/portal/en/publications/additive-glucoselowering-effects-of-glucagonlike-peptide-1-and-metformin-type-2-diabetes(84a6cf00-74c7-11db-bee9-02004c4f4f50).html.
  1218. M.B. Toft-Nielsen; S. Madsbad; Jens Juul Holst. "Determinants of the effectiveness of glucagon-like peptide- 1 in type 2 diabetes". J Clin Endocr Metab 86 (2001): 3853-3860. https://curis.ku.dk/portal/en/publications/determinants-of-the-effectiveness-of-glucagonlike-peptide-1-in-type-2-diabetes(a8bc0590-74c7-11db-bee9-02004c4f4f50).html.
  1219. C. Verdich; S. Toubro; B. Buemann; Jens Juul Holst. "The role of postprandial releases of insulin and incretin hormones in meal-induced satiety - effect of obesity and weight reduction". International Journal of Obesity 25 (2001): 1206-1214. https://curis.ku.dk/portal/en/publications/the-role-of-postprandial-releases-of-insulin-and-incretin-hormones-in-mealinduced-satiety--effect-of-obesity-and-weight-reduction(a6045fa0-74c7-11db-bee9-02004c4f4f50).html.
  1220. J.J. Meier; K. Huking; Jens Juul Holst; Carolyn Deacon; W.H. Schmiegel; M.A. Nauck. "Reduced insulinotropic effect of gastric inhibitory polypeptide in first-degree relatives of patients with type 2 diabetes". Diabetes 50 (2001): 2497-2504. https://curis.ku.dk/portal/en/publications/reduced-insulinotropic-effect-of-gastric-inhibitory-polypeptide-in-firstdegree-relatives-of-patients-with-type-2-diabetes(91fb96e0-74c7-11db-bee9-02004c4f4f50).html.
  1221. F.Y. Enc; N. Imeryuz; L. Akin; Jens Juul Holst. "Inhibition of gastric emptying by acarbose is correlated with GLP-1 response and accompanied by CCK release". Am J Physiol-Gastr L 281 (2001): G752-G763. https://curis.ku.dk/portal/en/publications/inhibition-of-gastric-emptying-by-acarbose-is-correlated-with-glp1-response-and-accompanied-by-cck-release(8a5dd240-74c7-11db-bee9-02004c4f4f50).html.
  1222. Henriksen JH; Holst JJ; Moller S; Andersen UB; Bendtsen F; Jensen G. "Elevated circulating leptin levels in arterial hypertension: relationship to arteriovenous overflow and extraction of leptin.". (2000): http://europepmc.org/abstract/med/11099396.
    10.1042/CS20000062
  1223. Burrin DG; Stoll B; Jiang R; Petersen Y; Elnif J; Buddington RK; Schmidt M; et al. "GLP-2 stimulates intestinal growth in premature TPN-fed pigs by suppressing proteolysis and apoptosis.". (2000): http://europepmc.org/abstract/med/11093948.
  1224. Tornøe K; Hannibal J; Jensen TB; Georg B; Rickelt LF; Andreasen MB; Fahrenkrug J; Holst JJ. "PACAP-(1-38) as neurotransmitter in the porcine adrenal glands.". (2000): http://europepmc.org/abstract/med/11093931.
  1225. Poulsen PL; Orskov L; Grøfte T; Møller J; Holst JJ; Schmitz O; Møller N. "Effects of oral glucose on systemic glucose metabolism during hyperinsulinemic hypoglycemia in normal man.". (2000): http://europepmc.org/abstract/med/11145123.
    10.1053/meta.2000.18558
  1226. Hartmann B; Thulesen J; Kissow H; Thulesen S; Orskov C; Ropke C; Poulsen SS; Holst JJ. "Dipeptidyl peptidase IV inhibition enhances the intestinotrophic effect of glucagon-like peptide-2 in rats and mice.". (2000): http://europepmc.org/abstract/med/11089531.
    10.1210/en.141.11.4013
  1227. Jørgensen JO; Rosenfalck AM; Fisker S; Nyholm B; Fineman MS; Schmitz O; Madsbad S; Holst JJ; Christiansen JS. "Circulating levels of incretin hormones and amylin in the fasting state and after oral glucose in GH-deficient patients before and after GH replacement: a placebo-controlled study.". (2000): http://europepmc.org/abstract/med/11078982.
    10.1530/eje.0.1430593
  1228. Deacon CF; Nauck MA; Meier J; Hücking K; Holst JJ. "Degradation of endogenous and exogenous gastric inhibitory polypeptide in healthy and in type 2 diabetic subjects as revealed using a new assay for the intact peptide.". (2000): http://europepmc.org/abstract/med/11061504.
    10.1210/jc.85.10.3575
  1229. Thulesen J; Hartmann B; Orskov C; Jeppesen PB; Holst JJ; Poulsen SS. "Potential targets for glucagon-like peptide 2 (GLP-2) in the rat: distribution and binding of i.v. injected (125)I-GLP-2.". (2000): http://europepmc.org/abstract/med/11068098.
    10.1016/S0196-9781(00)00305-3
  1230. Holst JJ. "Gut hormones as pharmaceuticals. From enteroglucagon to GLP-1 and GLP-2.". (2000): http://europepmc.org/abstract/med/11033052.
    10.1016/S0167-0115(00)00185-3
  1231. Jeppesen PB; Hartmann B; Thulesen J; Hansen BS; Holst JJ; Poulsen SS; Mortensen PB. "Elevated plasma glucagon-like peptide 1 and 2 concentrations in ileum resected short bowel patients with a preserved colon.". (2000): http://europepmc.org/abstract/med/10940274.
    10.1136/gut.47.3.370
  1232. Ahrén B; Holst JJ; Mårtensson H; Balkan B. "Improved glucose tolerance and insulin secretion by inhibition of dipeptidyl peptidase IV in mice.". (2000): http://europepmc.org/abstract/med/10980284.
    10.1016/S0014-2999(00)00600-2
  1233. Hartmann B; Harr MB; Jeppesen PB; Wojdemann M; Deacon CF; Mortensen PB; Holst JJ. "In vivo and in vitro degradation of glucagon-like peptide-2 in humans.". (2000): http://europepmc.org/abstract/med/10946898.
    10.1210/jcem.85.8.6717
  1234. Buemann B; Toubro S; Holst JJ; Rehfeld JF; Bibby BM; Astrup A. "D-tagatose, a stereoisomer of D-fructose, increases blood uric acid concentration.". (2000): http://europepmc.org/abstract/med/10954012.
    10.1053/meta.2000.7724
  1235. Filipsson K; Holst JJ; Ahrén B. "PACAP contributes to insulin secretion after gastric glucose gavage in mice.". (2000): http://europepmc.org/abstract/med/10938228.
  1236. Henriksen JE; Levin K; Thye-Rønn P; Alford F; Hother-Nielsen O; Holst JJ; Beck-Nielsen H. "Glucose-mediated glucose disposal in insulin-resistant normoglycemic relatives of type 2 diabetic patients.". (2000): http://europepmc.org/abstract/med/10909980.
    10.2337/diabetes.49.7.1209
  1237. Verdich C; Madsen JL; Toubro S; Buemann B; Holst JJ; Astrup A. "Effect of obesity and major weight reduction on gastric emptying.". (2000): http://europepmc.org/abstract/med/10918538.
    10.1038/sj.ijo.0801250
  1238. Vilsbøll T; Toft-Nielsen MB; Krarup T; Madsbad S; Dinesen B; Holst JJ. "Evaluation of beta-cell secretory capacity using glucagon-like peptide 1.". (2000): http://europepmc.org/abstract/med/10841001.
    10.2337/diacare.23.6.807
  1239. Burrin DG; Stoll B; Jiang R; Chang X; Hartmann B; Holst JJ; Greeley GH Jr; Reeds PJ. "Minimal enteral nutrient requirements for intestinal growth in neonatal piglets: how much is enough?". (2000): http://europepmc.org/abstract/med/10837305.
  1240. Hansen L; Hartmann B; Bisgaard T; Mineo H; Jørgensen PN; Holst JJ. "Somatostatin restrains the secretion of glucagon-like peptide-1 and -2 from isolated perfused porcine ileum.". (2000): http://europepmc.org/abstract/med/10827002.
  1241. P T Schmidt; Bolette Hartmann; S Bregenholt; Jens Juul Holst; Mogens Helweg Claesson. "Deficiency of the intestinal growth factor, glucagon-like peptide 2, in the colon of SCID mice with inflammatory bowel disease induced by transplantation of CD4+ T cells". Scandinavian Journal of Gastroenterology 35 5 (2000): 522-7. https://curis.ku.dk/portal/en/publications/deficiency-of-the-intestinal-growth-factor-glucagonlike-peptide-2-in-the-colon-of-scid-mice-with-inflammatory-bowel-disease-induced-by-transplantation-of-cd4-t-cells(6fa04fe0-74c8-11db-bee9-02004c4f4f50).html.
  1242. Juhl CB; Schmitz O; Pincus S; Holst JJ; Veldhuis J; Pørksen N. "Short-term treatment with GLP-1 increases pulsatile insulin secretion in Type II diabetes with no effect on orderliness.". (2000): http://europepmc.org/abstract/med/10855533.
    10.1007/s001250051347
  1243. Ahrén B; Holst JJ; Yu S. "1,5-Anhydro-D-fructose increases glucose tolerance by increasing glucagon-like peptide-1 and insulin in mice.". (2000): http://europepmc.org/abstract/med/10844116.
    10.1016/S0014-2999(00)00261-2
  1244. Schmidt PT; Holst JJ. "Tachykinins in regulation of gastric motility and secretion.". (2000): http://europepmc.org/abstract/med/11130458.
    10.1007/PL00000720
  1245. Vella A; Shah P; Basu R; Basu A; Holst JJ; Rizza RA. "Effect of glucagon-like peptide 1(7-36) amide on glucose effectiveness and insulin action in people with type 2 diabetes.". (2000): http://europepmc.org/abstract/med/10871199.
    10.2337/diabetes.49.4.611
  1246. Schmidt PT; Tornøe K; Poulsen SS; Rasmussen TN; Holst JJ. "Tachykinins in the porcine pancreas: potent exocrine and endocrine effects via NK-1 receptors.". (2000): http://europepmc.org/abstract/med/10766449.
    10.1097/00006676-200004000-00004
  1247. Flint A; Raben A; Rehfeld JF; Holst JJ; Astrup A. "The effect of glucagon-like peptide-1 on energy expenditure and substrate metabolism in humans.". (2000): http://europepmc.org/abstract/med/10757621.
    10.1038/sj.ijo.0801126
  1248. Ahrén B; Holst JJ; Efendic S. "Antidiabetogenic action of cholecystokinin-8 in type 2 diabetes.". (2000): http://europepmc.org/abstract/med/10720037.
    10.1210/jc.85.3.1043
  1249. Juntti-Berggren L; Pigon J; Hellström P; Holst JJ; Efendic S. "Influence of acarbose on post-prandial insulin requirements in patients with Type 1 diabetes.". (2000): http://europepmc.org/abstract/med/10824717.
  1250. Hartmann B; Johnsen AH; Orskov C; Adelhorst K; Thim L; Holst JJ. "Structure, measurement, and secretion of human glucagon-like peptide-2.". (2000): http://europepmc.org/abstract/med/10704722.
    10.1016/S0196-9781(99)00176-X
  1251. Hedetoft C; Sheikh SP; Larsen S; Holst JJ. "Effect of glucagon-like peptide 1(7-36)amide in insulin-treated patients with diabetes mellitus secondary to chronic pancreatitis.". (2000): http://europepmc.org/abstract/med/10630380.
    10.1097/00006676-200001000-00004
  1252. Carolyn Deacon; M.A. Nauck; J. Meier; K. Hücking; Jens Juul Holst. "Degradation of endogenous and exogenous gastric inhibitory polypeptide in healthy and in type 2 diabetic subjects as revealed using a new assay for the intact peptide". Journal of Clinical Endocrinology and Metabolism 85 (2000): 3575-3581. https://curis.ku.dk/portal/en/publications/degradation-of-endogenous-and-exogenous-gastric-inhibitory-polypeptide-in-healthy-and-in-type-2-diabetic-subjects-as-revealed-using-a-new-assay-for-the-intact-peptide(30fd27e0-74c8-11db-bee9-02004c4f4f50).html.
  1253. Bolette Hartmann; M.B. Harr; P.B. Jeppesen; M. Wojdemann; Carolyn Deacon; P.B. Mortensen; Jens Juul Holst. "In vivo and in vitro degradation of glucagon-like peptide-2 in humans". Journal of Clinical Endocrinology and Metabolism 85 (2000): 2884-2888. https://curis.ku.dk/portal/en/publications/in-vivo-and-in-vitro-degradation-of-glucagonlike-peptide2-in-humans(31f45920-74c8-11db-bee9-02004c4f4f50).html.
  1254. P.B. Jeppesen; Bolette Hartmann; B.S. Hansen; Steen Seier Poulsen; Jesper Thulesen; Jens Juul Holst; Per Brøbech Mortensen. "Elevated fasting glucagon-like peptide 1 and 2 secretion in ileum-resected short bowel patients with a preserved colon". Gut 47 (2000): 370-376. https://curis.ku.dk/portal/en/publications/elevated-fasting-glucagonlike-peptide-1-and-2-secretion-in-ileumresected-short-bowel-patients-with-a-preserved-colon(1abfcbe0-74c8-11db-bee9-02004c4f4f50).html.
  1255. D.G. Burrin; B. Stoll; R. Jiang; Xiaoquing Chang; B. Hartmann; Jens Juul Holst; G.H. Greeley; P.J. Reeds. "Minimal enteral nutrient requirements for intestinal growth in neonatal piglets: how much is enough?". Am. J. Clin. Nutr. 71 (2000): 1603-1610. https://curis.ku.dk/portal/en/publications/minimal-enteral-nutrient-requirements-for-intestinal-growth-in-neonatal-piglets-how-much-is-enough(fae5a6f0-74c7-11db-bee9-02004c4f4f50).html.
  1256. Bo Ahrén; Jens Juul Holst; S. Efendic. "Antidiabetogenic action of cholecystokinin in type 2 diabetes". J. Clin. Endocrinol. Metab. 85 (2000): 1043-8. https://curis.ku.dk/portal/en/publications/antidiabetogenic-action-of-cholecystokinin-in-type-2-diabetes(fa0299f0-74c7-11db-bee9-02004c4f4f50).html.
  1257. J.O.L. Jørgensen; A.M. Rosenfalck; S. Fisker; B. Nyholm; M.S. Fineman; O. Schmitz; S. Madsbad; Jens Juul Holst; J.S. Christiansen. "Circulating levels of incretin hormones an amylin in the fasting state and after oral glucose in growth hormone (GH-)deficient patients before and after GH replacement. A placebo controlled study". European Journal of Endocrinology 143 (2000): 593-599. https://curis.ku.dk/portal/en/publications/circulating-levels-of-incretin-hormones-an-amylin-in-the-fasting-state-and-after-oral-glucose-in-growth-hormone-ghdeficient-patients-before-and-after-gh-replacement-a-placebo-controlled-study(f9e4d8c0-74c7-11db-b.
  1258. D.G. Burrin; B. Stoll; R. Jiang; Y. Petersen; J. Elnif; R.K. Buddington; M. Schmidt; et al. "GLP-2 stimulates intestinal growth by suppressing proteolysis and apoptosis in TNP-fed premature pigs". Am. J. Physiol. 279 (2000): G1249-G1256. https://curis.ku.dk/portal/en/publications/glp2-stimulates-intestinal-growth-by-suppressing-proteolysis-and-apoptosis-in-tnpfed-premature-pigs(f7552d30-74c7-11db-bee9-02004c4f4f50).html.
  1259. L. Juntti-Berggren; J. Pigon; P.M. Hellström; Jens Juul Holst; S. Efendic. "Influence of acarbose on postprandial insulin requirements in patients with type 1 diabetes". Diab Nutr Metab 13 (2000): 7-12. https://curis.ku.dk/portal/en/publications/influence-of-acarbose-on-postprandial-insulin-requirements-in-patients-with-type-1-diabetes(fb2a5110-74c7-11db-bee9-02004c4f4f50).html.
  1260. K. Tornøe; J. Hannibal; L.F. Rickelt; M. Bolding Jensen; J.T. Børglum; Jan Fahrenkrug; Jens Juul Holst. "PACAP 1-38 as neurotransmitter in porcine adrenal glands". American Journal of Physiology: Endocrinology and Metabolism 279 (2000): E1412-E1425. https://curis.ku.dk/portal/en/publications/pacap-138-as-neurotransmitter-in-porcine-adrenal-glands(fa2a4630-74c7-11db-bee9-02004c4f4f50).html.
  1261. K. Filipsson; Jens Juul Holst; Bo Ahrén. "PACAP contributes to insulin secretion after gastric glucose gavage in mice". Am. J. Physiol. 279 (2000): R424-432. https://curis.ku.dk/portal/en/publications/pacap-contributes-to-insulin-secretion-after-gastric-glucose-gavage-in-mice(fad5a160-74c7-11db-bee9-02004c4f4f50).html.
  1262. A. Vella; P. Shah; R. Basu; A. Basu; Jens Juul Holst; R.A. Rizza. "Effect of glucagon-like peptide-1-(7,36)-amide on glucose effectiveness and insulin action in people with type 2 diabetes mellitus". Diabetes 49 (2000): 611-617. https://curis.ku.dk/portal/en/publications/effect-of-glucagonlike-peptide1736amide-on-glucose-effectiveness-and-insulin-action-in-people-with-type-2-diabetes-mellitus(fa0f9240-74c7-11db-bee9-02004c4f4f50).html.
  1263. Jesper Thulesen; Bolette Hartmann; Cathrine Ørskov; P.B. Jeppesen; Jens Juul Holst; Steen Seier Poulsen. "Potential targets for glucagon-like peptide 2 (GLP-2) in the rat: distribution and binding of i.v. injected (125)I-GLP-2". Peptides 10 (2000): 1511-1517. https://curis.ku.dk/portal/en/publications/potential-targets-for-glucagonlike-peptide-2-glp2-in-the-rat-distribution-and-binding-of-iv-injected-125iglp2(6f90e690-74c8-11db-bee9-02004c4f4f50).html.
  1264. T. Visbøll; M. Toft-Nielsen; T. Krarup; S. Madsbad; B. Dinesen; Jens Juul Holst. "Evaluation of ß-cell secretory capacity using glucagon-like peptide-1". Diabetes Care 23 (2000): 807-812. https://curis.ku.dk/portal/en/publications/evaluation-of-sscell-secretory-capacity-using-glucagonlike-peptide1(fb1c9570-74c7-11db-bee9-02004c4f4f50).html.
  1265. P.T. Schmidt; Jens Juul Holst. "Tachykinins in the regulation of gastric motility and secretion". Review Cellular and Molecular Life Sciences 57 (2000): 579-588. https://curis.ku.dk/portal/en/publications/tachykinins-in-the-regulation-of-gastric-motility-and-secretion(fac80cd0-74c7-11db-bee9-02004c4f4f50).html.
  1266. A. Flint; A. Raben; J.F. Rehfeld; Jens Juul Holst; Arne Astrup. "The effect of glucagon-like peptide-1 on energy expenditure and substrate metabolism in humans". International Journal of Obesity 24 (2000): 288-298. https://curis.ku.dk/portal/en/publications/the-effect-of-glucagonlike-peptide1-on-energy-expenditure-and-substrate-metabolism-in-humans(fb064e50-74c7-11db-bee9-02004c4f4f50).html.
  1267. L. Hansen; Bolette Hartmann; T. Bisgaard; H. Mineo; P.N. Jørgensen; Jens Juul Holst. "Somastostatin restrains the secretion of glucagon-like peptide-1 and 2 (GLP-1 and GLP-2) from isolated perfused porcine ileum". Am. J. Physiol. 278 (2000): E1010-E1018. https://curis.ku.dk/portal/en/publications/somastostatin-restrains-the-secretion-of-glucagonlike-peptide1-and-2-glp1-and-glp2-from-isolated-perfused-porcine-ileum(faf4c220-74c7-11db-bee9-02004c4f4f50).html.
  1268. C.B. Juhl; O. Schmitz; Jens Juul Holst; J. Vedhuis; N. Pørksen. "Short-term treatment with GLP-1 increases pulsatile secretion in type 2 diabetes with no effect on orderliness.". Diabetologia 43 (2000): 583-588. https://curis.ku.dk/portal/en/publications/shortterm-treatment-with-glp1-increases-pulsatile-secretion-in-type-2-diabetes-with-no-effect-on-orderliness(f79347a0-74c7-11db-bee9-02004c4f4f50).html.
  1269. J.E. Henriksen; K. Levin; Peter Thye-Rønn; F. Alford; Ole Hother-Nielsen; Jens Juul Holst; Henning Beck-Nielsen. "Glucose mediated glucose disposal in insulin resistant normoglycemic relatives of type 2 diabetic patients". Diabetes 49 (2000): 1209-1218. https://curis.ku.dk/portal/en/publications/glucose-mediated-glucose-disposal-in-insulin-resistant-normoglycemic-relatives-of-type-2-diabetic-patients(fb544740-74c7-11db-bee9-02004c4f4f50).html.
  1270. Jens H. Henriksen; Jens Juul Holst; S. Møller; G. Jensen; Flemming Bendtsen. "Elevated circulating leptin in arterial hypertension: relationship to arteriovenous overflow and extraction of leptin". Clin.Sci. 99 (2000): 527-534. https://curis.ku.dk/portal/en/publications/elevated-circulating-leptin-in-arterial-hypertension-relationship-to-arteriovenous-overflow-and-extraction-of-leptin(f9f4b740-74c7-11db-bee9-02004c4f4f50).html.
  1271. Bo Ahrén; Jens Juul Holst; H. Mårtensson; B. Balkan. "Improved glucagon tolerance and insulin secretion by inhibition of dipeptidyl peptidase IV in mice". Eur. J. Pharmacol. 404 (2000): 239-245. https://curis.ku.dk/portal/en/publications/improved-glucagon-tolerance-and-insulin-secretion-by-inhibition-of-dipeptidyl-peptidase-iv-in-mice(f73967d0-74c7-11db-bee9-02004c4f4f50).html.
  1272. Jens Juul Holst. "Gut hormones as pharmaceuticals. From enteroglucagon to GLP-1 and GLP-2". Review Regul Pept 93 (2000): 45-51. https://curis.ku.dk/portal/en/publications/gut-hormones-as-pharmaceuticals-from-enteroglucagon-to-glp1-and-glp2(f72da800-74c7-11db-bee9-02004c4f4f50).html.
  1273. P.L. Poulsen; T. Grøfte; P. Holck; J. Møller; O. Schmitz; L. Ørskov; Jens Juul Holst; N. Møller. "Effects of oral glucose on systemic glucose metabolism during hyperinsulinaemic hypoglycemia in normal man". Metabolism 49 (2000): 1598-1603. https://curis.ku.dk/portal/en/publications/effects-of-oral-glucose-on-systemic-glucose-metabolism-during-hyperinsulinaemic-hypoglycemia-in-normal-man(fb78bf30-74c7-11db-bee9-02004c4f4f50).html.
  1274. Bo Ahrén; Jens Juul Holst; J. Marcussen; S. Yu. "1,5-Anhydro fructose increase glucose tolerance by increasing GLP-1 and insulin in mice". Eur. J. Pharmacol. 397 (2000): 219-225. https://curis.ku.dk/portal/en/publications/15anhydro-fructose-increase-glucose-tolerance-by-increasing-glp1-and-insulin-in-mice(f7624c90-74c7-11db-bee9-02004c4f4f50).html.
  1275. C. Hedetoft; S. Larsen; S. Sheikh; Jens Juul Holst. "Effect of glucagon-like peptide 1 (7-356) amide in insulin treated patients with diabetes mellitus secondary to chronic pancreatitis". Pancreas 20 (2000): 25-31. https://curis.ku.dk/portal/en/publications/effect-of-glucagonlike-peptide-1-7356-amide-in-insulin-treated-patients-with-diabetes-mellitus-secondary-to-chronic-pancreatitis(f71f0200-74c7-11db-bee9-02004c4f4f50).html.
  1276. Bokvist K; Hoy M; Buschard K; Holst JJ; Thomsen MK; Gromada J. "Selectivity of prandial glucose regulators: nateglinide, but not repaglinide, accelerates exocytosis in rat pancreatic A-cells.". (1999): http://europepmc.org/abstract/med/10611470.
    10.1016/S0014-2999(99)00754-2
  1277. Klausen B; Toubro S; Ranneries C; Rehfeld JF; Holst JJ; Christensen NJ; Astrup A. "Increased intensity of a single exercise bout stimulates subsequent fat intake.". (1999): http://europepmc.org/abstract/med/10643685.
    10.1038/sj.ijo.0801074
  1278. Nyholm B; Walker M; Gravholt CH; Shearing PA; Sturis J; Alberti KG; Holst JJ; Schmitz O. "Twenty-four-hour insulin secretion rates, circulating concentrations of fuel substrates and gut incretin hormones in healthy offspring of Type II (non-insulin-dependent) diabetic parents: evidence of several aberrations.". (1999): http://europepmc.org/abstract/med/10550415.
    10.1007/s001250051444
  1279. Balkan B; Kwasnik L; Miserendino R; Holst JJ; Li X. "Inhibition of dipeptidyl peptidase IV with NVP-DPP728 increases plasma GLP-1 (7-36 amide) concentrations and improves oral glucose tolerance in obese Zucker rats.". (1999): http://europepmc.org/abstract/med/10550416.
    10.1007/s001250051445
  1280. Hansen L; Deacon CF; Orskov C; Holst JJ. "Glucagon-like peptide-1-(7-36)amide is transformed to glucagon-like peptide-1-(9-36)amide by dipeptidyl peptidase IV in the capillaries supplying the L cells of the porcine intestine.". (1999): http://europepmc.org/abstract/med/10537167.
    10.1210/en.140.11.5356
  1281. Holst JJ. "Glucagon-like peptide-1, a gastrointestinal hormone with a pharmaceutical potential.". (1999): http://europepmc.org/abstract/med/10519910.
  1282. Schmidt PT; Eriksen L; Loftager M; Rasmussen TN; Holst JJ. "Fast acting nervous regulation of immunoglobulin A secretion from isolated perfused porcine ileum.". (1999): http://europepmc.org/abstract/med/10517903.
    10.1136/gut.45.5.679
  1283. Thulesen J; Hartmann B; Nielsen C; Holst JJ; Poulsen SS. "Diabetic intestinal growth adaptation and glucagon-like peptide 2 in the rat: effects of dietary fibre.". (1999): http://europepmc.org/abstract/med/10517902.
    10.1136/gut.45.5.672
  1284. Jeppesen PB; Hartmann B; Hansen BS; Thulesen J; Holst JJ; Mortensen PB. "Impaired meal stimulated glucagon-like peptide 2 response in ileal resected short bowel patients with intestinal failure.". (1999): http://europepmc.org/abstract/med/10486365.
    10.1136/gut.45.4.559
  1285. Damholt AB; Buchan AM; Holst JJ; Kofod H. "Proglucagon processing profile in canine L cells expressing endogenous prohormone convertase 1/3 and prohormone convertase 2.". (1999): http://europepmc.org/abstract/med/10499540.
    10.1210/en.140.10.4800
  1286. Holst JJ. "Treatment of Type 2 diabetes mellitus based on glucagon-like peptide-1.". (1999): http://europepmc.org/abstract/med/15992158.
    10.1517/13543784.8.9.1409
  1287. Näslund E; Bogefors J; Skogar S; Grybäck P; Jacobsson H; Holst JJ; Hellström PM. "GLP-1 slows solid gastric emptying and inhibits insulin, glucagon, and PYY release in humans.". (1999): http://europepmc.org/abstract/med/10484511.
  1288. Olesen M; Gudmand-Høyer E; Holst JJ; Jørgensen S. "Importance of colonic bacterial fermentation in short bowel patients: small intestinal malabsorption of easily digestible carbohydrate.". (1999): http://europepmc.org/abstract/med/10505735.
    10.1023/A:1018819428678
  1289. Madsen P; Brand CL; Holst JJ; Knudsen B. "Advances in non-peptide glucagon receptor antagonists.". (1999): http://europepmc.org/abstract/med/10495358.
  1290. Schmidt PT; Rasmussen TN; Holst JJ. "Tachykinins stimulate acid and pepsinogen secretion in the isolated porcine stomach.". (1999): http://europepmc.org/abstract/med/10468671.
    10.1046/j.1365-201x.1999.00569.x
  1291. Holst JJ. "Glucagon-like Peptide 1 (GLP-1): An Intestinal Hormone, Signalling Nutritional Abundance, with an Unusual Therapeutic Potential.". (1999): http://europepmc.org/abstract/med/10407397.
    10.1016/S1043-2760(99)00157-5
  1292. Wøjdemann M; Wettergren A; Hartmann B; Hilsted L; Holst JJ. "Inhibition of sham feeding-stimulated human gastric acid secretion by glucagon-like peptide-2.". (1999): http://europepmc.org/abstract/med/10404829.
    10.1210/jc.84.7.2513
  1293. Schmidt PT; Rickelt LF; Holst JJ. "Tachykinins stimulate release of peptide hormones (glucagon-like peptide-1) and paracrine (somatostatin) and neurotransmitter (vasoactive intestinal polypeptide) from porcine ileum through NK-1 receptors.". (1999): http://europepmc.org/abstract/med/10489905.
    10.1023/A:1026610626068
  1294. Toft-Nielsen MB; Madsbad S; Holst JJ. "Continuous subcutaneous infusion of glucagon-like peptide 1 lowers plasma glucose and reduces appetite in type 2 diabetic patients.". (1999): http://europepmc.org/abstract/med/10388979.
    10.2337/diacare.22.7.1137
  1295. Henriksen JH; Holst JJ; Møller S; Brinch K; Bendtsen F. "Increased circulating leptin in alcoholic cirrhosis: relation to release and disposal.". (1999): http://europepmc.org/abstract/med/10347125.
    10.1002/hep.510290601
  1296. Plöckinger U; Holst JJ; Messerschmidt D; Hopfenmüller W; Quabbe HJ. "Octreotide suppresses the incretin glucagon-like peptide (7-36) amide in patients with acromegaly or clinically nonfunctioning pituitary tumors and in healthy subjects.". (1999): http://europepmc.org/abstract/med/10377503.
    10.1530/eje.0.1400538
  1297. Thomsen C; Rasmussen O; Lousen T; Holst JJ; Fenselau S; Schrezenmeir J; Hermansen K. "Differential effects of saturated and monounsaturated fatty acids on postprandial lipemia and incretin responses in healthy subjects.". (1999): http://europepmc.org/abstract/med/10357731.
  1298. Wøjdemann M; Riber C; Bisgaard T; Sternby B; Larsen S; Rehfeld JF; Holst JJ; Olsen O. "Inhibition of human gastric lipase by intraduodenal fat involves glucagon-like peptide-1 and cholecystokinin.". (1999): http://europepmc.org/abstract/med/10425652.
    10.1016/S0167-0115(99)00011-7
  1299. Tang-Christensen M; Holst JJ; Hartmann B; Vrang N. "The arcuate nucleus is pivotal in mediating the anorectic effects of centrally administered leptin.". (1999): http://europepmc.org/abstract/med/10363921.
    10.1097/00001756-199904260-00005
  1300. Deacon CF; Holst JJ; Carr RD. "Glucagon-like peptide-1: a basis for new approaches to the management of diabetes.". (1999): http://europepmc.org/abstract/med/12973381.
    10.1358/dot.1999.35.3.533845
  1301. Näslund E; Barkeling B; King N; Gutniak M; Blundell JE; Holst JJ; Rössner S; Hellström PM. "Energy intake and appetite are suppressed by glucagon-like peptide-1 (GLP-1) in obese men.". (1999): http://europepmc.org/abstract/med/10193877.
    10.1038/sj.ijo.0800818
  1302. Jensen PB; Kristensen P; Clausen JT; Judge ME; Hastrup S; Thim L; Wulff BS; et al. "The hypothalamic satiety peptide CART is expressed in anorectic and non-anorectic pancreatic islet tumors and in the normal islet of Langerhans.". (1999): http://europepmc.org/abstract/med/10214934.
    10.1016/S0014-5793(99)00291-4
  1303. M. Olesen; E. Gudmand-Høyer; Jens Juul Holst; S. Jørgensen. "Importance of colonic fermentation in short bowel patients. Small intestinal malabsorption of easily digestible carbohydrate". Dig. Dis. Sci. 44 (1999): 1914-1923. https://curis.ku.dk/portal/en/publications/importance-of-colonic-fermentation-in-short-bowel-patients-small-intestinal-malabsorption-of-easily-digestible-carbohydrate(fed6c1d0-74c8-11db-bee9-02004c4f4f50).html.
  1304. P.T. Schmidt; L.F. Rickelt; Jens Juul Holst. "Tachykinins stimulate the release of peptide hormones (glucagon-like peptide-1), and paracrine - (somatostatin) and neurotransmitters (vasoactive intestinal polypeptide) from porcine ileum through NK-1 receptors". Digestive Diseases and Sciences 44 (1999): 1273-1281. https://curis.ku.dk/portal/en/publications/tachykinins-stimulate-the-release-of-peptide-hormones-glucagonlike-peptide1-and-paracrine--somatostatin-and-neurotransmitters-vasoactive-intestinal-polypeptide-from-porcine-ileum-through-nk1-receptors(fc704920-74.
  1305. A.B. Damholt; A.M.J. Buchan; Jens Juul Holst; H. Kofod. "Proglucagon cleavage profile in canine L-cells expressing endogenous PC-1/3 and PC-2". Endokrinologiya 140 (1999): 4800-4808. https://curis.ku.dk/portal/en/publications/proglucagon-cleavage-profile-in-canine-lcells-expressing-endogenous-pc13-and-pc2(fc6302b0-74c8-11db-bee9-02004c4f4f50).html.
  1306. P. Madsen; L.B. Knudsen; C.L. Brand; Jens Juul Holst. "Advances in non-peptide glucagon receptor antagonist". Curr. Pharm Design 5 (1999): 683-691. https://curis.ku.dk/portal/en/publications/advances-in-nonpeptide-glucagon-receptor-antagonist(e3f3ab80-74c8-11db-bee9-02004c4f4f50).html.
  1307. M. Tang-Christensen; Jens Juul Holst; Bolette Hartmann; Niels Vrang. "The arcuate nucleus is pivotal in mediating the anorectic effects of centrally administered leptin". NeuroReport 10 (1999): 1183-1187. https://curis.ku.dk/portal/en/publications/the-arcuate-nucleus-is-pivotal-in-mediating-the-anorectic-effects-of-centrally-administered-leptin(08a1e330-74c8-11db-bee9-02004c4f4f50).html.
  1308. P.T. Schmidt; T.N. Rasmussen; Jens Juul Holst. "Tachykinins stimulate acid and pepsinogen secretion in the isolated perfused porcine stomach". Acta Physiologica (Print Edition) 166 (1999): 335-340. https://curis.ku.dk/portal/en/publications/tachykinins-stimulate-acid-and-pepsinogen-secretion-in-the-isolated-perfused-porcine-stomach(fc46c820-74c8-11db-bee9-02004c4f4f50).html.
  1309. P.B. Jeppesen; B.S. Hansen; B. Hartmann; Jens Juul Holst; P.B. Mortensen. "Impaired meal-stimulated glucagon-like peptide-2 responses in short bowel patients with intestinal failure". Gut 45 (1999): 559-563. https://curis.ku.dk/portal/en/publications/impaired-mealstimulated-glucagonlike-peptide2-responses-in-short-bowel-patients-with-intestinal-failure(e4c77640-74c8-11db-bee9-02004c4f4f50).html.
  1310. Jens Juul Holst. "Glucagon-like peptide-1, a gastrointestinal hormone with a pharmaceutical potential". Current Medicinal Chemistry 6 (1999): 1005-1017. https://curis.ku.dk/portal/en/publications/glucagonlike-peptide1-a-gastrointestinal-hormone-with-a-pharmaceutical-potential(e4702e80-74c8-11db-bee9-02004c4f4f50).html.
  1311. B. Klausen; S. Toubro; C. Ranneries; J.F. Rehfeld; Jens Juul Holst; N.J. Christensen; Arne Astrup. "Increased intensity of physical activity stimulates subsequent fat intake". International Journal of Obesity 23 (1999): 1282-1287. https://curis.ku.dk/portal/en/publications/increased-intensity-of-physical-activity-stimulates-subsequent-fat-intake(fb6cb140-74c7-11db-bee9-02004c4f4f50).html.
  1312. Birgit Nyholm; M.J.C. Walker; C.H. Gravholdt; K.G.M.M. Alberti; Jens Juul Holst; O. Schmitz. "Hour profiles of insulin, subtrates and gut incretin hormones: Early defects in glucose tolerant offspring of type II (non-insulin dependent) diabetic paitents". Diabetologia 42 (1999): 1314-1323. https://curis.ku.dk/portal/en/publications/hour-profiles-of-insulin-subtrates-and-gut-incretin-hormones-early-defects-in-glucose-tolerant-offspring-of-type-ii-noninsulin-dependent-diabetic-paitents(fd6dbbf0-74c8-11db-bee9-02004c4f4f50).html.
  1313. B. Balkan; L. Kwasnik; R. Miserendino; Jens Juul Holst; X. Lie. "Inhibition of dipeptidyl peptidase IV with NVP DPP728 increases plasma GLP-1 (7-36amide) concentrations and improves oral glucose tolerance in obese Zucker rats". Diabetologia 42 (1999): 1324-1331. https://curis.ku.dk/portal/en/publications/inhibition-of-dipeptidyl-peptidase-iv-with-nvp-dpp728-increases-plasma-glp1-736amide-concentrations-and-improves-oral-glucose-tolerance-in-obese-zucker-rats(ecafff80-74c8-11db-bee9-02004c4f4f50).html.
  1314. K. Bokvist; M. Høy; Karsten Buschard; Jens Juul Holst; M.K. Thomsen; Jesper Lindgren Gromada. "Selectivity of prandial glucose regulators: nateglinide, but not repaglinide, accelerates exocytosis in rat pancreatic A-cells". Eur. J. Pharmacol. 386 (1999): 105-111. https://curis.ku.dk/portal/en/publications/selectivity-of-prandial-glucose-regulators-nateglinide-but-not-repaglinide-accelerates-exocytosis-in-rat-pancreatic-acells(f76f1dd0-74c7-11db-bee9-02004c4f4f50).html.
  1315. P.B. Jensen; P. Kristensen; J.T. Clausen; M.E. Judge; S. Hastrup; Lars Thim; B. S. Wulff; et al. "The hypothalamic satiety peptide CART is expressed in anorectic and non-anorectic pancreatic islet tumors and in the normal islet of Langerhans". FEBS Letters 447 (1999): 139-143. https://curis.ku.dk/portal/en/publications/the-hypothalamic-satiety-peptide-cart-is-expressed-in-anorectic-and-nonanorectic-pancreatic-islet-tumors-and-in-the-normal-islet-of-langerhans(fc556e20-74c8-11db-bee9-02004c4f4f50).html.
  1316. U. Plöckinger; Jens Juul Holst; D. Messerschmidt; W. Hopfenmüller; H.J. Quabbe. "Octreotide suppresses the incretin GLP-1 in patients with acromegally, clinically nonfunctioning pituitary tumours and in healthy subjects". European Journal of Endocrinology 140 (1999): 538-544. https://curis.ku.dk/portal/en/publications/octreotide-suppresses-the-incretin-glp1-in-patients-with-acromegally-clinically-nonfunctioning-pituitary-tumours-and-in-healthy-subjects(fc2d73c0-74c8-11db-bee9-02004c4f4f50).html.
  1317. Jens Juul Holst. "Glucagon-like peptide-1 (GLP-1): An intestinal hormone, signalling nutritional abundance, with an unusual therapeutic potential". Trends in Endocrinology and Metabolism 10 (1999): 229-235. https://curis.ku.dk/portal/en/publications/glucagonlike-peptide1-glp1-an-intestinal-hormone-signalling-nutritional-abundance-with-an-unusual-therapeutic-potential(e49c6ea0-74c8-11db-bee9-02004c4f4f50).html.
  1318. E. Näslund; B. Barkeling; N. King; M.K. Gutniak; J.E. Blundell; Jens Juul Holst; S. Rössner; P.M. Hellström. "Energy intake and appetite is suppressed by glucagon-like peptide-1 (GLP-1) in obese men". International Journal of Obesity 23 (1999): 304-311. https://curis.ku.dk/portal/en/publications/energy-intake-and-appetite-is-suppressed-by-glucagonlike-peptide1-glp1-in-obese-men(fda12800-74c8-11db-bee9-02004c4f4f50).html.
  1319. M. Wøjdemann; A. Wettergren; B. Hartmann; L.M. Hilsted; Jens Juul Holst. "Inhibition of shamfeeding stimulated human gastric acid secretion by glucagon-like peptide-2". J. Clin. Endocrinol. Metab. 84 (1999): 2513-2517. https://curis.ku.dk/portal/en/publications/inhibition-of-shamfeeding-stimulated-human-gastric-acid-secretion-by-glucagonlike-peptide2(fc39f6e0-74c8-11db-bee9-02004c4f4f50).html.
  1320. M.B. Toft-Nielsen; S. Madsbad; Jens Juul Holst. "Continuous subcutaneous infusion of Glucagon-like Peptide-1 (GLP-1) lowers plasma glucose and reduces appetite in type II diabetic patients". Diabetes Care 22 (1999): 1137-1143. https://curis.ku.dk/portal/en/publications/continuous-subcutaneous-infusion-of-glucagonlike-peptide1-glp1-lowers-plasma-glucose-and-reduces-appetite-in-type-ii-diabetic-patients(fd94a4e0-74c8-11db-bee9-02004c4f4f50).html.
  1321. Jens H. Henriksen; Jens Juul Holst; S. Møller; K. Brinch; Flemming Bendtsen. "Increased Circulating leptin in cirrhosis: relation to release and disposal". Hepatology 29 (1999): 1818-1824. https://curis.ku.dk/portal/en/publications/increased-circulating-leptin-in-cirrhosis-relation-to-release-and-disposal(fc1dbc50-74c8-11db-bee9-02004c4f4f50).html.
  1322. P.T. Schmidt; L. Eriksen; M. Loftager; T.N. Rasmussen; Jens Juul Holst. "Fast acting nervous regulation of immunoglobulin A secretion from isolated perfused porcine ileum". Gut 45 (1999): 679-685. https://curis.ku.dk/portal/en/publications/fast-acting-nervous-regulation-of-immunoglobulin-a-secretion-from-isolated-perfused-porcine-ileum(ffa95410-74c8-11db-bee9-02004c4f4f50).html.
  1323. E. Näslund; J. Bogefors; S. Skogar; P. Grybäck; H.L. Jacobsen; Jens Juul Holst; P.M. Helström. "Glucagon-like peptide-1 slows solid gastric emptying and inhibits insulin, glucagon and peptide YY release in humans". Am. J. Physiol. 277 (1999): 910-916. https://curis.ku.dk/portal/en/publications/glucagonlike-peptide1-slows-solid-gastric-emptying-and-inhibits-insulin-glucagon-and-peptide-yy-release-in-humans(fd00c950-74c8-11db-bee9-02004c4f4f50).html.
  1324. C. Thomsen; O. Rasmussen; T. Lousen; K. Hermansen; Jens Juul Holst. "Differential effects of saturated and monounsaturated fat on postprandial lipaemia and GIP/GLP-1 response in healthy subjects". Am. J. Clin. Nutri. 69 (1999): 1135-1143. https://curis.ku.dk/portal/en/publications/differential-effects-of-saturated-and-monounsaturated-fat-on-postprandial-lipaemia-and-gipglp1-response-in-healthy-subjects(ff9be690-74c8-11db-bee9-02004c4f4f50).html.
  1325. M. Wøjdemann; C. Riber; T. Bisgaard; B. Sternby; S. Larsen; J.F. Rehfeld; Jens Juul Holst; O. Olesen. "Human gastric lipase secretion is inhibited by intraduodenal perfusion of dietary fat.". Regulatory Peptides 80 (1999): 101-106. https://curis.ku.dk/portal/en/publications/human-gastric-lipase-secretion-is-inhibited-by-intraduodenal-perfusion-of-dietary-fat(fd86c230-74c8-11db-bee9-02004c4f4f50).html.
  1326. L. Hansen; Carolyn Deacon; C. Ørskov; Jens Juul Holst. "Glucagon-like peptide-1(7-36)amide is transformed to glucagon-like peptide-1 (9-36)amide by dipeptidyl peptidase IV in the capillaries supplying the intestinal L-cells". Endokrinologiya 140 (1999): 5356-5363. https://curis.ku.dk/portal/en/publications/glucagonlike-peptide1736amide-is-transformed-to-glucagonlike-peptide1-936amide-by-dipeptidyl-peptidase-iv-in-the-capillaries-supplying-the-intestinal-lcells(e43102a0-74c8-11db-bee9-02004c4f4f50).html.
  1327. Holst JJ; Deacon C; Toft-Nielsen MB; Bjerre-Knudsen L. "On the treatment of diabetes mellitus with glucagon-like peptide-1.". (1998): http://europepmc.org/abstract/med/9928027.
    10.1111/j.1749-6632.1998.tb11193.x
  1328. Wettergren A; Wøjdemann M; Holst JJ. "Glucagon-like peptide-1 inhibits gastropancreatic function by inhibiting central parasympathetic outflow.". (1998): http://europepmc.org/abstract/med/9815028.
  1329. Nauck MA; Weber I; Bach I; Richter S; Orskov C; Holst JJ; Schmiegel W. "Normalization of fasting glycaemia by intravenous GLP-1 ([7-36 amide] or [7-37]) in type 2 diabetic patients.". (1998): http://europepmc.org/abstract/med/9827848.
    10.1002/(SICI)1096-9136(1998110)15:11<937::AID-DIA701>3.0.CO;2-0
  1330. Zimmermann-Belsing T; Dreyer M; Holst JJ; Feldt-Rasmussen U. "The relationship between the serum leptin concentrations of thyrotoxic patients during treatment and their total fat mass is different from that of normal subjects.". (1998): http://europepmc.org/abstract/med/10197073.
    10.1046/j.1365-2265.1998.00627.x
  1331. Nauck MA; Sauerwald A; Ritzel R; Holst JJ; Schmiegel W. "Influence of glucagon-like peptide 1 on fasting glycemia in type 2 diabetic patients treated with insulin after sulfonylurea secondary failure.". (1998): http://europepmc.org/abstract/med/9802745.
    10.2337/diacare.21.11.1925
  1332. Holst JJ; Deacon CF. "Inhibition of the activity of dipeptidyl-peptidase IV as a treatment for type 2 diabetes.". (1998): http://europepmc.org/abstract/med/9792533.
    10.2337/diabetes.47.11.1663
  1333. Toft-Nielsen M; Madsbad S; Holst JJ. "Exaggerated secretion of glucagon-like peptide-1 (GLP-1) could cause reactive hypoglycaemia.". (1998): http://europepmc.org/abstract/med/9794105.
    10.1007/s001250051049
  1334. Tolessa T; Gutniak M; Holst JJ; Efendic S; Hellström PM. "Glucagon-like peptide-1 retards gastric emptying and small bowel transit in the rat: effect mediated through central or enteric nervous mechanisms.". (1998): http://europepmc.org/abstract/med/9790467.
    10.1023/A:1026678925120
  1335. Wettergren A; Pridal L; Wøjdemann M; Holst JJ. "Amidated and non-amidated glucagon-like peptide-1 (GLP-1): non-pancreatic effects (cephalic phase acid secretion) and stability in plasma in humans.". (1998): http://europepmc.org/abstract/med/9809800.
    10.1016/S0167-0115(98)00044-5
  1336. Almind K; Ambye L; Urhammer SA; Hansen T; Echwald SM; Holst JJ; Gromada J; Thorens B; Pedersen O. "Discovery of amino acid variants in the human glucose-dependent insulinotropic polypeptide (GIP) receptor: the impact on the pancreatic beta cell responses and functional expression studies in Chinese hamster fibroblast cells.". (1998): http://europepmc.org/abstract/med/9794107.
    10.1007/s001250051051
  1337. Tolessa T; Gutniak M; Holst JJ; Efendic S; Hellström PM. "Inhibitory effect of glucagon-like peptide-1 on small bowel motility. Fasting but not fed motility inhibited via nitric oxide independently of insulin and somatostatin.". (1998): http://europepmc.org/abstract/med/9710445.
    10.1172/JCI942
  1338. Wøjdemann M; Wettergren A; Hartmann B; Holst JJ. "Glucagon-like peptide-2 inhibits centrally induced antral motility in pigs.". (1998): http://europepmc.org/abstract/med/9754730.
    10.1080/00365529850171486
  1339. Näslund E; Backman L; Holst JJ; Theodorsson E; Hellström PM. "Importance of small bowel peptides for the improved glucose metabolism 20 years after jejunoileal bypass for obesity.". (1998): http://europepmc.org/abstract/med/9678192.
    10.1381/096089298765554449
  1340. Seifarth C; Bergmann J; Holst JJ; Ritzel R; Schmiegel W; Nauck MA. "Prolonged and enhanced secretion of glucagon-like peptide 1 (7-36 amide) after oral sucrose due to alpha-glucosidase inhibition (acarbose) in Type 2 diabetic patients.". (1998): http://europepmc.org/abstract/med/9632123.
    10.1002/(SICI)1096-9136(199806)15:6<485::AID-DIA610>3.0.CO;2-Y
  1341. Deacon CF; Hughes TE; Holst JJ. "Dipeptidyl peptidase IV inhibition potentiates the insulinotropic effect of glucagon-like peptide 1 in the anesthetized pig.". (1998): http://europepmc.org/abstract/med/9588448.
    10.2337/diabetes.47.5.764
  1342. Näslund E; Grybäck P; Backman L; Jacobsson H; Holst JJ; Theodorsson E; Hellström PM. "Distal small bowel hormones: correlation with fasting antroduodenal motility and gastric emptying.". (1998): http://europepmc.org/abstract/med/9590405.
    10.1023/A:1018806129102
  1343. Gromada J; Holst JJ; Rorsman P. "Cellular regulation of islet hormone secretion by the incretin hormone glucagon-like peptide 1.". (1998): http://europepmc.org/abstract/med/9479010.
    10.1007/s004240050558
  1344. Holst JJ. "[Glucagon-like peptide-1--a new hormone and a new drug]". (1998): http://europepmc.org/abstract/med/9571809.
  1345. Wøjdemann M; Wettergren A; Sternby B; Holst JJ; Larsen S; Rehfeld JF; Olsen O. "Inhibition of human gastric lipase secretion by glucagon-like peptide-1.". (1998): http://europepmc.org/abstract/med/9558037.
    10.1023/A:1018874300026
  1346. Deacon CF; Knudsen LB; Madsen K; Wiberg FC; Jacobsen O; Holst JJ. "Dipeptidyl peptidase IV resistant analogues of glucagon-like peptide-1 which have extended metabolic stability and improved biological activity.". (1998): http://europepmc.org/abstract/med/9541166.
    10.1007/s001250050903
  1347. Rasmussen TN; Bersani M; Schmidt P; Thim L; Kofod H; Jørgensen PN; Poulsen SS; Holst JJ. "Isolation and molecular characterization of porcine calcitonin gene-related peptide (CGRP) and its endocrine effects in the porcine pancreas.". (1998): http://europepmc.org/abstract/med/9510144.
  1348. Flint A; Raben A; Astrup A; Holst JJ. "Glucagon-like peptide 1 promotes satiety and suppresses energy intake in humans.". (1998): http://europepmc.org/abstract/med/9449682.
    10.1172/JCI990
  1349. Holst JJ. "[Obesity--did anything happen since leptin?]". (1998): http://europepmc.org/abstract/med/9492632.
  1350. Gromada J; Bokvist K; Ding WG; Holst JJ; Nielsen JH; Rorsman P. "Glucagon-like peptide 1 (7-36) amide stimulates exocytosis in human pancreatic beta-cells by both proximal and distal regulatory steps in stimulus-secretion coupling.". (1998): http://europepmc.org/abstract/med/9421375.
    10.2337/diab.47.1.57
  1351. Jensen PB; Blume N; Mikkelsen JD; Larsen PJ; Jensen HI; Holst JJ; Madsen OD. "Transplantable rat glucagonomas cause acute onset of severe anorexia and adipsia despite highly elevated NPY mRNA levels in the hypothalamic arcuate nucleus.". (1998): http://europepmc.org/abstract/med/9435324.
    10.1172/JCI275
  1352. Svartberg J; Holst JJ; Gutniak M; Adner N. "The ethanol augmentation of glucose-induced insulin secretion is abolished by calcium antagonism with nifedipine: no evidence for a role of glucagon-like peptide-1 (GLP-1).". (1998): http://europepmc.org/abstract/med/9436865.
  1353. Pørksen N; Grøfte B; Nyholm B; Holst JJ; Pincus SM; Veldhuis JD; Schmitz O; Butler PC. "Glucagon-like peptide 1 increases mass but not frequency or orderliness of pulsatile insulin secretion.". (1998): http://europepmc.org/abstract/med/9421373.
    10.2337/diab.47.1.45
  1354. Willms B; Idowu K; Holst JJ; Creutzfeldt W; Nauck MA. "Overnight GLP-1 normalizes fasting but not daytime plasma glucose levels in NIDDM patients.". (1998): http://europepmc.org/abstract/med/9628239.
  1355. Wettergren A; Wøjdemann M; Holst JJ. "The inhibitory effect of glucagon-like peptide-1 (7-36)amide on antral motility is antagonized by its N-terminally truncated primary metabolite GLP-1 (9-36)amide.". (1998): http://europepmc.org/abstract/med/9663453.
    10.1016/S0196-9781(98)00020-5
  1356. A. Flint; Anne Raben; Arne Astrup; Jens Juul Holst. "Glucagon-like peptide 1 promotes satiety and suppresses energy intake in humans". Journal of Clinical Investigation 101 3 (1998): 515-520. https://curis.ku.dk/portal/en/publications/glucagonlike-peptide-1-promotes-satiety-and-suppresses-energy-intake-in-humans(1f7ef010-a1b8-11dd-b6ae-000ea68e967b).html.
  1357. M.A. Nauck; A. Sauerwald; R. Ritzel; Jens Juul Holst; W. Schmiegel. "Influence of glucagon-like peptide 1 on fasting glycemia in type 2 diabetic patients treated with insulin after sulfonylurea secondary failure". Diabetes Care 21 (1998): 1925-1931. https://curis.ku.dk/portal/en/publications/influence-of-glucagonlike-peptide-1-on-fasting-glycemia-in-type-2-diabetic-patients-treated-with-insulin-after-sulfonylurea-secondary-failure(d65fe960-74c9-11db-bee9-02004c4f4f50).html.
  1358. M Toft-Nielsen; Sten Madsbad; Jens Juul Holst. "Exaggerated secretion of glucagon-like peptide-1 (GLP-1) could cause reactive hypoglycaemia". Diabetologia 41 10 (1998): 1180-1186. https://curis.ku.dk/portal/en/publications/exaggerated-secretion-of-glucagonlike-peptide1-glp1-could-cause-reactive-hypoglycaemia(d5e36660-74c9-11db-bee9-02004c4f4f50).html.
  1359. M. Wojdemann; A. Wettergren; Bolette Hartmann; Jens Juul Holst. "Glucagon-like peptide-2 inhibits centrally induced antral motility in pigs". Scandinavian Journal of Gastroenterology 33 (1998): 828-832. https://curis.ku.dk/portal/en/publications/glucagonlike-peptide2-inhibits-centrally-induced-antral-motility-in-pigs(d2ce1010-74c9-11db-bee9-02004c4f4f50).html.
  1360. K. Almind; Louise Ambye; S.A. Urhammer; T. Hansen; S.M. Echwald; Jens Juul Holst; Jesper Lindgren Gromada; B. Thorens; O. Pedersen. "Discovery of amino acid variants in the human glucose-dependent insulinotropic polypeptide (GIP) receptor: the impact on the pancreatic beta cell responses and functional expression studies in CHL cells". Diabetologia 41 (1998): 1194-1198. https://curis.ku.dk/portal/en/publications/discovery-of-amino-acid-variants-in-the-human-glucosedependent-insulinotropic-polypeptide-gip-receptor-the-impact-on-the-pancreatic-beta-cell-responses-and-functional-expression-studies-in-chl-cells(ffd34a40-74c8.
  1361. Jens Juul Holst; Carolyn Deacon; M. Toft-Nielsen; L. Bjerre-Knudsen. "On the treatment of diabetes mellitus with glucagon-like peptide-1.". Annals of the New York Academy of Sciences 865 (1998): 336-343. https://curis.ku.dk/portal/en/publications/on-the-treatment-of-diabetes-mellitus-with-glucagonlike-peptide1(cbd0aa20-74c9-11db-bee9-02004c4f4f50).html.
  1362. Jens Juul Holst; K. Gromada; P. Rorsman. "Cellular regulation of islet hormone secretion by the incretin hormone glucagon-like peptide 1.". Pflugers Arch. 435 (1998): 583-594. https://curis.ku.dk/portal/en/publications/cellular-regulation-of-islet-hormone-secretion-by-the-incretin-hormone-glucagonlike-peptide-1(daf43e90-74c9-11db-bee9-02004c4f4f50).html.
  1363. A. Wettergren; L. Pridal; M. Wöjdemann; Jens Juul Holst. "Amidated and non-amidated glucagon-like peptide-1 (GLP-1): non-pancreatic effects (cephalic phase acid secretion) and stability in plasma in humans". Regul. Pept. 77 (1998): 83-88. https://curis.ku.dk/portal/en/publications/amidated-and-nonamidated-glucagonlike-peptide1-glp1-nonpancreatic-effects-cephalic-phase-acid-secretion-and-stability-in-plasma-in-humans(febaae50-74c8-11db-bee9-02004c4f4f50).html.
  1364. M.A. Nauck; I. Weber; I. Bach; S.H. Richter; C. Ørskov; Jens Juul Holst; W. Schmiegel. "Normalization of sting glycemia by intravenous GLP-1 (7-36amide) or (7-37) in Type 2 diabetic patients". Diabetic Medicine 15 (1998): 937-945. https://curis.ku.dk/portal/en/publications/normalization-of-sting-glycemia-by-intravenous-glp1-736amide-or-737-in-type-2-diabetic-patients(fdcdb640-74c8-11db-bee9-02004c4f4f50).html.
  1365. A. Wettergren; M. Wojdemann; Jens Juul Holst. "Glucagon-like peptide-1 inhibits gastropancreatic function by inhibiting central parasympathetic outflow". Am. J. Physiol. 275 (1998): G984-G992. https://curis.ku.dk/portal/en/publications/glucagonlike-peptide1-inhibits-gastropancreatic-function-by-inhibiting-central-parasympathetic-outflow(d59d0e90-74c9-11db-bee9-02004c4f4f50).html.
  1366. B. Willms; K. Idowu; Jens Juul Holst; W. Creutzfeldt; M.A. Nauck. "Overnight GLP-1 normalizes fasting but not daytime plasma glucose levels in NIDDM patients". Exp. Clin. Endocrinol. Diabetes 106 (1998): 103-107. https://curis.ku.dk/portal/en/publications/overnight-glp1-normalizes-fasting-but-not-daytime-plasma-glucose-levels-in-niddm-patients(d5847d80-74c9-11db-bee9-02004c4f4f50).html.
  1367. T. Zimmermann-Belsing; M. Dreyer; Jens Juul Holst; U. Feldt-Rasmussen. "Changes in serum leptin do not correlate to total fat mass in patients with thyrotoxicosis". J. Endocrinol. 49 (1998): 589-595. https://curis.ku.dk/portal/en/publications/changes-in-serum-leptin-do-not-correlate-to-total-fat-mass-in-patients-with-thyrotoxicosis(ff8ddcd0-74c8-11db-bee9-02004c4f4f50).html.
  1368. P.B. Jensen; N. Blume; J.D. Mikkelsen; P.J. Larsen; H.I. Jensen; Jens Juul Holst; O.D. Madsen. "Transplantable rat glucagonomas cause acute onset of severe anorexia and adipsia despite highly elevated NPY mRNA levels in the hypothalamic arcuate nucleus". J. Clin. Invest. 101 (1998): 503-510. https://curis.ku.dk/portal/en/publications/transplantable-rat-glucagonomas-cause-acute-onset-of-severe-anorexia-and-adipsia-despite-highly-elevated-npy-mrna-levels-in-the-hypothalamic-arcuate-nucleus(c0b50960-74c9-11db-bee9-02004c4f4f50).html.
  1369. Carolyn Deacon; L.B. Knudsen; K. Madsen; F.C. Wiberg; O. Jacobsen; Jens Juul Holst. "Dipeptidyl peptidase IV resistant analogues of glucagon-like peptide-1 which have extended metabolic stability and improved biological activity". Diabetologia 41 (1998): 271-278. https://curis.ku.dk/portal/en/publications/dipeptidyl-peptidase-iv-resistant-analogues-of-glucagonlike-peptide1-which-have-extended-metabolic-stability-and-improved-biological-activity(dcc18480-74c9-11db-bee9-02004c4f4f50).html.
  1370. N. Porksen; T. Grøfte; Birgit Nyholm; Jens Juul Holst; S.M. Pincus; J.D. Veldhuis; O. Schmitz; P.C. Butler. "Glucagon-like peptide 1 increases mass but not frequency or orderliness of pulsatile insulin secretion". Diabetes 47 (1998): 45-49. https://curis.ku.dk/portal/en/publications/glucagonlike-peptide-1-increases-mass-but-not-frequency-or-orderliness-of-pulsatile-insulin-secretion(d64adac0-74c9-11db-bee9-02004c4f4f50).html.
  1371. Jens Juul Holst. "Glucagon-like peptide-1 - a new hormone and a new drug". Ugeskrift for læger 160 (1998): 2371-2377. https://curis.ku.dk/portal/en/publications/glucagonlike-peptide1--a-new-hormone-and-a-new-drug(dad39730-74c9-11db-bee9-02004c4f4f50).html.
  1372. Carolyn Deacon; T.E. Hughes; Jens Juul Holst. "Dipeptidyl peptidase IV inhibition potentiates the insulinotropic effect of glucagon-like peptide 1 in the anesthetized pig.". Diabetes 47 (1998): 764-769. https://curis.ku.dk/portal/en/publications/dipeptidyl-peptidase-iv-inhibition-potentiates-the-insulinotropic-effect-of-glucagonlike-peptide-1-in-the-anesthetized-pig(dcf73a80-74c9-11db-bee9-02004c4f4f50).html.
  1373. Jens Juul Holst. "Obesity - did anything happen since leptin?". Ugeskrift for læger 160 (1998): 1182-1184. https://curis.ku.dk/portal/en/publications/obesity--did-anything-happen-since-leptin(dac629b0-74c9-11db-bee9-02004c4f4f50).html.
  1374. J. Svartberg; Jens Juul Holst; M.K. Gutniak; N. Adner. "The ethanol augmentation of glucose-induced insulin secretion is abolished by calcium antagonism with nifedipine: No evidence for a role of glucagon-like peptide-1 (GLP-1)". Pancreas 16 (1998): 66-71. https://curis.ku.dk/portal/en/publications/the-ethanol-augmentation-of-glucoseinduced-insulin-secretion-is-abolished-by-calcium-antagonism-with-nifedipine-no-evidence-for-a-role-of-glucagonlike-peptide1-glp1(d5fa49c0-74c9-11db-bee9-02004c4f4f50).html.
  1375. M. Wojdemann; A. Wettergren; B. Sternby; Jens Juul Holst; S. Larsen; J.F. Rehfeld; O. Olsen. "Inhibition of human gastric lipase secretion by glucagon-like peptide-1". Dig. Dis. Sci. 43 (1998): 799-805. https://curis.ku.dk/portal/en/publications/inhibition-of-human-gastric-lipase-secretion-by-glucagonlike-peptide1(d2b7c8f0-74c9-11db-bee9-02004c4f4f50).html.
  1376. E. Naslund; P. Gryback; L. Backman; H. Jacobsson; Jens Juul Holst; E. Theodorsson; P.M. Hellstrom. "Distal small bowel hormones: Correlation with fasting antroduodenal motility and gastric emptying". Dig. Dis. Sci. 43 (1998): 945-952. https://curis.ku.dk/portal/en/publications/distal-small-bowel-hormones-correlation-with-fasting-antroduodenal-motility-and-gastric-emptying(d67a4f30-74c9-11db-bee9-02004c4f4f50).html.
  1377. C. Seifarth; Jesper Bergmann; Jens Juul Holst; R. Ritzel; W. Schmiegel; M.A. Nauck. "Prolonged and enhanced secretion of glucagon-like peptide 1 (7-36 amide) after oral sucrose due to alpha-glucosidase inhibition (acarbose) in Type 2 diabetic patients". Diabet. Med. 15 (1998): 485-491. https://curis.ku.dk/portal/en/publications/prolonged-and-enhanced-secretion-of-glucagonlike-peptide-1-736-amide-after-oral-sucrose-due-to-alphaglucosidase-inhibition-acarbose-in-type-2-diabetic-patients(d6176eb0-74c9-11db-bee9-02004c4f4f50).html.
  1378. A. Wettergren; M. Wojdemann; Jens Juul Holst. "The inhibitory effect of glucagon-like peptide-1 (7-36) amide on antral motility is antagonized by its N-terminally truncated primary metabolite GLP-1 (9-36) amide.". Peptides 19 (1998): 877-882. https://curis.ku.dk/portal/en/publications/the-inhibitory-effect-of-glucagonlike-peptide1-736-amide-on-antral-motility-is-antagonized-by-its-nterminally-truncated-primary-metabolite-glp1-936-amide(d590d990-74c9-11db-bee9-02004c4f4f50).html.
  1379. Jens Juul Holst. "Treatment of type 2 diabetes with glucagonlike peptide 1". Current Opinion in Endocrin. and Diabetes 5 (1998): 108-115. https://curis.ku.dk/portal/en/publications/treatment-of-type-2-diabetes-with-glucagonlike-peptide-1(cba63ec0-74c9-11db-bee9-02004c4f4f50).html.
  1380. E. Naslund; L. Backman; Jens Juul Holst; E. Theodorsson; P.M. Hellstrom. "Importance of small bowel peptides for the improved glucose metabolism 20 years after jejunoileal bypass for obesity". Obes. Surg. 8 (1998): 253-260. https://curis.ku.dk/portal/en/publications/importance-of-small-bowel-peptides-for-the-improved-glucose-metabolism-20-years-after-jejunoileal-bypass-for-obesity(d66d7df0-74c9-11db-bee9-02004c4f4f50).html.
  1381. T. Tolessa; M.K. Gutniak; Jens Juul Holst; S. Efendic; P.M. Hellstrom. "Glucagon-like peptide-1 retards gastric emptying and small bowel transit in the rat: Effect mediated through central or enteric nervous mechanisms". Dig. Dis. Sci. 43 (1998): 2284-2290. https://curis.ku.dk/portal/en/publications/glucagonlike-peptide1-retards-gastric-emptying-and-small-bowel-transit-in-the-rat-effect-mediated-through-central-or-enteric-nervous-mechanisms(d5b68a00-74c9-11db-bee9-02004c4f4f50).html.
  1382. T. Tolessa; M.K. Gutniak; Jens Juul Holst; S. Efendic; P.M. Hellstrom. "Inhibitory effect of glucagon-like peptide-1 on small bowel motility. Fasting but not fed motility inhibited via nitric oxide independently of insulin and somatostatin". J. Clin. Invest. 102 (1998): 764-774. https://curis.ku.dk/portal/en/publications/inhibitory-effect-of-glucagonlike-peptide1-on-small-bowel-motility-fasting-but-not-fed-motility-inhibited-via-nitric-oxide-independently-of-insulin-and-somatostatin(d5aa2df0-74c9-11db-bee9-02004c4f4f50).html.
  1383. Jens Juul Holst; Carolyn Deacon. "Inhibition of the activity of dipeptidyl-peptidase IV as a treatment for type 2 diabetes". Diabetes 47 (1998): 1663-1670. https://curis.ku.dk/portal/en/publications/inhibition-of-the-activity-of-dipeptidylpeptidase-iv-as-a-treatment-for-type-2-diabetes(cd2abbe0-74c9-11db-bee9-02004c4f4f50).html.
  1384. Holst JJ. "[Molecular biology of pain. Cloning of a temperature sensitive pain receptor]". (1997): http://europepmc.org/abstract/med/9424783.
  1385. Gutniak MK; Larsson H; Sanders SW; Juneskans O; Holst JJ; Ahrén B. "GLP-1 tablet in type 2 diabetes in fasting and postprandial conditions.". (1997): http://europepmc.org/abstract/med/9405910.
    10.2337/diacare.20.12.1874
  1386. Rasmussen TN; Harling H; Rehfeld JF; Holst JJ. "Calcitonin gene-related peptide (CGRP), a potent regulator of biliary flow.". (1997): http://europepmc.org/abstract/med/9430789.
    10.1046/j.1365-2982.1997.d01-57.x
  1387. Nauck MA; Niedereichholz U; Ettler R; Holst JJ; Orskov C; Ritzel R; Schmiegel WH. "Glucagon-like peptide 1 inhibition of gastric emptying outweighs its insulinotropic effects in healthy humans.". (1997): http://europepmc.org/abstract/med/9374685.
  1388. Nauck MA; Holst JJ; Willms B. "Glucagon-like peptide 1 and its potential in the treatment of non-insulin-dependent diabetes mellitus.". (1997): http://europepmc.org/abstract/med/9370106.
  1389. Rasmussen L; Qvist N; Oster-Jørgensen E; Rehfeld JF; Holst JJ; Pedersen SA. "A double-blind placebo-controlled study on the effects of omeprazole on gut hormone secretion and gastric emptying rate.". (1997): http://europepmc.org/abstract/med/9299668.
  1390. Holst JJ; Gromada J; Nauck MA. "The pathogenesis of NIDDM involves a defective expression of the GIP receptor.". (1997): http://europepmc.org/abstract/med/9267997.
    10.1007/s001250050779
  1391. Ahrén B; Larsson H; Holst JJ. "Reduced gastric inhibitory polypeptide but normal glucagon-like peptide 1 response to oral glucose in postmenopausal women with impaired glucose tolerance.". (1997): http://europepmc.org/abstract/med/9272099.
    10.1530/eje.0.1370127
  1392. Gröger G; Unger A; Holst JJ; Goebell H; Layer P. "Ileal carbohydrates inhibit cholinergically stimulated exocrine pancreatic secretion in humans.". (1997): http://europepmc.org/abstract/med/9387021.
    10.1007/BF02803901
  1393. Larsson H; Holst JJ; Ahrén B. "Glucagon-like peptide-1 reduces hepatic glucose production indirectly through insulin and glucagon in humans.". (1997): http://europepmc.org/abstract/med/9338524.
    10.1046/j.1365-201X.1997.00161.x
  1394. Tornøe K; Hannibal J; Fahrenkrug J; Holst JJ. "PACAP-(1-38) as neurotransmitter in pig pancreas: receptor activation revealed by the antagonist PACAP-(6-38).". (1997): http://europepmc.org/abstract/med/9277423.
  1395. Raben A; Andersen K; Karberg MA; Holst JJ; Astrup A. "Acetylation of or beta-cyclodextrin addition to potato beneficial effect on glucose metabolism and appetite sensations.". (1997): http://europepmc.org/abstract/med/9250108.
  1396. Christiansen E; Tibell A; Vølund AA; Holst JJ; Rasmussen K; Schäffer L; Madsbad S. "Metabolism of oral glucose in pancreas transplant recipients with normal and impaired glucose tolerance.". (1997): http://europepmc.org/abstract/med/9215311.
    10.1210/jc.82.7.2299
  1397. Furuta M; Yano H; Zhou A; Rouillé Y; Holst JJ; Carroll R; Ravazzola M; et al. "Defective prohormone processing and altered pancreatic islet morphology in mice lacking active SPC2.". (1997): http://europepmc.org/abstract/med/9192619.
    10.1073/pnas.94.13.6646
  1398. Wettergren A; Maina P; Boesby S; Holst JJ. "Glucagon-like peptide-1 7-36 amide and peptide YY have additive inhibitory effect on gastric acid secretion in man.". (1997): http://europepmc.org/abstract/med/9200286.
  1399. Näslund E; Grybäck P; Hellström PM; Jacobsson H; Holst JJ; Theodorsson E; Backman L. "Gastrointestinal hormones and gastric emptying 20 years after jejunoileal bypass for massive obesity.". (1997): http://europepmc.org/abstract/med/9152741.
    10.1038/sj.ijo.0800418
  1400. Wettergren A; Wøjdemann M; Meisner S; Stadil F; Holst JJ. "The inhibitory effect of glucagon-like peptide-1 (GLP-1) 7-36 amide on gastric acid secretion in humans depends on an intact vagal innervation.". (1997): http://europepmc.org/abstract/med/9203936.
    10.1136/gut.40.5.597
  1401. Palnaes Hansen C; Andreasen JJ; Holst JJ. "The release of gastric inhibitory peptide, glucagon-like peptide-I, and insulin after oral glucose test in colectomized subjects.". (1997): http://europepmc.org/abstract/med/9175210.
  1402. Sandvik AK; Brenna E; Sundan A; Holst JJ; Waldum HI. "Bombesin inhibits histamine release from the rat oxyntic mucosa by a somatostatin-dependent mechanism.". (1997): http://europepmc.org/abstract/med/9175202.
  1403. Layer P; von der Ohe MR; Holst JJ; Jansen JB; Grandt D; Holtmann G; Goebell H. "Altered postprandial motility in chronic pancreatitis: role of malabsorption.". (1997): http://europepmc.org/abstract/med/9136842.
  1404. Hansen T; Eiberg H; Rouard M; Vaxillaire M; Møller AM; Rasmussen SK; Fridberg M; et al. "Novel MODY3 mutations in the hepatocyte nuclear factor-1alpha gene: evidence for a hyperexcitability of pancreatic beta-cells to intravenous secretagogues in a glucose-tolerant carrier of a P447L mutation.". (1997): http://europepmc.org/abstract/med/9075819.
    10.2337/diab.46.4.726
  1405. Larsen PJ; Tang-Christensen M; Holst JJ; Orskov C. "Distribution of glucagon-like peptide-1 and other preproglucagon-derived peptides in the rat hypothalamus and brainstem.". (1997): http://europepmc.org/abstract/med/9044391.
    10.1016/S0306-4522(96)00434-4
  1406. Balks HJ; Holst JJ; von zur Mühlen A; Brabant G. "Rapid oscillations in plasma glucagon-like peptide-1 (GLP-1) in humans: cholinergic control of GLP-1 secretion via muscarinic receptors.". (1997): http://europepmc.org/abstract/med/9062483.
    10.1210/jcem.82.3.3816
  1407. Ahrén B; Larsson H; Holst JJ. "Effects of glucagon-like peptide-1 on islet function and insulin sensitivity in noninsulin-dependent diabetes mellitus.". (1997): http://europepmc.org/abstract/med/9024239.
    10.1210/jc.82.2.473
  1408. Shalev A; Holst JJ; Keller U. "Effects of glucagon-like peptide 1 (7-36 amide) on whole-body protein metabolism in healthy man.". (1997): http://europepmc.org/abstract/med/9041371.
    10.1046/j.1365-2362.1997.540613.x
  1409. Thulesen J; Orskov C; Holst JJ; Poulsen SS. "Short-term insulin treatment prevents the diabetogenic action of streptozotocin in rats.". (1997): http://europepmc.org/abstract/med/8977386.
    10.1210/endo.138.1.4827
  1410. Holst JJ. "Enteroglucagon.". (1997): http://europepmc.org/abstract/med/9074764.
    10.1146/annurev.physiol.59.1.257
  1411. Nauck MA; Holst JJ; Willms B; Schmiegel W. "Glucagon-like peptide 1 (GLP-1) as a new therapeutic approach for type 2-diabetes.". (1997): http://europepmc.org/abstract/med/9285204.
  1412. Schmidt PT; Rasmussen TN; Holst JJ. "Tachykinins may mediate capsaicin-induced, but not vagally induced motility in porcine antrum.". (1997): http://europepmc.org/abstract/med/9437710.
    10.1016/S0196-9781(97)00226-X
  1413. Schmidt PT; Holst JJ. "Use of antagonists to define tachykininergic control of intestinal motility in pigs.". (1997): http://europepmc.org/abstract/med/9145423.
    10.1016/S0196-9781(96)00324-5
  1414. Bo Ahrén; H. Larsson; Jens Juul Holst. "GIP and GLP-1 after oral glucose in postmenopausal women with impaired glucose tolerance.". European Journal of Endocrinology 137 (1997): 127-131. https://curis.ku.dk/portal/en/publications/gip-and-glp1-after-oral-glucose-in-postmenopausal-women-with-impaired-glucose-tolerance(c7976b30-6c38-11dc-bee9-02004c4f4f50).html.
  1415. K. Tornøe; J. Hannibal; Jan Fahrenkrug; Jens Juul Holst. "PACAP 1-38 as neurotransmitter in the pig pancreas: PACAP-receptor activation revealed by the antagonist PACAP 6-38.". Am. J. Physiol. 273 (1997): G436-G446. https://curis.ku.dk/portal/en/publications/pacap-138-as-neurotransmitter-in-the-pig-pancreas-pacapreceptor-activation-revealed-by-the-antagonist-pacap-638(c74e5440-6c38-11dc-bee9-02004c4f4f50).html.
  1416. Bo Ahrén; H. Larsson; Jens Juul Holst. "Effects of glucagon-like peptide-1 on islet function and insulin sensitivity in non-insulin dependent diabetes mellitus.". J. Clin. Endocrinol. Metab. 82 (1997): 473-478. https://curis.ku.dk/portal/en/publications/effects-of-glucagonlike-peptide1-on-islet-function-and-insulin-sensitivity-in-noninsulin-dependent-diabetes-mellitus(73f3c420-74cb-11db-bee9-02004c4f4f50).html.
  1417. A. Wettergren; M. Wøjdemann; S. Meisner; F. Stadil; Jens Juul Holst. "The inhibitory effect of glucagon-like peptide-1 (GLP-1) 7-36 amide on gastric acid secretion in humans depends on an intact vagal innervation.". Gut 40 (1997): 597-601. https://curis.ku.dk/portal/en/publications/the-inhibitory-effect-of-glucagonlike-peptide1-glp1-736-amide-on-gastric-acid-secretion-in-humans-depends-on-an-intact-vagal-innervation(69870100-74cb-11db-bee9-02004c4f4f50).html.
  1418. L. Rasmussen; N. Qvist; E. Øster-Jørgensen; J.F. Rehfeld; Jens Juul Holst; S.A. Pedersen. "A double-blind placebo-controlled study on the effects of omeprazole on gut hormone secretion and gastric emptying rate.". Scandinavian Journal of Gastroenterology 32 (1997): 900-905. https://curis.ku.dk/portal/en/publications/a-doubleblind-placebocontrolled-study-on-the-effects-of-omeprazole-on-gut-hormone-secretion-and-gastric-emptying-rate(c7b99930-6c38-11dc-bee9-02004c4f4f50).html.
  1419. E. Näslund; P. Grybäck; P.M. Hellström; H. Jacobsson; Jens Juul Holst; E. Theodorsson; L. Backmann. "Gastrointestinal hormones and gastric emptying 20 years after jejunoileal bypass for massive obesity.". International Journal of Obesity 21 (1997): 387-392. https://curis.ku.dk/portal/en/publications/gastrointestinal-hormones-and-gastric-emptying-20-years-after-jejunoileal-bypass-for-massive-obesity(71a58e60-74cb-11db-bee9-02004c4f4f50).html.
  1420. M.A. Nauck; Jens Juul Holst; B. Willms; W. Schmiegel. "Glucagon-like peptide-1 (GLP-1) as a new therapeutic approach for type-2 diabetes.". Exp. Clin. Endocrinol. Diabetes 105 (1997): 187-195. https://curis.ku.dk/portal/en/publications/glucagonlike-peptide1-glp1-as-a-new-therapeutic-approach-for-type2-diabetes(57cd7f70-74cb-11db-bee9-02004c4f4f50).html.
  1421. Jesper Thulesen; Cathrine Ørskov; Jens Juul Holst; Steen Seier Poulsen. "Short term insulin treatment prevents the diabetogenic action of streptozotocin in rats". Endokrinologiya Vol. 138, (1997): 62-68. https://curis.ku.dk/portal/en/publications/short-term-insulin-treatment-prevents-the-diabetogenic-action-of-streptozotocin-in-rats(105635b0-74cb-11db-bee9-02004c4f4f50).html.
  1422. A.K. Sandvik; E. Brenna; A. Sundan; Jens Juul Holst; H.L. Waldum. "Bombesin inhibits histamine release from the rat oxyntic mucosa by a somatostatin-dependent mechanism.". Scandinavian Journal of Gastroenterology 30 (1997): 427-432. https://curis.ku.dk/portal/en/publications/bombesin-inhibits-histamine-release-from-the-rat-oxyntic-mucosa-by-a-somatostatindependent-mechanism(cc7facc0-6c38-11dc-bee9-02004c4f4f50).html.
  1423. M. Furuta; H. Yano; A. Zhou; Y. Rouille; Jens Juul Holst; R. Carroll; M. Ravazzolla; L. Orci; D.F. Steiner. "Defective prohormone processing and altered pancreatic islet morphology in mice lacking active SPC2.". Proc. Natl. Acad. Sci. 94 (1997): 6646-6651. https://curis.ku.dk/portal/en/publications/defective-prohormone-processing-and-altered-pancreatic-islet-morphology-in-mice-lacking-active-spc2(c71a4bf0-6c38-11dc-bee9-02004c4f4f50).html.
  1424. Jens Juul Holst. "Enteroglucagon". Annual Reviews of Physiology 59 (1997): 257-272. https://curis.ku.dk/portal/en/publications/enteroglucagon(c785b7f0-6c38-11dc-bee9-02004c4f4f50).html.
  1425. Jens Juul Holst; Jesper Lindgren Gromada; M.A. Nauck. "The pathogenesis of non-insulin dependent diabetes mellitus involves a defective expression of the GIP receptor.". Diabetologia 40 (1997): 984-986. https://curis.ku.dk/portal/en/publications/the-pathogenesis-of-noninsulin-dependent-diabetes-mellitus-involves-a-defective-expression-of-the-gip-receptor(715b3ef0-74cb-11db-bee9-02004c4f4f50).html.
  1426. C. Palnæs Hansen; Jørn Andreassen; Jens Juul Holst. "Glucose absorption and the release of insulin, gastric inhibitory polypeptide, and glucagon-like peptide-1 in patients after total colectomy.". Scandinavian Journal of Gastroenterology 32 (1997): 473-477. https://curis.ku.dk/portal/en/publications/glucose-absorption-and-the-release-of-insulin-gastric-inhibitory-polypeptide-and-glucagonlike-peptide1-in-patients-after-total-colectomy(74161930-74cb-11db-bee9-02004c4f4f50).html.
  1427. Peter Schmidt; Jens Juul Holst. "Use of antagonists to define tachykininergic control of intestinal motility in pigs.". Peptides 18 (1997): 373-379. https://curis.ku.dk/portal/en/publications/use-of-antagonists-to-define-tachykininergic-control-of-intestinal-motility-in-pigs(69dee500-74cb-11db-bee9-02004c4f4f50).html.
  1428. A. Shalev; Jens Juul Holst; U. Keller. "Effects of glucagon-like peptide-1 (7-36amide) on whole body protein metabolism in healthy man.". European Journal of Clinical Investigation 27 (1997): 10-16.. https://curis.ku.dk/portal/en/publications/effects-of-glucagonlike-peptide1-736amide-on-whole-body-protein-metabolism-in-healthy-man(667f3f40-74cb-11db-bee9-02004c4f4f50).html.
  1429. P. Layer; M.R. v.d. Ohe; D. Grandt; Jens Juul Holst; J.B.M.J. Jansen; G. Holtmann; J. Keller; H. Goebell. "Altered postprandial motility in chronic pancreatitis: role of malabsorption.". Today in Medicine. Gastroenterology 112 (1997): 1624-1634. https://curis.ku.dk/portal/en/publications/altered-postprandial-motility-in-chronic-pancreatitis-role-of-malabsorption(73de8e70-74cb-11db-bee9-02004c4f4f50).html.
  1430. R. Ritzelt; C. Ørskov; Jens Juul Holst; W. Schmiegel; M.A. Nauck. "Einfluss von subkutanem GLP-1 auf die frühe und langsame Phase der Insulin-sekretion nach intravenöser Glukosebelastung bei gesunden Probanden.". Diabetes und Stoffwechsel 6 (1997): 64-69.. https://curis.ku.dk/portal/en/publications/einfluss-von-subkutanem-glp1-auf-die-fruhe-und-langsame-phase-der-insulinsekretion-nach-intravenoeser-glukosebelastung-bei-gesunden-probanden(70ce6840-74cb-11db-bee9-02004c4f4f50).html.
  1431. A. Wettergren; P. Maina; S. Boesby; Jens Juul Holst. "Glucagon-like peptide-1 7-36amide and peptide YY have additive inhibitory effects on gastric acid secretion in man.". Scandinavian Journal of Gastroenterology 32 (1997): 552-555. https://curis.ku.dk/portal/en/publications/glucagonlike-peptide1-736amide-and-peptide-yy-have-additive-inhibitory-effects-on-gastric-acid-secretion-in-man(c7cc36d0-6c38-11dc-bee9-02004c4f4f50).html.
  1432. Jens Juul Holst. "Non-insulin-dependent diabetes mellitus - new drugs?". Drug Discovery Today 2 (1997): 128-129. https://curis.ku.dk/portal/en/publications/noninsulindependent-diabetes-mellitus--new-drugs(c72c9b70-6c38-11dc-bee9-02004c4f4f50).html.
  1433. Philip J. Larsen; M. Tang-Christensen; Jens Juul Holst; Cathrine Ørskov. "Distribution of glucagon-like peptide-1 and other preproglucagon-derived peptides in the rat hypothalamus and brainstem". Neuroscience Vol. 77, N (1997): 257-270. https://curis.ku.dk/portal/en/publications/distribution-of-glucagonlike-peptide1-and-other-preproglucagonderived-peptides-in-the-rat-hypothalamus-and-brainstem(0e283220-74cb-11db-bee9-02004c4f4f50).html.
  1434. H. Larsson; Jens Juul Holst; Bo Ahrén. "Glucagon-like peptide-1 (GLP-17-36amide) reduces hepatic glucose production indirectly through changes in insulin and glucagon secretion.". Acta Phys. Scand. 160 (1997): 413-422. https://curis.ku.dk/portal/en/publications/glucagonlike-peptide1-glp1736amide-reduces-hepatic-glucose-production-indirectly-through-changes-in-insulin-and-glucagon-secretion(c7f45840-6c38-11dc-bee9-02004c4f4f50).html.
  1435. Jens Juul Holst. "Holder GLP-1 som nyt terapeutisk princip i diabetesbehandlingen hvad det lovede?". Tidsskrift for Diabetesbehandling 2(7) (1997): 16-22. https://curis.ku.dk/portal/en/publications/holder-glp1-som-nyt-terapeutisk-princip-i-diabetesbehandlingen-hvad-det-lovede(71797550-74cb-11db-bee9-02004c4f4f50).html.
  1436. K. Filipson; K. Tornøe; Jens Juul Holst; Bo Ahrén. "Pituitary adenylate-cyclase-activating polypeptide stimulates insulin and glucagon secretion in humans.". J. Clin. Endocrinol. Metab. 82 (1997): 3093-3098. https://curis.ku.dk/portal/en/publications/pituitary-adenylatecyclaseactivating-polypeptide-stimulates-insulin-and-glucagon-secretion-in-humans(7115d180-74cb-11db-bee9-02004c4f4f50).html.
  1437. E. Christiansen; A. Tibell; Aa. Vølund; Jens Juul Holst; K. Rasmussen; L. Schäffer; S. Madsbad. "Metabolism of oral glucose in pancreas transplant recipients with normal and impaired glucose tolerance.". J. Clin. Endocrinol. Metab. 82 (1997): 2299-2307. https://curis.ku.dk/portal/en/publications/metabolism-of-oral-glucose-in-pancreas-transplant-recipients-with-normal-and-impaired-glucose-tolerance(6697f760-74cb-11db-bee9-02004c4f4f50).html.
  1438. T. Hansen; Hans Eiberg; M. Rouard; M. Vaxillaire; A.M. Møller; S.K. Rasmussen; M. Fridberg; Jens Juul Holst. "Novel Mody3 Mutations in the Hepatocyte Factor-1a Gene. Evidence for a Hyperexcitabillity of Pancreatic ß-cells to Intravenous Secretagogues in a Glucosetolerant Carrier of a P447L Mutation". Diabetes 46 (1997): 726-730. https://curis.ku.dk/portal/en/publications/novel-mody3-mutations-in-the-hepatocyte-factor1a-gene-evidence-for-a-hyperexcitabillity-of-pancreatic-sscells-to-intravenous-secretagogues-in-a-glucosetolerant-carrier-of-a-p447l-mutation(733c5b00-74cb-11db-bee9-.
  1439. Holst JJ; Toft-Nielsen MB; Orskov C; Nauck M; Willms B. "On the effects of glucagon-like peptide-1 on blood glucose regulation in normal and diabetic subjects.". (1996): http://europepmc.org/abstract/med/8993469.
  1440. Tornøe K; Hannibal J; Giezemann M; Schmidt P; Holst JJ. "PACAP 1-27 and 1-38 in the porcine pancreas: occurrence, localization, and effects.". (1996): http://europepmc.org/abstract/med/8993434.
  1441. Nauck MA; Wollschläger D; Werner J; Holst JJ; Orskov C; Creutzfeldt W; Willms B. "Effects of subcutaneous glucagon-like peptide 1 (GLP-1 [7-36 amide]) in patients with NIDDM.". (1996): http://europepmc.org/abstract/med/8960841.
    10.1007/s001250050613
  1442. Holst JJ. "[Leptin--a new weight-loss agent?]". (1996): http://europepmc.org/abstract/med/8966112.
  1443. Christiansen E; Tibell A; Vølund A; Rasmussen K; Groth CG; Holst JJ; Pedersen O; Christensen NJ; Madsbad S. "Pancreatic endocrine function in recipients of segmental and whole pancreas transplantation.". (1996): http://europepmc.org/abstract/med/8923846.
    10.1210/jc.81.11.3972
  1444. Vaag AA; Holst JJ; Vølund A; Beck-Nielsen HB. "Gut incretin hormones in identical twins discordant for non-insulin-dependent diabetes mellitus (NIDDM)--evidence for decreased glucagon-like peptide 1 secretion during oral glucose ingestion in NIDDM twins.". (1996): http://europepmc.org/abstract/med/8921824.
    10.1530/eje.0.1350425
  1445. Orskov L; Holst JJ; Møller J; Orskov C; Møller N; Alberti KG; Schmitz O. "GLP-1 does not not acutely affect insulin sensitivity in healthy man.". (1996): http://europepmc.org/abstract/med/8897012.
    10.1007/BF02658511
  1446. Schmidt P; Poulsen SS; Hilsted L; Rasmussen TN; Holst JJ. "Tachykinins mediate vagal inhibition of gastrin secretion in pigs.". (1996): http://europepmc.org/abstract/med/8831587.
  1447. Holst JJ. "GLP-1 in NIDDM.". (1996): http://europepmc.org/abstract/med/8894501.
  1448. Deacon CF; Pridal L; Klarskov L; Olesen M; Holst JJ. "Glucagon-like peptide 1 undergoes differential tissue-specific metabolism in the anesthetized pig.". (1996): http://europepmc.org/abstract/med/8843738.
  1449. Christiansen E; Vestergaard H; Tibell A; Hother-Nielsen O; Holst JJ; Pedersen O; Madsbad S. "Impaired insulin-stimulated nonoxidative glucose metabolism in pancreas-kidney transplant recipients. Dose-response effects of insulin on glucose turnover.". (1996): http://europepmc.org/abstract/med/8772733.
    10.2337/diab.45.9.1267
  1450. P Serup; J Jensen; F G Andersen; Mette Jørgensen; N Blume; Jens Juul Holst; O D Madsen. "Induction of insulin and islet amyloid polypeptide production in pancreatic islet glucagonoma cells by insulin promoter factor 1". Proceedings of the National Academy of Sciences of the United States of America 93 17 (1996): 9015-20. https://curis.ku.dk/portal/en/publications/induction-of-insulin-and-islet-amyloid-polypeptide-production-in-pancreatic-islet-glucagonoma-cells-by-insulin-promoter-factor-1(d19526a8-7056-41ad-9b5e-9b6b6d0d36ff).html.
  1451. Serup P; Jensen J; Andersen FG; Jørgensen MC; Blume N; Holst JJ; Madsen OD. "Induction of insulin and islet amyloid polypeptide production in pancreatic islet glucagonoma cells by insulin promoter factor 1.". (1996): http://europepmc.org/abstract/med/8799146.
    10.1073/pnas.93.17.9015
  1452. Gutniak MK; Juntti-Berggren L; Hellström PM; Guenifi A; Holst JJ; Efendic S. "Glucagon-like peptide I enhances the insulinotropic effect of glibenclamide in NIDDM patients and in the perfused rat pancreas.". (1996): http://europepmc.org/abstract/med/8842604.
    10.2337/diacare.19.8.857
  1453. Gutniak MK; Larsson H; Heiber SJ; Juneskans OT; Holst JJ; Ahrén B. "Potential therapeutic levels of glucagon-like peptide I achieved in humans by a buccal tablet.". (1996): http://europepmc.org/abstract/med/8842602.
    10.2337/diacare.19.8.843
  1454. Holst JJ. "[Leptin--a new way to diet?]". (1996): http://europepmc.org/abstract/med/8759384.
  1455. Brand CL; Jørgensen PN; Svendsen I; Holst JJ. "Evidence for a major role for glucagon in regulation of plasma glucose in conscious, nondiabetic, and alloxan-induced diabetic rabbits.". (1996): http://europepmc.org/abstract/med/8690155.
    10.2337/diab.45.8.1076
  1456. Ropert A; Cherbut C; Rozé C; Le Quellec A; Holst JJ; Fu-Cheng X; Bruley des Varannes S; Galmiche JP. "Colonic fermentation and proximal gastric tone in humans.". (1996): http://europepmc.org/abstract/med/8690193.
  1457. Orskov C; Wettergren A; Holst JJ. "Secretion of the incretin hormones glucagon-like peptide-1 and gastric inhibitory polypeptide correlates with insulin secretion in normal man throughout the day.". (1996): http://europepmc.org/abstract/med/8819215.
    10.3109/00365529609009147
  1458. Holst JJ. "Glucagon, glucagon-like peptide-1 and their receptors: an introduction.". (1996): http://europepmc.org/abstract/med/8830884.
    10.1046/j.1365-201X.1996.32261000.x
  1459. Orskov C; Poulsen SS; Møller M; Holst JJ. "Glucagon-like peptide I receptors in the subfornical organ and the area postrema are accessible to circulating glucagon-like peptide I.". (1996): http://europepmc.org/abstract/med/8635662.
    10.2337/diab.45.6.832
  1460. Van Dijk G; Lindskog S; Holst JJ; Steffens AB; Ahrén B. "Effects of glucagon-like peptide-I on glucose turnover in rats.". (1996): http://europepmc.org/abstract/med/8764187.
  1461. Toft-Nielsen M; Hvidberg A; Hilsted J; Dige-Petersen H; Holst JJ. "No effect of beta-adrenergic blockade on hypoglycaemic effect of glucagon-like peptide-1 (GLP-1) in normal subjects.". (1996): http://europepmc.org/abstract/med/8799658.
    10.1002/(SICI)1096-9136(199606)13:6<544::AID-DIA129>3.0.CO;2-X
  1462. Creutzfeldt WO; Kleine N; Willms B; Orskov C; Holst JJ; Nauck MA. "Glucagonostatic actions and reduction of fasting hyperglycemia by exogenous glucagon-like peptide I(7-36) amide in type I diabetic patients.". (1996): http://europepmc.org/abstract/med/8725855.
    10.2337/diacare.19.6.580
  1463. Toft-Nielson M; Madsbad S; Holst JJ. "The effect of glucagon-like peptide I (GLP-I) on glucose elimination in healthy subjects depends on the pancreatic glucoregulatory hormones.". (1996): http://europepmc.org/abstract/med/8621002.
    10.2337/diab.45.5.552
  1464. Rasmussen L; Oster-Jørgensen E; Qvist N; Holst JJ; Rehfeld JF; Hovendal CP; Pedersen SA. "The relationship between gut hormone secretion and gastric emptying in different phases of the migrating motor complex.". (1996): http://europepmc.org/abstract/med/8734342.
  1465. Barajon I; Bersani M; Quartu M; Del Fiacco M; Cavaletti G; Holst JJ; Tredici G. "Neuropeptides and morphological changes in cisplatin-induced dorsal root ganglion neuronopathy.". (1996): http://europepmc.org/abstract/med/8593900.
    10.1006/exnr.1996.0050
  1466. Nauck MA; Siemsglüss J; Orskov C; Holst JJ. "Release of glucagon-like peptide 1 (GLP-1 [7-36 amide]), gastric inhibitory polypeptide (GIP) and insulin in response to oral glucose after upper and lower intestinal resections.". (1996): http://europepmc.org/abstract/med/8650968.
  1467. Raben A; Holst JJ; Christensen NJ; Astrup A. "Determinants of postprandial appetite sensations: macronutrient intake and glucose metabolism.". (1996): http://europepmc.org/abstract/med/8646253.
  1468. Willms B; Werner J; Holst JJ; Orskov C; Creutzfeldt W; Nauck MA. "Gastric emptying, glucose responses, and insulin secretion after a liquid test meal: effects of exogenous glucagon-like peptide-1 (GLP-1)-(7-36) amide in type 2 (noninsulin-dependent) diabetic patients.". (1996): http://europepmc.org/abstract/med/8550773.
    10.1210/jcem.81.1.8550773
  1469. Hother-Nielsen O; Henriksen JE; Holst JJ; Beck-Nielsen H. "Effects of insulin on glucose turnover rates in vivo: isotope dilution versus constant specific activity technique.". (1996): http://europepmc.org/abstract/med/8544782.
    10.1016/S0026-0495(96)90204-8
  1470. Goll R; Nielsen SH; Holst JJ. "Regulation of motilin release from isolated perfused pig duodenum.". (1996): http://europepmc.org/abstract/med/8886578.
  1471. Pridal L; Deacon CF; Kirk O; Christensen JV; Carr RD; Holst JJ. "Glucagon-like peptide-1(7-37) has a larger volume of distribution than glucagon-like peptide-1(7-36)amide in dogs and is degraded more quickly in vitro by dog plasma.". (1996): http://europepmc.org/abstract/med/8839678.
    10.1007/BF03190278
  1472. Holst JJ; Fahrenkrug J; Stadil F; Rehfeld JF. "Gastrointestinal endocrinology.". (1996): http://europepmc.org/abstract/med/8726276.
  1473. Breidert M; Bornstein SR; Ehrhart-Bornstein M; Scherbaum WA; Holst JJ. "Angiotensin II regulates both adrenocortical and adrenomedullary function in isolated perfused pig adrenals.". (1996): http://europepmc.org/abstract/med/8801535.
    10.1016/0196-9781(95)02106-X
  1474. Wen J; Phillips SF; Sarr MG; Kost LJ; Holst JJ. "PYY and GLP-1 contribute to feedback inhibition from the canine ileum and colon.". (1995): http://europepmc.org/abstract/med/8572226.
  1475. Chu M; Nielsen FC; Franzén L; Rehfeld JF; Holst JJ; Borch K. "Effect of endogenous hypergastrinemia on gastrin receptor expressing human colon carcinoma transplanted to athymic rats.". (1995): http://europepmc.org/abstract/med/7557120.
    10.1016/0016-5085(95)90625-8
  1476. Blume N; Skouv J; Larsson LI; Holst JJ; Madsen OD. "Potent inhibitory effects of transplantable rat glucagonomas and insulinomas on the respective endogenous islet cells are associated with pancreatic apoptosis.". (1995): http://europepmc.org/abstract/med/7593609.
    10.1172/JCI118278
  1477. Holle GE; Steinbach E; Wünsch E; Holst JJ. "Effect of 17-norleucine-VIP on gastroduodenal motility relative to serum VIP concentration and blockade of NOS.". (1995): http://europepmc.org/abstract/med/7485511.
  1478. Deacon CF; Nauck MA; Toft-Nielsen M; Pridal L; Willms B; Holst JJ. "Both subcutaneously and intravenously administered glucagon-like peptide I are rapidly degraded from the NH2-terminus in type II diabetic patients and in healthy subjects.". (1995): http://europepmc.org/abstract/med/7657039.
    10.2337/diab.44.9.1126
  1479. Qualmann C; Nauck MA; Holst JJ; Orskov C; Creutzfeldt W. "Glucagon-like peptide 1 (7-36 amide) secretion in response to luminal sucrose from the upper and lower gut. A study using alpha-glucosidase inhibition (acarbose).". (1995): http://europepmc.org/abstract/med/8578189.
  1480. Brand CL; Jørgensen PN; Knigge U; Warberg J; Svendsen I; Kristensen JS; Holst JJ. "Role of glucagon in maintenance of euglycemia in fed and fasted rats.". (1995): http://europepmc.org/abstract/med/7573424.
  1481. Deacon CF; Johnsen AH; Holst JJ. "Human colon produces fully processed glucagon-like peptide-1 (7-36) amide.". (1995): http://europepmc.org/abstract/med/7556682.
    10.1016/0014-5793(95)00983-G
  1482. Pridal L; Ingwersen SH; Larsen FS; Holst JJ; Adelhorst K; Kirk O. "Comparison of sandwich enzyme-linked immunoadsorbent assay and radioimmunoassay for determination of exogenous glucagon-like peptide-1(7-36)amide in plasma.". (1995): http://europepmc.org/abstract/med/8562607.
    10.1016/0731-7085(95)01312-9
  1483. Ritzel R; Orskov C; Holst JJ; Nauck MA. "Pharmacokinetic, insulinotropic, and glucagonostatic properties of GLP-1 [7-36 amide] after subcutaneous injection in healthy volunteers. Dose-response-relationships.". (1995): http://europepmc.org/abstract/med/7672496.
    10.1007/s001250050344
  1484. Fieseler P; Bridenbaugh S; Nustede R; Martell J; Orskov C; Holst JJ; Nauck MA. "Physiological augmentation of amino acid-induced insulin secretion by GIP and GLP-I but not by CCK-8.". (1995): http://europepmc.org/abstract/med/7762650.
  1485. Layer P; Holst JJ; Grandt D; Goebell H. "Ileal release of glucagon-like peptide-1 (GLP-1). Association with inhibition of gastric acid secretion in humans.". (1995): http://europepmc.org/abstract/med/7729267.
    10.1007/BF02064202
  1486. Qualmann C; Nauck MA; Holst JJ; Orskov C; Creutzfeldt W. "Insulinotropic actions of intravenous glucagon-like peptide-1 (GLP-1) [7-36 amide] in the fasting state in healthy subjects.". (1995): http://europepmc.org/abstract/med/7612912.
    10.1007/BF00581038
  1487. Deacon CF; Johnsen AH; Holst JJ. "Degradation of glucagon-like peptide-1 by human plasma in vitro yields an N-terminally truncated peptide that is a major endogenous metabolite in vivo.". (1995): http://europepmc.org/abstract/med/7883856.
    10.1210/jc.80.3.952
  1488. Qvist N; Oster-Jørgensen E; Pedersen SA; Rasmussen L; Hovendal C; Holst JJ. "Increases in plasma motilin follow each episode of gallbladder emptying during the interdigestive period, and changes in serum bile acid concentration correlate to plasma motilin.". (1995): http://europepmc.org/abstract/med/7732333.
  1489. McConalogue K; Furness JB; Vremec MA; Holst JJ; Tornøe K; Marley PD. "Histochemical, pharmacological, biochemical and chromatographic evidence that pituitary adenylyl cyclase activating peptide is involved in inhibitory neurotransmission in the taenia of the guinea-pig caecum.". (1995): http://europepmc.org/abstract/med/7714325.
    10.1016/0165-1838(94)00102-P
  1490. Hannibal J; Mikkelsen JD; Clausen H; Holst JJ; Wulff BS; Fahrenkrug J. "Gene expression of pituitary adenylate cyclase activating polypeptide (PACAP) in the rat hypothalamus.". (1995): http://europepmc.org/abstract/med/7754101.
    10.1016/0167-0115(94)00099-J
  1491. Madsen OD; Karlsen C; Blume N; Jensen HI; Larsson LI; Holst JJ. "Transplantable glucagonomas derived from pluripotent rat islet tumor tissue cause severe anorexia and adipsia.". (1995): http://europepmc.org/abstract/med/7652479.
  1492. Ehrhart-Bornstein M; Bornstein SR; González-Hernández J; Holst JJ; Waterman MR; Scherbaum WA. "Sympathoadrenal regulation of adrenocortical steroidogenesis.". (1995): http://europepmc.org/abstract/med/7588375.
  1493. O.D. Madsen; C. Karlsen; N. Blume; H.I. Jensen; L.-I. Larsson; Jens Juul Holst. "Transplantable glucagonomas derived from pluripotent rat islet tumor tissue cause severe anorexia and adipsia". Scand. J. Clin. Lab. Invest. 55, suppl. (1995): 27-36. https://curis.ku.dk/portal/en/publications/transplantable-glucagonomas-derived-from-pluripotent-rat-islet-tumor-tissue-cause-severe-anorexia-and-adipsia(55cf5390-74cd-11db-bee9-02004c4f4f50).html.
  1494. R. Ritzel; Cathrine Ørskov; Jens Juul Holst; M.A. Nauck. "Pharmacokinetic, insulinotropic and glucagonostatic properties of GLP-1 (7-36 amide) after subcutaneous injection in healthy volunteers. Dose-response-relationships". Diabetologia 38 (1995): 720-725. https://curis.ku.dk/portal/en/publications/pharmacokinetic-insulinotropic-and-glucagonostatic-properties-of-glp1-736-amide-after-subcutaneous-injection-in-healthy-volunteers-doseresponserelationships(250eb480-74cd-11db-bee9-02004c4f4f50).html.
  1495. N. Blume; J. Skouv; L.-I. Larsson; Jens Juul Holst; O.D. Madsen. "Potent inhibitory effects of transplantable rat glucagonomas and insulinomas on the respective endogenous islet cells are associated with pancreatic apoptosis.". J. Clin. Invest. 96 (1995): 2227-2235. https://curis.ku.dk/portal/en/publications/potent-inhibitory-effects-of-transplantable-rat-glucagonomas-and-insulinomas-on-the-respective-endogenous-islet-cells-are-associated-with-pancreatic-apoptosis(5134e3e0-74cd-11db-bee9-02004c4f4f50).html.
  1496. C. Qualmann; M.A. Nauck; Jens Juul Holst; Cathrine Ørskov; W. Creutzfeldt. "Glucagon-like peptide 1 (7-36 amide) secretion in response to luminal sucrose from the upper and lower gut. A study using a-glucosidase inhibition (acarbose)". Scandinavian Journal of Gastroenterology 30 (1995): 892-896. https://curis.ku.dk/portal/en/publications/glucagonlike-peptide-1-736-amide-secretion-in-response-to-luminal-sucrose-from-the-upper-and-lower-gut-a-study-using-aglucosidase-inhibition-acarbose(2d3fdf80-74cd-11db-bee9-02004c4f4f50).html.
  1497. C. Qualmann; M.A. Nauck; Jens Juul Holst; Cathrine Ørskov; W. Creutzfeldt. "Insulintropic actions of intravenous glucagon-like peptide-1 (GLP-1) (7-36 amide) in the fasting state in healthy subjects". Acta Diabetologica 32 (1995): 13-16. https://curis.ku.dk/portal/en/publications/insulintropic-actions-of-intravenous-glucagonlike-peptide1-glp1-736-amide-in-the-fasting-state-in-healthy-subjects(2bd30910-74cd-11db-bee9-02004c4f4f50).html.
  1498. L. Pridal; S.H. Ingwersen; F.S. Larsen; Jens Juul Holst; Kim Adelhorst; O. Kirk. "Comparison of sandwich ELISA and RIA for determination of exogenous GLP-1 (7-36 amide) in plasma.". J Pharmaceutical and Biomedical Analysis 13 (1995): 841-850. https://curis.ku.dk/portal/en/publications/comparison-of-sandwich-elisa-and-ria-for-determination-of-exogenous-glp1-736-amide-in-plasma(55fa5b30-74cd-11db-bee9-02004c4f4f50).html.
  1499. Carolyn Deacon; A.H. Johnsen; Jens Juul Holst. "Degradation of glucagon-like peptide-1 in vitro yields an N-terminally truncated peptide which is a major endogenous metabolite in vivo.". Journal of Clinical Endocrinology and Metabolism 80 (1995): 952-957. https://curis.ku.dk/portal/en/publications/degradation-of-glucagonlike-peptide1-in-vitro-yields-an-nterminally-truncated-peptide-which-is-a-major-endogenous-metabolite-in-vivo(55df3210-74cd-11db-bee9-02004c4f4f50).html.
  1500. Carolyn Deacon; M.A. Nauck; M.T. Nielsen; L. Pridal; Jens Juul Holst. "Both subcutaneously and intravenously administered glucagon-like peptide-1 are rapidly degraded from the amino terminus in type II diabetic patients and in healthy subjects.". Diabetes 44 (1995): 1126-1131. https://curis.ku.dk/portal/en/publications/both-subcutaneously-and-intravenously-administered-glucagonlike-peptide1-are-rapidly-degraded-from-the-amino-terminus-in-type-ii-diabetic-patients-and-in-healthy-subjects(55c197f0-74cd-11db-bee9-02004c4f4f50).htm.
  1501. M. Chu; L. Franzén; J.F. Rehfeld; Jens Juul Holst; K. Borch. "Effect of endogenous hypergastrinemia on gastrin receptor expressing human colon carcinoma transplanted to athymic rats.". Today in Medicine. Gastroenterology 109 (1995): 1415-1420. https://curis.ku.dk/portal/en/publications/effect-of-endogenous-hypergastrinemia-on-gastrin-receptor-expressing-human-colon-carcinoma-transplanted-to-athymic-rats(528bc150-74cd-11db-bee9-02004c4f4f50).html.
  1502. G.E. Holle; E. Steinbach; E. Wünsch; Jens Juul Holst. "Effect of 17-norleucine-VIP on gastroduodenal motility relative to serum VIP concentration and blockade of NOS.". Am. J. Physiol. 269 (1995): G584-G590. https://curis.ku.dk/portal/en/publications/effect-of-17norleucinevip-on-gastroduodenal-motility-relative-to-serum-vip-concentration-and-blockade-of-nos(511e9cc0-74cd-11db-bee9-02004c4f4f50).html.
  1503. M. Møller; Jens Juul Holst; J.D. Mikkelsen; S. Webb. "Presence of somatostatin containing neuronal-like cells in the rat pineal gland.". Neuroendocrinol. Letters 17 (1995): 71-80. https://curis.ku.dk/portal/en/publications/presence-of-somatostatin-containing-neuronallike-cells-in-the-rat-pineal-gland(458e6840-74cd-11db-bee9-02004c4f4f50).html.
  1504. Carolyn Deacon; A.H. Johnsen; Jens Juul Holst. "Human colon produces fully processed glucagon-like peptide-1 (7-36 amide).". FEBS Letters 372 (1995): 269-272.. https://curis.ku.dk/portal/en/publications/human-colon-produces-fully-processed-glucagonlike-peptide1-736-amide(55b2cae0-74cd-11db-bee9-02004c4f4f50).html.
  1505. P. Layer; Jens Juul Holst; D. Grandt; H. Goebell. "Ileal release of glucagonlike peptide-1 (GLP-1): association with inhibition of gastric acid in humans". Digestive Disease Science 40 (1995): 1074-82. https://curis.ku.dk/portal/en/publications/ileal-release-of-glucagonlike-peptide1-glp1-association-with-inhibition-of-gastric-acid-in-humans(555c4670-74cd-11db-bee9-02004c4f4f50).html.
  1506. N. Qvist; E. Øster-Jørgensen; S.A. Pedersen; L. Rasmussen; C. Hovendal; Jens Juul Holst. "Increases in plasma motilin follow each episode of gallbladder emptying during the interdigestive period and changes in serum bile acid concentration correlate to plasma motilin.". Scandinavian Journal of Gastroenterology 30 (1995): 122-127. https://curis.ku.dk/portal/en/publications/increases-in-plasma-motilin-follow-each-episode-of-gallbladder-emptying-during-the-interdigestive-period-and-changes-in-serum-bile-acid-concentration-correlate-to-plasma-motilin(45d4c010-74cd-11db-bee9-02004c4f4f.
  1507. K. McConalogue; J.B. Furness; M.A. Vremec; Jens Juul Holst; K. Tornøe; P.D. Marley. "Histochemical, pharmacological, biochemical and chromatographic evidence that pituitary adenylyl cyclase activating peptide is involved in inhibitory neurotransm.in the taenia of the guinea-pig caecum". J. Autonom Nerv. System 50 (1995): 311-322. https://curis.ku.dk/portal/en/publications/histochemical-pharmacological-biochemical-and-chromatographic-evidence-that-pituitary-adenylyl-cyclase-activating-peptide-is-involved-in-inhibitory-neurotransmin-the-taenia-of-the-guineapig-caecum(45a858e0-74cd-1.
  1508. Monika Ehrhart-Bornstein; S.R. Bornstein; J. Gonzalez-Hernandez; Jens Juul Holst; M.R. Watermann; W.A. Scherbaum. "Sympathoadrenal regulation of adrenocortical steroidogenesis". Endocrine Research 21 (1995): 13-24. https://curis.ku.dk/portal/en/publications/sympathoadrenal-regulation-of-adrenocortical-steroidogenesis(5586b1d0-74cd-11db-bee9-02004c4f4f50).html.
  1509. C.L. Brand; P.N. Jørgensen; I. Svendsen; J.S. Kristensen; U. Knigge; J. Warberg; Jens Juul Holst. "The role of glucagon in the maintenance of euglycemia in the fed and the fasted state. Monoclonal antibody treatment as a tool in glucagon physiology in rats.". Am. J. Physiol. 269 (1995): E469-E477. https://curis.ku.dk/portal/en/publications/the-role-of-glucagon-in-the-maintenance-of-euglycemia-in-the-fed-and-the-fasted-state-monoclonal-antibody-treatment-as-a-tool-in-glucagon-physiology-in-rats(56342fe0-74cd-11db-bee9-02004c4f4f50).html.
  1510. Pia Fieseler; S. Bridenbaugh; R. Nustede; J. Martell; M.A. Nauck; Cathrine Ørskov; Jens Juul Holst. "Physiological augmentation of amino acid-induced insulin secretion by GIP and GLP-I but not by CCK-8". Am. J. Physiol. Vol 268 (1995): E949-E955. https://curis.ku.dk/portal/en/publications/physiological-augmentation-of-amino-acidinduced-insulin-secretion-by-gip-and-glpi-but-not-by-cck8(30b27100-74cd-11db-bee9-02004c4f4f50).html.
  1511. J. Hannibal; J.D. Mikkelsen; H. Clausen; Jens Juul Holst; B.S. Wulff; Jan Fahrenkrug. "Gene expression of pituitary adenylate cyclase activating polypeptide (PACAP) in the rat hypothalamus.". Regulatory Peptides 55 (1995): 133-148. https://curis.ku.dk/portal/en/publications/gene-expression-of-pituitary-adenylate-cyclase-activating-polypeptide-pacap-in-the-rat-hypothalamus(56790110-74cd-11db-bee9-02004c4f4f50).html.
  1512. Holst JJ. "Glucagonlike peptide 1: a newly discovered gastrointestinal hormone.". (1994): http://europepmc.org/abstract/med/7958701.
  1513. Thulesen J; Rasmussen TN; Schmidt P; Holst JJ; Poulsen SS. "Calcitonin gene-related peptide (CGRP) in the nipple of the rat mammary gland.". (1994): http://europepmc.org/abstract/med/7535296.
    10.1007/BF00269575
  1514. Schmidt WE; Schenk S; Nustede R; Holst JJ; Fölsch UR; Creutzfeldt W. "Cholecystokinin is a negative regulator of gastric acid secretion and postprandial release of gastrin in humans.". (1994): http://europepmc.org/abstract/med/7958670.
  1515. Raben A; Tagliabue A; Christensen NJ; Madsen J; Holst JJ; Astrup A. "Resistant starch: the effect on postprandial glycemia, hormonal response, and satiety.". (1994): http://europepmc.org/abstract/med/8092089.
  1516. Brand CL; Rolin B; Jørgensen PN; Svendsen I; Kristensen JS; Holst JJ. "Immunoneutralization of endogenous glucagon with monoclonal glucagon antibody normalizes hyperglycaemia in moderately streptozotocin-diabetic rats.". (1994): http://europepmc.org/abstract/med/7851693.
    10.1007/s001250050208
  1517. Schepp W; Schmidtler J; Riedel T; Dehne K; Schusdziarra V; Holst JJ; Eng J; Raufman JP; Classen M. "Exendin-4 and exendin-(9-39)NH2: agonist and antagonist, respectively, at the rat parietal cell receptor for glucagon-like peptide-1-(7-36)NH2.". (1994): http://europepmc.org/abstract/med/7851494.
    10.1016/0922-4106(94)90085-X
  1518. Raben A; Andersen HB; Christensen NJ; Madsen J; Holst JJ; Astrup A. "Evidence for an abnormal postprandial response to a high-fat meal in women predisposed to obesity.". (1994): http://europepmc.org/abstract/med/7943304.
  1519. Gutniak MK; Linde B; Holst JJ; Efendic S. "Subcutaneous injection of the incretin hormone glucagon-like peptide 1 abolishes postprandial glycemia in NIDDM.". (1994): http://europepmc.org/abstract/med/7988303.
    10.2337/diacare.17.9.1039
  1520. Schmidtler J; Dehne K; Allescher HD; Schusdziarra V; Classen M; Holst JJ; Polack A; Schepp W. "Rat parietal cell receptors for GLP-1-(7-36) amide: northern blot, cross-linking, and radioligand binding.". (1994): http://europepmc.org/abstract/med/7943240.
  1521. Holst JJ; Bersani M; Johnsen AH; Kofod H; Hartmann B; Orskov C. "Proglucagon processing in porcine and human pancreas.". (1994): http://europepmc.org/abstract/med/8034635.
  1522. Wettergren A; Petersen H; Orskov C; Christiansen J; Sheikh SP; Holst JJ. "Glucagon-like peptide-1 7-36 amide and peptide YY from the L-cell of the ileal mucosa are potent inhibitors of vagally induced gastric acid secretion in man.". (1994): http://europepmc.org/abstract/med/7915853.
  1523. Raben A; Christensen NJ; Madsen J; Holst JJ; Astrup A. "Decreased postprandial thermogenesis and fat oxidation but increased fullness after a high-fiber meal compared with a low-fiber meal.". (1994): http://europepmc.org/abstract/med/8198065.
  1524. Goll R; Poulsen JH; Schmidt P; Schjoldager B; Poulsen SS; Holst JJ. "Peptide-evoked release of amylase from isolated acini of the rat parotid gland.". (1994): http://europepmc.org/abstract/med/7524117.
    10.1016/0167-0115(94)90070-1
  1525. Jensen TD; Holst JJ; Fahrenkrug J. "Secretion of pancreastatins from the porcine digestive tract.". (1994): http://europepmc.org/abstract/med/8047816.
  1526. Ehrhart-Bornstein M; Bornstein SR; Güse-Behling H; Stromeyer HG; Rasmussen TN; Scherbaum WA; Adler G; Holst JJ. "Sympathoadrenal regulation of adrenal androstenedione release.". (1994): http://europepmc.org/abstract/med/8202222.
  1527. Orskov C; Rabenhøj L; Wettergren A; Kofod H; Holst JJ. "Tissue and plasma concentrations of amidated and glycine-extended glucagon-like peptide I in humans.". (1994): http://europepmc.org/abstract/med/8138058.
    10.2337/diab.43.4.535
  1528. Holst JJ; Rasmussen TN; Schmidt P. "Role of nitric oxide in neurally induced pancreatic exocrine secretion in pigs.". (1994): http://europepmc.org/abstract/med/8141293.
  1529. Hvidberg A; Nielsen MT; Hilsted J; Orskov C; Holst JJ. "Effect of glucagon-like peptide-1 (proglucagon 78-107amide) on hepatic glucose production in healthy man.". (1994): http://europepmc.org/abstract/med/8289665.
    10.1016/0026-0495(94)90164-3
  1530. Rasmussen TN; Bersani M; Johnsen AH; Kofod H; Holst JJ. "Pigs produce only a single form of CGRP, part of which is processed to N- and C-terminal fragments.". (1994): http://europepmc.org/abstract/med/8015985.
    10.1016/0196-9781(94)90175-9
  1531. Holst JJ; Schmidt P. "Gut hormones and intestinal function.". (1994): http://europepmc.org/abstract/med/8135701.
    10.1016/S0950-351X(05)80229-0
  1532. J.T. Børglum; Jens Juul Holst; Jan Fahrenkrug. "Secretion of pancreastatins from the porcine gastrointestinal tract". Scandinavian Journal of Gastroenterology 29 (1994): 376-384. https://curis.ku.dk/portal/en/publications/secretion-of-pancreastatins-from-the-porcine-gastrointestinal-tract(6688fbe0-74ce-11db-bee9-02004c4f4f50).html.
  1533. B. Göke; R. Göke; Jens Juul Holst; Cathrine Ørskov. "Glucagon-like peptide 1: on its way to clinical application". Digestion 54 (1994): 339-340. https://curis.ku.dk/portal/en/publications/glucagonlike-peptide-1-on-its-way-to-clinical-application(660d6340-74ce-11db-bee9-02004c4f4f50).html.
  1534. Anne Raben; H B Andersen; Niels Juel Christensen; J Madsen; Jens Juul Holst; Arne Astrup. "Evidence for an abnormal postprandial response to a high-fat meal in women predisposed to obesity". American Journal of Physiology: Endocrinology and Metabolism 267 4 part 1 (1994): E549-E559. https://curis.ku.dk/portal/en/publications/evidence-for-an-abnormal-postprandial-response-to-a-highfat-meal-in-women-predisposed-to-obesity(899aef6e-3bc7-4fd8-9e25-7abe0d96a553).html.
  1535. M.K. Gutniak; B. Linde; Jens Juul Holst; S. Efendic. "Subcutaneous injection of glucagon-like insulintropic peptide reduces postprandial glycemia in non-insulin dependent diabetes". Diabetes Care 17 (1994): 1039-1044. https://curis.ku.dk/portal/en/publications/subcutaneous-injection-of-glucagonlike-insulintropic-peptide-reduces-postprandial-glycemia-in-noninsulin-dependent-diabetes(66794470-74ce-11db-bee9-02004c4f4f50).html.
  1536. A. Raben; H.B. Andersen; N.J. Christensen; Joop Jørgen Viggo Madsen; Jens Juul Holst; A. Astrup. "Evidence for an abnormal postprandial response to a high-fat meal in women predisposed to obesity". Am. J. Physiol. 267 (1994): E549-E559. https://curis.ku.dk/portal/en/publications/evidence-for-an-abnormal-postprandial-response-to-a-highfat-meal-in-women-predisposed-to-obesity(661ccc90-74ce-11db-bee9-02004c4f4f50).html.
  1537. J. Schmidtler; K. Dehne; H.D. Allescher; V. Schusdziarra; M. Classen; Jens Juul Holst; A. Polack; W. Schepp. "Rat parietal cell receptors for GLP-1 (7-36) amide: Northern blot, cross-linking, and radioligand binding". Am. J. Physiol. 267 (1994): G423-G432. https://curis.ku.dk/portal/en/publications/rat-parietal-cell-receptors-for-glp1-736-amide-northern-blot-crosslinking-and-radioligand-binding(6710f090-74ce-11db-bee9-02004c4f4f50).html.
  1538. W.E. Schmidt; S. Schenk; R. Nustede; L.C. Rovati; Jens Juul Holst; U. Fölsch; W. Creutzfeldt. "Cholecystokinin is a negative regulator of gastric acid secretion and postprandial release of gastrin in humans.". Today in Medicine. Gastroenterology 107 (1994): 1610-1620. https://curis.ku.dk/portal/en/publications/cholecystokinin-is-a-negative-regulator-of-gastric-acid-secretion-and-postprandial-release-of-gastrin-in-humans(0d1ddc20-74cd-11db-bee9-02004c4f4f50).html.
  1539. L. Duntas; S.R. Bornstein; W. Scherbaum; Jens Juul Holst. "Atrial natriuretic peptide-like immunoreactive material (ANP-L1) is released from the adrenal gland by splanchnic nerve stimulation". Exp.Clin.Endocrinol. 101 (1994): 371-373. https://curis.ku.dk/portal/en/publications/atrial-natriuretic-peptidelike-immunoreactive-material-anpl1-is-released-from-the-adrenal-gland-by-splanchnic-nerve-stimulation(677c5c90-74ce-11db-bee9-02004c4f4f50).html.
  1540. W. Schepp; J. Schmidtler; Jens Juul Holst. "Exendin-4 and exendin (9-39)NH*U2-agonist and antagonist, respectively, at the rat parietal cell receptor for glucagon-like peptide-1 (7-36)NH*U2". Eur. J. Pharmacol. 269 (1994): 183-191. https://curis.ku.dk/portal/en/publications/exendin4-and-exendin-939nhu2agonist-and-antagonist-respectively-at-the-rat-parietal-cell-receptor-for-glucagonlike-peptide1-736nhu2(676ddda0-74ce-11db-bee9-02004c4f4f50).html.
  1541. A. Hvidberg; M.T. Nielsen; J. Hilsted; Jens Juul Holst; Cathrine Ørskov. "Effect of glucagon-like peptide-1 (proglucagon 78-107 amide) on hepatic glucose production in healthy man". Metabolism 43 (1994): 104-108. https://curis.ku.dk/portal/en/publications/effect-of-glucagonlike-peptide1-proglucagon-78107-amide-on-hepatic-glucose-production-in-healthy-man(cc840250-74ce-11db-bee9-02004c4f4f50).html.
  1542. J. Andreasen; Cathrine Ørskov; Jens Juul Holst. "Secretion of glucagon-like peptide-1 and reactive hypoglycemia after partial gastrectomy". Digestion 55 (1994): 221-228. https://curis.ku.dk/portal/en/publications/secretion-of-glucagonlike-peptide1-and-reactive-hypoglycemia-after-partial-gastrectomy(32a937f0-74cd-11db-bee9-02004c4f4f50).html.
  1543. R. Goll; J.H. Poulsen; P. Schmidt; B. Schjoldager; S.S. Poulsen; Jens Juul Holst. "Peptidergic control of amylase secretion from the rat parotid gland". Regulatory Peptides 51 (1994): 237-254. https://curis.ku.dk/portal/en/publications/peptidergic-control-of-amylase-secretion-from-the-rat-parotid-gland(66d71be0-74ce-11db-bee9-02004c4f4f50).html.
  1544. A. Raben; A. Tagliabue; N.J. Christensen; Joop Jørgen Viggo Madsen; Jens Juul Holst; Arne Astrup. "Resistant starch: The effect on postprandial glycemia, hormonal response and satiety". Am. J. Clin. Nutr. 60 (1994): 544-551. https://curis.ku.dk/portal/en/publications/resistant-starch-the-effect-on-postprandial-glycemia-hormonal-response-and-satiety(65ec94d0-74ce-11db-bee9-02004c4f4f50).html.
  1545. Cathrine Ørskov; L. Rabenhøj; H. Kofod; A. Wettergren; Jens Juul Holst. "Production and secretion of amidated and glycine-extended glucagon-like peptide-1 (GLP) in man". Diabetes 43 (1994): 535-39. https://curis.ku.dk/portal/en/publications/production-and-secretion-of-amidated-and-glycineextended-glucagonlike-peptide1-glp-in-man(67ab0db0-74ce-11db-bee9-02004c4f4f50).html.
  1546. T. Børglum; Jan Fahrenkrug; Jens Juul Holst. "Secretion of pancreastatins from isolated, perfused porcine adrenal glands". Peptides 15 (1994): 519-527. https://curis.ku.dk/portal/en/publications/secretion-of-pancreastatins-from-isolated-perfused-porcine-adrenal-glands(cf7d3a90-74cd-11db-bee9-02004c4f4f50).html.
  1547. Jensen TD; Fahrenkrug J; Holst JJ. "Secretion of pancreastatins from isolated, perfused, porcine adrenal glands.". (1994): http://europepmc.org/abstract/med/7937328.
    10.1016/0196-9781(94)90215-1
  1548. Andreasen JJ; Orskov C; Holst JJ. "Secretion of glucagon-like peptide-1 and reactive hypoglycemia after partial gastrectomy.". (1994): http://europepmc.org/abstract/med/8063025.
  1549. Jens Juul Holst; Torben Norre Rasmussen; P. Schmidt. "Nitric oxide (NO) is an important element in neurally induced pancreatic exocrine secretion in pigs". Am J Physiology 29 (1994): G206-G213. https://curis.ku.dk/portal/en/publications/nitric-oxide-no-is-an-important-element-in-neurally-induced-pancreatic-exocrine-secretion-in-pigs(66b514f0-74ce-11db-bee9-02004c4f4f50).html.
  1550. Monika Ehrhart-Bornstein; S.R. Bornstein; H.G. Behling; Jens Juul Holst; H.G. Strohmayer; Torben Norre Rasmussen; W.A. Scherbaum; G. Adler. "Sympathoadrenal regulation of adrenal androstenedione release". Neuroendocrinology 59 (1994): 406-412. https://curis.ku.dk/portal/en/publications/sympathoadrenal-regulation-of-adrenal-androstenedione-release(66981710-74ce-11db-bee9-02004c4f4f50).html.
  1551. Jens Juul Holst. "Glucagon-like peptide-1 (GLP-1) - A newly discovered Gl Hormone. Review.". Today in Medicine. Gastroenterology 107 (1994): 1848-1855. https://curis.ku.dk/portal/en/publications/glucagonlike-peptide1-glp1--a-newly-discovered-gl-hormone-review(55ed14c0-74cd-11db-bee9-02004c4f4f50).html.
  1552. Cathrine Ørskov; L. Rabenhøj; André Wettergren; H. Kofod; Jens Juul Holst. "Tissue and plasma concentrations of amidated and glycine-extended glucagon-like peptide-1 in humans". Diabetes 43 (1994): 535-539. https://curis.ku.dk/portal/en/publications/tissue-and-plasma-concentrations-of-amidated-and-glycineextended-glucagonlike-peptide1-in-humans(328b4fb0-74cd-11db-bee9-02004c4f4f50).html.
  1553. C.L. Brand; B. Rolin; P.N. Jørgensen; J.S. Svendsen; Jens Juul Holst. "Immunoneutralization of endogenous glucagon with monoclonal glucagon antibody normalizes hyperglycemia in moderately streptozotocin-diabetes rats". Diabetologia 37 (1994): 985-993. https://curis.ku.dk/portal/en/publications/immunoneutralization-of-endogenous-glucagon-with-monoclonal-glucagon-antibody-normalizes-hyperglycemia-in-moderately-streptozotocindiabetes-rats(66a66ef0-74ce-11db-bee9-02004c4f4f50).html.
  1554. A.B. Raben; N.J. Christensen; Joop Jørgen Viggo Madsen; Jens Juul Holst; A. Astrup. "Decreased postprandial thermogenesis and fat oxidation, but increased fullness after a high-fiber meal compared to a low-fiber meal". Am. J. Clin. Nutr. 59 (1994): 1386-1394. https://curis.ku.dk/portal/en/publications/decreased-postprandial-thermogenesis-and-fat-oxidation-but-increased-fullness-after-a-highfiber-meal-compared-to-a-lowfiber-meal(65dbcbf0-74ce-11db-bee9-02004c4f4f50).html.
  1555. André Wettergren; H. Petersen; Cathrine Ørskov; J. Christiansen; S. Sheikh; Jens Juul Holst. "Glucagon-like peptide-1 (GLP-1) 7-36 amide and peptide YY from L-cell in the ileal mucosa are potent inhibitors of vagally induced gastric acid secretion in man". Scandinavian Journal of Gastroenterology 29 (1994): 501-505. https://curis.ku.dk/portal/en/publications/glucagonlike-peptide1-glp1-736-amide-and-peptide-yy-from-lcell-in-the-ileal-mucosa-are-potent-inhibitors-of-vagally-induced-gastric-acid-secretion-in-man(3299f5b0-74cd-11db-bee9-02004c4f4f50).html.
  1556. Madsen OD; Karlsen C; Nielsen E; Lund K; Kofod H; Welinder B; Rehfeld JF; et al. "The dissociation of tumor-induced weight loss from hypoglycemia in a transplantable pluripotent rat islet tumor results in the segregation of stable alpha- and beta-cell tumor phenotypes.". (1993): http://europepmc.org/abstract/med/8404649.
    10.1210/en.133.5.2022
  1557. Nauck MA; Kleine N; Orskov C; Holst JJ; Willms B; Creutzfeldt W. "Normalization of fasting hyperglycaemia by exogenous glucagon-like peptide 1 (7-36 amide) in type 2 (non-insulin-dependent) diabetic patients.". (1993): http://europepmc.org/abstract/med/8405741.
    10.1007/BF00401145
  1558. Holst JJ; Bersani M; Hvidberg A; Knigge U; Christiansen E; Madsbad S; Harling H; Kofod H. "On the effects of human galanin in man.". (1993): http://europepmc.org/abstract/med/7689499.
    10.1007/BF00404076
  1559. Oktedalen O; Opstad PK; Holst JJ. "The effect of glucose on the plasma concentration of somatostatin during caloric deficiency in man.". (1993): http://europepmc.org/abstract/med/8103238.
  1560. Orskov C; Wettergren A; Holst JJ. "Biological effects and metabolic rates of glucagonlike peptide-1 7-36 amide and glucagonlike peptide-1 7-37 in healthy subjects are indistinguishable.". (1993): http://europepmc.org/abstract/med/8482423.
    10.2337/diab.42.5.658
  1561. Wettergren A; Schjoldager B; Mortensen PE; Myhre J; Christiansen J; Holst JJ. "Truncated GLP-1 (proglucagon 78-107-amide) inhibits gastric and pancreatic functions in man.". (1993): http://europepmc.org/abstract/med/8462365.
    10.1007/BF01316798
  1562. Lanng S; Thorsteinsson B; Røder ME; Orskov C; Holst JJ; Nerup J; Koch C. "Pancreas and gut hormone responses to oral glucose and intravenous glucagon in cystic fibrosis patients with normal, impaired, and diabetic glucose tolerance.". (1993): http://europepmc.org/abstract/med/8480468.
  1563. Heindorff H; Holst JJ; Almdal T; Vilstrup H. "Effect of glucagon immunoneutralization on the increase in urea synthesis after hysterectomy in rats.". (1993): http://europepmc.org/abstract/med/8477790.
    10.1111/j.1365-2362.1993.tb00756.x
  1564. Nauck MA; Heimesaat MM; Orskov C; Holst JJ; Ebert R; Creutzfeldt W. "Preserved incretin activity of glucagon-like peptide 1 [7-36 amide] but not of synthetic human gastric inhibitory polypeptide in patients with type-2 diabetes mellitus.". (1993): http://europepmc.org/abstract/med/8423228.
    10.1172/JCI116186
  1565. Rasmussen TN; Harling H; Thim L; Pierzynowski S; Weström BR; Holst JJ. "Regulation of secretion of pancreatic spasmolytic polypeptide from porcine pancreas.". (1993): http://europepmc.org/abstract/med/8430801.
  1566. Holst JJ; Rasmussen TN; Harling H; Schmidt P. "Effect of intestinal inhibitory peptides on vagally induced secretion from isolated perfused porcine pancreas.". (1993): http://europepmc.org/abstract/med/7678328.
  1567. O. Øktedalen; P.K. Opstad; Jens Juul Holst. "The effect of glucose on the plasma concentration of somatostatin during caloric deficiency in man". Scandinavian Journal of Gastroenterology 28 (1993): 652-656. https://curis.ku.dk/portal/en/publications/the-effect-of-glucose-on-the-plasma-concentration-of-somatostatin-during-caloric-deficiency-in-man(fce40ad0-74ce-11db-bee9-02004c4f4f50).html.
  1568. Y. Shiokawa; Jens Juul Holst; J.T.N. Rasmussen; P. Schmidt; N.-Aa. Svendgaard. "Cerebrovascular changes following administration of gammaglobulins against substance P or calcitonin gene related peptide in monkey with subarachnoid haemorrhage". British J. of Neurosurgery 7 (1993): 507-518. https://curis.ku.dk/portal/en/publications/cerebrovascular-changes-following-administration-of-gammaglobulins-against-substance-p-or-calcitonin-gene-related-peptide-in-monkey-with-subarachnoid-haemorrhage(fbc10ea0-74ce-11db-bee9-02004c4f4f50).html.
  1569. S.R. Bornstein; Monika Ehrhart-Bornstein; H.G. Stromeyer; G. Adler; W.A. Scherbaum; Jens Juul Holst. "Vasoactive intestinal peptide (VIP) stimulates androstenedione release in isolated perfused pig adrenals". Life Sciences 52 (1993): 135-140. https://curis.ku.dk/portal/en/publications/vasoactive-intestinal-peptide-vip-stimulates-androstenedione-release-in-isolated-perfused-pig-adrenals(fbb304e0-74ce-11db-bee9-02004c4f4f50).html.
  1570. Jens Juul Holst; T.N. Rasmussen; H. Harling; P. Schmidt. "Effect of intestinal inhibitory peptides on vagally induced secretion from isolated perfused porcine pancreas". Pancreas Vol. 8, no (1993): 80-87. https://curis.ku.dk/portal/en/publications/effect-of-intestinal-inhibitory-peptides-on-vagally-induced-secretion-from-isolated-perfused-porcine-pancreas(ffebf3a0-74ce-11db-bee9-02004c4f4f50).html.
  1571. G.E. Holle; I. Demir; J. Dietl; W.G. Forssmann; J.F. Rehfeld; Jens Juul Holst. "Effect of chemical myenteric ablation on the structure, proliferation and endocrine cells in the small intestinal mucosa". Advances in the Innervation of the Gastrointestinal Tract (1993): 89-98. https://curis.ku.dk/portal/en/publications/effect-of-chemical-myenteric-ablation-on-the-structure-proliferation-and-endocrine-cells-in-the-small-intestinal-mucosa(315751a0-74cf-11db-bee9-02004c4f4f50).html.
  1572. Jens Juul Holst. "Glucagon-like peptide-1 - et nyt hormon med mulig anvendelse i diabetesbehandlingen". Tidsskrift for Diabetesbehandling 3 (1993): 33-39. https://curis.ku.dk/portal/en/publications/glucagonlike-peptide1--et-nyt-hormon-med-mulig-anvendelse-i-diabetesbehandlingen(317ed6d0-74cf-11db-bee9-02004c4f4f50).html.
  1573. Susanne Laang; B. Thorsteinsson; M.E. Røder; Cathrine Ørskov; Jens Juul Holst; Jørn Nerup; Christian Koch. "Pancreas and gut hormone responses to oral glucose and intravenous glucagon in cystic fibrosis patients with normal, impaired and diabetic glucose tolerance". Acta Endoctrinologica 128 (1993): 207-214. https://curis.ku.dk/portal/en/publications/pancreas-and-gut-hormone-responses-to-oral-glucose-and-intravenous-glucagon-in-cystic-fibrosis-patients-with-normal-impaired-and-diabetic-glucose-tolerance(274c0f70-74cf-11db-bee9-02004c4f4f50).html.
  1574. A. Wettergren; B. Schjoldager; P.E. Mortensen; J. Myhre; J. Christiansen; Jens Juul Holst. "Truncated GLP-1 (proglucagon 78-107-amide) inhibits gastric and pancreatic functions in man". Digestive Diseases and Sciences Vol. 38, n (1993): 665-673. https://curis.ku.dk/portal/en/publications/truncated-glp1-proglucagon-78107amide-inhibits-gastric-and-pancreatic-functions-in-man(fc97bf90-74ce-11db-bee9-02004c4f4f50).html.
  1575. J. Miholic; C. Ørskov; Jens Juul Holst; J. Kotzerke; R. Pichlmayr. "Postprandial release of glucagon-like peptide-1, pancreatic glucagon, and insulin after esophageal resection". Digestion 54 (1993): 73-78. https://curis.ku.dk/portal/en/publications/postprandial-release-of-glucagonlike-peptide1-pancreatic-glucagon-and-insulin-after-esophageal-resection(fc394be0-74ce-11db-bee9-02004c4f4f50).html.
  1576. M.A. Nauck; N. Kleine; C. Ørskov; Jens Juul Holst; B. Willms; W. Creutzfeldt. "Normalization of fasting hyperglycaemia by exogenous-glucagon-like peptide 1 (7-36 amide) in type 2 (non-insulin-dependent) diabetic patients". Diabetologia 36 (1993): 741-744. https://curis.ku.dk/portal/en/publications/normalization-of-fasting-hyperglycaemia-by-exogenousglucagonlike-peptide-1-736-amide-in-type-2-noninsulindependent-diabetic-patients(fff84fb0-74ce-11db-bee9-02004c4f4f50).html.
  1577. M.A. Nauck; M.M. Heimesaat; C. Ørskov; Jens Juul Holst; Reinholdt Ebert; W. Creutzfeldt. "Preserved incretin activity of glucagon-like peptide 1 (7-36 amide) but not of synthetic human gastric inhibitory polypeptide in patients with type-2 diabetes mellitus". Journal of Clinical Investigation 91 (1993): 301-307. https://curis.ku.dk/portal/en/publications/preserved-incretin-activity-of-glucagonlike-peptide-1-736-amide-but-not-of-synthetic-human-gastric-inhibitory-polypeptide-in-patients-with-type2-diabetes-mellitus(ff6e3820-74ce-11db-bee9-02004c4f4f50).html.
  1578. Torben Norre Rasmussen; H. Harling; Lars Thim; S. Pierzynowski; B. R. Weström; Jens Juul Holst. "Regulation of secretion of pancreatic spasmolytic polypeptide from porcine pancreas". The American Journal of Physiology (1993): G22-G29. https://curis.ku.dk/portal/en/publications/regulation-of-secretion-of-pancreatic-spasmolytic-polypeptide-from-porcine-pancreas(3172a1d0-74cf-11db-bee9-02004c4f4f50).html.
  1579. Jens Juul Holst. "Neural regulation of pancreatic exocrine funktion". The Pancreas: Biology, Pathobiology an Disease (1993): 381-402. https://curis.ku.dk/portal/en/publications/neural-regulation-of-pancreatic-exocrine-funktion(fcf066e0-74ce-11db-bee9-02004c4f4f50).html.
  1580. Torben Norre Rasmussen; H. Gregersen; H. Harling; Jens Juul Holst. "Calcitonin gene-related peptide: effect on contractile activity and luminal-cross-sectional area in isolated, perfused porcine ileum". Scandinavian Journal of Gastroenterology 27 (1993): 787-792. https://curis.ku.dk/portal/en/publications/calcitonin-generelated-peptide-effect-on-contractile-activity-and-luminalcrosssectional-area-in-isolated-perfused-porcine-ileum(00226cf0-74cf-11db-bee9-02004c4f4f50).html.
  1581. Cathrine Ørskov; André Wettergren; Jens Juul Holst. "Biological effects and metabolic rates of GLP-1 7-36 amide and GLP-1 7-37 in healthy volunteers are indistinguishable". Diabetes 42 (1993): 658-661. https://curis.ku.dk/portal/en/publications/biological-effects-and-metabolic-rates-of-glp1-736-amide-and-glp1-737-in-healthy-volunteers-are-indistinguishable(277939f0-74cf-11db-bee9-02004c4f4f50).html.
  1582. O.D. Madsen; G. Karlsen; E. Nielsen; K. Lund; H. Kofod; B. Welinder; J.F. Rehfeld; et al. "The dissociation of tumor-induced weight loss from hypoglycemia in a transplantable pluripotent rat islet tumor results in the segregation of stable *Ga- and *Gb-cell tumor phenotypes". Endokrinologiya vol. 133, (1993): 2022-2030. https://curis.ku.dk/portal/en/publications/the-dissociation-of-tumorinduced-weight-loss-from-hypoglycemia-in-a-transplantable-pluripotent-rat-islet-tumor-results-in-the-segregation-of-stable-ga-and-gbcell-tumor-phenotypes(3163adb0-74cf-11db-bee9-02004c4f4.
  1583. Schmidt P; Rasmussen TN; Holst JJ. "Release of immunoreactive somatostatin, vasoactive intestinal polypeptide (VIP), and galanin during propulsive complexes in isolated pig ileum.". (1993): http://europepmc.org/abstract/med/7683399.
    10.1016/0196-9781(93)90032-C
  1584. Duntas L; Bornstein SR; Scherbaum WA; Holst JJ. "Atrial natriuretic peptide-like immunoreactive material (ANP-LI) is released from the adrenal gland by splanchnic nerve stimulation.". (1993): http://europepmc.org/abstract/med/8157094.
  1585. Shiokawa Y; Holst JJ; Torben J; Rasmussen N; Schmidt P; Svendgaard NA. "Cerebrovascular changes following administration of gammaglobulins against substance P or calcitonin gene related peptide in monkey with subarachnoid haemorrhage.". (1993): http://europepmc.org/abstract/med/7505591.
    10.3109/02688699308995073
  1586. Bornstein SR; Ehrhart-Bornstein M; Stromeyer HG; Adler G; Scherbaum WA; Holst JJ. "Vasoactive intestinal peptide (VIP) stimulates androstenedione release in isolated perfused pig adrenals.". (1993): http://europepmc.org/abstract/med/8394961.
    10.1016/0024-3205(93)90132-M
  1587. Miholic J; Orskov C; Holst JJ; Kotzerke J; Pichlmayr R. "Postprandial release of glucagon-like peptide-1, pancreatic glucagon, and insulin after esophageal resection.". (1993): http://europepmc.org/abstract/med/8319842.
  1588. P. Schmidt; T.N. Rasmussen; Jens Juul Holst. "Release of immunoreactive somatostatin, vasoactive intestinal polypeptide (VIP), and galanin during propulsive complexes in isolated pig ileum". Peptides Vol. 14 (1993): 215-220. https://curis.ku.dk/portal/en/publications/release-of-immunoreactive-somatostatin-vasoactive-intestinal-polypeptide-vip-and-galanin-during-propulsive-complexes-in-isolated-pig-ileum(fcbc85a0-74ce-11db-bee9-02004c4f4f50).html.
  1589. H. Heindorff; Jens Juul Holst; Thomas Peter Almdal; H. Vilstrup. "Effect of glucagon immunoneutralization on the increase in urea synthesis after hysterectomy in rats". European Journal of Clinical Investigation 23 (1993): 166-170. https://curis.ku.dk/portal/en/publications/effect-of-glucagon-immunoneutralization-on-the-increase-in-urea-synthesis-after-hysterectomy-in-rats(fc553850-74ce-11db-bee9-02004c4f4f50).html.
  1590. Holst JJ; Jørgensen PN; Rasmussen TN; Schmidt P. "Somatostatin restraint of gastrin secretion in pigs revealed by monoclonal antibody immunoneutralization.". (1992): http://europepmc.org/abstract/med/1362042.
  1591. Holst JJ; Orskov C. "Discussing the role of glucagonlike peptide-I.". (1992): http://europepmc.org/abstract/med/1425120.
    10.2337/diacare.15.10.1440
  1592. Rasmussen TN; Raaberg L; Poulsen SS; Thim L; Holst JJ. "Immunohistochemical localization of pancreatic spasmolytic polypeptide (PSP) in the pig.". (1992): http://europepmc.org/abstract/med/1429019.
    10.1007/BF00717002
  1593. Rasmussen TN; Gregersen H; Harling H; Holst JJ. "Calcitonin gene-related peptide: effect on contractile activity and luminal cross-sectional area in the isolated, perfused porcine ileum.". (1992): http://europepmc.org/abstract/med/1411287.
  1594. Holst JJ; Skak-Nielsen T; Orskov C; Seier-Poulsen S. "Vagal control of the release of somatostatin, vasoactive intestinal polypeptide, gastrin-releasing peptide, and HCl from porcine non-antral stomach.". (1992): http://europepmc.org/abstract/med/1359631.
  1595. Møller M; Mikkelsen JD; Holst JJ; Phansuwan-Pujito P. "Somatostatin and prosomatostatin immunoreactive nerve fibers in the bovine pineal gland.". (1992): http://europepmc.org/abstract/med/1357571.
  1596. Olsen O; Holst JJ; Schaffalitzky De Muckadell OB. "Effects of oleic acid and endogenous bile on duodenal secretion of somatostatin in man.". (1992): http://europepmc.org/abstract/med/1352199.
    10.1007/BF01300282
  1597. Shokouh-Amiri MH; Falholt K; Holst JJ; Rahimi-Saber S; Orbaek Andersen H; Jensen SL. "Pancreas endocrine function in pigs after segmental pancreas autotransplantation with either systemic or portal venous drainage.". (1992): http://europepmc.org/abstract/med/1604619.
  1598. Gutniak M; Orskov C; Holst JJ; Ahrén B; Efendic S. "Antidiabetogenic effect of glucagon-like peptide-1 (7-36)amide in normal subjects and patients with diabetes mellitus.". (1992): http://europepmc.org/abstract/med/1348845.
    10.1056/NEJM199205143262003
  1599. Schmidt P; Rasmussen TN; Holst JJ. "Nervous control of the release of substance P and neurokinin A from the isolated perfused porcine ileum.". (1992): http://europepmc.org/abstract/med/1377730.
    10.1016/0165-1838(92)90229-A
  1600. Messell T; Harling H; Poulsen SS; Bersani M; Holst JJ. "Extrinsic control of the release of galanin and VIP from intrinsic nerves of isolated, perfused, porcine ileum.". (1992): http://europepmc.org/abstract/med/1375382.
    10.1016/0167-0115(92)90101-Y
  1601. Larsen PJ; Bersani M; Holst JJ; Møller M; Mikkelsen JD. "Distribution and characterization of different molecular products of pro-somatostatin in the hypothalamus and posterior pituitary lobe of the Mongolian gerbil (Meriones unguiculatus).". (1992): http://europepmc.org/abstract/med/1347564.
  1602. Orskov C; Andreasen J; Holst JJ. "All products of proglucagon are elevated in plasma from uremic patients.". (1992): http://europepmc.org/abstract/med/1730817.
    10.1210/jc.74.2.379
  1603. Harling H; Holst JJ. "Circulating galanin: origin, metabolism, and pharmacokinetics in anesthetized pigs.". (1992): http://europepmc.org/abstract/med/1370746.
  1604. Almdal TP; Holst JJ; Heindorff H; Vilstrup H. "Glucagon immunoneutralization in diabetic rats normalizes urea synthesis and decreases nitrogen wasting.". (1992): http://europepmc.org/abstract/med/1727732.
    10.2337/diab.41.1.12
  1605. Morten Møller; J.D. Mikkelsen; Jens Juul Holst. "Somostatin and Prosomatostatin-immunoreactive nerve fibers in the bovine pineal gland". Neuroendocrinology Vol. 56 (2 (1992): 278-283. https://curis.ku.dk/portal/en/publications/somostatin-and-prosomatostatinimmunoreactive-nerve-fibers-in-the-bovine-pineal-gland(66aecc00-74d1-11db-bee9-02004c4f4f50).html.
  1606. Cathrine Ørskov; Jan Andreasen; Jens Juul Holst. "All products of proglucagon are elevated in plasma from ureamic patients". Journal of Clinical Endocrinology and Metabolism 79 (1992): 379-383. https://curis.ku.dk/portal/en/publications/all-products-of-proglucagon-are-elevated-in-plasma-from-ureamic-patients(7c2862d0-74d1-11db-bee9-02004c4f4f50).html.
  1607. Thomas Peter Almdal; Jens Juul Holst; H. Vilstrup. "Glucagon immunoneutralization in diabetic rats normalizes urea synthesis and decreases nitrogen wasting". Diabetes 41 (1992): 12-16. https://curis.ku.dk/portal/en/publications/glucagon-immunoneutralization-in-diabetic-rats-normalizes-urea-synthesis-and-decreases-nitrogen-wasting(1aa3bec0-74d0-11db-bee9-02004c4f4f50).html.
  1608. Jens Juul Holst; T. Skak-Nielsen; Cathrine Ørskov; S.S. Poulsen. "Vagal control of the release of somatostatin, vasoactive intestinal polypeptide, gastrin releasing peptide and HC1 from porcine non-antral stomach". Scandinavian Journal of Gastroenterology 27 (1992): 677-685. https://curis.ku.dk/portal/en/publications/vagal-control-of-the-release-of-somatostatin-vasoactive-intestinal-polypeptide-gastrin-releasing-peptide-and-hc1-from-porcine-nonantral-stomach(398f6500-74d0-11db-bee9-02004c4f4f50).html.
  1609. Tina Messel; H. Harling; S.S. Poulsen; Maurizio Bersani; Jens Juul Holst. "Extrinsic control of the release of galanin and VIP from intrinsic nerves of isolated, perfused porcine ileum". Regulatory Peptides 38 (1992): 179-198. https://curis.ku.dk/portal/en/publications/extrinsic-control-of-the-release-of-galanin-and-vip-from-intrinsic-nerves-of-isolated-perfused-porcine-ileum(443f5630-74d1-11db-bee9-02004c4f4f50).html.
  1610. P. Schmidt; Torben Norre Rasmussen; Jens Juul Holst. "Nervous control of the release of substance P and neurokinin A from the isolated perfused porcine ileum". J. of the Autonomic Nerv. System 38 (1992): 85-96. https://curis.ku.dk/portal/en/publications/nervous-control-of-the-release-of-substance-p-and-neurokinin-a-from-the-isolated-perfused-porcine-ileum(1afcdb40-74d0-11db-bee9-02004c4f4f50).html.
  1611. Jens Juul Holst; Cathrine Ørskov. "Glucagon-like peptide 1 - a new hormone which may change the treatment of non-insulin dependent diabetes mellitus". MedView 6 (1992): 259-263. https://curis.ku.dk/portal/en/publications/glucagonlike-peptide-1--a-new-hormone-which-may-change-the-treatment-of-noninsulin-dependent-diabetes-mellitus(1ae115e0-74d0-11db-bee9-02004c4f4f50).html.
  1612. Torben Norre Rasmussen; L. Raaberg; S.S. Poulsen; Lars Thim; Jens Juul Holst. "Immunohistochemical localization of pancreatic spasmolytic polypeptide in the pig". Histochemistry 98 (1992): 113-119. https://curis.ku.dk/portal/en/publications/immunohistochemical-localization-of-pancreatic-spasmolytic-polypeptide-in-the-pig(441204a0-74d1-11db-bee9-02004c4f4f50).html.
  1613. Holst JJ; Orskov C; Seier-Poulsen S. "Somatostatin is an essential paracrine link in acid inhibition of gastrin secretion.". (1992): http://europepmc.org/abstract/med/1354190.
  1614. Philip J. Larsen; Maurizio Bersani; Jens Juul Holst; Morten Møller; J.D. Mikkelsen. "Distribution and characterization of different molecular products of Pro-somatostatin in the hypothalmus and posterior pituitary lobe of the mongolian gerbil (Meriones unguiculatus)". Journal of Neuroscience 12, h{\ae (1992): 946-961. https://curis.ku.dk/portal/en/publications/distribution-and-characterization-of-different-molecular-products-of-prosomatostatin-in-the-hypothalmus-and-posterior-pituitary-lobe-of-the-mongolian-gerbil-meriones-unguiculatus(b3591160-74d0-11db-bee9-02004c4f4.
  1615. H. Harling; Jens Juul Holst. "Circulating galanin: origin, metabolism, and pharmacokinetics in anesthetized pigs". Am. J. of Physiology 262 (1992): E52-E57. https://curis.ku.dk/portal/en/publications/circulating-galanin-origin-metabolism-and-pharmacokinetics-in-anesthetized-pigs(1b18a0a0-74d0-11db-bee9-02004c4f4f50).html.
  1616. Cathrine Ørskov; J. Andreasen; Jens Juul Holst. "Proglucagon products in plasma of uraemic patients and normals in the fasting state". J. Clin. Endocrinol. Metab. 74 (1992): 379-384. https://curis.ku.dk/portal/en/publications/proglucagon-products-in-plasma-of-uraemic-patients-and-normals-in-the-fasting-state(1aee0e30-74d0-11db-bee9-02004c4f4f50).html.
  1617. O. Olsen; Jens Juul Holst; O.B. Schaffalitzky de Muckadell. "Effects of oleic acid and endogenous bile on the duodenal secretion of somatostatin in man". Dig. Diseases and Sciences 37(7) (1992): 1025-1028. https://curis.ku.dk/portal/en/publications/effects-of-oleic-acid-and-endogenous-bile-on-the-duodenal-secretion-of-somatostatin-in-man(1a934400-74d0-11db-bee9-02004c4f4f50).html.
  1618. Mark Gutniak; Cathrine Ørskov; Jens Juul Holst; Bo Ahrén; Suad Efendic. "Antidiabetogenic Effect of glucagon-like peptide-1 (7-36) amide in normal subjects and patients with diabetes mellitus". New England Journal of Medicine 326 (1992): 1316-1322. https://curis.ku.dk/portal/en/publications/antidiabetogenic-effect-of-glucagonlike-peptide1-736-amide-in-normal-subjects-and-patients-with-diabetes-mellitus(7cd28580-74d1-11db-bee9-02004c4f4f50).html.
  1619. Jens Juul Holst; Cathrine Ørskov; S.S. Poulsen. "Somatostatin is an essential paracrine link in acid inhibition of gastrin secretion". Digestion 51 (1992): 95-102. https://curis.ku.dk/portal/en/publications/somatostatin-is-an-essential-paracrine-link-in-acid-inhibition-of-gastrin-secretion(7c1b6a80-74d1-11db-bee9-02004c4f4f50).html.
  1620. Børglum Jensen TD; Holst JJ; Fahrenkrug J. "Characterization of immunoreactive pancreastatin in porcine tissues.". (1991): http://europepmc.org/abstract/med/1806983.
    10.3109/00365519109104581
  1621. Ehrhart-Bornstein M; Bornstein SR; Scherbaum WA; Pfeiffer EF; Holst JJ. "Role of the vasoactive intestinal peptide in a neuroendocrine regulation of the adrenal cortex.". (1991): http://europepmc.org/abstract/med/1664501.
  1622. Hilsted J; Frandsen H; Holst JJ; Christensen NJ; Nielsen SL. "Plasma glucagon and glucose recovery after hypoglycemia: the effect of total autonomic blockade.". (1991): http://europepmc.org/abstract/med/1661996.
  1623. Bersani M; Thim L; Rasmussen TN; Holst JJ. "Galanin and galanin extended at the N-terminus with seven and nine amino acids are produced in and secreted from the porcine adrenal medulla in almost equal amounts.". (1991): http://europepmc.org/abstract/med/1718731.
    10.1210/endo-129-5-2693
  1624. Mikkelsen JD; Bersani M; Holst JJ; Larsen PJ. "Nerve fibers in the rat posterior pituitary lobe contain prosomatostatin (1-64).". (1991): http://europepmc.org/abstract/med/1684227.
  1625. Miholic J; Orskov C; Holst JJ; Kotzerke J; Meyer HJ. "Emptying of the gastric substitute, glucagon-like peptide-1 (GLP-1), and reactive hypoglycemia after total gastrectomy.". (1991): http://europepmc.org/abstract/med/1914756.
    10.1007/BF01296800
  1626. Messell T; Dunning BE; Sheikh S; Holst JJ. "Neuropeptide Y (NPY) and vasoactive intestinal polypeptide (VIP), but not galanin, are autonomic cotransmitters in the porcine pancreas.". (1991): http://europepmc.org/abstract/med/1721082.
  1627. Bjørnskov-Bartholdy L; Bersani M; Holst JJ. "Identification, characterization and release of GRP gene-associated peptides from the normal porcine and human gastro-intestinal tract.". (1991): http://europepmc.org/abstract/med/1924888.
    10.1016/0167-0115(91)90179-K
  1628. Holst JJ; Ehrhart-Bornstein M; Messell T; Poulsen SS; Harling H. "Release of galanin from isolated perfused porcine adrenal glands: role of splanchnic nerves.". (1991): http://europepmc.org/abstract/med/1713413.
  1629. Bersani M; Johnsen AH; Højrup P; Dunning BE; Andreasen JJ; Holst JJ. "Human galanin: primary structure and identification of two molecular forms.". (1991): http://europepmc.org/abstract/med/1710578.
    10.1016/0014-5793(91)80585-Q
  1630. Scopsi L; Di Palma S; Ferrari C; Holst JJ; Rehfeld JF; Rilke F. "C-cell hyperplasia accompanying thyroid diseases other than medullary carcinoma: an immunocytochemical study by means of antibodies to calcitonin and somatostatin.". (1991): http://europepmc.org/abstract/med/1676840.
  1631. Schjoldager B; Poulsen SS; Schmidt P; Coy DH; Holst JJ. "Gastrin-releasing peptide is a transmitter mediating porcine gallbladder contraction.". (1991): http://europepmc.org/abstract/med/1708207.
  1632. Orskov C; Jeppesen J; Madsbad S; Holst JJ. "Proglucagon products in plasma of noninsulin-dependent diabetics and nondiabetic controls in the fasting state and after oral glucose and intravenous arginine.". (1991): http://europepmc.org/abstract/med/1991827.
    10.1172/JCI115012
  1633. Kofod H; Thams P; Holst JJ. "Differential effects of secretin-fragments imply a dual mechanism of action for secretin.". (1991): http://europepmc.org/abstract/med/1850389.
  1634. Bersani M; Johnsen AH; Holst JJ. "Oxidation/reduction explains heterogeneity of pancreatic somatostatin.". (1991): http://europepmc.org/abstract/med/1672110.
    10.1016/0014-5793(91)80157-X
  1635. Busch-Sørensen M; Holst JJ; Lyngsøe J. "Short time effects of growth hormone on glucose metabolism and insulin and glucagon secretion in normal man.". (1991): http://europepmc.org/abstract/med/1675225.
    10.1007/BF03350253
  1636. J. Miholic; Cathrine Ørskov; Jens Juul Holst; H.-J. Meyer; R. Pichlmayr. "Glucagon-like peptide-1 (GLP-1), Entleerung des Magenersatzes und das Dumpingsyndrom nach Gastrektomie". Langerbecks Archiv für Chirurgie. (108. Kongress der Deutsch.Gesellsch.Chirurgie Suppl.1991 (1991): 430-432. https://curis.ku.dk/portal/en/publications/glucagonlike-peptide1-glp1-entleerung-des-magenersatzes-und-das-dumpingsyndrom-nach-gastrektomie(070756f0-74d1-11db-bee9-02004c4f4f50).html.
  1637. Jens Juul Holst; Monika Ehrhart-Bornstein; T. Messell. "Release of galanin from isolated, perfused porcine adrenal glands. Role of the splanchnic nerves". Amer.J. Physiology 261 (1991): E31-E40. https://curis.ku.dk/portal/en/publications/release-of-galanin-from-isolated-perfused-porcine-adrenal-glands-role-of-the-splanchnic-nerves(f8763e80-74d0-11db-bee9-02004c4f4f50).html.
  1638. Maurizio Bersani; A.H. Johnsen; P. Højrup; B.E. Dunning; Jens Juul Holst; J.J. Andreasen. "Human galanin: primary structure and identification of two molecular forms". FEBS Letters 283 (1991): 189-194. https://curis.ku.dk/portal/en/publications/human-galanin-primary-structure-and-identification-of-two-molecular-forms(06ec54e0-74d1-11db-bee9-02004c4f4f50).html.
  1639. J. Miholic; Cathrine Ørskov; Jens Juul Holst; J. Kotzerke; H.J. Meyer. "Emptying of the Gastric Substitute, Glucagon-like Peptide-1 (GLP-1), and Reactive hypoglycemia after Total Gastrectomy". Digestive Diseases and Sciences 36, no.10 (1991): 1361-1370. https://curis.ku.dk/portal/en/publications/emptying-of-the-gastric-substitute-glucagonlike-peptide1-glp1-and-reactive-hypoglycemia-after-total-gastrectomy(06c45a80-74d1-11db-bee9-02004c4f4f50).html.
  1640. Monika Ehrhart-Bornstein; S.R. Bornstein; Jens Juul Holst. "Vasoactive intestinal peptide in the porcine adrenal gland". Neuroendocrinology 54 (1991): 623-628. https://curis.ku.dk/portal/en/publications/vasoactive-intestinal-peptide-in-the-porcine-adrenal-gland(f8922af0-74d0-11db-bee9-02004c4f4f50).html.
  1641. Cathrine Ørskov; J. Jeppesen; J. Madsbad; Jens Juul Holst. "Proglucagon products in plasma of noninsulin-dependent diabetics and nondiabetic controls in the fasting-state and after oral glucose and intravenous arginine". J. Clin. Invest. 87 (1991): 415-423. https://curis.ku.dk/portal/en/publications/proglucagon-products-in-plasma-of-noninsulindependent-diabetics-and-nondiabetic-controls-in-the-fastingstate-and-after-oral-glucose-and-intravenous-arginine(aaf082b0-74d0-11db-bee9-02004c4f4f50).html.
  1642. Maurizio Bersani; Lars Thim; Torben Norre Rasmussen; Jens Juul Holst. "Galanin and galanin extended at the N-terminus with 7 and 9 amino acids are produced in and secreted from the porcine adrenal medulla in almost equal amounts". Endokrinologiya 129 (1991): 2693-2698. https://curis.ku.dk/portal/en/publications/galanin-and-galanin-extended-at-the-nterminus-with-7-and-9-amino-acids-are-produced-in-and-secreted-from-the-porcine-adrenal-medulla-in-almost-equal-amounts(aab9e250-74d0-11db-bee9-02004c4f4f50).html.
  1643. M. Busch Sørensen; H. Sjøstrand; Jens Juul Holst; H. Sengeløv; M. Tiefenthal Thrane; J. Lyngsøe. "Influence of short term verapamil treatment on glucose metabolism in patients with non-insulin dependent diabetes mellitus". EUR. J. Clin. Pharmacol. 41 (1991): 401-404. https://curis.ku.dk/portal/en/publications/influence-of-short-term-verapamil-treatment-on-glucose-metabolism-in-patients-with-noninsulin-dependent-diabetes-mellitus(062422e0-74d1-11db-bee9-02004c4f4f50).html.
  1644. Maurizio Bersani; A.H. Johnsen; Jens Juul Holst. "Oxidation/reduction explains heterogeneity of pancreatic somatostatin". FEBS Letter 279, no.2 (1991): 237-239. https://curis.ku.dk/portal/en/publications/oxidationreduction-explains-heterogeneity-of-pancreatic-somatostatin(06048cf0-74d1-11db-bee9-02004c4f4f50).html.
  1645. L. Scopsi; S. di Palma; C. Ferrari; Jens Juul Holst; J.F. Rehfeld. "C-cell hyperplasia accompanying thyroid diseases other than medullary carcinoma: an immunocytochemical study by means of antibodies to calcitonin and somatostatin". Modern Pathology Vol 4, no. (1991): 297-304. https://curis.ku.dk/portal/en/publications/ccell-hyperplasia-accompanying-thyroid-diseases-other-than-medullary-carcinoma-an-immunocytochemical-study-by-means-of-antibodies-to-calcitonin-and-somatostatin(07890a10-74d1-11db-bee9-02004c4f4f50).html.
  1646. Jens Juul Holst; Maurizio Bersani. "Assays for Peptide Products of Somatostatin Gene Expression". Methods in Neurosciences 5 (1991): 3-22. https://curis.ku.dk/portal/en/publications/assays-for-peptide-products-of-somatostatin-gene-expression(077d2330-74d1-11db-bee9-02004c4f4f50).html.
  1647. J. Christiansen; M. Lorentzen; Jens Juul Holst. "Influence of peptides on anorectal function". Annals of Medicine 22 (1991): 413-418. https://curis.ku.dk/portal/en/publications/influence-of-peptides-on-anorectal-function(076f8ea0-74d1-11db-bee9-02004c4f4f50).html.
  1648. Leif Bjørnskov-Bartholdy; Maurizio Bersani; Jens Juul Holst. "Identification, characterization and release of GRP gene-associated peptides from the normal porcine and human gastro-intestinal tract". Regulatory Peptides 34 (1991): 197-209. https://curis.ku.dk/portal/en/publications/identification-characterization-and-release-of-grp-geneassociated-peptides-from-the-normal-porcine-and-human-gastrointestinal-tract(06fad3d0-74d1-11db-bee9-02004c4f4f50).html.
  1649. T. Messell; B.E. Dunning; S. Sheikh; Jens Juul Holst. "Neuropeptide Y (NPY) and vasoactive intestinal polypeptide (VIP), but not galanin, are autonomic cotransmitters in the porcine pancreas". International Journal of Gastrointestinal Cancer 10 (1991): 133-141. https://curis.ku.dk/portal/en/publications/neuropeptide-y-npy-and-vasoactive-intestinal-polypeptide-vip-but-not-galanin-are-autonomic-cotransmitters-in-the-porcine-pancreas(06986880-74d1-11db-bee9-02004c4f4f50).html.
  1650. T.D. Børglum; Jens Juul Holst; Jan Fahrenkrug. "Characterization of immunoactive pancreastatin in porcine tissues". Scand. J. Clin. Lab. Invest. 51 (1991): 681-691. https://curis.ku.dk/portal/en/publications/characterization-of-immunoactive-pancreastatin-in-porcine-tissues(1b0abdf0-74d0-11db-bee9-02004c4f4f50).html.
  1651. J. Hilsted; H. Frandsen; Jens Juul Holst; J. Christensen; S.L. Nielsen. "Plasma glucagon and glucose recovery after hypoglycemia: The effect of total autonomic blockade". Acta Endocrinol. 125 (1991): 466-469. https://curis.ku.dk/portal/en/publications/plasma-glucagon-and-glucose-recovery-after-hypoglycemia-the-effect-of-total-autonomic-blockade(1a6a8650-74d0-11db-bee9-02004c4f4f50).html.
  1652. M. Harling; Tina Messel; Jens Juul Holst; S.S. Poulsen. "Galanin and vasoactive intestinal polypeptide: Release during intraluminal, chemical irritation and distension of the isolated perfused porcine ileum". Digestion 50 (1991): 61-71. https://curis.ku.dk/portal/en/publications/galanin-and-vasoactive-intestinal-polypeptide-release-during-intraluminal-chemical-irritation-and-distension-of-the-isolated-perfused-porcine-ileum(3971f1f0-74d0-11db-bee9-02004c4f4f50).html.
  1653. Harling H; Messell T; Poulsen SS; Rasmussen TN; Holst JJ. "Galanin and vasoactive intestinal polypeptide: coexistence and corelease from the vascularly perfused pig ileum during distension and chemical stimulation of the mucosa.". (1991): http://europepmc.org/abstract/med/1725160.
  1654. Schmidt P; Poulsen SS; Rasmussen TN; Bersani M; Holst JJ. "Substance P and neurokinin A are codistributed and colocalized in the porcine gastrointestinal tract.". (1991): http://europepmc.org/abstract/med/1724799.
    10.1016/0196-9781(91)90045-Q
  1655. J.D. Mikkelsen; Maurizio Bersani; Jens Juul Holst; Philip J. Larsen. "Nerve fibers in the rat posterior pituitary lobe contain Prosomatostatin (1-64)". Neuroendocrinology 54 (1991): 469-476. https://curis.ku.dk/portal/en/publications/nerve-fibers-in-the-rat-posterior-pituitary-lobe-contain-prosomatostatin-164(3b60fb40-74d1-11db-bee9-02004c4f4f50).html.
  1656. Larsen JN; Bersani M; Olcese J; Holst JJ; Møller M. "Somatostatin and prosomatostatin in the retina of the rat: an immunohistochemical, in-situ hybridization, and chromatographic study.". (1990): http://europepmc.org/abstract/med/1981146.
  1657. Holst JJ. "Neuronal control of pancreatic exocrine secretion.". (1990): http://europepmc.org/abstract/med/2124995.
    10.1111/j.1365-2362.1990.tb01775.x
  1658. Holst JJ; Schaffalitzky de Muckadell OB; Fahrenkrug J. "Somatostatin inhibits neurally stimulated pancreatic secretion indirectly.". (1990): http://europepmc.org/abstract/med/1978315.
  1659. Hilsted J; Wilken-Jensen C; Birch K; Damkjaer Nielsen M; Holst JJ; Kehlet H. "Endocrine, metabolic and cardiovascular responses to adrenaline after abdominal surgery.". (1990): http://europepmc.org/abstract/med/2171289.
  1660. Scopsi L; Ferrari C; Pilotti S; Holst JJ; Rehfeld JF; Fossati G; Rilke F. "Immunocytochemical localization and identification of prosomatostatin gene products in medullary carcinoma of human thyroid gland.". (1990): http://europepmc.org/abstract/med/1974875.
    10.1016/0046-8177(90)90051-6
  1661. Bornstein SR; Ehrhart-Bornstein M; Scherbaum WA; Pfeiffer EF; Holst JJ. "Effects of splanchnic nerve stimulation on the adrenal cortex may be mediated by chromaffin cells in a paracrine manner.". (1990): http://europepmc.org/abstract/med/2373060.
    10.1210/endo-127-2-900
  1662. Holst JJ; Ostenson CG; Harling H; Messell T. "Porcine pancreastatin has no effect on endocrine secretion from the pig pancreas.". (1990): http://europepmc.org/abstract/med/1976102.
    10.1007/BF00404088
  1663. Sjövall M; Holst JJ; Olbe L; Lundell L. "Somatostatin release induced by gastrin-releasing peptide in man. Effect of proximal gastric vagotomy and cholinergic blockade.". (1990): http://europepmc.org/abstract/med/1977187.
    10.1016/0167-0115(90)90076-9
  1664. Messell T; Harling H; Böttcher G; Johnsen AH; Holst JJ. "Galanin in the porcine pancreas.". (1990): http://europepmc.org/abstract/med/1693004.
    10.1016/0167-0115(90)90015-O
  1665. Shokouh-Amiri MH; Lindkaer S; Holst JJ; Vagn Nielsen O; Sanchez-Almeyra R; Lauritsen KB. "Glucagon response to hypoglycemia and the effect of oral glucose tolerance test on gastric inhibitory polypeptide secretion in pancreas transplanted pigs.". (1990): http://europepmc.org/abstract/med/2109392.
  1666. Holst Pedersen J; Christiansen J; Holst JJ; Krarup T; Hint K; Palmgren N. "Inhibition of gastric acid secretion by jejunal glucose and its relation to osmolality and glucose load.". (1990): http://europepmc.org/abstract/med/1968287.
  1667. Holst JJ; Harling H; Messell T; Coy DH. "Identification of the neurotransmitter/neuromodulator functions of the neuropeptide gastrin-releasing peptide in the porcine antrum, using the antagonist (Leu13-psi-CH2 NH-Leu14)-bombesin.". (1990): http://europepmc.org/abstract/med/1968286.
  1668. Philipsen EK; Myhre J; Larsen S; Damkjaer Nielsen M; Holst JJ; Hilsted J. "The relationship between some beta-adrenergic mediated responses and plasma concentrations of adrenaline and cyclic AMP in man.". (1990): http://europepmc.org/abstract/med/1968306.
  1669. Harling H; Gregersen H; Rasmussen TN; Poulsen SS; Holst JJ; Jenson SL. "Galanin: distribution and effect on contractile activity and release of vasoactive intestinal polypeptide from the isolated perfused porcine ileum.". (1990): http://europepmc.org/abstract/med/1712741.
  1670. Rasmussen TN; Thim L; Raaberg L; Harling H; Holst JJ. "Pancreatic spasmolytic polypeptide, a potential growth factor for the intestine: neural control of secretion.". (1990): http://europepmc.org/abstract/med/2262056.
  1671. Holst JJ. "Peptidergic mechanisms in the pancreas.". (1990): http://europepmc.org/abstract/med/2196859.
  1672. Sheikh SP; Holst JJ; Orskov C; Ekman R; Schwartz TW. "Release of PYY from pig intestinal mucosa; luminal and neural regulation.". (1989): http://europepmc.org/abstract/med/2623190.
    10.1016/0167-0115(89)90193-6
  1673. Holst JJ; Hansen M; Bork E; Schwartz TW. "Elevated plasma concentrations of C-flanking gastrin-releasing peptide in small-cell lung cancer.". (1989): http://europepmc.org/abstract/med/2555450.
  1674. Shennan KI; Holst JJ; Docherty K. "Proglucagon expression, posttranslational processing and secretion in SV40-transformed islet cells.". (1989): http://europepmc.org/abstract/med/2558932.
    10.1016/0303-7207(89)90234-7
  1675. Schjoldager B; Mortensen PE; Myhre J; Christiansen J; Holst JJ. "Oxyntomodulin from distal gut. Role in regulation of gastric and pancreatic functions.". (1989): http://europepmc.org/abstract/med/2670487.
    10.1007/BF01538078
  1676. Holst JJ; Orskov C; Knuhtsen S; Sheikh S; Nielsen OV. "On the regulatory functions of neuropeptide Y (NPY) with respect to vascular resistance and exocrine and endocrine secretion in the pig pancreas.". (1989): http://europepmc.org/abstract/med/2675536.
    10.1111/j.1748-1716.1989.tb08697.x
  1677. Orskov C; Bersani M; Johnsen AH; Højrup P; Holst JJ. "Complete sequences of glucagon-like peptide-1 from human and pig small intestine.". (1989): http://europepmc.org/abstract/med/2753890.
  1678. Ostenson CG; Efendic S; Holst JJ. "Pancreastatin-like immunoreactivity and insulin are released in parallel from the perfused porcine pancreas.". (1989): http://europepmc.org/abstract/med/2656247.
    10.1210/endo-124-6-2986
  1679. Bersani M; Thim L; Baldissera FG; Holst JJ. "Prosomatostatin 1-64 is a major product of somatostatin gene expression in pancreas and gut.". (1989): http://europepmc.org/abstract/med/2567292.
  1680. Schjoldager BT; Mortensen PE; Christiansen J; Orskov C; Holst JJ. "GLP-1 (glucagon-like peptide 1) and truncated GLP-1, fragments of human proglucagon, inhibit gastric acid secretion in humans.". (1989): http://europepmc.org/abstract/med/2714145.
    10.1007/BF01540341
  1681. Olsen J; Mortensen PE; Schaffalitzky de Muckadell OB; Holst JJ; Christiansen J. "Effect of low-dose exogenous secretin and somatostatin on pentagastrin-stimulated gastric acid secretion in man.". (1989): http://europepmc.org/abstract/med/2571184.
  1682. Orskov C; Buhl T; Rabenhøj L; Kofod H; Holst JJ. "Carboxypeptidase-B-like processing of the C-terminus of glucagon-like peptide-2 in pig and human small intestine.". (1989): http://europepmc.org/abstract/med/2714431.
    10.1016/0014-5793(89)81332-8
  1683. Sandvik AK; Holst JJ; Waldum HL. "The effect of gastrin-releasing peptide on acid secretion and the release of gastrin, somatostatin, and histamine in the totally isolated, vascularly perfused rat stomach.". (1989): http://europepmc.org/abstract/med/2467348.
  1684. Holst JJ; Knuhtsen S; Nielsen OV. "Role of gastrin-releasing peptide in neural control of pancreatic exocrine secretion.". (1989): http://europepmc.org/abstract/med/2813328.
  1685. Harling H; Messell T; Jensen SL; Holst JJ; Poulsen SS. "Occurrence, distribution and motor effects of galanin in the porcine lower esophageal sphincter.". (1989): http://europepmc.org/abstract/med/2475382.
  1686. Kofod H; Holst JJ; Lernmark A. "Secretin uncouples glucose inhibition of glucagon-producing cells resulting in a simultaneous stimulation of both glucagon and insulin release.". (1988): http://europepmc.org/abstract/med/3070646.
    10.1016/0167-0115(88)90232-7
  1687. Skak-Nielsen T; Holst JJ; Nielsen OV. "Role of gastrin-releasing peptide in the neural control of pepsinogen secretion from the pig stomach.". (1988): http://europepmc.org/abstract/med/3169490.
  1688. Sandvik AK; Kofstad J; Holst JJ; Waldum HL. "Ionized calcium influences gastrin stimulated histamine release and acid secretion, but not histamine stimulated acid output in the totally isolated vascularly perfused rat stomach.". (1988): http://europepmc.org/abstract/med/2465675.
    10.1111/j.1748-1716.1988.tb08513.x
  1689. Schjoldager BT; Baldissera FG; Mortensen PE; Holst JJ; Christiansen J. "Oxyntomodulin: a potential hormone from the distal gut. Pharmacokinetics and effects on gastric acid and insulin secretion in man.". (1988): http://europepmc.org/abstract/med/3147901.
    10.1111/j.1365-2362.1988.tb01046.x
  1690. Orskov C; Holst JJ; Nielsen OV. "Effect of truncated glucagon-like peptide-1 [proglucagon-(78-107) amide] on endocrine secretion from pig pancreas, antrum, and nonantral stomach.". (1988): http://europepmc.org/abstract/med/2901341.
    10.1210/endo-123-4-2009
  1691. Skak-Nielsen T; Holst JJ; Christensen JD; Fjalland B. "Role of gastrin-releasing peptide in pepsinogen secretion from the isolated perfused rat stomach.". (1988): http://europepmc.org/abstract/med/3148968.
    10.1016/0167-0115(88)90425-9
  1692. Hansen AB; Gespach CP; Rosselin GE; Holst JJ. "Effect of truncated glucagon-like peptide 1 on cAMP in rat gastric glands and HGT-1 human gastric cancer cells.". (1988): http://europepmc.org/abstract/med/2841160.
    10.1016/0014-5793(88)80297-7
  1693. Sheikh SP; Holst JJ; Skak-Nielsen T; Knigge U; Warberg J; Theodorsson-Norheim E; Hökfelt T; Lundberg JM; Schwartz TW. "Release of NPY in pig pancreas: dual parasympathetic and sympathetic regulation.". (1988): http://europepmc.org/abstract/med/3389414.
  1694. Buhl T; Thim L; Kofod H; Orskov C; Harling H; Holst JJ. "Naturally occurring products of proglucagon 111-160 in the porcine and human small intestine.". (1988): http://europepmc.org/abstract/med/3379036.
  1695. Bork E; Hansen M; Urdal P; Paus E; Holst JJ; Schifter S; Fenger M; Engbaek F. "Early detection of response in small cell bronchogenic carcinoma by changes in serum concentrations of creatine kinase, neuron specific enolase, calcitonin, ACTH, serotonin and gastrin releasing peptide.". (1988): http://europepmc.org/abstract/med/2842159.
    10.1016/0277-5379(88)90154-X
  1696. Baldissera FG; Holst JJ; Knuhtsen S; Hilsted L; Nielsen OV. "Oxyntomodulin (glicentin-(33-69)): pharmacokinetics, binding to liver cell membranes, effects on isolated perfused pig pancreas, and secretion from isolated perfused lower small intestine of pigs.". (1988): http://europepmc.org/abstract/med/2839871.
    10.1016/0167-0115(88)90099-7
  1697. Holst Pedersen J; Knuthsen S; Bernabei M; Orskov C; Holst JJ. "Secretion of neurotensin from isolated perfused porcine ileum.". (1988): http://europepmc.org/abstract/med/3393691.
    10.1016/0167-0115(88)90086-9
  1698. Loud FB; Holst JJ; Rehfeld JF; Christiansen J. "Inhibition of gastric acid secretion in humans by glucagon during euglycemia, hyperglycemia, and hypoglycemia.". (1988): http://europepmc.org/abstract/med/3359907.
    10.1007/BF01798352
  1699. Loud FB; Holst JJ; Christiansen J; Rehfeld JF. "Effect of glucagon on vagally induced gastric acid secretion in humans.". (1988): http://europepmc.org/abstract/med/3349886.
    10.1007/BF01536022
  1700. Wogensen LD; Mandrup-Poulsen T; Markholst H; Mølvig J; Lernmark A; Holst JJ; Dinarello CA; Nerup J. "Interleukin-1 potentiates glucose stimulated insulin release in the isolated perfused pancreas.". (1988): http://europepmc.org/abstract/med/3289298.
  1701. Jens Juul Holst; S. KNUHTSEN; Cathrine Ørskov; T. SKAK-NIELSEN; Steen Seier Poulsen; O. VAGN NIELSEN. "Role of Gastrin-Releasing Peptide in Vagal Control of Gastrin Secretion". Annals of the New York Academy of Sciences 547 1 (1988): 514-515. https://curis.ku.dk/portal/en/publications/role-of-gastrinreleasing-peptide-in-vagal-control-of-gastrin-secretion(d20c2715-1a2d-45b5-a0cf-5800ab6f7595).html.
    10.1111/j.1749-6632.1988.tb23940.x
  1702. Gehl J; Jeppesen JL; Poulsen SS; Holst JJ. "The gastric acid secretagogue gastrin-releasing peptide and the inhibitor oxyntomodulin do not exert their effect directly on the parietal cell in the rat.". (1988): http://europepmc.org/abstract/med/3234620.
  1703. Holst JJ; Knuhtsen S; Skak-Nielsen T. "The role of gastrin-releasing peptide in pancreatic exocrine secretion.". (1988): http://europepmc.org/abstract/med/3071221.
    10.1111/j.1749-6632.1988.tb23892.x
  1704. Holst JJ; Jensen SL; Skak-Nielsen T; Christiansen LA. "GRP-producing nerves in the control of gastric secretion.". (1988): http://europepmc.org/abstract/med/3067471.
  1705. Holst JJ; Baldissera FG; Bersani M; Skak-Nielsen T; Seier-Poulsen S; Nielsen OV. "Processing and secretion of prosomatostatin by the pig pancreas.". (1988): http://europepmc.org/abstract/med/2906123.
  1706. Knigge U; Holst JJ; Knuhtsen S; Bach FW; Bang P. "Corticotropin-releasing activity of gastrin-releasing peptide in normal men.". (1987): http://europepmc.org/abstract/med/2824553.
    10.1210/jcem-65-6-1291
  1707. Holst JJ; Knuhtsen S; Orskov C; Skak-Nielsen T; Poulsen SS; Nielsen OV. "GRP-producing nerves control antral somatostatin and gastrin secretion in pigs.". (1987): http://europepmc.org/abstract/med/2892416.
  1708. Skak-Nielsen T; Holst JJ; Baldissera FG; Poulsen SS. "Localization in the gastrointestinal tract of immunoreactive prosomatostatin.". (1987): http://europepmc.org/abstract/med/2893436.
    10.1016/0167-0115(87)90275-8
  1709. Holst JJ; Knuhtsen S; Orskov C; Skak-Nielsen T; Poulsen SS; Jensen SL; Nielsen OV. "GRP nerves in pig antrum: role of GRP in vagal control of gastrin secretion.". (1987): http://europepmc.org/abstract/med/2446506.
  1710. Orskov C; Holst JJ; Poulsen SS; Kirkegaard P. "Pancreatic and intestinal processing of proglucagon in man.". (1987): http://europepmc.org/abstract/med/3446554.
  1711. Thuesen B; Schaffalitzky de Muckadell OB; Holst JJ; Bahnsen M. "The relationship of secretin and somatostatin levels in plasma to glucose administration and acid secretion during fasting.". (1987): http://europepmc.org/abstract/med/2886043.
  1712. Cantor P; Holst JJ; Knuhtsen S; Rehfeld JF. "Effect of neuroactive agents on cholecystokinin release from the isolated, perfused porcine duodenum.". (1987): http://europepmc.org/abstract/med/3509961.
    10.1111/j.1748-1716.1987.tb08185.x
  1713. Knuhtsen S; Holst JJ; Schwartz TW; Jensen SL; Nielsen OV. "The effect of gastrin-releasing peptide on the endocrine pancreas.". (1987): http://europepmc.org/abstract/med/2885899.
    10.1016/0167-0115(87)90284-9
  1714. Knuhtsen S; Holst JJ; Baldissera FG; Skak-Nielsen T; Poulsen SS; Jensen SL; Nielsen OV. "Gastrin-releasing peptide in the porcine pancreas.". (1987): http://europepmc.org/abstract/med/3549425.
  1715. Orskov C; Holst JJ. "Radio-immunoassays for glucagon-like peptides 1 and 2 (GLP-1 and GLP-2).". (1987): http://europepmc.org/abstract/med/3576119.
  1716. Jensen SL; Holst JJ; Christiansen LA; Shokouh-Amiri MH; Lorentsen M; Beck H; Jensen HE. "Effect of intragastric pH on antral gastrin and somatostatin release in anaesthetised, atropinised duodenal ulcer patients and controls.". (1987): http://europepmc.org/abstract/med/2881850.
    10.1136/gut.28.2.206
  1717. Holst JJ; Fahrenkrug J; Knuhtsen S; Jensen SL; Nielsen OV; Lundberg JM; Hökfelt T. "VIP and PHI in the pig pancreas: coexistence, corelease, and cooperative effects.". (1987): http://europepmc.org/abstract/med/3548423.
  1718. Stenquist B; Lind T; Haglund U; Holst JJ; Rehfeld JF; Olbe L. "Do enkephalins participate in vagal activation of gastric acid secretion in man?". (1987): http://europepmc.org/abstract/med/3562904.
    10.1016/0167-0115(87)90028-0
  1719. Krarup T; Holst JJ; Madsbad S. "Heterogeneity of immunoreactive gastric inhibitory polypeptide in the plasma of newly diagnosed type 1 (insulin-dependent) diabetics.". (1987): http://europepmc.org/abstract/med/3544634.
  1720. Holst JJ; Orskov C; Nielsen OV; Schwartz TW. "Truncated glucagon-like peptide I, an insulin-releasing hormone from the distal gut.". (1987): http://europepmc.org/abstract/med/3542566.
    10.1016/0014-5793(87)81430-8
  1721. Holst JJ. "Does the endocrine secretion of the pancreas exert a local control of the exocrine secretion?". (1987): http://europepmc.org/abstract/med/3313382.
  1722. Skak-Nielsen T; Poulsen SS; Holst JJ. "Immunohistochemical detection of ganglia in the rat stomach serosa, containing neurons immunoreactive for gastrin-releasing peptide and vasoactive intestinal peptide.". (1987): http://europepmc.org/abstract/med/2886455.
    10.1007/BF00518723
  1723. Olesen M; Holst JJ; Sottimano C; Nielsen OV. "Autonomic nervous control of fundic secretion of somatostatin and antral secretion of gastrin and somatostatin in pigs.". (1987): http://europepmc.org/abstract/med/2881824.
  1724. Holst JJ. "Identification of peptidergic nervous control of gastrointestinal functions.". (1987): http://europepmc.org/abstract/med/3327276.
  1725. Cantor P; Holst JJ; Knuhtsen S; Rehfeld JF. "The effect of vagal stimulation on the release of cholecystokinin in anaesthetized pigs.". (1986): http://europepmc.org/abstract/med/3810006.
  1726. Orskov C; Holst JJ; Knuhtsen S; Baldissera FG; Poulsen SS; Nielsen OV. "Glucagon-like peptides GLP-1 and GLP-2, predicted products of the glucagon gene, are secreted separately from pig small intestine but not pancreas.". (1986): http://europepmc.org/abstract/med/3530719.
    10.1210/endo-119-4-1467
  1727. Holst JJ; Schwartz TW; Knuhtsen S; Jensen SL; Nielsen OV. "Autonomic nervous control of the endocrine secretion from the isolated, perfused pig pancreas.". (1986): http://europepmc.org/abstract/med/2877020.
    10.1016/0165-1838(86)90045-7
  1728. Baldissera FG; Holst JJ. "Glicentin 1-61 probably represents a major fraction of glucagon-related peptides in plasma of anaesthetized uraemic pigs.". (1986): http://europepmc.org/abstract/med/3743926.
    10.1007/BF00506540
  1729. Astrup A; Madsen J; Holst JJ; Christensen NJ. "The effect of chronic ephedrine treatment on substrate utilization, the sympathoadrenal activity, and energy expenditure during glucose-induced thermogenesis in man.". (1986): http://europepmc.org/abstract/med/3512957.
    10.1016/0026-0495(86)90211-8
  1730. Vilhardt H; Krarup T; Holst JJ; Bie P. "The mechanism of the effect of oxytocin on plasma concentrations of glucose, insulin and glucagon in conscious dogs.". (1986): http://europepmc.org/abstract/med/2869096.
    10.1677/joe.0.1080293
  1731. Krarup T; Holst JJ; Larsen KL. "Responses and molecular heterogeneity of IR-GIP after intraduodenal glucose and fat.". (1985): http://europepmc.org/abstract/med/4025540.
  1732. Baldissera FG; Nielsen OV; Holst JJ. "The intestinal mucosa preferentially releases somatostatin-28 in pigs.". (1985): http://europepmc.org/abstract/med/2865773.
    10.1016/0167-0115(85)90057-6
  1733. Baldissera FG; Poulsen K; Holst JJ. "Mouse salivary glands secrete a glucagon-degrading enzyme, not glucagon.". (1985): http://europepmc.org/abstract/med/3839183.
    10.1210/endo-117-1-84
  1734. Loud FB; Holst JJ; Egense E; Petersen B; Christiansen J. "Is somatostatin a humoral regulator of the endocrine pancreas and gastric acid secretion in man?". (1985): http://europepmc.org/abstract/med/2860053.
    10.1136/gut.26.5.445
  1735. Aggestrup S; Uddman R; Jensen SL; Sundler F; Schaffalitzky de Muckadell O; Holst JJ; Håkanson R; Ekman R; Sørensen HR. "Regulatory peptides in the lower esophageal sphincter of man.". (1985): http://europepmc.org/abstract/med/2581286.
    10.1016/0167-0115(85)90011-4
  1736. Petersen B; Christiansen J; Holst JJ. "A glucose-dependent mechanism in jejunum inhibits gastric acid secretion: a response mediated through enteroglucagon?". (1985): http://europepmc.org/abstract/med/3992176.
  1737. Knuhtsen S; Holst JJ; Jensen SL; Knigge U; Nielsen OV. "Gastrin-releasing peptide: effect on exocrine secretion and release from isolated perfused porcine pancreas.". (1985): http://europepmc.org/abstract/med/3976887.
  1738. Holst JJ; Knuhtsen S; Fahrenkrug J; Jensen SL; Poulsen SS; Nielsen OV. "[Neuropeptides in health and disease]". (1985): http://europepmc.org/abstract/med/2858611.
  1739. Baldissera FG; Holst JJ; Jensen SL; Krarup T. "Distribution and molecular forms of peptides containing somatostatin immunodeterminants in extracts from the entire gastrointestinal tract of man and pig.". (1985): http://europepmc.org/abstract/med/2857096.
    10.1016/0304-4165(85)90259-4
  1740. Sheikh SP; Baldissera FG; Karlsen FO; Holst JJ. "Glicentin is present in the pig pancreas.". (1985): http://europepmc.org/abstract/med/3965295.
    10.1016/0014-5793(85)80178-2
  1741. Holst JJ. "Neural regulation of pancreatic hormone secretion.". (1985): http://europepmc.org/abstract/med/2870834.
  1742. Ala-Kulju K; Nummi P; Holst J. "Conservative treatment of ureteric stones. Ureteric stones--surgical intervention.". (1985): http://europepmc.org/abstract/med/4096481.
  1743. Hammarbäck S; Bäckström T; Holst J; von Schoultz B; Lyrenäs S. "Cyclical mood changes as in the premenstrual tension syndrome during sequential estrogen-progestagen postmenopausal replacement therapy.". (1985): http://europepmc.org/abstract/med/4061059.
    10.3109/00016348509155154
  1744. Baldissera FG; Holst JJ. "On the contamination of commercially available aprotinins with pancreatic islet peptides.". (1984): http://europepmc.org/abstract/med/6085188.
  1745. Kirkegaard P; Olsen PS; Nexø E; Holst JJ; Poulsen SS. "Effect of vasoactive intestinal polypeptide and somatostatin on secretion of epidermal growth factor and bicarbonate from Brunner's glands.". (1984): http://europepmc.org/abstract/med/6149978.
    10.1136/gut.25.11.1225
  1746. Nilsson B; Holst J; von Schoultz B. "Serum levels of unbound 17 beta-oestradiol during oral and percutaneous postmenopausal replacement therapy.". (1984): http://europepmc.org/abstract/med/6541503.
  1747. Krarup T; Holst JJ. "The heterogeneity of gastric inhibitory polypeptide in porcine and human gastrointestinal mucosa evaluated with five different antisera.". (1984): http://europepmc.org/abstract/med/6505290.
    10.1016/0167-0115(84)90005-3
  1748. Knigge U; Holst JJ; Knuhtsen S; Petersen B; Krarup T; Holst-Pedersen J; Christiansen PM. "Gastrin-releasing peptide: pharmacokinetics and effects on gastro-entero-pancreatic hormones and gastric secretion in normal men.". (1984): http://europepmc.org/abstract/med/6736205.
    10.1210/jcem-59-2-310
  1749. Knuhtsen S; Holst JJ; Knigge U; Olesen M; Nielsen OV. "Radioimmunoassay, pharmacokinetics, and neuronal release of gastrin-releasing peptide in anesthetized pigs.". (1984): http://europepmc.org/abstract/med/6735080.
  1750. Holst JJ; Fahrenkrug J; Knuhtsen S; Jensen SL; Poulsen SS; Nielsen OV. "Vasoactive intestinal polypeptide (VIP) in the pig pancreas: role of VIPergic nerves in control of fluid and bicarbonate secretion.". (1984): http://europepmc.org/abstract/med/6379759.
    10.1016/0167-0115(84)90066-1
  1751. Kirkegaard P; Skov Olsen P; Seier Poulsen S; Holst JJ; Schaffalitzky de Muckadell OB; Christiansen J. "Effect of secretin and glucagon on Brunner's gland secretion in the rat.". (1984): http://europepmc.org/abstract/med/6698442.
    10.1136/gut.25.3.264
  1752. Baldissera FG; Holst JJ. "Glucagon-related peptides in the human gastrointestinal mucosa.". (1984): http://europepmc.org/abstract/med/6546922.
    10.1007/BF00252412
  1753. Jensen SL; Christiansen LA; Oxholm AM; Holst JJ. "Duodenal somatostatinoma.". (1984): http://europepmc.org/abstract/med/6318875.
    10.1002/bjs.1800710232
  1754. Holst J. "[Estrogen treatment and liver protein synthesis]". (1984): http://europepmc.org/abstract/med/6714101.
  1755. Graffner H; Farnebo LO; Holst J; Järhult J. "Pirenzepine depresses plasma noradrenaline in duodenal ulcer patients.". (1984): http://europepmc.org/abstract/med/6150592.
  1756. Olesen M; Sottimano C; Holst JJ; Nielsen OV. "Autonomic nervous control of gastric somatostatin and gastrin release.". (1984): http://europepmc.org/abstract/med/6146188.
  1757. Holst JJ; Jensen SL; Knuhtsen S; Nielsen OV. "Autonomic nervous control of pancreatic somatostatin secretion.". (1983): http://europepmc.org/abstract/med/6140851.
  1758. Holst JJ; Pedersen JH; Baldissera F; Stadil F. "Circulating glucagon after total pancreatectomy in man.". (1983): http://europepmc.org/abstract/med/6653943.
    10.1007/BF00282517
  1759. Gale EA; Bennett T; Macdonald IA; Holst JJ; Matthews JA. "The physiological effects of insulin-induced hypoglycaemia in man: responses at differing levels of blood glucose.". (1983): http://europepmc.org/abstract/med/6347499.
  1760. Linnestad P; Myrvang B; Ritland S; Bergan A; Valnes K; Holst JJ. "[Glucagon producing tumors of the pancreas. A case report and literature review]". (1983): http://europepmc.org/abstract/med/6314588.
  1761. Krarup T; Madsbad S; Moody AJ; Regeur L; Faber OK; Holst JJ; Sestoft L. "Diminished immunoreactive gastric inhibitory polypeptide response to a meal in newly diagnosed type I (insulin-dependent) diabetics.". (1983): http://europepmc.org/abstract/med/6341393.
    10.1210/jcem-56-6-1306
  1762. Holst JJ. "Gut glucagon, enteroglucagon, gut glucagonlike immunoreactivity, glicentin--current status.". (1983): http://europepmc.org/abstract/med/6188645.
  1763. Holst J; Cajander S; Carlström K; Damber MG; von Schoultz B. "Percutaneous oestrogen therapy opposed by lynestrenol or natural progesterone--effects on circulating oestrogens, FSH, sex hormone binding globulin and pregnancy zone protein.". (1983): http://europepmc.org/abstract/med/6410156.
    10.1016/0378-5122(83)90015-4
  1764. Holst JJ. "Molecular heterogeneity of glucagon in normal subjects and in patients with glucagon-producing tumours.". (1983): http://europepmc.org/abstract/med/6307793.
  1765. Holst JJ; Jensen SL; Knuhtsen S; Nielsen OV; Rehfeld JF. "Effect of vagus, gastric inhibitory polypeptide, and HCl on gastrin and somatostatin release from perfused pig antrum.". (1983): http://europepmc.org/abstract/med/6133453.
  1766. Baldissera FG; Munoz-Perez MA; Holst JJ. "Somatostatin 1-28 circulates in human plasma.". (1983): http://europepmc.org/abstract/med/6191365.
    10.1016/0167-0115(83)90135-0
  1767. Holst J; Cajander S; Carlström K; Damber MG; von Schoultz B. "A comparison of liver protein induction in postmenopausal women during oral and percutaneous oestrogen replacement therapy.". (1983): http://europepmc.org/abstract/med/6682335.
  1768. Holst JJ; Aggestrup S; Loud FB; Olesen M. "Content and gel filtration profiles of glucagon-like and somatostatin-like immunoreactivity in human fundic mucosa.". (1983): http://europepmc.org/abstract/med/6687598.
    10.1210/jcem-56-4-729
  1769. Holst JJ. "Glucagon--how to prove its role in amino acid metabolism.". (1983): http://europepmc.org/abstract/med/6409631.
    10.1111/j.1365-2362.1983.tb00072.x
  1770. Grønholt R; Holst JJ. "Stripping of endogenous ligands from antisera against glucagon.". (1983): http://europepmc.org/abstract/med/6833768.
    10.1016/0022-1759(83)90265-X
  1771. El Munshid HA; Holst JJ; Lundquist I; Lundqvist G; Schaffalitzky De Muckadell OB; Håkanson R. "Role of the kidneys in elimination of glucagon, insulin, secretin and somatostatin in the rat.". (1983): http://europepmc.org/abstract/med/6134426.
    10.1111/j.1748-1716.1983.tb07175.x
  1772. Holst J; Koskela O; von Schoultz B. "Endometrial findings following curettage in 2018 women according to age and indications.". (1983): http://europepmc.org/abstract/med/6660829.
  1773. Holst JJ; Schwartz TW; Lovgreen NA; Pedersen O; Beck-Nielsen H. "Diurnal profile of pancreatic polypeptide, pancreatic glucagon, gut glucagon and insulin in human morbid obesity.". (1983): http://europepmc.org/abstract/med/6360922.
  1774. Holst J; von Schoultz B. "[Percutaneous estrogen replacement therapy. An alternative for oral treatment]". (1983): http://europepmc.org/abstract/med/6653450.
  1775. Holst JJ; Knuhtsen S; Jensen SL; Fahrenkrug J; Larsson LI; Nielsen OV. "Interrelation of nerves and hormones in stomach and pancreas.". (1983): http://europepmc.org/abstract/med/6138853.
  1776. Holst J; Cajander S; von Schoultz B. "Cellular morphometric analysis of the postmenopausal endometrium during treatment with percutaneous estradiol-17 beta with and without oral gestagen.". (1983): http://europepmc.org/abstract/med/6624399.
    10.3109/00016348309155806
  1777. Cajander S; Holst J; Carlström K; Damber MG; von Schoultz B. "Endometrial response following percutaneous estrogen replacement therapy. A morphometric investigation.". (1983): http://europepmc.org/abstract/med/6408885.
    10.3109/00016348309155771
  1778. Holst J; Cajander S; Carlström K; Damber MG; von Schoultz B. "Percutaneous estrogen replacement therapy. Effects on circulating estrogens, gonadotropins and prolactin.". (1983): http://europepmc.org/abstract/med/6858624.
    10.3109/00016348309155758
  1779. Holst J. "Percutaneous estrogen therapy. Endometrial response and metabolic effects.". (1983): http://europepmc.org/abstract/med/6574685.
  1780. Sørensen TI; Lauritsen KB; Holst JJ; Stadil F; Andersen B. "Gut and pancreatic hormones after jejunoileal bypass with 3:1 or 1:3 jejunoileal ratio.". (1983): http://europepmc.org/abstract/med/6343164.
  1781. Andersson PO; Holst J; Järhult J. "Effects of adrenergic blockade on the release of insulin, glucagon and somatostatin from the pancreas in response to splanchnic nerve stimulation in cats.". (1982): http://europepmc.org/abstract/med/6133409.
    10.1111/j.1748-1716.1982.tb07158.x
  1782. Holst JJ. "[The dental school - at 17 Stormgade]". (1982): http://europepmc.org/abstract/med/6763362.
  1783. Holst JJ. "Evidence that enteroglucagon (II) is identical with the C-terminal sequence (residues 33-69) of glicentin.". (1982): http://europepmc.org/abstract/med/7165698.
  1784. Holst J; Kettunen J; Damber MG; von Schoultz B; Agnhage K. "[Gynecologic curettage--evaluation of the benefits and costs]". (1982): http://europepmc.org/abstract/med/7144376.
  1785. Skov Olsen P; Kirkegaard P; Holst JJ; Christiansen J. "Vagal control of glucagon-induced inhibition of gastric acid secretion in duodenal ulcer patients.". (1982): http://europepmc.org/abstract/med/7178826.
  1786. Hilsted L; Holst JJ. "On the accuracy of radioimmunological determination of somatostatin in plasma.". (1982): http://europepmc.org/abstract/med/6126917.
    10.1016/0167-0115(82)90105-7
  1787. Lauritsen KB; Frederiksen HJ; Uhrenholdt A; Holst JJ. "The correlation between gastric emptying time and the response of GIP and enteroglucagon to oral glucose in duodenal ulcer patients.". (1982): http://europepmc.org/abstract/med/6753108.
  1788. Christiansen J; Holst JJ; Molin J. "Interaction of glucagon and pentagastrin on pepsin secretion in healthy subjects.". (1982): http://europepmc.org/abstract/med/6804315.
    10.1136/gut.23.6.528
  1789. Kirkegaard P; Moody AJ; Holst JJ; Loud FB; Olsen PS; Christiansen J. "Glicentin inhibits gastric acid secretion in the rat.". (1982): http://europepmc.org/abstract/med/7078630.
    10.1038/297156a0
  1790. Kølendorf K; Jensen HA; Holst JJ; Poulsen JE. "Effect of acute selective beta-1-adrenoceptor blockade on hormonal and cardiovascular response to insulin-induced hypoglycaemia in insulin-dependent diabetic patients.". (1982): http://europepmc.org/abstract/med/6127782.
  1791. Andersson PO; Farnebo LO; Fredholm BB; Hamberger B; Holst J; Järhult J. "Metabolic and hormonal adjustments during hemorrhage in cats after interference with the sympatho-adrenal system.". (1982): http://europepmc.org/abstract/med/6291325.
    10.1111/j.1748-1716.1982.tb06959.x
  1792. Rehfeld JF; Holst JJ; Jensen SL. "The molecular nature of vascularly released cholecystokinin from the isolated perfused porcine duodenum.". (1982): http://europepmc.org/abstract/med/7054860.
    10.1016/0167-0115(82)90003-9
  1793. Holst J; Hofer PA; Cajander S; von Schoultz B. "Percutaneous estrogen therapy--a semi-quantitative histologic study of the abdominal skin.". (1982): http://europepmc.org/abstract/med/7164779.
    10.3109/00016348209156605
  1794. Newgard CB; Holst JJ. "Heterogeneity of somatostatin like immunoreactivity (SLI) in extracts of porcine, canine and human pancreas.". (1981): http://europepmc.org/abstract/med/6118002.
  1795. Järhult J; Farnebo LO; Hamberger B; Holst J; Schwartz TW. "The relation between catecholamines, glucagon and pancreatic polypeptide during hypoglycaemia in man.". (1981): http://europepmc.org/abstract/med/7027713.
  1796. Järhult J; Ericsson M; Holst J; Ingemansson S. "Lack of suppression of insulin secretion by exercise in patients with insulinoma.". (1981): http://europepmc.org/abstract/med/6274547.
    10.1111/j.1365-2265.1981.tb00679.x
  1797. Holst JJ; Lauritsen K; Jensen SL; Nielsen OV; Schaffalitzky de Muckadell OB. "Secretin release from the isolated, vascularly perfused pig duodenum.". (1981): http://europepmc.org/abstract/med/7320893.
  1798. Thieden HI; Holst JJ; Dich J; Moody A; Sundby F. "Effect of highly purified porcine gut glucagon-like immunoreactivity (glicentin) on glucose release from isolated rat hepatocytes.". (1981): http://europepmc.org/abstract/med/6268182.
    10.1016/0304-4165(81)90222-1
  1799. Richter EA; Galbo H; Holst JJ; Sonne B. "Significance of glucagon for insulin secretion and hepatic glycogenolysis during exercise in rats.". (1981): http://europepmc.org/abstract/med/7021387.
  1800. Loud FB; Chirstiansen J; Holst JJ; Petersen B; Kirkegaard P. "Effect of endogenous pancreatic glucagon on gastric acid secretion in patients with duodenal ulcer before and after parietal cell vagotomy.". (1981): http://europepmc.org/abstract/med/7250747.
    10.1136/gut.22.5.359
  1801. Lauritsen B; Holst JJ; Moody AJ. "Depression of insulin release by anti-GIP serum after oral glucose in rats.". (1981): http://europepmc.org/abstract/med/16435485.
  1802. Jensen SL; Holst JJ; Nielsen OV; Lauritsen KB. "Secretory effects of gastric inhibitory polypeptide on the isolated perfused porcine pancreas.". (1981): http://europepmc.org/abstract/med/7032210.
    10.1111/j.1748-1716.1981.tb06731.x
  1803. Jensen SL; Rehfeld JF; Holst JJ; Nielsen OV; Fahrenkrug J; Schaffalitzky de Muckadell OB. "Secretory effects of cholecystokinins on the isolated perfused porcine pancreas.". (1981): http://europepmc.org/abstract/med/7032209.
    10.1111/j.1748-1716.1981.tb06730.x
  1804. Moody AJ; Holst JJ; Thim L; Jensen SL. "Relationship of glicentin to proglucagon and glucagon in the porcine pancreas.". (1981): http://europepmc.org/abstract/med/7007887.
    10.1038/289514a0
  1805. Linde S; Hansen B; Sonne O; Holst JJ; Gliemann J. "Tyrosine A14[125I]monoiodoinsulin: Preparation, Biologic Properties, and long-term stability.". (1981): http://europepmc.org/abstract/med/7014299.
    10.2337/diab.30.1.1
  1806. Holst JJ; Grønholt R; Schaffalitzky de Muckadell OB; Fahrenkrug J. "Nervous control of pancreatic endocrine secretion in pigs. II. The effect of pharmacological blocking agents on the response to vagal stimulation.". (1981): http://europepmc.org/abstract/med/6111894.
    10.1111/j.1748-1716.1981.tb06698.x
  1807. Holst JJ; Grønholt R; Schaffalitzky de Muckadell OB; Fahrenkrug J. "Nervous control of pancreatic endocrine secretion in pigs. I. Insulin and glucagon responses to electrical stimulation of the vagus nerves.". (1981): http://europepmc.org/abstract/med/7013421.
    10.1111/j.1748-1716.1981.tb06697.x
  1808. Jensen SL; Holst JJ; Nielsen OV; Rehfeld JF. "Effect of sulfation of CCK-8 on its stimulation of the endocrine and exocrine secretion from the isolated perfused porcine pancreas.". (1981): http://europepmc.org/abstract/med/6277714.
  1809. Holst JJ; Grønholt R; Schaffalitzky de Muckadell OB; Fahrenkrug J. "Nervous control of pancreatic endocrine secretion in pigs. IV. The effect of somatostatin on the insulin and glucagon responses to electrical vagal stimulation and to intraarterial acetylcholine.". (1981): http://europepmc.org/abstract/med/6125083.
    10.1111/j.1748-1716.1981.tb06896.x
  1810. Holst JJ; Grønholt R; Schaffalitzky de Muckadell OB; Fahrenkrug J. "Nervous control of pancreatic endocrine secretion in pigs. V. Influence of the sympathetic nervous system on the pancreatic secretion of insulin and glucagon, and on the insulin and glucagon response to vagal stimulation.". (1981): http://europepmc.org/abstract/med/6125084.
    10.1111/j.1748-1716.1981.tb06897.x
  1811. Holst JJ; Sottimano C; Olesen M; Lindkaer S; Nielsen OV. "Nervous control of gastro-pancreatic somatostatin secretion in pigs.". (1981): http://europepmc.org/abstract/med/6123987.
  1812. Holst JJ; Schaffalitzky de Muckadell OB; Fahrenkrug J. "Nervous control of pancreatic exocrine secretion in pigs.". (1979): http://europepmc.org/abstract/med/33532.
    10.1111/j.1748-1716.1979.tb06312.x
  1813. Christiansen J; Bech A; Fahrenkrug J; Holst JJ; Lauritsen K; Moody AJ; Schaffalitzky de Muckadell O. "Fat-induced jejunal inhibition of gastric acid secretion and release of pancreatic glucagon, enteroglucagon, gastric inhibitory polypeptide, and vasoactive intestinal polypeptide in man.". (1979): http://europepmc.org/abstract/med/107575.
  1814. Holst JJ. "Possible entries to the diagnosis of a glucagon-producing tumour.". (1979): http://europepmc.org/abstract/med/225789.
  1815. Jensen SL; Fahrenkrug J; Holst JJ; Kühl C; Nielsen OV; Schaffalitzky de Muckadell OB. "Secretory effects of secretin on isolated perfused porcine pancreas.". (1978): http://europepmc.org/abstract/med/696858.
  1816. Jensen SL; Fahrenkrug J; Holst JJ; Nielsen OV; Schaffalitzky de Muckadell OB. "Secretory effects of VIP on isolated perfused porcine pancreas.". (1978): http://europepmc.org/abstract/med/696859.
  1817. Järhult J; Holst JJ. "Reflex adrenergic control of endocrine pancreas evoked by unloading of carotid baroreceptors in cats.". (1978): http://europepmc.org/abstract/med/362828.
    10.1111/j.1748-1716.1978.tb06266.x
  1818. Holst JJ; Fahrenkrug J; Schaffalitzky de Muckadell O. "Secretin does not inhibit glucagon secretion in pigs.". (1978): http://europepmc.org/abstract/med/361532.
  1819. Fahrenkrug J; Galbo H; Holst JJ; Schaffalitzky de Muckadell OB. "Influence of the autonomic nervous system on the release of vasoactive intestinal polypeptide from the porcine gastrointestinal tract.". (1978): http://europepmc.org/abstract/med/690895.
    10.1113/jphysiol.1978.sp012391
  1820. Lyngsøe J; Clausen JP; Trap-Jensen J; Sestoft L; Schaffalitzky de Muckadell O; Holst JJ; Nielsen SL; Rehfeld JF. "Exchange of metabolites in the leg of exercising juvenile diabetic subjects.". (1978): http://europepmc.org/abstract/med/668270.
  1821. Holst JJ; Galbo H; Richter EA. "Neutralization of glucagon by antiserum as a tool in glucagon physiology. Lack of depression of basal blood glucose after antiserum treatment in rats.". (1978): http://europepmc.org/abstract/med/659632.
    10.1172/JCI109104
  1822. Holst JJ; Kreutzfeldt M; Holm G; Jensen E; Poulsen JS; Sparsö B; Schmidt A. "Absence of true pancreatic glucagon but persistence of circulating pancreatic glucagon-like immunoreactivity after pancreatectomy in pigs.". (1978): http://europepmc.org/abstract/med/680313.
  1823. Galbo H; Richter EA; Christensen NJ; Holst JJ. "Sympathetic control of metabolic and hormonal responses to exercise in rats.". (1978): http://europepmc.org/abstract/med/654936.
    10.1111/j.1748-1716.1978.tb06092.x
  1824. Larsson LI; Fahrenkrug J; Holst JJ; Schaffalitzky de Muckadell OB. "Innervation of the pancreas by vasoactive intestinal polypeptide (VIP) immunoreactive nerves.". (1978): http://europepmc.org/abstract/med/642723.
    10.1016/0024-3205(78)90246-1
  1825. Schwartz TW; Holst JJ; Fahrenkrug J; Jensen SL; Nielsen OV; Rehfeld JF; de Muckadell OB; Stadil F. "Vagal, cholinergic regulation of pancreatic polypeptide secretion.". (1978): http://europepmc.org/abstract/med/641155.
    10.1172/JCI108992
  1826. Rehfeld JF; Holst JJ; Kühl C. "The effect of gastrin on basal and aminoacid-stimulated insulin and glucagon secretion in man.". (1978): http://europepmc.org/abstract/med/417933.
    10.1111/j.1365-2362.1978.tb00800.x
  1827. Fahrenkrug J; Schaffalitzky de Muckadell OB; Holst JJ. "Elimination of porcine secretin in pigs.". (1978): http://europepmc.org/abstract/med/620494.
  1828. Loud FB; Froberg D; Reichardt J; Holst JJ; Rehfeld JF; Christiansen J. "Inhibition of meal-stimulated gastric acid secretion in man by exogenous and endogenous pancreatic glucagon.". (1978): http://europepmc.org/abstract/med/725501.
  1829. Holst JJ. "Extrapancreatic glucagons.". (1978): http://europepmc.org/abstract/med/342323.
  1830. Galbo H; Richter EA; Holst JJ; Christensen NJ. "Diminished hormonal responses to exercise in trained rats.". (1977): http://europepmc.org/abstract/med/606699.
  1831. Galbo H; Christensen NJ; Holst JJ. "Catecholamines and pancreatic hormones during autonomic blockade in exercising man.". (1977): http://europepmc.org/abstract/med/596218.
    10.1111/j.1748-1716.1977.tb06026.x
  1832. Sestoft L; Trap-Jensen J; Lyngsooe J; Clausen JP; Holst JJ; Nielsen SL; Rehfeld JF; Schaffalitzky de Muckadell OS. "Regulation of gluconeogenesis and ketogenesis during rest and exercise in diabetic subjects and normal men.". (1977): http://europepmc.org/abstract/med/201421.
  1833. Holst JJ; Madsen OG; Knop J; Schmidt A. "The effect of intraportal and peripheral infusions of glucagon on insulin and glucose concentrations and glucose tolerance in normal man.". (1977): http://europepmc.org/abstract/med/908472.
    10.1007/BF01234501
  1834. Galbo H; Richter EA; Holst JJ; Christensen NJ. "Lak of influence of glucagon on glucose homeostasis after prolonged exercise in rats.". (1977): http://europepmc.org/abstract/med/560004.
    10.1007/BF00580805
  1835. Galbo H; Christensen NJ; Holst JJ. "Glucose-induced decrease in glucagon and pinephrine responses to exercise in man.". (1977): http://europepmc.org/abstract/med/863812.
  1836. Holst JJ. "Extraction, gel filtration pattern, and receptor binding of porcine gastrointestinal glucagon-like immunoreactivity.". (1977): http://europepmc.org/abstract/med/856653.
    10.1007/BF00745145
  1837. Larsson LI; Hirsch MA; Holst JJ; Ingemansson S; Kühl C; Jensen SL; Lundqvist G; Rehfeld JF; Schwartz TW. "Pancreatic somatostatinoma. Clinical features and physiological implications.". (1977): http://europepmc.org/abstract/med/66472.
    10.1016/S0140-6736(77)92113-4
  1838. Järhult J; Holst JJ. "Stimulation of glucagon and inhibition of insulin secretion evoked from carotid baroreceptors.". (1977): http://europepmc.org/abstract/med/191288.
    10.1007/BF02124086
  1839. Schaffalitzky de Muckadell OB; Fahrenkrug J; Holst JJ. "Release of vasoactive intestinal polypeptide (VIP) by electric stimulation of the vagal nerves.". (1977): http://europepmc.org/abstract/med/830595.
  1840. Schaffalitzky de Muckadell OB; Fahrenkrug J; Holst JJ. "Plasma secretin concentration and pancreatic exocrine secretion after intravenous secretin or intraduodenal HC1 in anaesthetized pigs.". (1977): http://europepmc.org/abstract/med/866988.
  1841. Fahrenkrug J; Schaffalitzky de Muckadell OB; Holst JJ. "Plasma secretin concentration in anaesthetized pigs after intraduodenal glucose, fat, aminoacids, or meals with various pH.". (1977): http://europepmc.org/abstract/med/17153.
  1842. Christiansen J; Lauritzen K; Moesgaard J; Holst JJ. "Effect of endogenous and exogenous glucagon on pentagastrin-stimulated lower esophageal sphincter pressure in man.". (1977): http://europepmc.org/abstract/med/834967.
  1843. Galbo H; Richter EA; Hilsted J; Holst JJ; Christensen NJ; Henriksson J. "Hormonal regulation during prolonged exercise.". (1977): http://europepmc.org/abstract/med/337877.
    10.1111/j.1749-6632.1977.tb38187.x
  1844. Schaffalitzky de Muckadell OB; Fahrenkrug J; Holst JJ; Lauritsen KB. "Release of vasoactive intestinal polypeptide (VIP) by intraduodenal stimuli.". (1977): http://europepmc.org/abstract/med/594650.
  1845. A. Shalev; Jens Juul Holst; M. Keller. "Effects of glucagon-like peptide-1 (GLP-1) on glucose elimination in healthy subjects depends on the pancreatic glucoregulatory hormones.". European Journal of Clinical Investigation 27 (1977): 10-16. https://curis.ku.dk/portal/en/publications/effects-of-glucagonlike-peptide1-glp1-on-glucose-elimination-in-healthy-subjects-depends-on-the-pancreatic-glucoregulatory-hormones(cac07090-6c38-11dc-bee9-02004c4f4f50).html.
  1846. Galbo H; Holst JJ; Christensen NJ; Hilsted J. "Glucagon and plasma catecholamines during beta-receptor blockade in exercising man.". (1976): http://europepmc.org/abstract/med/931921.
  1847. Christiansen J; Holst JJ; Kalaja E. "Inhibition of gastric acid secretion in man by exogenous and endogenous pancreatic glucagon.". (1976): http://europepmc.org/abstract/med/1261759.
  1848. Galbo H; Holst JJ. "The influence of glucagon on hepatic glycogen mobilization in exercising rats.". (1976): http://europepmc.org/abstract/med/944910.
    10.1007/BF00587401
  1849. Kuhl C; Holst JJ. "Plasma glucagon and the insulin:glucagon ratio in gestational diabetes.". (1976): http://europepmc.org/abstract/med/1245265.
    10.2337/diab.25.1.16
  1850. Christiansen J; Holst JJ; Rokkjaer M. "Jejunal inhibition of pentagastrin-induced gastric acid secretion in man and Heidenhain pouch dogs.". (1976): http://europepmc.org/abstract/med/1265443.
  1851. Holst JJ; Christiansen J; Kühl C. "The enteroglucagon response to intrajejunal infusion of glucose, triglycerides, and sodium chloride, and its relation to jejunal inhibition of gastric acid secretion in man.". (1976): http://europepmc.org/abstract/med/1273505.
  1852. Kühl C; Jensen SL; Nielsen OV; Holst JJ. "Influence of basal plasma glucose concentration on the glucagon response to arginine.". (1976): http://europepmc.org/abstract/med/1064140.
  1853. Jensen SL; Kühl C; Nielsen OV; Holst JJ. "Isolation and perfusion of the porcine pancreas.". (1976): http://europepmc.org/abstract/med/1064141.
  1854. Pedersen NB; Jonsson L; Holst JJ. "Necrolytic migratory erythema and glucagon cell tumour of the pancreas: the glucagonoma syndrome. Report of two cases.". (1976): http://europepmc.org/abstract/med/78626.
  1855. Holst JJ; Jonsson L; Pedersen NB; Thomsen K. "[Glucagon syndrome]". (1975): http://europepmc.org/abstract/med/1189072.
  1856. Knudsen JB; Holst JJ; Asnaes S; Johansen A. "Identification of cells with pancreatic-type and gut-type glucagon immunoreactivity in the human colon.". (1975): http://europepmc.org/abstract/med/1189925.
  1857. Holst JJ. "A radioreceptor-assay for glucagon: binding of enteroglucagon to liver plasma membranes.". (1975): http://europepmc.org/abstract/med/168110.
    10.1007/BF00422324
  1858. Galbo H; Holst JJ; Christensen NJ. "Glucagon and plasma catecholamine responses to graded and prolonged exercise in man.". (1975): http://europepmc.org/abstract/med/1110246.
  1859. Holst JJ; Christiansen J. "The effect of intravenous glucose on pentagastrin-induced gastric acid secretion in man.". (1975): http://europepmc.org/abstract/med/1154983.
  1860. Holst JJ; Aasted B. "Production and evaluation of glucagon antibodies for radioimmunoassay.". (1974): http://europepmc.org/abstract/med/4479706.
  1861. Blichert-Toft M; Hansen OH; Holst JJ; Nielsen OV. "Adrenocortical function after major gastric surgery.". (1973): http://europepmc.org/abstract/med/4355006.
    10.1016/S0002-9610(73)80004-2
  1862. Holst JJ; Hending LG; Rehfeld JF. "Gut glucagon and reactive hypoglycaemia.". (1973): http://europepmc.org/abstract/med/4121574.
    10.1016/S0140-6736(73)91659-0
  1863. Rehfeld JF; Heding LG; Holst JJ. "Increased gut glucagon release as pathogenetic factor in reactive hypoglycaemia?". (1973): http://europepmc.org/abstract/med/4118464.
    10.1016/S0140-6736(73)90193-1
  1864. Höj L; Holst JJ; Rune SJ. "A trial of exogenous secretin in the treatment of duodenal ulcer pain.". (1973): http://europepmc.org/abstract/med/4724928.
Newspaper article
  1. Ulla M. Wewer; Jens Juul Holst; Thue W. Schwartz; Bjørn Quistorff. "KU bestemmer selv over sin forskning", Universitetsavisen, 2011, https://curis.ku.dk/portal/en/publications/ku-bestemmer-selv-over-sin-forskning(1f2288a2-aa70-430a-9878-141d73cd5ac4).html.
  2. P. J. Larsen; Jens Juul Holst; Arne Astrup. "Et æble om dagen", Politiken, 2003, https://curis.ku.dk/portal/en/publications/et-aeble-om-dagen(d66f87e0-a1bc-11dd-b6ae-000ea68e967b).html.
Online resource
  1. Charlotte Janus; Nicolai Wewer Albrechtsen; Jens Juul Holst. GLP-1 defects in diabetes. 2015. https://curis.ku.dk/portal/en/publications/glp1-defects-in-diabetes(ad713056-00fa-44a2-8890-f6bac8573893).html.
    10.14496/dia.0104336116.6
Report
  1. Jens Juul Holst. 2004. Enteroglucagon. https://curis.ku.dk/portal/en/publications/enteroglucagon(1788e0a0-74c4-11db-bee9-02004c4f4f50).html.

Intellectual property

Patent
  1. Harald S. Hansen; Thi Ai Diep; Jens Juul Holst; Mette Marie Rosenkilde; Niels Wellner Andersen. 2010. "Treatment of insulin resistance and obesity by stimulating GLP-1 release".

Other

Other output
  1. Incretin Hormones and Type 2 Diabetes – Mechanistic Insights and Therapeutic Approaches. 2020. Geke Aline Boer; Jens Juul Holst. https://doi.org/10.20944/preprints202011.0684.v1.
    10.20944/preprints202011.0684.v1
  2. Glucose response to low-dose glucagon for insulin-induced mild hypoglycaemia after 12 weeks of high versus low carbohydrate diet. A pilot study. 2020. Ajenthen G. Ranjan; Signe Schmidt; Jens J. Holst; Merete B. Christensen; Kirsten Nørgaard. https://doi.org/10.1101/2020.10.30.20222794.
    10.1101/2020.10.30.20222794
  3. Long-acting glucagon-like peptide-1 receptor agonist-status December 2018. 2019. Jens Juul Holst. https://curis.ku.dk/portal/en/publications/longacting-glucagonlike-peptide1-receptor-agoniststatus-december-2018(9205e9ed-98df-4c9e-93e6-b3f6a0e967cc).html.
    10.21037/atm.2019.01.09
  4. Bariatric surgery-which procedure is the optimal choice?. 2019. Sten Madsbad; Jens Juul Holst. https://curis.ku.dk/portal/en/publications/bariatric-surgerywhich-procedure-is-the-optimal-choice(16ef4dfd-afb2-4775-9dd4-2c96e9507078).html.
    10.1016/S0140-6736(19)30489-1
  5. Which to choose, an oral or an injectable glucagon-like peptide-1 receptor agonist?. 2019. Jens Juul Holst. https://curis.ku.dk/portal/en/publications/which-to-choose-an-oral-or-an-injectable-glucagonlike-peptide1-receptor-agonist(7a05639d-b932-49f5-ba86-27597a941d90).html.
    10.1016/S0140-6736(19)31350-9
  6. Response to Letter to the Editor. "Hemodynamic Effects of Glucagon: A Literature Review". 2018. Kasper Meidahl Petersen; Søren Bøgevig; Jens Juul Holst; Filip Krag Knop; Mikkel Bring Christensen. https://curis.ku.dk/portal/en/publications/response-to-letter-to-the-editor(1637a127-5e02-44fa-9a94-f30d2ff81f36).html.
    10.1210/jc.2018-01825
  7. Renoprotective effects of dulaglutide in patients with T2DM and CKD. 2018. Charlotte Mehlin Sørensen; Jens Juul Holst. https://curis.ku.dk/portal/en/publications/renoprotective-effects-of-dulaglutide-in-patients-with-t2dm-and-ckd(95994869-6441-43ba-a2ad-734ccb5195dc).html.
    10.1038/s41581-018-0055-x
  8. Semaglutide seems to be more effective the other GLP-1Ras. 2017. Jens Juul Holst; Sten Madsbad. https://curis.ku.dk/portal/en/publications/semaglutide-seems-to-be-more-effective-the-other-glp1ras(ebbee089-ea4a-4bee-a627-115600eadc87).html.
    10.21037/atm.2017.11.10
  9. Guidelines. Surgical or medical therapy for patients with obesity and T2DM?. 2016. Sten Madsbad; Jens Juul Holst. https://curis.ku.dk/portal/en/publications/guidelines(c2627dd8-25ac-41c0-8285-ca3a0b8c5e25).html.
    10.1038/nrendo.2016.111
  10. Response to Comment on Færch et al. GLP-1 Response to Oral Glucose Is Reduced in Prediabetes, Screen-Detected Type 2 Diabetes, and Obesity and Influenced by Sex. The ADDITION-PRO Study. Diabetes 2015;64:2513–2525. 2015. Kristine Ferch; Signe Torekov; Dorte Vistisen; Nanna B Johansen; Daniel R Witte; Anna Jonsson; Oluf Pedersen; et al. https://curis.ku.dk/portal/en/publications/response-to-comment-on-faerch-et-al-glp1-response-to-oral-glucose-is-reduced-in-prediabetes-screendetected-type-2-diabetes-and-obesity-and-influenced-by-sex(c6a5c02d-edf2-4bcb-a784-65db1a0a9e97).html.
    10.2337/db15-0743
  11. In vivo efficacy of HD0471953. A novel GPR119 agonist for the treatment of type 2 diabetes mellitus. 2015. L. M. 'T Hart; A. Fritsche; G. Nijpels; N. Van Leeuwen; L. A. Donnelly; J. M. Dekker; M. Alssema; et al. https://curis.ku.dk/portal/en/publications/in-vivo-efficacy-of-hd0471953(07fc7d0c-394c-4082-8fed-36b74d77e54d).html.
    10.1089/dia.2015.1514
Distinctions

Award

2020 The Warren Alpert Foundation Prize
Beth Israel Deaconess Medical Center / Harvard Medical School Program in Placebo Studies and the Therapeutic Encounter, United States
2017 The UCPH Innovation Prize for the project ”Gut Hormone as drug targets” and the work on developing treatments based on basic research
2017 The Harrington Prize for Innovation in Medicine
2015 The Eric K. Fernströms Nordiska Pris
2013 The Anders Jahre Senior Medical Prize
2013 The Marie and August Krogh Award
2012 The European Medal of the Society for Endocrinology
2010 The Bagger-Sørensen Award
2009 The KFJ prize of the Faculty of Health Sciences
2009 The Knud Lundbæk award and lecture of the Scandinavian Society for the Study of Diabetes
2005 The “Claude Bernard lecture and award
2002 The "Paul Langerhans Medal"
1992 The Novo Nordisk Award for Medical Research
1990 The Odd Fellow award for medical research
1984 The Anders Jahre Medical Prize to young medical scientists